[
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "vicuna-13b_response": "Acrokeratosis paraneoplastica is a medical condition characterized by the development of thick, scaly patches on the skin of the hands and feet. The condition is often seen in individuals with cancer, particularly those with lung, breast, or ovarian cancer.\nOne synonym for acrokeratosis paraneoplastica is \"acrokeratotic hyperplasia.\" This term refers to the thick, scaly patches that develop on the skin, as well as the increased cell growth that occurs in the affected areas.\nOther synonyms for acrokeratosis paraneoplastica include \"paraneoplastic acrokeratitis,\" \"acrokeratosis associated with malignancy,\" and \"neoplastic acrokeratosis.\" These terms all refer to the connection between the development of acrokeratosis paraneoplastica and the presence of cancer in the body.\nIt is important to note that while acrokeratosis paraneoplastica is often seen in individuals with cancer, it is not necessarily a direct result of the cancer itself. Rather, it is thought to be caused by a reaction to the cancer or its treatment.",
    "vicuna-13b_fact_raw": "1. Acrokeratosis paraneoplastica is characterized by the development of thick, scaly patches on the skin of the hands and feet.\n2. The condition is often seen in individuals with cancer, particularly those with lung, breast, or ovarian cancer.\n3. \"Acrokeratotic hyperplasia\" is a synonym for acrokeratosis paraneoplastica.\n4. \"Paraneoplastic acrokeratitis\" is another synonym for acrokeratosis paraneoplastica.\n5. Acrokeratosis paraneoplastica is thought to be caused by a reaction to cancer or its treatment, not necessarily a direct result of the cancer itself.",
    "vicuna-13b_fact": [
      "Acrokeratosis paraneoplastica is characterized by the development of thick, scaly patches on the skin of the hands and feet.",
      "The condition is often seen in individuals with cancer, particularly those with lung, breast, or ovarian cancer.",
      "\"Acrokeratotic hyperplasia\" is a synonym for acrokeratosis paraneoplastica.",
      "\"Paraneoplastic acrokeratitis\" is another synonym for acrokeratosis paraneoplastica.",
      "Acrokeratosis paraneoplastica is thought to be caused by a reaction to cancer or its treatment, not necessarily a direct result of the cancer itself."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: \"Acrokeratotic hyperplasia\" is not a recognized synonym for acrokeratosis paraneoplastica. The term does not specifically refer to this condition.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "vicuna-13b_response": "Weaver syndrome and Sotos syndrome are both genetic disorders that can affect a person's physical development and growth. However, they are different conditions with different characteristics.\nWeaver syndrome, also known as mesomelic dwarfism with normal intelligence, is a rare genetic disorder that affects bone growth and development. People with Weaver syndrome typically have short stature, with an average height of around 4 feet, and normal intelligence. They may also have other features such as a broad chest, short arms and legs, and a large head.\nSotos syndrome, on the other hand, is a genetic disorder that affects growth and development in several areas of the body. People with Sotos syndrome tend to be tall, with an average height of around 6 feet, and they may have a high degree of intelligence. However, they may also have other features such as a broad forehead, long arms and legs, and a large hands and feet.\nWhile both Weaver syndrome and Sotos syndrome can affect a person's physical development and growth, they are distinct conditions with different characteristics.",
    "vicuna-13b_fact_raw": "1. Weaver syndrome is a genetic disorder that affects bone growth and development.\n2. Individuals with Weaver syndrome typically have an average height of around 4 feet.\n3. People with Weaver syndrome generally have normal intelligence.\n4. Sotos syndrome is a genetic disorder that affects growth and development in several areas of the body.\n5. Individuals with Sotos syndrome tend to be tall, with an average height of around 6 feet.",
    "vicuna-13b_fact": [
      "Weaver syndrome is a genetic disorder that affects bone growth and development.",
      "Individuals with Weaver syndrome typically have an average height of around 4 feet.",
      "People with Weaver syndrome generally have normal intelligence.",
      "Sotos syndrome is a genetic disorder that affects growth and development in several areas of the body.",
      "Individuals with Sotos syndrome tend to be tall, with an average height of around 6 feet."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Individuals with Weaver syndrome are typically taller than average, not 4 feet.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "vicuna-13b_response": "The JASPAR database is a repository of transcription factor (TF) binding profiles calculated using a variety of bioinformatics tools. Here is a list of the major releases of the JASPAR database:\n1. JASPAR 2014: This was the first official release of the JASPAR database, which included TF binding profiles for 1288 transcription factors and 6288 genomic regions.\n2. JASPAR 2016: This release expanded the database to include TF binding profiles for 1779 transcription factors and 10,507 genomic regions. It also introduced new features such as improved data quality control and visualization tools.\n3. JASPAR 2020: This release expanded the database to include TF binding profiles for 2129 transcription factors and 17,445 genomic regions. It also introduced new features such as improved data integration and analysis tools.\n4. JASPAR 2021: This is the latest release of the JASPAR database as of my knowledge cutoff (September 2021). It includes TF binding profiles for 2247 transcription factors and 20,891 genomic regions, and introduces new features such as improved data visualization and analysis tools.\nIt's worth noting that there may be additional, smaller releases of the JASPAR database between these major releases. However, these are the main releases that have been announced by the JASPAR team.",
    "vicuna-13b_fact_raw": "1. JASPAR 2014 included transcription factor binding profiles for 1288 transcription factors and 6288 genomic regions.\n2. JASPAR 2016 expanded the database to include transcription factor binding profiles for 1779 transcription factors and 10,507 genomic regions.\n3. JASPAR 2020 included transcription factor binding profiles for 2129 transcription factors and 17,445 genomic regions.\n4. JASPAR 2021 included transcription factor binding profiles for 2247 transcription factors and 20,891 genomic regions.\n5. The JASPAR database releases include new features such as improved data quality control, visualization, integration, and analysis tools with each major update.",
    "vicuna-13b_fact": [
      "JASPAR 2014 included transcription factor binding profiles for 1288 transcription factors and 6288 genomic regions.",
      "JASPAR 2016 expanded the database to include transcription factor binding profiles for 1779 transcription factors and 10,507 genomic regions.",
      "JASPAR 2020 included transcription factor binding profiles for 2129 transcription factors and 17,445 genomic regions.",
      "JASPAR 2021 included transcription factor binding profiles for 2247 transcription factors and 20,891 genomic regions.",
      "The JASPAR database releases include new features such as improved data quality control, visualization, integration, and analysis tools with each major update."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: JASPAR 2014 included transcription factor binding profiles for 130 transcription factors across vertebrates, plants, and fungi, but the exact number of genomic regions is not specified in the statement.\n2. FALSE [correction]: JASPAR 2016 expanded the database to include transcription factor binding profiles for 180 transcription factors, but the exact number of genomic regions is not specified in the statement.\n3. FALSE [correction]: JASPAR 2020 included transcription factor binding profiles for 610 transcription factors, but the exact number of genomic regions is not specified in the statement.\n4. FALSE [correction]: JASPAR 2021 included transcription factor binding profiles for 637 transcription factors, but the exact number of genomic regions is not specified in the statement.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "vicuna-13b_response": "The KP4 protein is a viral protein that is produced by the KP strain of the bacteriophage Î¦KP1. The KP4 protein is a structural protein that is involved in the assembly and stability of the virion, which is the infectious particle of the bacteriophage.\nThe KP4 protein is a major component of the virion and is thought to play a role in the recognition and binding of the virion to the host cell. The KP4 protein is also involved in the stability and resistance of the virion to host cell defenses and to environmental stresses.\nIn addition to its role in the virion, the KP4 protein has been shown to have antioxidant and anti-inflammatory properties, and it may play a role in protecting the host cell from oxidative stress and inflammation.\nOverall, the function of the KP4 protein is to support the assembly and stability of the virion, and to protect the virion from host cell defenses and environmental stresses. Additionally, the KP4 protein may have beneficial effects on the host cell by providing antioxidant and anti-inflammatory protection.",
    "vicuna-13b_fact_raw": "1. The KP4 protein is produced by the KP strain of the bacteriophage Î¦KP1.\n2. The KP4 protein is involved in the assembly and stability of the virion of the bacteriophage.\n3. The KP4 protein plays a role in the recognition and binding of the virion to the host cell.\n4. The KP4 protein contributes to the virion's resistance to host cell defenses and environmental stresses.\n5. The KP4 protein has antioxidant and anti-inflammatory properties.",
    "vicuna-13b_fact": [
      "The KP4 protein is produced by the KP strain of the bacteriophage Î¦KP1.",
      "The KP4 protein is involved in the assembly and stability of the virion of the bacteriophage.",
      "The KP4 protein plays a role in the recognition and binding of the virion to the host cell.",
      "The KP4 protein contributes to the virion's resistance to host cell defenses and environmental stresses.",
      "The KP4 protein has antioxidant and anti-inflammatory properties."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The KP4 protein is not involved in the assembly and stability of the virion; it is a viral protein that inhibits fungal growth and protects the bacteriophage from being trapped by the fungal host's defense mechanisms.\n3. FALSE [correction]: The KP4 protein does not play a role in the recognition and binding of the virion to the host cell; it functions to inhibit the growth of the fungal host.\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "vicuna-13b_response": "Yes, DITPA (3,5-diiodothyropropionic acid) is a thyroid hormone analog that has been used in experimental and clinical studies. It is a synthetic form of the thyroid hormone triiodothyronine (T3), which is one of the two major hormones produced by the thyroid gland. DITPA is similar in structure to T3, but it has some differences in its chemical properties and biological effects.\nDITPA has been used in research to study the effects of T3 on various physiological processes, such as metabolism and growth. It has also been used as a tracer in imaging studies to assess thyroid function and to identify abnormalities in thyroid hormone metabolism. In addition, DITPA has been investigated as a potential treatment for various conditions, such as hypothyroidism and obesity, although its use in clinical settings is limited.\nOverall, DITPA is an important tool in the study of thyroid physiology and pathology, and it has contributed to our understanding of the role of T3 in various biological processes. However, more research is needed to fully understand its potential therapeutic uses and to determine its safety and efficacy in clinical settings.",
    "vicuna-13b_fact_raw": "1. DITPA (3,5-diiodothyropropionic acid) is a thyroid hormone analog used in experimental and clinical studies.\n2. DITPA is a synthetic form of the thyroid hormone triiodothyronine (T3).\n3. DITPA has been used in research to study the effects of T3 on metabolism and growth.\n4. DITPA has been used as a tracer in imaging studies to assess thyroid function.\n5. DITPA has been investigated as a potential treatment for conditions such as hypothyroidism and obesity.",
    "vicuna-13b_fact": [
      "DITPA (3,5-diiodothyropropionic acid) is a thyroid hormone analog used in experimental and clinical studies.",
      "DITPA is a synthetic form of the thyroid hormone triiodothyronine (T3).",
      "DITPA has been used in research to study the effects of T3 on metabolism and growth.",
      "DITPA has been used as a tracer in imaging studies to assess thyroid function.",
      "DITPA has been investigated as a potential treatment for conditions such as hypothyroidism and obesity."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: DITPA is not typically used as a tracer in imaging studies to assess thyroid function. Radioactive isotopes of iodine or technetium are commonly used for this purpose.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "vicuna-13b_response": "COUGER is an open-source tool that is used for testing and evaluating the security of web applications. It is designed to identify vulnerabilities in web applications by exploiting known vulnerabilities and weaknesses. COUGER is a command-line tool that can be used to perform various tests, including SQL injection, cross-site scripting (XSS), and remote file inclusion (RFI) tests.\nCOUGER is a useful tool for security professionals, developers, and researchers who are interested in testing the security of web applications. It can be used to identify vulnerabilities and weaknesses in web applications, which can then be fixed to improve the overall security of the application. COUGER can also be used to test the effectiveness of security controls and to evaluate the security posture of a web application.\nOverall, COUGER is a powerful and useful tool for anyone who is interested in testing the security of web applications. It is easy to use and can provide valuable information about the security of a web application.",
    "vicuna-13b_fact_raw": "1. COUGER is an open-source tool used for testing and evaluating the security of web applications.\n2. COUGER is designed to identify vulnerabilities by exploiting known vulnerabilities and weaknesses.\n3. COUGER is a command-line tool.\n4. COUGER can perform tests such as SQL injection, cross-site scripting (XSS), and remote file inclusion (RFI).\n5. COUGER is used by security professionals, developers, and researchers.",
    "vicuna-13b_fact": [
      "COUGER is an open-source tool used for testing and evaluating the security of web applications.",
      "COUGER is designed to identify vulnerabilities by exploiting known vulnerabilities and weaknesses.",
      "COUGER is a command-line tool.",
      "COUGER can perform tests such as SQL injection, cross-site scripting (XSS), and remote file inclusion (RFI).",
      "COUGER is used by security professionals, developers, and researchers."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The statement seems to refer to a security tool, but there is no well-known open-source tool named COUGER for testing web application security. It might be a confusion with another tool, possibly OWASP ZAP or similar.\n2. UNKNOWN: Since the existence of COUGER as a security tool is not established, the statement about its design cannot be confirmed.\n3. UNKNOWN: The statement about COUGER being a command-line tool cannot be confirmed without knowing the actual tool in question.\n4. UNKNOWN: Without confirmation of the tool's existence, the types of tests it can perform cannot be determined.\n5. UNKNOWN: Since the existence of COUGER is not established, it cannot be confirmed whether it is used by security professionals, developers, and researchers.",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "vicuna-13b_response": "Yes, there are drugs for Tick-borne Encephalitis (TBE). TBE is a viral infection that is spread through the bite of infected ticks, and can cause symptoms such as fever, headache, and muscle weakness.\nThe most common treatment for TBE is the use of antiviral medications, such as oseltamivir (Tamiflu) and zanamivir (Relenza). These drugs can help reduce the severity and duration of the illness, and may be prescribed by a doctor if the patient is experiencing severe symptoms.\nIt is important to note that antiviral medications work best when started early in the course of the illness, so it is important to seek medical attention if you suspect that you may have TBE. In addition to antiviral medications, supportive care such as rest, hydration, and pain management may also be provided to help manage symptoms.\nIt is also important to take measures to prevent tick bites, such as using tick repellents, wearing protective clothing, and tucking pants into socks. If you find a tick attached to your skin, remove it promptly using a tick removal tool or by using a pair of tweezers to grasp the tick as close to the skin as possible and pulling it out.",
    "vicuna-13b_fact_raw": "1. Tick-borne Encephalitis (TBE) is a viral infection spread through the bite of infected ticks.\n2. Symptoms of TBE can include fever, headache, and muscle weakness.\n3. Antiviral medications such as oseltamivir (Tamiflu) and zanamivir (Relenza) are used to treat TBE.\n4. Antiviral medications for TBE are most effective when started early in the course of the illness.\n5. Preventative measures against tick bites include using tick repellents, wearing protective clothing, and tucking pants into socks.",
    "vicuna-13b_fact": [
      "Tick-borne Encephalitis (TBE) is a viral infection spread through the bite of infected ticks.",
      "Symptoms of TBE can include fever, headache, and muscle weakness.",
      "Antiviral medications such as oseltamivir (Tamiflu) and zanamivir (Relenza) are used to treat TBE.",
      "Antiviral medications for TBE are most effective when started early in the course of the illness.",
      "Preventative measures against tick bites include using tick repellents, wearing protective clothing, and tucking pants into socks."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There are no specific antiviral medications for the treatment of Tick-borne Encephalitis (TBE). Treatment is supportive and focuses on relieving symptoms.\n4. FALSE [correction]: Since there are no specific antiviral medications for TBE, this statement is not applicable. However, early supportive treatment can help manage symptoms and complications.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "vicuna-13b_response": "There are several genome browser databases available for DNA shape annotations, including:\n1. Ensembl: Ensembl is a comprehensive genome browser that provides a variety of DNA shape annotations, such as chromosome views, gene views, and regulatory region views.\n2. UCSC Genome Browser: The UCSC Genome Browser is a widely used genome browser that provides a variety of DNA shape annotations, such as chromosome views, gene views, and regulatory region views.\n3. Genome Data Viewer: The Genome Data Viewer is a genome browser developed by the Broad Institute that provides a variety of DNA shape annotations, such as chromosome views, gene views, and regulatory region views.\n4. Integrative Genomics Viewer (IGV): IGV is a genome browser developed by the University of California, Santa Cruz that provides a variety of DNA shape annotations, such as chromosome views, gene views, and regulatory region views.\n5. JBrowse: JBrowse is a genome browser developed by the European Bioinformatics Institute that provides a variety of DNA shape annotations, such as chromosome views, gene views, and regulatory region views.\nThese are just a few examples of the many genome browser databases available for DNA shape annotations.",
    "vicuna-13b_fact_raw": "1. Ensembl is a genome browser that provides DNA shape annotations.\n2. The UCSC Genome Browser is a widely used genome browser that offers DNA shape annotations.\n3. Genome Data Viewer is a genome browser developed by the Broad Institute with DNA shape annotations.\n4. Integrative Genomics Viewer (IGV) is a genome browser developed by the University of California, Santa Cruz, offering DNA shape annotations.\n5. JBrowse is a genome browser developed by the European Bioinformatics Institute that provides DNA shape annotations.",
    "vicuna-13b_fact": [
      "Ensembl is a genome browser that provides DNA shape annotations.",
      "The UCSC Genome Browser is a widely used genome browser that offers DNA shape annotations.",
      "Genome Data Viewer is a genome browser developed by the Broad Institute with DNA shape annotations.",
      "Integrative Genomics Viewer (IGV) is a genome browser developed by the University of California, Santa Cruz, offering DNA shape annotations.",
      "JBrowse is a genome browser developed by the European Bioinformatics Institute that provides DNA shape annotations."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Ensembl is a genome browser, but it primarily provides access to genomic information like gene models, regulatory features, and variant data, not specifically DNA shape annotations.\n2. UNKNOWN: While the UCSC Genome Browser is a widely used genome browser, it is not clear from the statement whether it offers DNA shape annotations as part of its standard features or through external plugins or user-provided data.\n3. FALSE [correction]: Genome Data Viewer is a genome browser developed by the National Center for Biotechnology Information (NCBI), not the Broad Institute.\n4. FALSE [correction]: Integrative Genomics Viewer (IGV) is a genome browser developed by the Broad Institute, not the University of California, Santa Cruz.\n5. FALSE [correction]: JBrowse is a genome browser, but it was originally developed by a team at the University of California, Berkeley, and is now a community project with contributions from many institutions, not specifically the European Bioinformatics Institute.",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "vicuna-13b_response": "Mutations in the EZH2 gene have been associated with several syndromes, including:\n1. Beckwith-Wiedemann syndrome: a genetic disorder characterized by an overgrowth of certain parts of the body, such as an enlarged tongue (macroglossia), an overactive thyroid gland (hyperthyroidism), and an increased risk of developing certain tumors, such as Wilms tumor, hepatoblastoma, and rhabdomyosarcoma.\n2. Wiedemann-Beckwith syndrome: a condition that is similar to Beckwith-Wiedemann syndrome, but with less severe symptoms.\n3. Weaver syndrome: a rare genetic disorder characterized by an overgrowth of certain parts of the body, such as an enlarged tongue (macroglossia), an overactive thyroid gland (hyperthyroidism), and an increased risk of developing certain tumors, such as Wilms tumor and hepatoblastoma.\n4. Sotos syndrome: a genetic disorder characterized by an overgrowth of certain parts of the body, such as an enlarged tongue (macroglossia), an overactive thyroid gland (hyperthyroidism), and an increased risk of developing certain tumors, such as Wilms tumor and rhabdomyosarcoma.\nIt's important to note that these syndromes are rare and the association between EZH2 mutations and these syndromes is still being researched and understood.",
    "vicuna-13b_fact_raw": "1. Mutations in the EZH2 gene are associated with Beckwith-Wiedemann syndrome.\n2. Beckwith-Wiedemann syndrome is characterized by an overgrowth of certain body parts and an increased risk of developing certain tumors.\n3. Wiedemann-Beckwith syndrome is similar to Beckwith-Wiedemann syndrome but with less severe symptoms.\n4. Weaver syndrome is a rare genetic disorder associated with mutations in the EZH2 gene.\n5. Sotos syndrome is a genetic disorder associated with mutations in the EZH2 gene and characterized by certain overgrowth and an increased risk of developing tumors.",
    "vicuna-13b_fact": [
      "Mutations in the EZH2 gene are associated with Beckwith-Wiedemann syndrome.",
      "Beckwith-Wiedemann syndrome is characterized by an overgrowth of certain body parts and an increased risk of developing certain tumors.",
      "Wiedemann-Beckwith syndrome is similar to Beckwith-Wiedemann syndrome but with less severe symptoms.",
      "Weaver syndrome is a rare genetic disorder associated with mutations in the EZH2 gene.",
      "Sotos syndrome is a genetic disorder associated with mutations in the EZH2 gene and characterized by certain overgrowth and an increased risk of developing tumors."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Mutations in the EZH2 gene are not associated with Beckwith-Wiedemann syndrome. Beckwith-Wiedemann syndrome is most commonly associated with changes on chromosome 11p15.\n2. TRUE\n3. FALSE [correction]: Wiedemann-Beckwith syndrome is not a separate condition; it is another name for Beckwith-Wiedemann syndrome.\n4. TRUE\n5. FALSE [correction]: Sotos syndrome is associated with mutations in the NSD1 gene, not the EZH2 gene.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "vicuna-13b_response": "A dimer-to-tetramer transition refers to a change in the oligomerization state of a protein from a dimer (a protein consisting of two identical or similar subunits) to a tetramer (a protein consisting of four identical or similar subunits).\nThere are several human proteins that are subject to a dimer-to-tetramer transition, including:\n1. Hemoglobin: Hemoglobin is a protein found in red blood cells that is responsible for carrying oxygen from the lungs to the body's tissues and for carrying carbon dioxide from the tissues to the lungs. Hemoglobin is composed of two alpha and two beta chains, and it undergoes a dimer-to-tetramer transition as it binds to oxygen.\n2. Myoglobin: Myoglobin is a protein found in muscle cells that functions as an oxygen storage protein. Like hemoglobin, myoglobin is composed of two alpha and two beta chains, and it undergoes a dimer-to-tetramer transition as it binds to oxygen.\n3. Cytochrome c: Cytochrome c is a protein found in the mitochondria of cells that plays a role in cellular respiration. Cytochrome c is composed of three polypeptide chains, and it undergoes a dimer-to-tetramer transition as it participates in electron transport.\n4. Apolipoprotein A-1: Apolipoprotein A-1 is a protein found in lipoproteins that plays a role in the transport of cholesterol and other lipids in the blood. Apolipoprotein A-1 is composed of two identical subunits, and it undergoes a dimer-to-tetramer transition as it binds to lipids.\n5. Hemopexin: Hemopexin is a protein found in the blood that plays a role in the regulation of iron homeostasis. Hemopexin is composed of two identical subunits, and it undergoes a dimer-to-tetramer transition as it binds to iron.\nThese are just a few examples of human proteins that undergo a dimer-to-tetram",
    "vicuna-13b_fact_raw": "1. Hemoglobin is a protein found in red blood cells that carries oxygen and carbon dioxide and undergoes a dimer-to-tetramer transition as it binds to oxygen.\n2. Myoglobin is a protein found in muscle cells that stores oxygen and undergoes a dimer-to-tetramer transition as it binds to oxygen.\n3. Cytochrome c is a protein found in the mitochondria that participates in electron transport and undergoes a dimer-to-tetramer transition.\n4. Apolipoprotein A-1 is a protein involved in lipid transport in the blood and undergoes a dimer-to-tetramer transition as it binds to lipids.\n5. Hemopexin is a protein involved in iron homeostasis and undergoes a dimer-to-tetramer transition as it binds to iron.",
    "vicuna-13b_fact": [
      "Hemoglobin is a protein found in red blood cells that carries oxygen and carbon dioxide and undergoes a dimer-to-tetramer transition as it binds to oxygen.",
      "Myoglobin is a protein found in muscle cells that stores oxygen and undergoes a dimer-to-tetramer transition as it binds to oxygen.",
      "Cytochrome c is a protein found in the mitochondria that participates in electron transport and undergoes a dimer-to-tetramer transition.",
      "Apolipoprotein A-1 is a protein involved in lipid transport in the blood and undergoes a dimer-to-tetramer transition as it binds to lipids.",
      "Hemopexin is a protein involved in iron homeostasis and undergoes a dimer-to-tetramer transition as it binds to iron."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Myoglobin is a protein found in muscle cells that stores oxygen, but it does not undergo a dimer-to-tetramer transition as it binds to oxygen. Myoglobin is a single-chain globular protein.\n3. FALSE [correction]: Cytochrome c is a protein found in the mitochondria that participates in electron transport, but it does not undergo a dimer-to-tetramer transition.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "vicuna-13b_response": "One protein that has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein is the protein known as \"Bcl-2\".\nBcl-2 is a member of the Bcl-2 protein family, which plays a critical role in regulating programmed cell death, or apoptosis. Bcl-2 is an anti-apoptotic protein, meaning that it helps to prevent cell death. Bcl-2 has been found to interact with phospholamban (PLN) through its N-terminal domain, which is involved in the regulation of its anti-apoptotic function.\nThe interaction between Bcl-2 and phospholamban (PLN) has been shown to be important in regulating the activity of the cardiac sarcoendoplasmic reticulum Ca2+-ATPase (SERCA), which is an enzyme that pumps calcium ions into the sarcoplasmic reticulum (SR) of heart muscle cells. The interaction between Bcl-2 and PLN has been shown to modulate the activity of SERCA, and this can have important implications for the regulation of heart function and the prevention of cell death in heart muscle cells.\nOverall, the interaction between Bcl-2 and phospholamban (PLN) is an important regulatory mechanism that helps to maintain the proper function of heart muscle cells and prevent cell death.",
    "vicuna-13b_fact_raw": "1. Bcl-2 is a protein that interacts with phospholamban (PLN).\n2. Bcl-2 is an anti-apoptotic protein, which means it helps to prevent cell death.\n3. The Bcl-2 protein family plays a critical role in regulating programmed cell death, or apoptosis.\n4. The interaction between Bcl-2 and PLN is important in regulating the activity of the cardiac sarcoendoplasmic reticulum Ca2+-ATPase (SERCA).\n5. The interaction between Bcl-2 and PLN can have implications for the regulation of heart function and the prevention of cell death in heart muscle cells.",
    "vicuna-13b_fact": [
      "Bcl-2 is a protein that interacts with phospholamban (PLN).",
      "Bcl-2 is an anti-apoptotic protein, which means it helps to prevent cell death.",
      "The Bcl-2 protein family plays a critical role in regulating programmed cell death, or apoptosis.",
      "The interaction between Bcl-2 and PLN is important in regulating the activity of the cardiac sarcoendoplasmic reticulum Ca2+-ATPase (SERCA).",
      "The interaction between Bcl-2 and PLN can have implications for the regulation of heart function and the prevention of cell death in heart muscle cells."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements regarding the specific interaction between Bcl-2 and phospholamban (PLN), and its implications for heart function, are not common knowledge and would require specific scientific literature to confirm or refute. Therefore, without additional context or references, the veracity of statements 1, 4, and 5 cannot be determined.",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "vicuna-13b_response": "Yes, vitamin D has been shown to reduce the incidence of falls in older people in clinical trials. Several studies have found that vitamin D supplementation can improve balance and reduce the risk of falls in older adults.\nOne randomized controlled trial published in the Journal of the American Geriatrics Society found that older adults who took vitamin D supplements had a 20% lower risk of falling compared to those who did not take vitamin D supplements. Another study published in the Journal of Clinical Endocrinology & Metabolism found that vitamin D supplementation reduced the risk of falls in postmenopausal women by 30%.\nOther studies have also found that vitamin D supplementation can improve muscle strength, balance, and cognitive function, all of which can help reduce the risk of falls in older adults.\nIt's important to note that while vitamin D supplementation can be beneficial for reducing the risk of falls, it is not a guarantee and should not be the sole intervention for fall prevention. A comprehensive fall prevention program should include a combination of strategies such as exercise, home safety assessments, and medication management.",
    "vicuna-13b_fact_raw": "1. Vitamin D supplementation has been shown to reduce the incidence of falls in older people in clinical trials.\n2. A study published in the Journal of the American Geriatrics Society reported a 20% lower risk of falling in older adults who took vitamin D supplements compared to those who did not.\n3. The Journal of Clinical Endocrinology & Metabolism published a study indicating that vitamin D supplementation reduced the risk of falls in postmenopausal women by 30%.\n4. Research suggests that vitamin D supplementation can improve muscle strength, balance, and cognitive function in older adults.\n5. A comprehensive fall prevention program for older adults should include strategies such as exercise, home safety assessments, and medication management, in addition to vitamin D supplementation.",
    "vicuna-13b_fact": [
      "Vitamin D supplementation has been shown to reduce the incidence of falls in older people in clinical trials.",
      "A study published in the Journal of the American Geriatrics Society reported a 20% lower risk of falling in older adults who took vitamin D supplements compared to those who did not.",
      "The Journal of Clinical Endocrinology & Metabolism published a study indicating that vitamin D supplementation reduced the risk of falls in postmenopausal women by 30%.",
      "Research suggests that vitamin D supplementation can improve muscle strength, balance, and cognitive function in older adults.",
      "A comprehensive fall prevention program for older adults should include strategies such as exercise, home safety assessments, and medication management, in addition to vitamin D supplementation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE: Vitamin D supplementation has been shown in various clinical trials to reduce the incidence of falls in older people by improving muscle function and bone health.\n2. UNKNOWN: Without access to the specific study from the Journal of the American Geriatrics Society, the exact risk reduction percentage cannot be verified.\n3. UNKNOWN: Without access to the specific study from the Journal of Clinical Endocrinology & Metabolism, the exact risk reduction percentage cannot be verified.\n4. TRUE: Research has suggested that vitamin D supplementation can improve muscle strength and balance, which are factors that can contribute to fall prevention in older adults. However, the impact on cognitive function is less clear and may not be as directly related to fall prevention.\n5. TRUE: A comprehensive fall prevention program for older adults typically includes multiple strategies such as exercise, home safety assessments, and medication management, along with vitamin D supplementation if needed.",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "vicuna-13b_response": "Yes, there is an association between Jarid2 and miR-155 in Th17 cells.\nJarid2 is a transcriptional repressor that has been shown to play a role in regulating the differentiation and function of T helper 17 (Th17) cells, which are a subset of T cells that play a critical role in regulating the immune response.\nmiR-155 is a microRNA that has been shown to be involved in the regulation of Th17 cell differentiation and function. Specifically, miR-155 has been shown to target the Jarid2 gene, leading to the repression of Jarid2 expression and the promotion of Th17 cell differentiation.\nIn addition, miR-155 has been shown to be involved in the regulation of other aspects of Th17 cell biology, including their survival, proliferation, and cytokine production.\nOverall, the association between Jarid2 and miR-155 in Th17 cells is important for the regulation of Th17 cell differentiation and function, and dysregulation of this pathway has been implicated in the pathogenesis of a variety of autoimmune diseases.",
    "vicuna-13b_fact_raw": "1. Jarid2 is a transcriptional repressor involved in regulating the differentiation and function of Th17 cells.\n2. Th17 cells are a subset of T cells that play a critical role in regulating the immune response.\n3. miR-155 is a microRNA that regulates Th17 cell differentiation and function.\n4. miR-155 targets the Jarid2 gene, leading to repression of Jarid2 expression and promotion of Th17 cell differentiation.\n5. Dysregulation of the association between Jarid2 and miR-155 in Th17 cells has been implicated in the pathogenesis of various autoimmune diseases.",
    "vicuna-13b_fact": [
      "Jarid2 is a transcriptional repressor involved in regulating the differentiation and function of Th17 cells.",
      "Th17 cells are a subset of T cells that play a critical role in regulating the immune response.",
      "miR-155 is a microRNA that regulates Th17 cell differentiation and function.",
      "miR-155 targets the Jarid2 gene, leading to repression of Jarid2 expression and promotion of Th17 cell differentiation.",
      "Dysregulation of the association between Jarid2 and miR-155 in Th17 cells has been implicated in the pathogenesis of various autoimmune diseases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements provided are consistent with current scientific understanding. Jarid2 is known to be a transcriptional regulator involved in various cellular processes, including the differentiation of Th17 cells. Th17 cells are indeed a subset of T cells important for immune response. miR-155 is a microRNA that has been shown to play a role in the regulation of immune cells, including Th17 cells. It is known to target various genes, including Jarid2, influencing their expression and thereby affecting cell differentiation. Dysregulation of such interactions has been associated with autoimmune diseases. However, it is important to note that scientific knowledge is always evolving, and these statements should be interpreted in the context of the most current research.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "vicuna-13b_response": "The human hoxD cluster contains 39 genes. The hoxD cluster is a group of genes that are involved in the development of the body plan of an organism, and is located on chromosome 13. These genes play a crucial role in the process of embryonic development, and are responsible for the proper formation and differentiation of various body parts. The hoxD cluster is one of the largest clusters of genes in the human genome, and is thought to have evolved through a process of gene duplication and diversification.",
    "vicuna-13b_fact_raw": "1. The human hoxD cluster contains 39 genes.\n2. The hoxD cluster is involved in the development of the body plan of an organism.\n3. The hoxD cluster is located on chromosome 13.\n4. Genes in the hoxD cluster are responsible for the proper formation and differentiation of various body parts.\n5. The hoxD cluster is one of the largest clusters of genes in the human genome.",
    "vicuna-13b_fact": [
      "The human hoxD cluster contains 39 genes.",
      "The hoxD cluster is involved in the development of the body plan of an organism.",
      "The hoxD cluster is located on chromosome 13.",
      "Genes in the hoxD cluster are responsible for the proper formation and differentiation of various body parts.",
      "The hoxD cluster is one of the largest clusters of genes in the human genome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The human HOXD cluster contains 9 genes.\n2. TRUE\n3. FALSE [correction]: The HOXD cluster is located on chromosome 2.\n4. TRUE\n5. FALSE [correction]: The HOXD cluster is not one of the largest clusters of genes in the human genome; it is relatively small compared to some other gene clusters.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "vicuna-13b_response": "Casein Kinase 1 (CK1) is a family of serine/threonine protein kinases that play important roles in various cellular processes, such as cell cycle progression, differentiation, and apoptosis. The phosphorylation consensus motifs for CK1 are as follows:\n1. S/T-X-R/K-X-S/T\n2. S/T-P-S/T-P-S/T-P\n3. S/T-P-S/T-P-S/T-P-P\n4. S/T-P-S/T-P-S/T-P-P-P\n5. S/T-P-S/T-P-S/T-P-P-P-P\nThese consensus motifs are based on the sequence analysis of known CK1 substrates and are not exhaustive. Additionally, CK1 can also phosphorylate other amino acids such as tyrosine and histidine in some cases.",
    "vicuna-13b_fact_raw": "1. Casein Kinase 1 (CK1) is a family of serine/threonine protein kinases.\n2. CK1 plays roles in cell cycle progression, differentiation, and apoptosis.\n3. The phosphorylation consensus motif for CK1 includes S/T-X-R/K-X-S/T.\n4. CK1 can phosphorylate other amino acids such as tyrosine and histidine in some cases.\n5. The listed phosphorylation consensus motifs for CK1 are based on the sequence analysis of known CK1 substrates.",
    "vicuna-13b_fact": [
      "Casein Kinase 1 (CK1) is a family of serine/threonine protein kinases.",
      "CK1 plays roles in cell cycle progression, differentiation, and apoptosis.",
      "The phosphorylation consensus motif for CK1 includes S/T-X-R/K-X-S/T.",
      "CK1 can phosphorylate other amino acids such as tyrosine and histidine in some cases.",
      "The listed phosphorylation consensus motifs for CK1 are based on the sequence analysis of known CK1 substrates."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The phosphorylation consensus motif for CK1 is generally S/T-X-X-S/T, where X can be any amino acid.\n4. FALSE [correction]: CK1 is known to specifically phosphorylate serine or threonine residues, not tyrosine or histidine.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "vicuna-13b_response": "The ASPH gene in humans encodes for the aspartate beta-hydroxylase enzyme, which is involved in the metabolism of certain amino acids. There are several different proteins/isoforms that can be encoded by the ASPH gene, including:\n1. Aspartate beta-hydroxylase 1 (ABH1)\n2. Aspartate beta-hydroxylase 2 (ABH2)\n3. Aspartate beta-hydroxylase 3 (ABH3)\nEach of these isoforms of the enzyme has slightly different properties and functions, and they may be expressed in different tissues and under different conditions. For example, ABH1 is expressed in the liver and kidneys, while ABH2 is expressed in the brain and testis.",
    "vicuna-13b_fact_raw": "1. The ASPH gene in humans encodes for the aspartate beta-hydroxylase enzyme.\n2. The ASPH gene can encode several different proteins/isoforms.\n3. Aspartate beta-hydroxylase 1 (ABH1) is an isoform encoded by the ASPH gene.\n4. Aspartate beta-hydroxylase 2 (ABH2) is an isoform encoded by the ASPH gene.\n5. ABH1 is expressed in the liver and kidneys, while ABH2 is expressed in the brain and testis.",
    "vicuna-13b_fact": [
      "The ASPH gene in humans encodes for the aspartate beta-hydroxylase enzyme.",
      "The ASPH gene can encode several different proteins/isoforms.",
      "Aspartate beta-hydroxylase 1 (ABH1) is an isoform encoded by the ASPH gene.",
      "Aspartate beta-hydroxylase 2 (ABH2) is an isoform encoded by the ASPH gene.",
      "ABH1 is expressed in the liver and kidneys, while ABH2 is expressed in the brain and testis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: There is no isoform of aspartate beta-hydroxylase known as Aspartate beta-hydroxylase 2 (ABH2) encoded by the ASPH gene.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "vicuna-13b_response": "Empagliflozin is a medication used to treat type 2 diabetes. It was approved by the U.S. Food and Drug Administration (FDA) in 2014. The FDA approved empagliflozin under the brand name Jardiance, which is manufactured by Boehringer Ingelheim and Eli Lilly and Company. Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, which helps the body remove excess glucose through the urine. It is taken orally and is used in combination with diet and exercise to improve blood sugar control in people with type 2 diabetes.",
    "vicuna-13b_fact_raw": "1. Empagliflozin was approved by the U.S. Food and Drug Administration (FDA) in 2014.\n2. The FDA approved empagliflozin under the brand name Jardiance.\n3. Empagliflozin is manufactured by Boehringer Ingelheim and Eli Lilly and Company.\n4. Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.\n5. Empagliflozin is used to treat type 2 diabetes and is taken orally.",
    "vicuna-13b_fact": [
      "Empagliflozin was approved by the U.S. Food and Drug Administration (FDA) in 2014.",
      "The FDA approved empagliflozin under the brand name Jardiance.",
      "Empagliflozin is manufactured by Boehringer Ingelheim and Eli Lilly and Company.",
      "Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.",
      "Empagliflozin is used to treat type 2 diabetes and is taken orally."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "vicuna-13b_response": "Loss of the protein Lon1 in the plant Arabidopsis has been shown to have a number of effects on plant growth and development. Some of the results of Lon1 loss in Arabidopsis include:\n1. Increased sensitivity to oxidative stress: Lon1 is involved in the degradation of proteins that are damaged by oxidative stress, and loss of Lon1 leads to an accumulation of these damaged proteins. This accumulation can make the plant more sensitive to oxidative stress, which can lead to decreased growth and development.\n2. Impaired chlorophyll synthesis: Lon1 is involved in the degradation of proteins that are involved in chlorophyll synthesis, and loss of Lon1 can lead to decreased chlorophyll content and a decrease in the ability of the plant to photosynthesize. This can lead to decreased growth and development.\n3. Altered plant growth and development: Loss of Lon1 can lead to altered growth and development in Arabidopsis, including decreased plant height, smaller leaves, and a delay in flowering.\n4. Increased susceptibility to disease: Loss of Lon1 can lead to increased susceptibility to disease in Arabidopsis, as the accumulation of damaged proteins can make the plant more vulnerable to pathogens.\nOverall, the loss of Lon1 in Arabidopsis can have a significant impact on plant growth and development, and further research is needed to fully understand the mechanisms underlying these effects.",
    "vicuna-13b_fact_raw": "1. Loss of the protein Lon1 in Arabidopsis leads to increased sensitivity to oxidative stress.\n2. Loss of Lon1 in Arabidopsis is associated with impaired chlorophyll synthesis.\n3. Arabidopsis plants lacking Lon1 exhibit altered growth and development, such as decreased plant height and smaller leaves.\n4. Arabidopsis plants without Lon1 have a delay in flowering.\n5. Loss of Lon1 in Arabidopsis increases the plant's susceptibility to disease.",
    "vicuna-13b_fact": [
      "Loss of the protein Lon1 in Arabidopsis leads to increased sensitivity to oxidative stress.",
      "Loss of Lon1 in Arabidopsis is associated with impaired chlorophyll synthesis.",
      "Arabidopsis plants lacking Lon1 exhibit altered growth and development, such as decreased plant height and smaller leaves.",
      "Arabidopsis plants without Lon1 have a delay in flowering.",
      "Loss of Lon1 in Arabidopsis increases the plant's susceptibility to disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN\n\nThe first four statements are consistent with the known functions of Lon proteases in plants, which are involved in various cellular processes including response to stress, chlorophyll synthesis, and growth regulation. However, without specific information from the passage regarding the plant's susceptibility to disease due to the loss of Lon1, the truth of statement 5 cannot be determined.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "vicuna-13b_response": "Yes, linker histones are present in the yeast genome. Linker histones are a type of non-coding RNA that play a role in regulating gene expression by binding to chromatin and modifying chromatin structure. In yeast, linker histones are essential for the proper organization of chromatin and the regulation of gene expression.\nThere are several types of linker histones in yeast, including H1, H2A, H2B, and H3. These linker histones are involved in the formation of a variety of chromatin structures, including chromosome condensation, chromatin compaction, and the regulation of access to the chromatin.\nIn addition to their role in chromatin regulation, linker histones also play a role in the regulation of transcription and the maintenance of chromosome stability. Overall, linker histones are essential for the proper functioning of the yeast genome and are an important component of the chromatin regulatory network.",
    "vicuna-13b_fact_raw": "1. Linker histones are present in the yeast genome.\n2. Linker histones in yeast play a role in regulating gene expression by binding to chromatin.\n3. In yeast, linker histones are essential for the proper organization of chromatin.\n4. Types of linker histones in yeast include H1, H2A, H2B, and H3.\n5. Linker histones in yeast are involved in chromosome condensation and chromatin compaction.",
    "vicuna-13b_fact": [
      "Linker histones are present in the yeast genome.",
      "Linker histones in yeast play a role in regulating gene expression by binding to chromatin.",
      "In yeast, linker histones are essential for the proper organization of chromatin.",
      "Types of linker histones in yeast include H1, H2A, H2B, and H3.",
      "Linker histones in yeast are involved in chromosome condensation and chromatin compaction."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Linker histones such as H1 are generally not present in most yeast species, including Saccharomyces cerevisiae.\n2. FALSE [correction]: Since most yeast species do not have linker histones like H1, they do not play a role in yeast chromatin structure and gene regulation in the same way they do in other eukaryotes.\n3. FALSE [correction]: In yeast, chromatin organization and proper structure are maintained without the presence of linker histones like H1, which are not essential in most yeast species.\n4. FALSE [correction]: H2A, H2B, and H3 are not linker histones; they are core histones. The typical linker histone in other eukaryotes is H1, which is generally not found in most yeast species.\n5. UNKNOWN: While linker histones in other eukaryotes are involved in chromosome condensation and chromatin compaction, the statement is unclear regarding yeast because most yeast species do not have typical linker histones. However, yeast still undergo chromosome condensation and chromatin compaction through other mechanisms.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "vicuna-13b_response": "There is some evidence that drinking tomato juice may help to lower cholesterol levels. Tomatoes are a good source of a compound called lycopene, which has been shown to have cholesterol-lowering properties. Studies have found that consuming tomato products, such as tomato juice, can increase the levels of lycopene in the blood, which may help to lower cholesterol levels.\nOne study published in the Journal of the American College of Nutrition found that participants who drank 1.4 liters of tomato juice per week for 12 weeks had a significant decrease in total cholesterol and LDL (bad) cholesterol levels compared to a control group that did not drink tomato juice.\nAnother study published in the Journal of Nutrition found that consuming tomato products as part of a low-fat, low-cholesterol diet may help to further lower cholesterol levels.\nHowever, it's important to note that more research is needed to fully understand the effects of tomato juice on cholesterol levels, and it should not be relied upon as the sole means of managing cholesterol levels. It's always best to consult with a healthcare professional before making any changes to your diet or cholesterol-lowering regimen.",
    "vicuna-13b_fact_raw": "1. Tomatoes contain a compound called lycopene, which has cholesterol-lowering properties.\n2. Consuming tomato products can increase the levels of lycopene in the blood.\n3. A study published in the Journal of the American College of Nutrition reported that participants who drank 1.4 liters of tomato juice per week for 12 weeks had a significant decrease in total cholesterol and LDL cholesterol levels.\n4. The Journal of Nutrition published a study suggesting that consuming tomato products as part of a low-fat, low-cholesterol diet may help lower cholesterol levels.\n5. More research is needed to fully understand the effects of tomato juice on cholesterol levels.",
    "vicuna-13b_fact": [
      "Tomatoes contain a compound called lycopene, which has cholesterol-lowering properties.",
      "Consuming tomato products can increase the levels of lycopene in the blood.",
      "A study published in the Journal of the American College of Nutrition reported that participants who drank 1.4 liters of tomato juice per week for 12 weeks had a significant decrease in total cholesterol and LDL cholesterol levels.",
      "The Journal of Nutrition published a study suggesting that consuming tomato products as part of a low-fat, low-cholesterol diet may help lower cholesterol levels.",
      "More research is needed to fully understand the effects of tomato juice on cholesterol levels."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN (without access to the specific study, the details cannot be verified)\n4. UNKNOWN (without access to the specific study, the details cannot be verified)\n5. TRUE (This is a common conclusion in nutritional studies, suggesting that while current research is promising, more comprehensive studies are required to confirm the findings.)",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "vicuna-13b_response": "Hsp70 and Hsp110 are two different types of heat shock proteins (HSPs) that play important roles in the regulation of protein folding and mRNA stability.\nHsp70 proteins are molecular chaperones that help to fold and transport proteins to their correct locations within the cell. They also help to refold denatured proteins and prevent protein aggregation. Hsp70 proteins are involved in the regulation of mRNA stability by binding to and stabilizing mRNAs that are targeted for degradation. This binding prevents the degradation of these mRNAs and allows them to be translated into proteins.\nHsp110 proteins are also involved in the regulation of mRNA stability. They are capable of binding to and destabilizing mRNAs that are targeted for degradation, leading to their degradation and inhibition of protein translation. Hsp110 proteins also play a role in the regulation of protein folding and transport.\nIn conclusion, Hsp70 and Hsp110 play important roles in the regulation of mRNA stability by binding to and stabilizing or destabilizing mRNAs, respectively. These proteins help to ensure that the proper balance of protein synthesis and degradation is maintained in the cell, and they play a critical role in the response of cells to stress.",
    "vicuna-13b_fact_raw": "1. Hsp70 proteins help to fold and transport proteins to their correct locations within the cell.\n2. Hsp70 proteins are involved in the regulation of mRNA stability by binding to and stabilizing mRNAs targeted for degradation.\n3. Hsp110 proteins are involved in the regulation of mRNA stability by binding to and destabilizing mRNAs targeted for degradation.\n4. Both Hsp70 and Hsp110 proteins play a role in the regulation of protein folding and transport.\n5. Hsp70 and Hsp110 proteins contribute to the cellular response to stress.",
    "vicuna-13b_fact": [
      "Hsp70 proteins help to fold and transport proteins to their correct locations within the cell.",
      "Hsp70 proteins are involved in the regulation of mRNA stability by binding to and stabilizing mRNAs targeted for degradation.",
      "Hsp110 proteins are involved in the regulation of mRNA stability by binding to and destabilizing mRNAs targeted for degradation.",
      "Both Hsp70 and Hsp110 proteins play a role in the regulation of protein folding and transport.",
      "Hsp70 and Hsp110 proteins contribute to the cellular response to stress."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Hsp70 proteins are primarily known for their role in protein folding and stabilization, not for the regulation of mRNA stability. Proteins that are involved in mRNA stability often include RNA-binding proteins and enzymes that degrade or process mRNA, but Hsp70's main function is not to stabilize mRNAs targeted for degradation.\n3. UNKNOWN: The statement about Hsp110 proteins is specific, and without additional context, it's difficult to confirm or deny the role of Hsp110 in mRNA stability. Hsp110 proteins are a subfamily of Hsp70 and are known to assist in protein folding, but their role in mRNA regulation is not well-established in the general knowledge.\n4. TRUE: Both Hsp70 and Hsp110 proteins are chaperones that assist in protein folding and help transport proteins to their correct locations within the cell.\n5. TRUE: Hsp70 and Hsp110 proteins are heat shock proteins, which are upregulated in response to stress and contribute to the cellular stress response by helping to refold damaged proteins and protect cells from stress-induced damage.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "vicuna-13b_response": "There are two main types of deiodinases present in skeletal muscle: deiodinase 1 (D1) and deiodinase 2 (D2).\nD1 is the main enzyme responsible for converting the inactive form of thyroid hormone (T4) to the active form (T3) in skeletal muscle tissue. D1 is expressed at high levels in skeletal muscle, and its activity is regulated by a number of factors, including muscle contraction, exercise, and changes in the levels of other hormones such as glucocorticoids.\nD2, on the other hand, is responsible for converting T4 to T3, but it has a much lower activity than D1. D2 is also expressed in skeletal muscle, but at much lower levels than D1.\nBoth D1 and D2 are important for the proper functioning of thyroid hormone in skeletal muscle. D1 is critical for the conversion of T4 to T3, which is necessary for the regulation of muscle metabolism and protein synthesis. D2, on the other hand, plays a role in the regulation of T3 levels in the body, and may be involved in the feedback regulation of thyroid hormone synthesis and secretion by the thyroid gland.\nOverall, the balance between D1 and D2 activity is important for maintaining proper thyroid hormone levels in skeletal muscle, and dysregulation of these enzymes can have significant effects on muscle function and metabolism.",
    "vicuna-13b_fact_raw": "1. Deiodinase 1 (D1) and deiodinase 2 (D2) are the two main types of deiodinases present in skeletal muscle.\n2. Deiodinase 1 (D1) is responsible for converting the inactive form of thyroid hormone (T4) to the active form (T3) in skeletal muscle tissue.\n3. Deiodinase 1 (D1) is expressed at high levels in skeletal muscle.\n4. Deiodinase 2 (D2) has a much lower activity than D1 in converting T4 to T3.\n5. Deiodinase 2 (D2) is expressed in skeletal muscle at much lower levels than D1.",
    "vicuna-13b_fact": [
      "Deiodinase 1 (D1) and deiodinase 2 (D2) are the two main types of deiodinases present in skeletal muscle.",
      "Deiodinase 1 (D1) is responsible for converting the inactive form of thyroid hormone (T4) to the active form (T3) in skeletal muscle tissue.",
      "Deiodinase 1 (D1) is expressed at high levels in skeletal muscle.",
      "Deiodinase 2 (D2) has a much lower activity than D1 in converting T4 to T3.",
      "Deiodinase 2 (D2) is expressed in skeletal muscle at much lower levels than D1."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Deiodinase 1 (D1), deiodinase 2 (D2), and deiodinase 3 (D3) are the three main types of deiodinases present in the human body, not just in skeletal muscle.\n2. TRUE: Deiodinase 1 (D1) is indeed responsible for converting the inactive form of thyroid hormone (T4) to the active form (T3), although it is not limited to skeletal muscle tissue.\n3. FALSE [correction]: Deiodinase 1 (D1) is not expressed at high levels in skeletal muscle; it is primarily expressed in the liver and kidneys.\n4. FALSE [correction]: Deiodinase 2 (D2) is actually more active than D1 in converting T4 to T3 in certain tissues, including the brain and skeletal muscle.\n5. FALSE [correction]: Deiodinase 2 (D2) is not necessarily expressed at much lower levels than D1 in skeletal muscle. D2 is important for local T3 production in skeletal muscle and other tissues, and its expression can be tissue-specific and regulated by different factors.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "vicuna-13b_response": "Caspases are a family of cysteine proteases that play a crucial role in cellular apoptosis (programmed cell death). There are several types of caspases, including inflammatory caspases. Inflammatory caspases are a subset of caspases that are involved in the inflammatory response. Here are some of the inflammatory caspases:\n1. Caspase-1: Caspase-1 is an inflammatory caspase that is activated by the inflammasome, a complex that plays a crucial role in the innate immune response. Caspase-1 cleaves and activates pro-inflammatory cytokines such as interleukin-1Î² (IL-1Î²) and interleukin-18 (IL-18), which play important roles in the immune response.\n2. Caspase-4: Caspase-4 is another inflammatory caspase that is activated by the inflammasome. It cleaves and activates pro-inflammatory cytokines such as IL-1Î² and IL-18.\n3. Caspase-5: Caspase-5 is an inflammatory caspase that is activated by the inflammasome. It cleaves and activates the pro-inflammatory cytokine gasdermin D, which plays a role in the immune response.\n4. Caspase-12: Caspase-12 is an inflammatory caspase that is activated by the inflammasome. It cleaves and activates the pro-inflammatory cytokine IL-18.\nOverall, inflammatory caspases play a crucial role in the inflammatory response and the immune system. Dysregulation of inflammatory caspases has been implicated in a variety of diseases, including autoimmune diseases and chronic inflammation.",
    "vicuna-13b_fact_raw": "1. Caspase-1 is an inflammatory caspase that is activated by the inflammasome.\n2. Caspase-1 cleaves and activates pro-inflammatory cytokines such as interleukin-1Î² (IL-1Î²) and interleukin-18 (IL-18).\n3. Caspase-4 is an inflammatory caspase that cleaves and activates pro-inflammatory cytokines such as IL-1Î² and IL-18.\n4. Caspase-5 is an inflammatory caspase that cleaves and activates the pro-inflammatory cytokine gasdermin D.\n5. Caspase-12 is an inflammatory caspase that cleaves and activates the pro-inflammatory cytokine IL-18.",
    "vicuna-13b_fact": [
      "Caspase-1 is an inflammatory caspase that is activated by the inflammasome.",
      "Caspase-1 cleaves and activates pro-inflammatory cytokines such as interleukin-1Î² (IL-1Î²) and interleukin-18 (IL-18).",
      "Caspase-4 is an inflammatory caspase that cleaves and activates pro-inflammatory cytokines such as IL-1Î² and IL-18.",
      "Caspase-5 is an inflammatory caspase that cleaves and activates the pro-inflammatory cytokine gasdermin D.",
      "Caspase-12 is an inflammatory caspase that cleaves and activates the pro-inflammatory cytokine IL-18."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Caspase-4, also known as caspase-11 in mice, is an inflammatory caspase that can induce pyroptosis, a form of programmed cell death, and is involved in the response to intracellular pathogens. It does not directly cleave and activate pro-inflammatory cytokines such as IL-1Î² and IL-18.\n4. FALSE [correction]: Caspase-5 is an inflammatory caspase that is part of the inflammasome complex and can be involved in the activation of pro-inflammatory cytokines, but it is not known to cleave and activate gasdermin D. Gasdermin D is cleaved by caspase-1 and caspase-4/5/11 to induce pyroptosis.\n5. FALSE [correction]: Caspase-12 is not an inflammatory caspase; it is actually associated with the attenuation of the inflammatory response. It does not cleave and activate pro-inflammatory cytokines like IL-18.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "vicuna-13b_response": "Yes, there is a link between the Aurora B kinase and the Polycomb protein Ring1B. Aurora B is a key regulator of mitosis, and it is involved in the formation of the mitotic spindle and the proper segregation of chromosomes during cell division. Ring1B is a member of the Polycomb group of proteins, which are involved in the regulation of gene expression and the maintenance of the cell's developmental state.\nStudies have shown that Ring1B interacts with and is phosphorylated by Aurora B. This interaction is important for the proper functioning of the mitotic spindle and the proper segregation of chromosomes during cell division. Ring1B also plays a role in the regulation of the Aurora B kinase, and it is thought to do so by modifying the activity of the protein or by controlling its localization.\nIn conclusion, there is a link between the Aurora B kinase and the Polycomb protein Ring1B, and their interaction is important for the proper functioning of the mitotic spindle and the proper segregation of chromosomes during cell division.",
    "vicuna-13b_fact_raw": "1. Aurora B kinase is a key regulator of mitosis.\n2. Aurora B kinase is involved in the formation of the mitotic spindle.\n3. Ring1B is a member of the Polycomb group of proteins, which regulate gene expression and maintain the cell's developmental state.\n4. Ring1B interacts with and is phosphorylated by Aurora B kinase.\n5. The interaction between Aurora B kinase and Ring1B is important for the proper functioning of the mitotic spindle and the proper segregation of chromosomes during cell division.",
    "vicuna-13b_fact": [
      "Aurora B kinase is a key regulator of mitosis.",
      "Aurora B kinase is involved in the formation of the mitotic spindle.",
      "Ring1B is a member of the Polycomb group of proteins, which regulate gene expression and maintain the cell's developmental state.",
      "Ring1B interacts with and is phosphorylated by Aurora B kinase.",
      "The interaction between Aurora B kinase and Ring1B is important for the proper functioning of the mitotic spindle and the proper segregation of chromosomes during cell division."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Aurora A kinase, not Aurora B kinase, is primarily involved in the formation of the mitotic spindle.\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "vicuna-13b_response": "Non-canonical sequence motifs are sequence patterns that deviate from the typical splice site consensus sequence. In vertebrates, the most frequent non-canonical sequence motifs at the donor and acceptor splice sites are as follows:\nAt the donor splice site:\n1. The presence of a purine at the -3 position, immediately upstream of the splice site.\n2. The presence of a pyrimidine at the +1 position, immediately downstream of the splice site.\n3. The presence of a guanine at the +2 position, immediately downstream of the splice site.\nAt the acceptor splice site:\n1. The presence of a pyrimidine at the -3 position, immediately upstream of the splice site.\n2. The presence of a purine at the +1 position, immediately downstream of the splice site.\n3. The presence of a guanine at the +2 position, immediately downstream of the splice site.\nIt is important to note that these non-canonical sequence motifs are not exclusive to vertebrates, but are also observed in other organisms. Additionally, the presence of these motifs does not guarantee that a particular sequence will be included in the final mRNA transcript, as other factors such as the presence of regulatory elements and RNA-binding proteins can also influence the splicing process.",
    "vicuna-13b_fact_raw": "1. A purine is frequently present at the -3 position upstream of the donor splice site in vertebrates.\n2. A pyrimidine is frequently present at the +1 position downstream of the donor splice site in vertebrates.\n3. A guanine is frequently present at the +2 position downstream of the donor splice site in vertebrates.\n4. A pyrimidine is frequently present at the -3 position upstream of the acceptor splice site in vertebrates.\n5. A purine is frequently present at the +1 position downstream of the acceptor splice site in vertebrates.",
    "vicuna-13b_fact": [
      "A purine is frequently present at the -3 position upstream of the donor splice site in vertebrates.",
      "A pyrimidine is frequently present at the +1 position downstream of the donor splice site in vertebrates.",
      "A guanine is frequently present at the +2 position downstream of the donor splice site in vertebrates.",
      "A pyrimidine is frequently present at the -3 position upstream of the acceptor splice site in vertebrates.",
      "A purine is frequently present at the +1 position downstream of the acceptor splice site in vertebrates."
    ],
    "vicuna-13b_judge_raw": "1. TRUE: A purine, specifically a guanine, is frequently present at the -3 position upstream of the donor splice site in vertebrates, which is part of the consensus sequence.\n2. FALSE [correction]: A pyrimidine is not frequently present at the +1 position downstream of the donor splice site in vertebrates. Instead, a guanine is frequently present at the +1 position downstream of the donor splice site.\n3. TRUE: A guanine is frequently present at the +2 position downstream of the donor splice site in vertebrates, which is consistent with the consensus sequence for the donor splice site.\n4. TRUE: A pyrimidine is frequently present at the -3 position upstream of the acceptor splice site in vertebrates, which is part of the polypyrimidine tract that precedes the acceptor splice site.\n5. FALSE [correction]: A purine is not frequently present at the +1 position downstream of the acceptor splice site in vertebrates. Instead, an adenine is frequently present at the +1 position downstream of the acceptor splice site, which is part of the consensus sequence for the acceptor splice site.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "vicuna-13b_response": "The event that results in the acetylation of S6K1 is the activation of the S6K1 kinase by the upstream kinase, such as mTOR. This leads to the phosphorylation of S6K1, which in turn results in its acetylation by acetyltransferase enzymes, such as CREB-binding protein (CBP) and p300. The acetylation of S6K1 modulates its activity and plays a role in regulating cellular metabolism and growth.",
    "vicuna-13b_fact_raw": "1. The acetylation of S6K1 is a result of its activation by upstream kinases like mTOR.\n2. The activation of S6K1 kinase leads to its phosphorylation.\n3. The phosphorylation of S6K1 results in its acetylation by acetyltransferase enzymes.\n4. CREB-binding protein (CBP) and p300 are examples of acetyltransferase enzymes that can acetylate S6K1.\n5. The acetylation of S6K1 modulates its activity and is involved in regulating cellular metabolism and growth.",
    "vicuna-13b_fact": [
      "The acetylation of S6K1 is a result of its activation by upstream kinases like mTOR.",
      "The activation of S6K1 kinase leads to its phosphorylation.",
      "The phosphorylation of S6K1 results in its acetylation by acetyltransferase enzymes.",
      "CREB-binding protein (CBP) and p300 are examples of acetyltransferase enzymes that can acetylate S6K1.",
      "The acetylation of S6K1 modulates its activity and is involved in regulating cellular metabolism and growth."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: The phosphorylation of S6K1 does not result in its acetylation by acetyltransferase enzymes. Phosphorylation and acetylation are separate post-translational modifications that can regulate protein function independently.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "vicuna-13b_response": "Episodic ataxia type 6 (EA6) is a rare, inherited disorder that affects the nervous system and causes episodes of ataxia, which is a lack of coordination and balance. The cause of EA6 is a mutation in the CACNA1A gene, which provides instructions for making a protein called a voltage-gated calcium channel.\nThese channels play a critical role in the normal functioning of nerve cells, including the transmission of electrical signals that are important for movement and coordination. The mutation in the CACNA1A gene that causes EA6 leads to the production of an abnormal version of the protein, which disrupts the normal functioning of the voltage-gated calcium channels and can cause episodes of ataxia.\nEA6 is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition.",
    "vicuna-13b_fact_raw": "1. Episodic ataxia type 6 (EA6) is a rare, inherited disorder that affects the nervous system.\n2. EA6 causes episodes of ataxia, which is a lack of coordination and balance.\n3. The cause of EA6 is a mutation in the CACNA1A gene.\n4. The CACNA1A gene mutation leads to the production of an abnormal version of a protein that disrupts the normal functioning of voltage-gated calcium channels.\n5. EA6 is inherited in an autosomal recessive pattern, requiring two copies of the mutated gene to develop the condition.",
    "vicuna-13b_fact": [
      "Episodic ataxia type 6 (EA6) is a rare, inherited disorder that affects the nervous system.",
      "EA6 causes episodes of ataxia, which is a lack of coordination and balance.",
      "The cause of EA6 is a mutation in the CACNA1A gene.",
      "The CACNA1A gene mutation leads to the production of an abnormal version of a protein that disrupts the normal functioning of voltage-gated calcium channels.",
      "EA6 is inherited in an autosomal recessive pattern, requiring two copies of the mutated gene to develop the condition."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The cause of EA6 is a mutation in the SLC1A3 gene, not the CACNA1A gene.\n4. FALSE [correction]: The mutation in the SLC1A3 gene, not the CACNA1A gene, leads to the production of an abnormal version of a protein that disrupts the normal functioning of glutamate transporters.\n5. FALSE [correction]: EA6 is inherited in an autosomal dominant pattern, meaning only one copy of the mutated gene is necessary to develop the condition.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "vicuna-13b_response": "Chromomethylases are enzymes that add methyl groups to the DNA molecule, leading to the formation of 5-methylcytosine, a modified form of cytosine. These enzymes are present in certain bacteria and archaea, but their presence in animal genomes is less clear.\nSome studies have suggested that chromomethylases may be present in certain animal species, such as mice and rats. However, other studies have found no evidence of these enzymes in the genomes of other animal species, including humans.\nOverall, the presence of chromomethylases in animal genomes is still an area of active research and the exact extent of their presence in animal species is not yet fully understood.",
    "vicuna-13b_fact_raw": "1. Chromomethylases are enzymes that add methyl groups to the DNA molecule.\n2. Chromomethylases lead to the formation of 5-methylcytosine.\n3. Chromomethylases are present in certain bacteria and archaea.\n4. Some studies suggest that chromomethylases may be present in certain animal species, such as mice and rats.\n5. Other studies have found no evidence of chromomethylases in the genomes of some animal species, including humans.",
    "vicuna-13b_fact": [
      "Chromomethylases are enzymes that add methyl groups to the DNA molecule.",
      "Chromomethylases lead to the formation of 5-methylcytosine.",
      "Chromomethylases are present in certain bacteria and archaea.",
      "Some studies suggest that chromomethylases may be present in certain animal species, such as mice and rats.",
      "Other studies have found no evidence of chromomethylases in the genomes of some animal species, including humans."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Chromomethylases are typically found in plants, not in bacteria and archaea.\n4. FALSE [correction]: Chromomethylases have not been reported in animal species such as mice and rats; they are generally associated with plants.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "vicuna-13b_response": "There are several packages available in R/Bioconductor for transcription factor binding site (TFBS) analysis. Some of the most popular ones are:\n1. BioMart: BioMart is a comprehensive database of genomic data that provides access to a wide range of functional genomics data, including ChIP-seq and DNase-seq data for transcription factors. BioMart can be used to identify TFBS in the genome using ChIP-seq data.\n2. ChIPseeker: ChIPseeker is a tool for identifying transcription factor binding sites in ChIP-seq data. It uses a motif-based approach to identify TFBS and can be used with a variety of transcription factors.\n3. HOMER: HOMER is a package for modeling gene expression data, including ChIP-seq data, to identify TFBS in the genome. It uses a Bayesian approach to model gene expression and can identify TFBS using a variety of models.\n4. JASPAR: JASPAR is a database of transcription factor binding profiles that can be used to identify TFBS in the genome. It provides a collection of experimentally determined transcription factor binding profiles for a variety of transcription factors.\n5. TFBS: TFBS is a package for identifying transcription factor binding sites in ChIP-seq data. It uses a motif-based approach and can be used with a variety of transcription factors.\nThese are just a few examples of the packages available for TFBS analysis in R/Bioconductor. There are many other packages available, each with its own strengths and weaknesses, so it's important to choose the right tool for the job based on the specific needs of the experiment.",
    "vicuna-13b_fact_raw": "1. BioMart is a database in R/Bioconductor that provides access to functional genomics data, including ChIP-seq and DNase-seq data for transcription factors.\n2. ChIPseeker is an R/Bioconductor tool designed to identify transcription factor binding sites in ChIP-seq data using a motif-based approach.\n3. HOMER is an R/Bioconductor package that models gene expression data to identify transcription factor binding sites in the genome.\n4. JASPAR is a database within R/Bioconductor that contains transcription factor binding profiles for identifying TFBS in the genome.\n5. TFBS is an R/Bioconductor package that identifies transcription factor binding sites in ChIP-seq data using a motif-based approach.",
    "vicuna-13b_fact": [
      "BioMart is a database in R/Bioconductor that provides access to functional genomics data, including ChIP-seq and DNase-seq data for transcription factors.",
      "ChIPseeker is an R/Bioconductor tool designed to identify transcription factor binding sites in ChIP-seq data using a motif-based approach.",
      "HOMER is an R/Bioconductor package that models gene expression data to identify transcription factor binding sites in the genome.",
      "JASPAR is a database within R/Bioconductor that contains transcription factor binding profiles for identifying TFBS in the genome.",
      "TFBS is an R/Bioconductor package that identifies transcription factor binding sites in ChIP-seq data using a motif-based approach."
    ],
    "vicuna-13b_judge_raw": "1. TRUE: BioMart is indeed a database accessible through R/Bioconductor that provides access to a variety of functional genomics data, which can include ChIP-seq and DNase-seq data.\n\n2. FALSE [correction]: ChIPseeker is an R/Bioconductor package that is designed to annotate ChIP-seq data and identify transcription factor binding sites, but it does not specifically use a motif-based approach. It is more focused on annotating peaks in ChIP-seq data with genomic context and visualization.\n\n3. FALSE [correction]: HOMER is not an R/Bioconductor package; it is a standalone software suite for ChIP-seq, motif discovery, next-gen sequencing data analysis, and more. It does include functions for identifying transcription factor binding sites, but it is not part of R/Bioconductor.\n\n4. FALSE [correction]: JASPAR is a database of transcription factor binding profiles, but it is not contained within R/Bioconductor. It can be accessed through R/Bioconductor using packages like 'rGADEM', 'TFBSTools', or 'JASPAR2018', but it is not a database within R/Bioconductor itself.\n\n5. FALSE [correction]: TFBS is not a package in R/Bioconductor. There is a package called 'TFBSTools' in R/Bioconductor that is designed for the analysis and manipulation of transcription factor binding sites, but 'TFBS' as stated is not correct.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "vicuna-13b_response": "Sarcopenia is the loss of muscle mass and strength that can occur with aging. Clinical trials are research studies that involve people, and they are designed to determine whether a treatment is safe and effective. Here are some examples of clinical trials that are focused on the prevention of sarcopenia:\n1. The Sarcopenia and Obesity: Rehabilitation, Exercise, and Nutrition (SOREAN) Study: This is a randomized controlled trial that is investigating the effectiveness of a comprehensive rehabilitation program, including exercise and nutrition counseling, in preventing or reversing sarcopenia in older adults.\n2. The Sarcopenia Prevention and Treatment Trial (SPOTT): This is a randomized controlled trial that is investigating the effectiveness of resistance training and nutritional supplementation in preventing or treating sarcopenia in older adults.\n3. The Sarcopenia in Older Adults: Prevention and Treatment (SOPHIA) Study: This is a randomized controlled trial that is investigating the effectiveness of a combination of exercise and nutritional supplementation in preventing or treating sarcopenia in older adults.\n4. The Effect of Exercise and Nutrition on Sarcopenia in Older Adults (ENSCO) Study: This is a randomized controlled trial that is investigating the effectiveness of a comprehensive exercise and nutrition program in preventing or treating sarcopenia in older adults.\nThese are just a few examples of clinical trials that are focused on the prevention of sarcopenia. It is important to note that these trials are still in progress, and it will be some time before the results are available. If you are interested in participating in a clinical trial, it is important to speak with your doctor or a research coordinator to determine whether you are eligible and to get more information about the trial.",
    "vicuna-13b_fact_raw": "1. The Sarcopenia and Obesity: Rehabilitation, Exercise, and Nutrition (SOREAN) Study is a randomized controlled trial.\n2. The Sarcopenia Prevention and Treatment Trial (SPOTT) is investigating the effectiveness of resistance training and nutritional supplementation in older adults.\n3. The Sarcopenia in Older Adults: Prevention and Treatment (SOPHIA) Study is a randomized controlled trial.\n4. The Effect of Exercise and Nutrition on Sarcopenia in Older Adults (ENSCO) Study is a randomized controlled trial.\n5. The clinical trials mentioned are focused on the prevention or treatment of sarcopenia in older adults.",
    "vicuna-13b_fact": [
      "The Sarcopenia and Obesity: Rehabilitation, Exercise, and Nutrition (SOREAN) Study is a randomized controlled trial.",
      "The Sarcopenia Prevention and Treatment Trial (SPOTT) is investigating the effectiveness of resistance training and nutritional supplementation in older adults.",
      "The Sarcopenia in Older Adults: Prevention and Treatment (SOPHIA) Study is a randomized controlled trial.",
      "The Effect of Exercise and Nutrition on Sarcopenia in Older Adults (ENSCO) Study is a randomized controlled trial.",
      "The clinical trials mentioned are focused on the prevention or treatment of sarcopenia in older adults."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE\n\nThe statements about the specific clinical trials (SOREAN, SPOTT, SOPHIA, and ENSCO) cannot be verified as true or false without additional context or information about these studies. However, based on the names and acronyms given, it is reasonable to infer that they are related to sarcopenia in older adults, which makes the last statement true.",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "vicuna-13b_response": "There are several databases that contain information on molecular recognition features in membrane proteins. Some of the most well-known databases include:\n1. The Membrane Protein Data Bank (MPDB): This database contains a large collection of three-dimensional structures of membrane proteins, along with information on the molecular recognition features that are important for their function.\n2. The Protein Data Bank (PDB): This database contains a wide range of protein structures, including membrane proteins, and can be searched using various criteria, including molecular recognition features.\n3. The Comparative Membrane Protein Structure Database (COMPASS): This database provides a comprehensive collection of membrane protein structures and associated information, including details on molecular recognition features.\n4. The Molecular Recognition Database (MoRD): This database contains a large collection of molecular recognition data, including information on the interactions between proteins and small molecules, which can be used to study membrane protein function.\n5. The Membrane Protein Interaction Database (MPIDB): This database contains information on the interactions between membrane proteins and other proteins, lipids, and small molecules, including details on the molecular recognition features involved in these interactions.\nThese databases can be useful resources for researchers studying membrane protein function and molecular recognition.",
    "vicuna-13b_fact_raw": "1. The Membrane Protein Data Bank (MPDB) contains three-dimensional structures of membrane proteins and information on their molecular recognition features.\n2. The Protein Data Bank (PDB) includes a range of protein structures, such as membrane proteins, and allows searches based on molecular recognition features.\n3. The Comparative Membrane Protein Structure Database (COMPASS) offers a collection of membrane protein structures with associated information on molecular recognition features.\n4. The Molecular Recognition Database (MoRD) has a collection of data on interactions between proteins and small molecules relevant to membrane protein function.\n5. The Membrane Protein Interaction Database (MPIDB) provides information on interactions between membrane proteins and other entities, including molecular recognition features.",
    "vicuna-13b_fact": [
      "The Membrane Protein Data Bank (MPDB) contains three-dimensional structures of membrane proteins and information on their molecular recognition features.",
      "The Protein Data Bank (PDB) includes a range of protein structures, such as membrane proteins, and allows searches based on molecular recognition features.",
      "The Comparative Membrane Protein Structure Database (COMPASS) offers a collection of membrane protein structures with associated information on molecular recognition features.",
      "The Molecular Recognition Database (MoRD) has a collection of data on interactions between proteins and small molecules relevant to membrane protein function.",
      "The Membrane Protein Interaction Database (MPIDB) provides information on interactions between membrane proteins and other entities, including molecular recognition features."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements about the Membrane Protein Data Bank (MPDB) and the Protein Data Bank (PDB) are consistent with the general knowledge that these databases contain structural information about proteins, including membrane proteins, and often include data on molecular recognition features. However, without specific knowledge about the Comparative Membrane Protein Structure Database (COMPASS), the Molecular Recognition Database (MoRD), and the Membrane Protein Interaction Database (MPIDB), it is not possible to confirm the accuracy of statements 3, 4, and 5. These databases are not as widely known or referenced as the PDB, and without additional context or information, their existence and the details provided cannot be verified.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "vicuna-13b_response": "Yes, rivaroxaban is metabolized in the kidneys. Rivaroxaban is an oral anticoagulant medication that is used to prevent blood clots from forming in the body. It is a direct factor Xa inhibitor and works by inhibiting the activity of factor Xa, which is an enzyme that plays a role in the coagulation cascade.\nRivaroxaban is metabolized in the liver and kidneys by enzymes such as CYP3A4 and CYP2J2. The metabolism of rivaroxaban results in the formation of several active and inactive metabolites. The active metabolites of rivaroxaban have similar anticoagulant activity as the parent compound, while the inactive metabolites are eliminated from the body in the urine.\nIt is important to note that the metabolism of rivaroxaban can be affected by other medications that a patient is taking, as well as by certain genetic factors. Therefore, the dosage and monitoring of rivaroxaban therapy should be individualized based on the patient's specific medical condition and other factors.",
    "vicuna-13b_fact_raw": "1. Rivaroxaban is metabolized in the liver and kidneys.\n2. Rivaroxaban is an oral anticoagulant medication used to prevent blood clots.\n3. Rivaroxaban works by inhibiting the activity of factor Xa, an enzyme in the coagulation cascade.\n4. The metabolism of rivaroxaban involves enzymes such as CYP3A4 and CYP2J2.\n5. The active metabolites of rivaroxaban have similar anticoagulant activity to the parent compound.",
    "vicuna-13b_fact": [
      "Rivaroxaban is metabolized in the liver and kidneys.",
      "Rivaroxaban is an oral anticoagulant medication used to prevent blood clots.",
      "Rivaroxaban works by inhibiting the activity of factor Xa, an enzyme in the coagulation cascade.",
      "The metabolism of rivaroxaban involves enzymes such as CYP3A4 and CYP2J2.",
      "The active metabolites of rivaroxaban have similar anticoagulant activity to the parent compound."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The active metabolites of rivaroxaban are considered to have negligible anticoagulant activity compared to the parent compound.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "vicuna-13b_response": "TRÎ±2 (also known as TR2) is a transcription factor that plays a role in the regulation of several genes involved in cardiac development and function. Some of the genes that have been shown to be regulated by TRÎ±2 in the heart include:\n1. Ankyrin-2: TRÎ±2 has been shown to regulate the expression of Ankyrin-2, a protein that is important for the formation of cardiac sarcomeres and the maintenance of cardiac muscle integrity.\n2. Beta-myosin heavy chain: TRÎ±2 has been shown to regulate the expression of Beta-myosin heavy chain, a protein that is important for the contraction of cardiac muscle.\n3. Cardiac troponin I: TRÎ±2 has been shown to regulate the expression of Cardiac troponin I, a protein that is important for the regulation of muscle contraction in the heart.\n4. Nkx2-5: TRÎ±2 has been shown to regulate the expression of Nkx2-5, a transcription factor that is important for the development and differentiation of cardiac muscle cells.\n5. GATA4: TRÎ±2 has been shown to regulate the expression of GATA4, a transcription factor that is important for the development and function of the heart.\nThese are just a few examples of the genes that have been shown to be regulated by TRÎ±2 in the heart. It is important to note that the specific genes regulated by TRÎ±2 can vary depending on the context and the stage of development or disease being studied.",
    "vicuna-13b_fact_raw": "1. TRÎ±2 regulates the expression of Ankyrin-2 in the heart.\n2. TRÎ±2 regulates the expression of Beta-myosin heavy chain in the heart.\n3. TRÎ±2 regulates the expression of Cardiac troponin I in the heart.\n4. TRÎ±2 regulates the expression of Nkx2-5 in the heart.\n5. TRÎ±2 regulates the expression of GATA4 in the heart.",
    "vicuna-13b_fact": [
      "TRÎ±2 regulates the expression of Ankyrin-2 in the heart.",
      "TRÎ±2 regulates the expression of Beta-myosin heavy chain in the heart.",
      "TRÎ±2 regulates the expression of Cardiac troponin I in the heart.",
      "TRÎ±2 regulates the expression of Nkx2-5 in the heart.",
      "TRÎ±2 regulates the expression of GATA4 in the heart."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements provided are specific to the field of molecular biology and the regulation of gene expression in the heart by TRÎ±2 (thyroid hormone receptor alpha 2). Without specific scientific literature or research data to confirm or refute these statements, it is not possible to accurately determine the truthfulness of these claims. Therefore, the response to each statement is UNKNOWN.",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "vicuna-13b_response": "There are several biomedical question answering systems available, including:\n1. BM25: A statistical model that uses a combination of term frequency and inverse document frequency to rank the relevance of documents to a given query.\n2. MedSpacy: A biomedical text mining library built on top of the Spacy library that provides tools for text preprocessing, entity recognition, and relation extraction.\n3. BERT: A pre-trained language model that can be fine-tuned for biomedical question answering tasks using a variety of neural network architectures.\n4. Unified Medical Language System (UMLS): A set of integrated biomedical terminologies and ontologies that can be used for question answering, information retrieval, and other biomedical text processing tasks.\n5. Neural Information Processing System (NIPS): A collection of biomedical datasets and tools for training and evaluating machine learning models for question answering tasks.\n6. PubMed Query Language (PubMedQL): A natural language processing tool that can be used to search the PubMed database of biomedical literature using a variety of query types.\n7. BioASQ: A biomedical question answering challenge that provides a large dataset of biomedical questions and answers for researchers to develop and evaluate their question answering systems.\nThese are just a few examples of the many biomedical question answering systems that are available.",
    "vicuna-13b_fact_raw": "1. BM25 is a statistical model used to rank the relevance of documents to a query based on term frequency and inverse document frequency.\n2. MedSpacy is a biomedical text mining library that operates on top of the Spacy library.\n3. BERT is a pre-trained language model that can be fine-tuned for biomedical question answering tasks.\n4. The Unified Medical Language System (UMLS) integrates biomedical terminologies and ontologies for various text processing tasks.\n5. BioASQ is a challenge that provides a dataset for developing and evaluating biomedical question answering systems.",
    "vicuna-13b_fact": [
      "BM25 is a statistical model used to rank the relevance of documents to a query based on term frequency and inverse document frequency.",
      "MedSpacy is a biomedical text mining library that operates on top of the Spacy library.",
      "BERT is a pre-trained language model that can be fine-tuned for biomedical question answering tasks.",
      "The Unified Medical Language System (UMLS) integrates biomedical terminologies and ontologies for various text processing tasks.",
      "BioASQ is a challenge that provides a dataset for developing and evaluating biomedical question answering systems."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: BM25 is a ranking function used to estimate the relevance of documents to a given search query, primarily based on the term frequency (TF) and inverse document frequency (IDF) of the query terms in the documents, not on term frequency and inverse document frequency alone.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "vicuna-13b_response": "The transcription factor that activates the betalain pathway is called \"Betalain-responsive transcription factor 1\" (BTF1). BTF1 is a transcription factor that regulates the expression of genes involved in the betalain pathway, which is responsible for the production of the pigments that give red and yellow color to some fruits and vegetables, such as beets and carrots. BTF1 is a key regulator of the betalain pathway, and it is activated in response to environmental stress, such as high temperatures, drought, and disease. The activation of BTF1 leads to the upregulation of genes involved in the betalain pathway, which results in the production of the pigments that give red and yellow color to some fruits and vegetables.",
    "vicuna-13b_fact_raw": "1. The transcription factor that activates the betalain pathway is called \"Betalain-responsive transcription factor 1\" (BTF1).\n2. BTF1 regulates the expression of genes involved in the betalain pathway.\n3. The betalain pathway is responsible for the production of pigments that give red and yellow color to some fruits and vegetables, such as beets and carrots.\n4. BTF1 is activated in response to environmental stress, including high temperatures, drought, and disease.\n5. Activation of BTF1 leads to the upregulation of genes involved in the betalain pathway.",
    "vicuna-13b_fact": [
      "The transcription factor that activates the betalain pathway is called \"Betalain-responsive transcription factor 1\" (BTF1).",
      "BTF1 regulates the expression of genes involved in the betalain pathway.",
      "The betalain pathway is responsible for the production of pigments that give red and yellow color to some fruits and vegetables, such as beets and carrots.",
      "BTF1 is activated in response to environmental stress, including high temperatures, drought, and disease.",
      "Activation of BTF1 leads to the upregulation of genes involved in the betalain pathway."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: The betalain pathway is responsible for the production of pigments that give red and yellow color to some fruits and vegetables, such as beets, but not carrots. Carrots get their color primarily from carotenoids.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "vicuna-13b_response": "There are several technologies that can be used for the enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses. The choice of technology depends on various factors, such as the sample type, the number of phosphorylation sites, the dynamic range of phosphorylation levels, and the sensitivity required. Here are some of the preferred technologies for the enrichment of phosphorylated peptides:\n1. Ion Mobility Mass Spectrometry (IM-MS): IM-MS is a powerful tool for the enrichment and identification of phosphorylated peptides. IM-MS separates ions based on their mobility in a strong electric field, which allows for the separation of ions based on their mass-to-charge ratio and shape. IM-MS can be used for the enrichment of phosphorylated peptides by trapping ions based on their mobility and charge state.\n2. Phospho-specific antibodies: Phospho-specific antibodies can be used to enrich for phosphorylated peptides by binding specifically to phosphorylated epitopes. This method is widely used in proteomics and has been used for the enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses.\n3. Phosphate affinity chromatography: Phosphate affinity chromatography is a method that uses a phosphate-based ligand to bind to phosphorylated peptides. This method can be used to enrich for phosphorylated peptides by binding specifically to phosphorylated epitopes.\n4. TiO2: TiO2 is a material that can be used for the enrichment of phosphorylated peptides by immobilizing phosphorylated peptides on its surface. This method is based on the interaction between phosphate groups and TiO2, which can be used to enrich for phosphorylated peptides.\n5. HPLC: High-performance liquid chromatography (HPLC) can be used for the enrichment of phosphorylated peptides by separating peptides based on their hydrophobicity, size",
    "vicuna-13b_fact_raw": "1. Ion Mobility Mass Spectrometry (IM-MS) is used for the enrichment and identification of phosphorylated peptides in global quantitative phosphoproteomic analyses.\n2. Phospho-specific antibodies are used to enrich for phosphorylated peptides by binding specifically to phosphorylated epitopes in proteomics.\n3. Phosphate affinity chromatography employs a phosphate-based ligand to bind to phosphorylated peptides for enrichment purposes.\n4. TiO2 is utilized for the enrichment of phosphorylated peptides by immobilizing them on its surface.\n5. High-performance liquid chromatography (HPLC) is applied for the enrichment of phosphorylated peptides by separating them based on their hydrophobicity.",
    "vicuna-13b_fact": [
      "Ion Mobility Mass Spectrometry (IM-MS) is used for the enrichment and identification of phosphorylated peptides in global quantitative phosphoproteomic analyses.",
      "Phospho-specific antibodies are used to enrich for phosphorylated peptides by binding specifically to phosphorylated epitopes in proteomics.",
      "Phosphate affinity chromatography employs a phosphate-based ligand to bind to phosphorylated peptides for enrichment purposes.",
      "TiO2 is utilized for the enrichment of phosphorylated peptides by immobilizing them on its surface.",
      "High-performance liquid chromatography (HPLC) is applied for the enrichment of phosphorylated peptides by separating them based on their hydrophobicity."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: High-performance liquid chromatography (HPLC) is used for the separation of peptides based on their hydrophobicity, but it is not specifically used for the enrichment of phosphorylated peptides. Enrichment of phosphorylated peptides is typically achieved using methods like immobilized metal affinity chromatography (IMAC) or metal oxide affinity chromatography (MOAC), such as with TiO2 as mentioned in statement 4.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "vicuna-13b_response": "The Palmini classification is a system for classifying different types of depression. It was developed by Italian psychiatrist Giovanni Palmini and his colleagues in the 1980s. The Palmini classification system is based on a combination of clinical and psychological factors, and it is used to help diagnose and treat depression.\nThe Palmini classification system includes four main types of depression:\n1. Endogenous depression: This type of depression is thought to be caused by biological factors, such as genetics or hormonal imbalances. It is characterized by a tendency to feel sad or hopeless for no apparent reason, and it often improves with antidepressant medication.\n2. Neurotic depression: This type of depression is thought to be caused by psychological factors, such as stress or anxiety. It is characterized by feelings of sadness or anxiety that are related to specific life events or situations. It may improve with therapy or counseling.\n3. Atypical depression: This type of depression is characterized by symptoms that do not fit into the other two categories. It may include symptoms such as excessive sleeping, increased appetite, and a lack of energy. It may respond to a combination of medication and therapy.\n4. Melancholic depression: This type of depression is characterized by a loss of interest in activities, a lack of energy, and feelings of hopelessness or pessimism. It may respond well to antidepressant medication, but it often requires a higher dose than other types of depression.\nIt's important to note that the Palmini classification system is not universally accepted and some experts may use different classification systems to diagnose and treat depression. It's always best to consult with a qualified mental health professional for a proper diagnosis and treatment plan.",
    "vicuna-13b_fact_raw": "1. The Palmini classification is a system for classifying different types of depression.\n2. It was developed by Italian psychiatrist Giovanni Palmini and his colleagues in the 1980s.\n3. The Palmini classification system includes four main types of depression: Endogenous, Neurotic, Atypical, and Melancholic.\n4. Endogenous depression is thought to be caused by biological factors and often improves with antidepressant medication.\n5. The Palmini classification system is not universally accepted among experts.",
    "vicuna-13b_fact": [
      "The Palmini classification is a system for classifying different types of depression.",
      "It was developed by Italian psychiatrist Giovanni Palmini and his colleagues in the 1980s.",
      "The Palmini classification system includes four main types of depression: Endogenous, Neurotic, Atypical, and Melancholic.",
      "Endogenous depression is thought to be caused by biological factors and often improves with antidepressant medication.",
      "The Palmini classification system is not universally accepted among experts."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Palmini classification is not a recognized system for classifying different types of depression. The widely known classifications are the DSM (Diagnostic and Statistical Manual of Mental Disorders) and the ICD (International Classification of Diseases).\n2. FALSE [correction]: Since the Palmini classification is not a recognized system, it was not developed by Giovanni Palmini or any other individual.\n3. FALSE [correction]: As the Palmini classification system does not exist, it does not include any types of depression. The types of depression commonly recognized are Major Depressive Disorder, Persistent Depressive Disorder (Dysthymia), Bipolar Disorder, Seasonal Affective Disorder (SAD), and others.\n4. TRUE: While the statement about endogenous depression is true in the context of depression classification, it is not related to the non-existent Palmini classification. Endogenous depression is a term that was used historically to describe depression thought to be caused by biological factors rather than external stressors, and it is often responsive to antidepressant medication.\n5. TRUE: Since the Palmini classification system does not exist, it is indeed not universally accepted among experts.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "vicuna-13b_response": "Human subacute thyroiditis is a type of inflammatory thyroid disease that is characterized by inflammation and swelling of the thyroid gland. The exact cause of subacute thyroiditis is not fully understood, but it is thought to be triggered by a viral infection in some cases.\nThere is evidence to suggest that certain viruses, such as the Epstein-Barr virus (EBV) and the cytomegalovirus (CMV), may play a role in the development of subacute thyroiditis. These viruses are known to cause inflammation and swelling of the thyroid gland, leading to the symptoms of subacute thyroiditis.\nHowever, it is important to note that not all cases of subacute thyroiditis are caused by viral infections. In some cases, the condition may be caused by other factors, such as a reaction to certain medications or an autoimmune disorder.\nIf you are experiencing symptoms of subacute thyroiditis, it is important to speak with a healthcare provider for proper diagnosis and treatment. They will be able to determine the underlying cause of your condition and recommend the appropriate course of treatment.",
    "vicuna-13b_fact_raw": "1. Human subacute thyroiditis is characterized by inflammation and swelling of the thyroid gland.\n2. The exact cause of subacute thyroiditis is not fully understood.\n3. Subacute thyroiditis is thought to be triggered by a viral infection in some cases.\n4. The Epstein-Barr virus (EBV) and the cytomegalovirus (CMV) may play a role in the development of subacute thyroiditis.\n5. Not all cases of subacute thyroiditis are caused by viral infections; other factors may include reactions to certain medications or autoimmune disorders.",
    "vicuna-13b_fact": [
      "Human subacute thyroiditis is characterized by inflammation and swelling of the thyroid gland.",
      "The exact cause of subacute thyroiditis is not fully understood.",
      "Subacute thyroiditis is thought to be triggered by a viral infection in some cases.",
      "The Epstein-Barr virus (EBV) and the cytomegalovirus (CMV) may play a role in the development of subacute thyroiditis.",
      "Not all cases of subacute thyroiditis are caused by viral infections; other factors may include reactions to certain medications or autoimmune disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "vicuna-13b_response": "Yes, STAT3 is involved in EIF2AK2-dependent suppression of autophagy. EIF2AK2, also known as PKR-like endoplasmic reticulum (ER) kinase (PERK), is a protein kinase that plays a critical role in the regulation of protein synthesis and the unfolded protein response (UPR) in the ER. STAT3, on the other hand, is a transcription factor that is involved in a variety of cellular processes, including cell proliferation, differentiation, and survival.\nSeveral studies have shown that EIF2AK2 can phosphorylate and activate STAT3, leading to the suppression of autophagy. When EIF2AK2 is activated by ER stress, it phosphorylates and activates PERK, which then phosphorylates and activates STAT3. This activation of STAT3 then leads to the suppression of autophagy by inhibiting the expression of autophagy-related genes.\nIn conclusion, EIF2AK2-dependent suppression of autophagy is mediated, in part, by the activation of STAT3. The activation of STAT3 by EIF2AK2 in response to ER stress inhibits autophagy, which helps to maintain protein synthesis and prevent cell death.",
    "vicuna-13b_fact_raw": "1. STAT3 is involved in EIF2AK2-dependent suppression of autophagy.\n2. EIF2AK2, also known as PKR-like endoplasmic reticulum kinase (PERK), plays a role in the regulation of protein synthesis and the unfolded protein response in the ER.\n3. STAT3 is a transcription factor involved in cellular processes such as cell proliferation, differentiation, and survival.\n4. EIF2AK2 can phosphorylate and activate STAT3, which leads to the suppression of autophagy.\n5. Activation of STAT3 by EIF2AK2 in response to ER stress inhibits the expression of autophagy-related genes.",
    "vicuna-13b_fact": [
      "STAT3 is involved in EIF2AK2-dependent suppression of autophagy.",
      "EIF2AK2, also known as PKR-like endoplasmic reticulum kinase (PERK), plays a role in the regulation of protein synthesis and the unfolded protein response in the ER.",
      "STAT3 is a transcription factor involved in cellular processes such as cell proliferation, differentiation, and survival.",
      "EIF2AK2 can phosphorylate and activate STAT3, which leads to the suppression of autophagy.",
      "Activation of STAT3 by EIF2AK2 in response to ER stress inhibits the expression of autophagy-related genes."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: EIF2AK2, also known as Protein Kinase R (PKR), is involved in the regulation of protein synthesis and the response to viral infections. PERK is actually EIF2AK3, which is involved in the unfolded protein response in the ER.\n3. TRUE\n4. FALSE [correction]: EIF2AK2 (PKR) does not directly phosphorylate and activate STAT3. STAT3 is typically activated by Janus kinases (JAKs) in response to cytokine signaling.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "vicuna-13b_response": "Theatre is a software tool that is used for genomic analysis. It is designed to help researchers and scientists analyze large amounts of genomic data, such as DNA sequencing data, in a more efficient and effective way.\nTheatre allows users to easily visualize and explore their genomic data, using a variety of different visualization and analysis tools. This can help researchers to identify patterns and trends in their data, and to gain insights into the underlying biology of their samples.\nSome of the key features of Theatre include:\n* Support for a wide range of different file formats, including FASTQ, BAM, and VCF\n* A powerful query and filtering system, which allows users to quickly narrow down their data to specific subsets\n* A range of different visualization tools, including track viewers, heatmaps, and gene expression plots\n* Integration with other popular genomic analysis tools, such as GATK and bcftools\nOverall, Theatre is a valuable tool for anyone who needs to analyze large amounts of genomic data, and it is widely used in a variety of different research and clinical settings.",
    "vicuna-13b_fact_raw": "1. Theatre is a software tool used for genomic analysis.\n2. It is designed to help analyze large amounts of genomic data, including DNA sequencing data.\n3. Theatre supports various file formats such as FASTQ, BAM, and VCF.\n4. The software includes a query and filtering system to narrow down data to specific subsets.\n5. Theatre integrates with other genomic analysis tools like GATK and bcftools.",
    "vicuna-13b_fact": [
      "Theatre is a software tool used for genomic analysis.",
      "It is designed to help analyze large amounts of genomic data, including DNA sequencing data.",
      "Theatre supports various file formats such as FASTQ, BAM, and VCF.",
      "The software includes a query and filtering system to narrow down data to specific subsets.",
      "Theatre integrates with other genomic analysis tools like GATK and bcftools."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Theatre is not known as a software tool for genomic analysis. The statement may be referring to a different software tool, but without the correct name, it's not possible to provide a specific correction.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nSince the first statement is false and there is no known genomic analysis tool named Theatre, the validity of the subsequent statements cannot be determined without the correct name of the software tool in question. If the correct name of the software tool were provided, the statements could be evaluated accordingly.",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "vicuna-13b_response": "The execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences depends on several factors, including:\n1. Length of the sequences: The longer the sequences, the more computational time is required for the alignment.\n2. Number of gaps in the sequences: The more gaps in the sequences, the more computational time is required for the alignment.\n3. Number of mismatches allowed: The more mismatches allowed in the alignment, the more computational time is required for the alignment.\n4. The scoring matrix used: The scoring matrix used in the Smith-Waterman algorithm can affect the computational time. For example, using a diagonal matrix as the scoring matrix can reduce the computational time, but it may not provide the best alignment.\nIn general, the Smith-Waterman algorithm has a time complexity of O(n \\* m \\* log(n \\* m)), where n and m are the lengths of the sequences. This makes it an efficient algorithm for aligning large sequences. However, the actual execution time can be much longer than this, depending on the factors mentioned above.",
    "vicuna-13b_fact_raw": "1. The execution time of the Smith-Waterman algorithm for sequence alignment increases with the length of the sequences.\n2. The execution time of the Smith-Waterman algorithm increases with the number of gaps in the sequences.\n3. The execution time of the Smith-Waterman algorithm increases with the number of mismatches allowed in the alignment.\n4. The scoring matrix used in the Smith-Waterman algorithm can affect its computational time.\n5. The Smith-Waterman algorithm has a time complexity of O(n * m * log(n * m)), where n and m are the lengths of the sequences.",
    "vicuna-13b_fact": [
      "The execution time of the Smith-Waterman algorithm for sequence alignment increases with the length of the sequences.",
      "The execution time of the Smith-Waterman algorithm increases with the number of gaps in the sequences.",
      "The execution time of the Smith-Waterman algorithm increases with the number of mismatches allowed in the alignment.",
      "The scoring matrix used in the Smith-Waterman algorithm can affect its computational time.",
      "The Smith-Waterman algorithm has a time complexity of O(n * m * log(n * m)), where n and m are the lengths of the sequences."
    ],
    "vicuna-13b_judge_raw": "1. TRUE: The execution time of the Smith-Waterman algorithm does indeed increase with the length of the sequences because it involves a dynamic programming matrix whose size is proportional to the product of the lengths of the two sequences being aligned.\n\n2. FALSE [correction]: The execution time of the Smith-Waterman algorithm is not directly affected by the number of gaps in the sequences. The algorithm computes the optimal local alignment, which includes identifying the best scoring gaps, but the number of gaps does not change the execution time, which is determined by the lengths of the sequences.\n\n3. UNKNOWN: The statement is vague because the Smith-Waterman algorithm's execution time is not typically described in terms of the \"number of mismatches allowed\" in the alignment. The algorithm finds the optimal local alignment based on a scoring system, which includes penalties for mismatches, but the execution time is not directly affected by the number of mismatches.\n\n4. TRUE: The scoring matrix, which defines the scores for matches, mismatches, and gaps, can affect the computational time of the Smith-Waterman algorithm because different scoring matrices can lead to different alignments and thus different computational paths through the dynamic programming matrix.\n\n5. FALSE [correction]: The Smith-Waterman algorithm has a time complexity of O(n * m), where n and m are the lengths of the two sequences being aligned. The algorithm fills in a matrix of size n*m, and each cell computation is done in constant time, leading to a quadratic time complexity.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "vicuna-13b_response": "FLVCR1 (Follicular Dendritic Cell Sarcoma Recurrence 1) is a member of the SLC (Solute Carrier) family of proteins. SLC proteins are a diverse family of transmembrane proteins that play important roles in the transport of solutes across cell membranes. FLVCR1 is a type I transmembrane protein that functions as a folate transporter and is involved in the uptake of folate, a B vitamin essential for cellular metabolism, into cells.",
    "vicuna-13b_fact_raw": "1. FLVCR1 stands for Follicular Dendritic Cell Sarcoma Recurrence 1.\n2. FLVCR1 is a member of the SLC (Solute Carrier) family of proteins.\n3. SLC proteins are transmembrane proteins involved in the transport of solutes across cell membranes.\n4. FLVCR1 is a type I transmembrane protein.\n5. FLVCR1 functions as a folate transporter involved in the uptake of folate into cells.",
    "vicuna-13b_fact": [
      "FLVCR1 stands for Follicular Dendritic Cell Sarcoma Recurrence 1.",
      "FLVCR1 is a member of the SLC (Solute Carrier) family of proteins.",
      "SLC proteins are transmembrane proteins involved in the transport of solutes across cell membranes.",
      "FLVCR1 is a type I transmembrane protein.",
      "FLVCR1 functions as a folate transporter involved in the uptake of folate into cells."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: FLVCR1 stands for Feline Leukemia Virus, subgroup C, Receptor 1.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: FLVCR1 functions as a heme transporter involved in the export of heme from cells.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "vicuna-13b_response": "GATA-1 is a transcription factor that plays a crucial role in the development and differentiation of hematopoietic cells. Several studies have identified GATA-1 interacting partners using the biotinylation tagging approach. Here are some of the known GATA-1 interacting partners:\n1. TFIIB: GATA-1 was shown to interact with TFIIB, a transcription factor that plays a role in the initiation of transcription.\n2. TBP: GATA-1 was found to interact with TBP, a component of the transcriptional preinitiation complex.\n3. RFX: GATA-1 was shown to interact with RFX, a transcription factor involved in the regulation of immune cell development.\n4. NF-E2: GATA-1 was found to interact with NF-E2, a transcription factor that regulates the expression of genes involved in erythropoiesis.\n5. GATA-2: GATA-1 was shown to interact with GATA-2, another GATA transcription factor that is involved in the development of hematopoietic cells.\n6. PU.1: GATA-1 was found to interact with PU.1, a transcription factor that plays a role in the differentiation of myeloid cells.\nThese are just a few examples of GATA-1 interacting partners that have been identified using the biotinylation tagging approach. Further studies are needed to fully understand the role of these interactions in the regulation of hematopoietic cell development and function.",
    "vicuna-13b_fact_raw": "1. GATA-1 was shown to interact with TFIIB, a transcription factor involved in the initiation of transcription.\n2. GATA-1 was found to interact with TBP, a component of the transcriptional preinitiation complex.\n3. GATA-1 was shown to interact with RFX, a transcription factor involved in the regulation of immune cell development.\n4. GATA-1 was found to interact with NF-E2, a transcription factor that regulates the expression of genes involved in erythropoiesis.\n5. GATA-1 was shown to interact with GATA-2, another GATA transcription factor involved in hematopoietic cell development.",
    "vicuna-13b_fact": [
      "GATA-1 was shown to interact with TFIIB, a transcription factor involved in the initiation of transcription.",
      "GATA-1 was found to interact with TBP, a component of the transcriptional preinitiation complex.",
      "GATA-1 was shown to interact with RFX, a transcription factor involved in the regulation of immune cell development.",
      "GATA-1 was found to interact with NF-E2, a transcription factor that regulates the expression of genes involved in erythropoiesis.",
      "GATA-1 was shown to interact with GATA-2, another GATA transcription factor involved in hematopoietic cell development."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nGATA-1 is a transcription factor known to interact with various other proteins and factors involved in the regulation of gene expression, particularly in the context of hematopoiesis. The statements provided are consistent with the known interactions of GATA-1, although without specific references to the research that demonstrated these interactions, the responses are based on general knowledge of GATA-1's role in transcriptional regulation.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "vicuna-13b_response": "TAF10 is a transcription factor that plays a role in the regulation of gene expression in many organisms, including humans. GATA1 is another transcription factor that is involved in the regulation of gene expression, particularly in the development and function of hematopoietic cells.\nThe outcome of TAF10 interacting with the GATA1 transcription factor can vary depending on the specific context and the target genes being regulated. However, in general, the interaction of TAF10 with GATA1 can enhance the transcriptional activity of GATA1, leading to the upregulation of target genes involved in hematopoiesis and other processes.\nFor example, TAF10 has been shown to interact with GATA1 and enhance its transcriptional activity in the regulation of the erythroid differentiation pathway in hematopoietic cells. In addition, TAF10 has been shown to interact with GATA1 and regulate the expression of genes involved in the immune response and inflammation.\nOverall, the interaction of TAF10 with GATA1 can play an important role in the regulation of gene expression and cellular processes, and further research is needed to fully understand the mechanisms and outcomes of this interaction.",
    "vicuna-13b_fact_raw": "1. TAF10 is a transcription factor involved in the regulation of gene expression in many organisms, including humans.\n2. GATA1 is a transcription factor involved in the regulation of gene expression, particularly in hematopoietic cell development and function.\n3. The interaction of TAF10 with GATA1 can enhance GATA1's transcriptional activity.\n4. TAF10 has been shown to interact with GATA1 in the regulation of the erythroid differentiation pathway in hematopoietic cells.\n5. TAF10's interaction with GATA1 can regulate the expression of genes involved in the immune response and inflammation.",
    "vicuna-13b_fact": [
      "TAF10 is a transcription factor involved in the regulation of gene expression in many organisms, including humans.",
      "GATA1 is a transcription factor involved in the regulation of gene expression, particularly in hematopoietic cell development and function.",
      "The interaction of TAF10 with GATA1 can enhance GATA1's transcriptional activity.",
      "TAF10 has been shown to interact with GATA1 in the regulation of the erythroid differentiation pathway in hematopoietic cells.",
      "TAF10's interaction with GATA1 can regulate the expression of genes involved in the immune response and inflammation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements about TAF10 and GATA1 are specific and would require specialized knowledge in molecular biology or access to scientific literature to confirm. While TAF10 and GATA1 are indeed transcription factors, and GATA1 is involved in hematopoietic cell development, the specifics of their interactions and the pathways they regulate are not common knowledge and would need to be verified with current scientific research.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "vicuna-13b_response": "Yes, there are decision support systems for chronic pain management. These systems are designed to help healthcare professionals, such as doctors and nurses, make informed decisions about the treatment of chronic pain. They typically use algorithms and other tools to analyze patient data, such as medical history, symptoms, and test results, and provide recommendations for treatment options. Some decision support systems for chronic pain management may also take into account patient preferences and values, as well as the latest research and guidelines. These systems can be useful in helping healthcare professionals to select the most appropriate treatment for each individual patient, and to optimize pain management strategies over time.",
    "vicuna-13b_fact_raw": "1. Decision support systems for chronic pain management exist.\n2. These systems are designed to assist healthcare professionals in making informed decisions about chronic pain treatment.\n3. Decision support systems for chronic pain management typically use algorithms to analyze patient data.\n4. The systems provide recommendations for treatment options based on patient data such as medical history, symptoms, and test results.\n5. Some decision support systems for chronic pain management incorporate patient preferences and values, as well as current research and guidelines.",
    "vicuna-13b_fact": [
      "Decision support systems for chronic pain management exist.",
      "These systems are designed to assist healthcare professionals in making informed decisions about chronic pain treatment.",
      "Decision support systems for chronic pain management typically use algorithms to analyze patient data.",
      "The systems provide recommendations for treatment options based on patient data such as medical history, symptoms, and test results.",
      "Some decision support systems for chronic pain management incorporate patient preferences and values, as well as current research and guidelines."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "vicuna-13b_response": "Angiogenin is a protein that plays a role in the process of angiogenesis, which is the formation of new blood vessels. The subcellular localization of angiogenin is not well understood, but it is thought to be involved in the regulation of various cellular processes, including cell division and differentiation. Some studies have suggested that angiogenin may be localized in the cytoplasm and the nucleus of cells, and that it may be involved in the regulation of gene expression. However, further research is needed to fully understand the subcellular localization of angiogenin and its role in cellular processes.",
    "vicuna-13b_fact_raw": "1. Angiogenin is a protein involved in angiogenesis, the formation of new blood vessels.\n2. The subcellular localization of angiogenin is not well understood.\n3. Angiogenin is thought to be involved in the regulation of cellular processes such as cell division and differentiation.\n4. Some studies suggest that angiogenin may be localized in the cytoplasm and the nucleus of cells.\n5. Angiogenin may be involved in the regulation of gene expression.",
    "vicuna-13b_fact": [
      "Angiogenin is a protein involved in angiogenesis, the formation of new blood vessels.",
      "The subcellular localization of angiogenin is not well understood.",
      "Angiogenin is thought to be involved in the regulation of cellular processes such as cell division and differentiation.",
      "Some studies suggest that angiogenin may be localized in the cytoplasm and the nucleus of cells.",
      "Angiogenin may be involved in the regulation of gene expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The subcellular localization of angiogenin is understood to some extent; it is known to be localized in the cytoplasm and nucleus of cells.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "vicuna-13b_response": "Ranolazine is a medication that is used to treat angina (chest pain) and heart rhythm disorders. It works by blocking the late sodium channels in the heart, which helps to reduce the amount of oxygen needed by the heart muscle during exercise.\nRanolazine has also been shown to affect kinase signaling activation in the heart. Kinases are enzymes that play a role in cell signaling and are involved in a variety of cellular processes, including the regulation of cell growth and division.\nRanolazine has been shown to inhibit the activation of certain kinases in the heart, including the Akt and extracellular signal-regulated kinase (ERK) pathways. These kinases are involved in the regulation of cell survival and proliferation, and their inhibition has been shown to have a negative impact on cardiac function.\nIn addition, ranolazine has been shown to inhibit the activation of the protein kinase C (PKC) pathway in the heart. The PKC pathway is involved in the regulation of cardiac contractility and is thought to play a role in the development of heart failure.\nOverall, the effects of ranolazine on kinase signaling activation in the heart are complex and depend on the specific kinase pathway being considered. While ranolazine has been shown to have a negative impact on cardiac function in some cases, it is still an important treatment option for certain heart conditions.",
    "vicuna-13b_fact_raw": "1. Ranolazine is used to treat angina and heart rhythm disorders.\n2. Ranolazine works by blocking the late sodium channels in the heart.\n3. Ranolazine inhibits the activation of certain kinases in the heart, including the Akt and extracellular signal-regulated kinase (ERK) pathways.\n4. The Akt and ERK pathways are involved in the regulation of cell survival and proliferation.\n5. Ranolazine also inhibits the activation of the protein kinase C (PKC) pathway in the heart.",
    "vicuna-13b_fact": [
      "Ranolazine is used to treat angina and heart rhythm disorders.",
      "Ranolazine works by blocking the late sodium channels in the heart.",
      "Ranolazine inhibits the activation of certain kinases in the heart, including the Akt and extracellular signal-regulated kinase (ERK) pathways.",
      "The Akt and ERK pathways are involved in the regulation of cell survival and proliferation.",
      "Ranolazine also inhibits the activation of the protein kinase C (PKC) pathway in the heart."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Ranolazine is not primarily known for inhibiting the activation of kinases such as Akt and ERK in the heart. Its main mechanism of action is related to the inhibition of late sodium channels, which can reduce intracellular calcium overload and improve cardiac function in angina.\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "vicuna-13b_response": "The regulation of Vsr endonuclease is not necessarily independent of the growth phase of bacteria. Vsr endonuclease is an enzyme that is involved in the regulation of gene expression in bacteria, and its activity can be affected by various factors, including the growth phase of the bacteria.\nStudies have shown that the expression of the Vsr endonuclease gene is regulated by the transcription factor VcrA, which is involved in the regulation of virulence genes in bacteria. The expression of VcrA is itself regulated by the global transcriptional regulator Lrp, which is involved in the regulation of bacterial metabolism and stress responses.\nIn addition, the activity of Vsr endonuclease can be affected by the growth phase of the bacteria. For example, Vsr endonuclease activity has been shown to be highest in the exponential growth phase and lowest in the stationary phase of bacteria. This suggests that the regulation of Vsr endonuclease may be influenced by the growth phase of the bacteria.\nOverall, while the regulation of Vsr endonuclease is not necessarily independent of the growth phase of bacteria, it is a complex process that is influenced by a variety of factors, including the transcription factor VcrA, the global transcriptional regulator Lrp, and the growth phase of the bacteria.",
    "vicuna-13b_fact_raw": "1. Vsr endonuclease is an enzyme involved in the regulation of gene expression in bacteria.\n2. The activity of Vsr endonuclease can be affected by the growth phase of the bacteria.\n3. The expression of the Vsr endonuclease gene is regulated by the transcription factor VcrA.\n4. VcrA is involved in the regulation of virulence genes in bacteria.\n5. The global transcriptional regulator Lrp is involved in the regulation of bacterial metabolism and stress responses.",
    "vicuna-13b_fact": [
      "Vsr endonuclease is an enzyme involved in the regulation of gene expression in bacteria.",
      "The activity of Vsr endonuclease can be affected by the growth phase of the bacteria.",
      "The expression of the Vsr endonuclease gene is regulated by the transcription factor VcrA.",
      "VcrA is involved in the regulation of virulence genes in bacteria.",
      "The global transcriptional regulator Lrp is involved in the regulation of bacterial metabolism and stress responses."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Vsr endonuclease is an enzyme involved in DNA mismatch repair in bacteria, not directly in the regulation of gene expression.\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "vicuna-13b_response": "Beta-barrel transmembrane proteins are a type of protein that are characterized by having a beta-sheet structure that forms a barrel-shaped structure across the membrane. These proteins play important roles in various cellular processes, such as transport of molecules across the cell membrane, and are often targets for drug development. There are several computational tools that can be used for the prediction of beta-barrel transmembrane proteins, including:\n1. TMHMM: TMHMM (Transmembrane Helix Membrane Modeling) is a widely used tool for predicting transmembrane proteins, including beta-barrel proteins. It uses a combination of machine learning and statistical methods to predict transmembrane helices and the location of the membrane-spanning segments.\n2. Phobos: Phobos is a web-based tool that uses a combination of sequence and structural features to predict transmembrane proteins, including beta-barrel proteins. It can also predict the topology of the protein and the location of the transmembrane segments.\n3. BetaBarrel: BetaBarrel is a standalone tool that can be used for the prediction of beta-barrel transmembrane proteins. It uses a combination of sequence and structural features to predict the presence of beta-barrel domains in a protein sequence.\n4. TOPCONS: TOPCONS (Transmembrane Protein Structure Prediction using Consensus Sites) is a tool that uses a combination of machine learning and consensus sites to predict the topology and structure of transmembrane proteins, including beta-barrel proteins.\n5. BetaRod: BetaRod is a web-based tool that can be used for the prediction of beta-barrel transmembrane proteins. It uses a combination of sequence and structural features to predict the presence of beta-barrel domains in a protein sequence.\nThese are some of the computational tools that can be used for the prediction of beta-barrel transmembrane proteins. It is important to note that these tools are not perfect and may have some limitations in their predictions. Therefore, it is important to validate the predictions using experimental data.",
    "vicuna-13b_fact_raw": "1. TMHMM is a computational tool used for predicting transmembrane proteins, including beta-barrel proteins.\n2. Phobos is a web-based tool that predicts transmembrane proteins and can determine the topology and location of transmembrane segments.\n3. BetaBarrel is a standalone computational tool designed for predicting beta-barrel transmembrane proteins.\n4. TOPCONS is a computational tool that predicts the topology and structure of transmembrane proteins using machine learning and consensus sites.\n5. BetaRod is a web-based tool for predicting beta-barrel transmembrane proteins based on sequence and structural features.",
    "vicuna-13b_fact": [
      "TMHMM is a computational tool used for predicting transmembrane proteins, including beta-barrel proteins.",
      "Phobos is a web-based tool that predicts transmembrane proteins and can determine the topology and location of transmembrane segments.",
      "BetaBarrel is a standalone computational tool designed for predicting beta-barrel transmembrane proteins.",
      "TOPCONS is a computational tool that predicts the topology and structure of transmembrane proteins using machine learning and consensus sites.",
      "BetaRod is a web-based tool for predicting beta-barrel transmembrane proteins based on sequence and structural features."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: TMHMM is a computational tool used for predicting transmembrane helices in proteins, not specifically beta-barrel proteins.\n2. UNKNOWN: The statement could be referring to a hypothetical tool named \"Phobos,\" but without specific information about this tool, it's not possible to verify the accuracy of the statement. Commonly known tools for transmembrane protein prediction include Phobius, not Phobos.\n3. UNKNOWN: The statement could be referring to a hypothetical tool named \"BetaBarrel,\" but without specific information about this tool, it's not possible to verify the accuracy of the statement. There are tools like PRED-TMBB for predicting beta-barrel transmembrane proteins.\n4. TRUE: TOPCONS is a consensus prediction server for the topology of transmembrane proteins that uses multiple methods to provide a consensus prediction.\n5. UNKNOWN: The statement could be referring to a hypothetical tool named \"BetaRod,\" but without specific information about this tool, it's not possible to verify the accuracy of the statement. There are tools for predicting beta-barrel transmembrane proteins, but \"BetaRod\" is not a widely recognized tool in the scientific community as of my knowledge cutoff date.",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "vicuna-13b_response": "Galassi classification is used for the classification of mental and behavioral disorders. It is a system of classification that was developed by the Italian psychiatrist, Enrico Galassi, in the early 20th century. The Galassi classification system is based on the principle of grouping disorders based on their underlying psychological mechanisms, rather than on their symptoms or external features.\nThe Galassi classification system is divided into three main categories:\n1. Psychoneurotic disorders: These are disorders that are characterized by anxiety, depression, and other emotional disturbances.\n2. Personality disorders: These are disorders that are characterized by long-term patterns of behavior and thinking that deviate from the norm of the individual's culture.\n3. Organic mental disorders: These are disorders that are caused by physical illness or injury, or by the use of certain medications.\nThe Galassi classification system is not widely used in modern psychiatry, as it has been replaced by other classification systems, such as the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases (ICD). However, the principles of the Galassi classification system continue to influence the way that mental and behavioral disorders are understood and treated.",
    "vicuna-13b_fact_raw": "1. The Galassi classification is used for the classification of mental and behavioral disorders.\n2. Enrico Galassi, an Italian psychiatrist, developed the Galassi classification system in the early 20th century.\n3. The Galassi classification system groups disorders based on their underlying psychological mechanisms.\n4. The Galassi classification system includes categories for psychoneurotic disorders, personality disorders, and organic mental disorders.\n5. The Galassi classification system has been replaced by other classification systems like the DSM and ICD in modern psychiatry.",
    "vicuna-13b_fact": [
      "The Galassi classification is used for the classification of mental and behavioral disorders.",
      "Enrico Galassi, an Italian psychiatrist, developed the Galassi classification system in the early 20th century.",
      "The Galassi classification system groups disorders based on their underlying psychological mechanisms.",
      "The Galassi classification system includes categories for psychoneurotic disorders, personality disorders, and organic mental disorders.",
      "The Galassi classification system has been replaced by other classification systems like the DSM and ICD in modern psychiatry."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Galassi classification is not used for the classification of mental and behavioral disorders; it is a system used for the classification of middle ear effusions.\n2. FALSE [correction]: Enrico Galassi was an Italian otologist, not a psychiatrist, and he developed the Galassi classification system for middle ear effusions, not mental and behavioral disorders.\n3. FALSE [correction]: Since the Galassi classification is for middle ear effusions, it does not group disorders based on their underlying psychological mechanisms.\n4. FALSE [correction]: The Galassi classification system does not include categories for psychoneurotic disorders, personality disorders, and organic mental disorders as it is not related to psychiatry.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "vicuna-13b_response": "Shapiro syndrome, also known as Shapiro-Thompson syndrome, is a rare genetic disorder that affects the development of the eyes, ears, and other parts of the body. Some common features of this condition include:\n1. Developmental delays: Children with Shapiro syndrome may experience developmental delays in reaching certain milestones, such as crawling, walking, and talking.\n2. Intellectual disability: Many individuals with Shapiro syndrome have some degree of intellectual disability, which can range from mild to severe.\n3. Eye abnormalities: People with Shapiro syndrome often have abnormalities of the eyes, such as cataracts, glaucoma, and strabismus (a condition in which the eyes do not align properly).\n4. Hearing loss: Many individuals with Shapiro syndrome have hearing loss, which can range from mild to severe.\n5. Facial abnormalities: Some people with Shapiro syndrome have distinctive facial features, such as a flat face, a small jaw, and a broad nasal bridge.\n6. Skeletal abnormalities: People with Shapiro syndrome may have abnormalities of the skeletal system, such as short stature, joint laxity, and loose ligaments.\n7. Cardiovascular problems: Some individuals with Shapiro syndrome may have heart defects or other cardiovascular problems.\n8. Kidney problems: Some people with Shapiro syndrome may have kidney problems, such as nephrotic syndrome (a condition in which the kidneys do not properly filter waste and fluids from the blood).\nIt's important to note that not everyone with Shapiro syndrome will have all of these features, and the severity of the condition can vary from person to person.",
    "vicuna-13b_fact_raw": "1. Shapiro syndrome is a rare genetic disorder that affects the development of the eyes, ears, and other parts of the body.\n2. Children with Shapiro syndrome may experience developmental delays in reaching certain milestones, such as crawling, walking, and talking.\n3. Many individuals with Shapiro syndrome have some degree of intellectual disability.\n4. People with Shapiro syndrome often have abnormalities of the eyes, such as cataracts, glaucoma, and strabismus.\n5. Many individuals with Shapiro syndrome have hearing loss, which can range from mild to severe.",
    "vicuna-13b_fact": [
      "Shapiro syndrome is a rare genetic disorder that affects the development of the eyes, ears, and other parts of the body.",
      "Children with Shapiro syndrome may experience developmental delays in reaching certain milestones, such as crawling, walking, and talking.",
      "Many individuals with Shapiro syndrome have some degree of intellectual disability.",
      "People with Shapiro syndrome often have abnormalities of the eyes, such as cataracts, glaucoma, and strabismus.",
      "Many individuals with Shapiro syndrome have hearing loss, which can range from mild to severe."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Shapiro syndrome is a rare neurological disorder characterized by recurrent episodes of spontaneous hypothermia, hyperhidrosis, and agenesis of the corpus callosum, not primarily affecting the development of the eyes, ears, and other parts of the body.\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: Shapiro syndrome does not typically involve abnormalities of the eyes such as cataracts, glaucoma, and strabismus. These are not standard features of Shapiro syndrome.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "vicuna-13b_response": "BRAG1 is a gene that plays a role in regulating cell growth and division. Mutations in the BRAG1 gene have been linked to the development of certain types of cancer, including ovarian cancer, glioblastoma, and acute myeloid leukemia. BRAG1 mutations have also been associated with the development of other diseases, such as inherited bone marrow disorders and neurodegenerative diseases. However, it is important to note that not all diseases are directly linked to mutations within BRAG1, and the specific disease associated with BRAG1 mutations can vary depending on the specific mutation and other factors.",
    "vicuna-13b_fact_raw": "1. Mutations in the BRAG1 gene have been linked to the development of certain types of cancer.\n2. Ovarian cancer is one of the cancers associated with mutations in the BRAG1 gene.\n3. Glioblastoma has been linked to mutations within the BRAG1 gene.\n4. Acute myeloid leukemia is associated with mutations in the BRAG1 gene.\n5. Inherited bone marrow disorders and neurodegenerative diseases have been associated with BRAG1 mutations.",
    "vicuna-13b_fact": [
      "Mutations in the BRAG1 gene have been linked to the development of certain types of cancer.",
      "Ovarian cancer is one of the cancers associated with mutations in the BRAG1 gene.",
      "Glioblastoma has been linked to mutations within the BRAG1 gene.",
      "Acute myeloid leukemia is associated with mutations in the BRAG1 gene.",
      "Inherited bone marrow disorders and neurodegenerative diseases have been associated with BRAG1 mutations."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Mutations in the BRCA1 gene have been linked to the development of certain types of cancer, not BRAG1.\n2. TRUE (assuming the intended gene is BRCA1, as BRAG1 is not associated with cancer)\n3. FALSE [correction]: Glioblastoma has not been commonly linked to mutations within the BRCA1 gene; it is primarily associated with other genetic alterations.\n4. UNKNOWN (While BRCA1 mutations are most commonly associated with breast and ovarian cancers, there is ongoing research into their possible associations with other cancer types, including hematological malignancies. However, a direct, well-established link between BRCA1 mutations and acute myeloid leukemia is not widely recognized as of my knowledge cutoff date.)\n5. FALSE [correction]: Inherited bone marrow disorders and neurodegenerative diseases have not been commonly associated with BRCA1 mutations. BRCA1 mutations are primarily known for their association with an increased risk of breast and ovarian cancers.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "vicuna-13b_response": "Protein phosphatase 1 (PP1) is a ubiquitous serine/threonine phosphatase that plays a critical role in regulating a wide range of cellular processes, including cell growth, differentiation, and survival. PP1 is regulated by a number of different proteins, including inhibitors that modulate its activity.\nOne of the main inhibitors of PP1 is a protein called PP1-binding protein (PP1B). PP1B is a large, structurally complex protein that binds to the regulatory subunit of PP1 and inhibits its activity. PP1B is expressed in a variety of tissues and cells, and its expression is regulated by a number of different signaling pathways.\nAnother inhibitor of PP1 is a protein called PP1-interacting protein (PP1IP). PP1IP is a small protein that binds to the catalytic subunit of PP1 and inhibits its activity. PP1IP is expressed in a variety of tissues and cells, and its expression is regulated by a number of different signaling pathways.\nIn summary, PP1 is inhibited by PP1-binding protein (PP1B) and PP1-interacting protein (PP1IP). These inhibitors play important roles in regulating the activity of PP1 and modulating its effects on cellular processes.",
    "vicuna-13b_fact_raw": "1. Protein phosphatase 1 (PP1) is a serine/threonine phosphatase involved in regulating cell growth, differentiation, and survival.\n2. PP1-binding protein (PP1B) is one of the main inhibitors of PP1.\n3. PP1B binds to the regulatory subunit of PP1 and inhibits its activity.\n4. PP1-interacting protein (PP1IP) is another inhibitor of PP1.\n5. PP1IP binds to the catalytic subunit of PP1 and inhibits its activity.",
    "vicuna-13b_fact": [
      "Protein phosphatase 1 (PP1) is a serine/threonine phosphatase involved in regulating cell growth, differentiation, and survival.",
      "PP1-binding protein (PP1B) is one of the main inhibitors of PP1.",
      "PP1B binds to the regulatory subunit of PP1 and inhibits its activity.",
      "PP1-interacting protein (PP1IP) is another inhibitor of PP1.",
      "PP1IP binds to the catalytic subunit of PP1 and inhibits its activity."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: PP1-binding proteins, generally referred to as PP1 regulatory subunits, can have various effects on PP1, including targeting it to specific locations in the cell, modulating its activity, and sometimes inhibiting it. However, without a specific protein named \"PP1B,\" it is not accurate to claim it as one of the main inhibitors.\n3. UNKNOWN: Without specific information about a protein named \"PP1B,\" it is not possible to determine the accuracy of this statement. PP1 regulatory subunits do bind to PP1 and can modulate its activity, but without knowing if PP1B is a recognized regulatory subunit, the statement's validity is unclear.\n4. UNKNOWN: The statement refers to a protein called \"PP1-interacting protein\" (PP1IP), but without additional context or a specific reference, it is not possible to verify the existence of this protein or its function.\n5. UNKNOWN: Similar to the previous statement, without specific information about a protein named \"PP1IP,\" it is not possible to determine the accuracy of this statement. If PP1IP is a recognized protein that interacts with PP1, the statement could be true, but without confirmation, the validity remains unknown.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "vicuna-13b_response": "Adaptive mutagenesis, also known as stationary-phase mutagenesis, is a phenomenon observed in Bacillus subtilis where the rate of spontaneous mutations increases during the stationary phase of growth. This occurs when the bacteria have reached a state of exponential growth and are no longer able to increase their population size.\nSeveral mechanisms have been proposed to underlie adaptive mutagenesis in Bacillus subtilis. One of the main mechanisms is the activation of stress response pathways, such as the DNA damage response and the SOS response, during the stationary phase of growth. These pathways induce the expression of genes that promote mutagenesis, such as those involved in DNA repair and replication, as well as those that inhibit translesion DNA synthesis.\nAnother mechanism that has been proposed to contribute to adaptive mutagenesis is the accumulation of mutations in key genes involved in DNA repair and replication during the stationary phase of growth. These mutations can lead to changes in the activity of these genes, which can further increase the rate of mutations.\nAdditionally, it has been suggested that the decrease in the rate of bacterial division during the stationary phase of growth may lead to an increase in the rate of mutations, as the cells are more likely to undergo DNA replication errors.\nOverall, the mechanisms underlying adaptive mutagenesis in Bacillus subtilis are complex and multifactorial, and likely involve a combination of the mechanisms mentioned above.",
    "vicuna-13b_fact_raw": "1. Adaptive mutagenesis in Bacillus subtilis is observed when the rate of spontaneous mutations increases during the stationary phase of growth.\n2. The activation of stress response pathways, such as the DNA damage response and the SOS response, is one proposed mechanism for adaptive mutagenesis in Bacillus subtilis.\n3. These stress response pathways induce the expression of genes that promote mutagenesis, including those involved in DNA repair and replication.\n4. Accumulation of mutations in key genes involved in DNA repair and replication during the stationary phase is another proposed mechanism for adaptive mutagenesis in Bacillus subtilis.\n5. A decrease in the rate of bacterial division during the stationary phase may lead to an increase in the rate of mutations due to more DNA replication errors.",
    "vicuna-13b_fact": [
      "Adaptive mutagenesis in Bacillus subtilis is observed when the rate of spontaneous mutations increases during the stationary phase of growth.",
      "The activation of stress response pathways, such as the DNA damage response and the SOS response, is one proposed mechanism for adaptive mutagenesis in Bacillus subtilis.",
      "These stress response pathways induce the expression of genes that promote mutagenesis, including those involved in DNA repair and replication.",
      "Accumulation of mutations in key genes involved in DNA repair and replication during the stationary phase is another proposed mechanism for adaptive mutagenesis in Bacillus subtilis.",
      "A decrease in the rate of bacterial division during the stationary phase may lead to an increase in the rate of mutations due to more DNA replication errors."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Accumulation of mutations in key genes during the stationary phase is not a proposed mechanism for adaptive mutagenesis in Bacillus subtilis. Instead, the stress responses during the stationary phase can induce mutagenic processes that increase the mutation rate.\n5. FALSE [correction]: A decrease in the rate of bacterial division during the stationary phase does not lead to an increase in the rate of mutations due to more DNA replication errors. In fact, less replication occurs during the stationary phase because the cells are not dividing as frequently. Adaptive mutagenesis is thought to be a response to stress rather than a result of increased DNA replication errors during stationary phase.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "vicuna-13b_response": "Erucism is a term that refers to the phenomenon of feeling an itching or tickling sensation on the skin, often in response to an external stimulus such as the presence of an insect or a piece of lint on the skin. There are several possible causes of erucism:\n1. Insect bites or stings: Insects such as mosquitoes, ticks, and bed bugs can cause an itchy sensation on the skin when they bite or sting the person.\n2. Contact dermatitis: This is a type of skin irritation that occurs when the skin comes into contact with an irritant, such as a chemical or an allergen. The itching sensation that occurs with contact dermatitis is often accompanied by redness, swelling, and blisters.\n3. Dry skin: When the skin becomes dry, it can become itchy and flaky. This can be caused by a lack of moisture in the air, or by using harsh soaps or detergents on the skin.\n4. Allergies: Some people are allergic to certain substances, such as pollen or animal dander, which can cause an itchy rash on the skin.\n5. Psychological factors: In some cases, the itching sensation on the skin can be caused by psychological factors such as stress, anxiety, or obsessive-compulsive disorder (OCD).\nOverall, erucism can be caused by a variety of factors, and the specific cause will depend on the individual case. If you are experiencing persistent or severe itching, it is important to speak with a healthcare provider to determine the underlying cause and to receive appropriate treatment.",
    "vicuna-13b_fact_raw": "1. Erucism refers to the sensation of itching or tickling on the skin.\n2. Insect bites or stings from mosquitoes, ticks, and bed bugs can cause erucism.\n3. Contact dermatitis, a type of skin irritation, can cause itching, redness, swelling, and blisters.\n4. Dry skin, which can be caused by a lack of moisture or harsh soaps, can lead to an itchy and flaky sensation.\n5. Psychological factors such as stress, anxiety, or obsessive-compulsive disorder can cause an itching sensation on the skin.",
    "vicuna-13b_fact": [
      "Erucism refers to the sensation of itching or tickling on the skin.",
      "Insect bites or stings from mosquitoes, ticks, and bed bugs can cause erucism.",
      "Contact dermatitis, a type of skin irritation, can cause itching, redness, swelling, and blisters.",
      "Dry skin, which can be caused by a lack of moisture or harsh soaps, can lead to an itchy and flaky sensation.",
      "Psychological factors such as stress, anxiety, or obsessive-compulsive disorder can cause an itching sensation on the skin."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Erucism refers to the irritation and dermatitis caused by contact with the hairs or bristles of certain caterpillars and moths, not just any sensation of itching or tickling on the skin.\n2. FALSE [correction]: Erucism is specifically caused by contact with the hairs or bristles of certain caterpillars and moths, not by insect bites or stings from mosquitoes, ticks, and bed bugs.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "vicuna-13b_response": "Hydrochlorothiazide is a diuretic medication that is primarily used to treat hypertension (high blood pressure) and edema (swelling). It is also sometimes used in combination with other medications to treat diabetes insipidus, a condition in which the body produces too much urine and has an excessive thirst. Hydrochlorothiazide works by increasing the excretion of sodium and chloride ions in the urine, which in turn helps to lower blood pressure and reduce edema. It is usually taken orally, and the dosage and duration of treatment will depend on the individual patient's condition and response to the medication.",
    "vicuna-13b_fact_raw": "1. Hydrochlorothiazide is used to treat hypertension.\n2. Hydrochlorothiazide is used to treat edema.\n3. Hydrochlorothiazide can be used in combination with other medications to treat diabetes insipidus.\n4. Hydrochlorothiazide increases the excretion of sodium and chloride ions in the urine.\n5. Hydrochlorothiazide is usually taken orally.",
    "vicuna-13b_fact": [
      "Hydrochlorothiazide is used to treat hypertension.",
      "Hydrochlorothiazide is used to treat edema.",
      "Hydrochlorothiazide can be used in combination with other medications to treat diabetes insipidus.",
      "Hydrochlorothiazide increases the excretion of sodium and chloride ions in the urine.",
      "Hydrochlorothiazide is usually taken orally."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Hydrochlorothiazide is not typically used to treat diabetes insipidus; instead, medications like desmopressin are used for this condition.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "vicuna-13b_response": "Yes, silicone has been used in the treatment of incontinence. Incontinence is the loss of bladder or bowel control, which can be caused by a variety of factors such as aging, childbirth, surgery, or neurological conditions.\nSilicone is a material that is commonly used in medical devices, including those used for incontinence treatment. One type of device that uses silicone is the silicone urethral sling, which is a surgical procedure used to treat stress urinary incontinence in women. In this procedure, a strip of silicone is placed under the urethra to help support it and prevent leakage of urine.\nSilicone is also used in other types of incontinence devices, such as pads and liners, which are designed to absorb urine or feces and prevent skin irritation or rashes. These devices can be worn internally or externally, depending on the type of incontinence and the individual's needs.\nIt's important to note that not all incontinence treatments involve the use of silicone, and the effectiveness of silicone-based treatments may vary depending on the individual's specific condition and needs. If you are experiencing incontinence, it's important to speak with a healthcare provider to determine the best treatment options for you.",
    "vicuna-13b_fact_raw": "1. Silicone has been used in the treatment of incontinence.\n2. Incontinence is the loss of bladder or bowel control.\n3. The silicone urethral sling is a surgical procedure used to treat stress urinary incontinence in women.\n4. Silicone is used in medical devices such as pads and liners for incontinence treatment.\n5. Silicone-based incontinence devices can be worn internally or externally.",
    "vicuna-13b_fact": [
      "Silicone has been used in the treatment of incontinence.",
      "Incontinence is the loss of bladder or bowel control.",
      "The silicone urethral sling is a surgical procedure used to treat stress urinary incontinence in women.",
      "Silicone is used in medical devices such as pads and liners for incontinence treatment.",
      "Silicone-based incontinence devices can be worn internally or externally."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Silicone is not typically used in disposable medical devices such as pads and liners for incontinence treatment. These products are usually made from absorbent materials like cotton, fluff pulp, and superabsorbent polymers.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "vicuna-13b_response": "There is some evidence to suggest that there may be an association between the moon cycle and the rupture risk of intracranial aneurysms. Intracranial aneurysms are abnormal, weakened areas in the blood vessels that supply blood to the brain. They can rupture and cause bleeding into the brain, which can be life-threatening.\nSeveral studies have suggested that there may be a correlation between the moon cycle and the risk of intracranial aneurysm rupture. One study published in the journal Neurosurgery found that there was a significant increase in the number of ruptured aneurysms admitted to the hospital on days corresponding to full moon and new moon phases, compared to other days of the month. Another study published in the journal Stroke found that the risk of ruptured aneurysm was higher on full moon days compared to other days.\nThe exact mechanism by which the moon cycle may affect the rupture risk of intracranial aneurysms is not well understood. Some researchers have suggested that the increased gravitational force of the full moon may contribute to the increased risk of rupture. However, more research is needed to confirm these findings and to determine the underlying mechanisms involved.\nIt is important to note that the association between the moon cycle and intracranial aneurysm rupture risk is still a topic of debate and further research is needed to fully understand this potential relationship.",
    "vicuna-13b_fact_raw": "1. Intracranial aneurysms are abnormal, weakened areas in the blood vessels that supply blood to the brain.\n2. A study published in the journal Neurosurgery found a significant increase in the number of ruptured aneurysms admitted to the hospital on days corresponding to full moon and new moon phases.\n3. Another study published in the journal Stroke found that the risk of ruptured aneurysm was higher on full moon days compared to other days.\n4. Some researchers have suggested that the increased gravitational force of the full moon may contribute to the increased risk of rupture of intracranial aneurysms.\n5. The association between the moon cycle and intracranial aneurysm rupture risk is a topic of debate and requires further research.",
    "vicuna-13b_fact": [
      "Intracranial aneurysms are abnormal, weakened areas in the blood vessels that supply blood to the brain.",
      "A study published in the journal Neurosurgery found a significant increase in the number of ruptured aneurysms admitted to the hospital on days corresponding to full moon and new moon phases.",
      "Another study published in the journal Stroke found that the risk of ruptured aneurysm was higher on full moon days compared to other days.",
      "Some researchers have suggested that the increased gravitational force of the full moon may contribute to the increased risk of rupture of intracranial aneurysms.",
      "The association between the moon cycle and intracranial aneurysm rupture risk is a topic of debate and requires further research."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: There is no scientific evidence to support the claim that the increased gravitational force of the full moon contributes to the increased risk of rupture of intracranial aneurysms. This is a speculative idea and not a widely accepted scientific theory.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "vicuna-13b_response": "Yes, the HuR protein is known to regulate the splicing process in cells. Splicing is a process by which the introns (non-coding sequences) are removed from the messenger RNA (mRNA) molecule, resulting in a mature mRNA that can be translated into a protein. The HuR protein is a RNA-binding protein that binds to the untranslated regions of mRNA molecules and regulates their stability and translation.\nHuR has been shown to play a role in the regulation of alternative splicing, a process by which different versions of a gene can be expressed in different cells or under different conditions. HuR can either enhance or repress the inclusion of specific exons in the mRNA molecule, depending on the cellular context and the stage of the cell cycle.\nOverall, the regulation of splicing by the HuR protein is important for proper gene expression and cellular function, and dysregulation of HuR has been implicated in various diseases, including cancer and neurodegenerative disorders.",
    "vicuna-13b_fact_raw": "1. The HuR protein regulates the splicing process in cells.\n2. Splicing is a process that removes introns from the messenger RNA (mRNA) molecule.\n3. The HuR protein is a RNA-binding protein that binds to untranslated regions of mRNA molecules.\n4. HuR plays a role in the regulation of alternative splicing, which allows different versions of a gene to be expressed.\n5. Dysregulation of HuR has been implicated in various diseases, including cancer and neurodegenerative disorders.",
    "vicuna-13b_fact": [
      "The HuR protein regulates the splicing process in cells.",
      "Splicing is a process that removes introns from the messenger RNA (mRNA) molecule.",
      "The HuR protein is a RNA-binding protein that binds to untranslated regions of mRNA molecules.",
      "HuR plays a role in the regulation of alternative splicing, which allows different versions of a gene to be expressed.",
      "Dysregulation of HuR has been implicated in various diseases, including cancer and neurodegenerative disorders."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The HuR protein does not regulate the splicing process in cells; it is involved in the regulation of mRNA stability and translation.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "vicuna-13b_response": "Prothymosin alpha is a protein that is expressed in many tissues, including the brain, and has been shown to have a variety of functions. One of the known functions of the prothymosin alpha c-terminal peptide is its ability to regulate the activity of certain ion channels, including the NMDA receptor. The NMDA receptor is a type of ion channel that is involved in the transmission of signals between neurons and plays a role in the development and maintenance of synapses, the connections between neurons.\nThe prothymosin alpha c-terminal peptide has been shown to modulate the activity of the NMDA receptor by interacting with a specific region of the receptor called the GluN2B subunit. This interaction can either enhance or inhibit the activity of the NMDA receptor, depending on the specific context in which it occurs.\nIn addition to its effects on ion channels, the prothymosin alpha c-terminal peptide has also been shown to have effects on the activity of certain neurotransmitter receptors, including the dopamine D2 receptor. The prothymosin alpha c-terminal peptide can bind to the D2 receptor and modulate its activity, leading to changes in the levels of dopamine in the brain and potentially affecting mood and behavior.\nOverall, the prothymosin alpha c-terminal peptide plays an important role in the regulation of various aspects of brain function, including the activity of ion channels and neurotransmitter receptors. Further research is needed to fully understand the mechanisms by which the prothymosin alpha c-terminal peptide exerts its effects and to determine its potential as a therapeutic target for a variety of neurological disorders.",
    "vicuna-13b_fact_raw": "1. Prothymosin alpha is expressed in many tissues, including the brain.\n2. The prothymosin alpha c-terminal peptide can regulate the activity of certain ion channels, including the NMDA receptor.\n3. The NMDA receptor is involved in the transmission of signals between neurons and in the development and maintenance of synapses.\n4. The prothymosin alpha c-terminal peptide interacts with the GluN2B subunit of the NMDA receptor, which can enhance or inhibit the receptor's activity.\n5. The prothymosin alpha c-terminal peptide can bind to the dopamine D2 receptor and modulate its activity, affecting dopamine levels in the brain.",
    "vicuna-13b_fact": [
      "Prothymosin alpha is expressed in many tissues, including the brain.",
      "The prothymosin alpha c-terminal peptide can regulate the activity of certain ion channels, including the NMDA receptor.",
      "The NMDA receptor is involved in the transmission of signals between neurons and in the development and maintenance of synapses.",
      "The prothymosin alpha c-terminal peptide interacts with the GluN2B subunit of the NMDA receptor, which can enhance or inhibit the receptor's activity.",
      "The prothymosin alpha c-terminal peptide can bind to the dopamine D2 receptor and modulate its activity, affecting dopamine levels in the brain."
    ],
    "vicuna-13b_judge_raw": "1. TRUE: Prothymosin alpha is indeed expressed in many tissues, including the brain, where it plays a role in cell proliferation, immune response, and other processes.\n2. TRUE: The prothymosin alpha c-terminal peptide has been shown to regulate the activity of certain ion channels, including the NMDA receptor, which is important in neuronal communication.\n3. TRUE: The NMDA receptor is crucial for the transmission of signals between neurons and plays a significant role in synaptic plasticity, which is essential for learning and memory.\n4. TRUE: The prothymosin alpha c-terminal peptide has been reported to interact with the GluN2B subunit of the NMDA receptor, which can modulate the receptor's activity, although the exact effects (enhancement or inhibition) can depend on the context of the interaction.\n5. UNKNOWN: Without specific evidence or references provided in the context, it is difficult to confirm the interaction between the prothymosin alpha c-terminal peptide and the dopamine D2 receptor. This statement requires more information to determine its validity.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "vicuna-13b_response": "Cystatin C is a protein that is involved in regulating the activity of other proteins, known as cysteine proteases. It is a potent inhibitor of a variety of proteases, including the papain-like cysteine proteases, such as cathepsin B, C, and L, and the chymotrypsin-like cysteine proteases, such as elastase and plasmin. Cystatin C is a key player in the regulation of proteolytic activity in various physiological and pathological processes, including inflammation, fibrosis, and cancer.\nIn terms of its role in human cystatin C fibrillization, it is important to note that cystatin C is a large, hydrophilic protein that is composed of three identical chains of 110 amino acids. It has a unique, highly conserved structure that includes a tightly folded core region and a more flexible, disordered C-terminal tail. This structure is thought to play a key role in the aggregation of cystatin C into amyloid fibrils, which is a hallmark of a number of protein misfolding diseases, including Alzheimer's disease, Parkinson's disease, and prion diseases.\nSeveral studies have suggested that the C-terminal tail of cystatin C is particularly important in the formation of amyloid fibrils. For example, mutations in the C-terminal tail of cystatin C have been shown to increase its propensity to form amyloid fibrils, and to enhance its aggregation behavior in vitro. Additionally, the C-terminal tail of cystatin C has been shown to interact with the core region of the protein, and to play a key role in the formation of stable, cross-beta structure in amyloid fibrils.\nOverall, while there are several peptides that play a role in human cystatin C fibrillization, the C-terminal tail of the protein is thought to be particularly important in this process.",
    "vicuna-13b_fact_raw": "1. Cystatin C is a protein that regulates the activity of cysteine proteases.\n2. Cystatin C inhibits a variety of proteases, including cathepsin B, C, L, elastase, and plasmin.\n3. Cystatin C is composed of three identical chains of 110 amino acids.\n4. Mutations in the C-terminal tail of cystatin C increase its propensity to form amyloid fibrils.\n5. The C-terminal tail of cystatin C interacts with the core region of the protein and is important in the formation of stable, cross-beta structure in amyloid fibrils.",
    "vicuna-13b_fact": [
      "Cystatin C is a protein that regulates the activity of cysteine proteases.",
      "Cystatin C inhibits a variety of proteases, including cathepsin B, C, L, elastase, and plasmin.",
      "Cystatin C is composed of three identical chains of 110 amino acids.",
      "Mutations in the C-terminal tail of cystatin C increase its propensity to form amyloid fibrils.",
      "The C-terminal tail of cystatin C interacts with the core region of the protein and is important in the formation of stable, cross-beta structure in amyloid fibrils."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Cystatin C is composed of a single chain of about 120 amino acids, not three identical chains.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1Î± increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "vicuna-13b_response": "Yes, the concentration of protein HIF-1Î± has been shown to increase after the administration of the cytoprotective prodrug \"amifostine\" (ethyol). Amifostine is a cytoprotective agent that has been used in cancer treatment to protect normal cells from the toxic effects of chemotherapy and radiation. It is also being studied for its potential to protect against ischemia-reperfusion injury, which is a type of tissue damage that can occur when blood flow is restored to an area after a period of ischemia (reduced blood flow).\nOne of the mechanisms by which amifostine exerts its cytoprotective effects is through the activation of the hypoxia-inducible factor (HIF) signaling pathway. HIF is a transcription factor that regulates the expression of genes that help cells to adapt to low oxygen levels. Amifostine has been shown to increase the expression and activity of HIF-1Î±, a subunit of HIF, in cells. This increase in HIF-1Î± activity can lead to the expression of genes that promote cell survival and protect against oxidative stress and inflammation.\nIn conclusion, the administration of amifostine has been shown to increase the concentration of protein HIF-1Î±, which plays a crucial role in the cytoprotective effects of the drug.",
    "vicuna-13b_fact_raw": "1. The concentration of protein HIF-1Î± increases after the administration of the cytoprotective prodrug \"amifostine\" (ethyol).\n2. Amifostine is used in cancer treatment to protect normal cells from the toxic effects of chemotherapy and radiation.\n3. Amifostine is being studied for its potential to protect against ischemia-reperfusion injury.\n4. The hypoxia-inducible factor (HIF) signaling pathway is activated by amifostine.\n5. HIF-1Î± is a subunit of HIF that regulates the expression of genes that help cells adapt to low oxygen levels.",
    "vicuna-13b_fact": [
      "The concentration of protein HIF-1Î± increases after the administration of the cytoprotective prodrug \"amifostine\" (ethyol).",
      "Amifostine is used in cancer treatment to protect normal cells from the toxic effects of chemotherapy and radiation.",
      "Amifostine is being studied for its potential to protect against ischemia-reperfusion injury.",
      "The hypoxia-inducible factor (HIF) signaling pathway is activated by amifostine.",
      "HIF-1Î± is a subunit of HIF that regulates the expression of genes that help cells adapt to low oxygen levels."
    ],
    "vicuna-13b_judge_raw": "1. TRUE: The concentration of HIF-1Î± can increase after the administration of certain cytoprotective agents like amifostine, as it is known to have protective effects against hypoxia and radiation-induced damage, which could involve the HIF pathway.\n2. TRUE: Amifostine is indeed used in cancer treatment to protect normal cells from the toxic effects of chemotherapy and radiation therapy.\n3. TRUE: Amifostine has been studied for its potential to protect against various forms of tissue damage, including ischemia-reperfusion injury, due to its cytoprotective properties.\n4. TRUE: The hypoxia-inducible factor (HIF) signaling pathway can be activated by various stimuli, including cytoprotective agents like amifostine, which may mimic hypoxic conditions or protect cells from hypoxic stress.\n5. TRUE: HIF-1Î± is indeed a subunit of the HIF-1 complex that regulates the expression of genes that help cells adapt to hypoxic (low oxygen) conditions.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "vicuna-13b_response": "Set7 is a histone methyltransferase enzyme that deposits methyl groups on histone H3 at position K4, also known as H3K4me. This modification is often referred to as \"Set7 modification\" or \"H3K4me1\". Set7 is involved in various cellular processes, including transcriptional regulation, DNA repair, and chromosome segregation. The Set7 enzyme is recruited to specific target genes through interactions with other proteins, such as the transcription factor YY1, and is thought to play a role in the regulation of gene expression. In addition to H3K4me, Set7 has also been shown to deposit methyl groups on histone H4 at position K16, also known as H4K16me, although this is less well characterized.",
    "vicuna-13b_fact_raw": "1. Set7 is a histone methyltransferase enzyme.\n2. Set7 deposits methyl groups on histone H3 at position K4 (H3K4me).\n3. The modification by Set7 is often referred to as \"H3K4me1\".\n4. Set7 is involved in transcriptional regulation, DNA repair, and chromosome segregation.\n5. Set7 has been shown to deposit methyl groups on histone H4 at position K16 (H4K16me).",
    "vicuna-13b_fact": [
      "Set7 is a histone methyltransferase enzyme.",
      "Set7 deposits methyl groups on histone H3 at position K4 (H3K4me).",
      "The modification by Set7 is often referred to as \"H3K4me1\".",
      "Set7 is involved in transcriptional regulation, DNA repair, and chromosome segregation.",
      "Set7 has been shown to deposit methyl groups on histone H4 at position K16 (H4K16me)."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Set7 (also known as Set7/9 or SETD7) is a histone methyltransferase enzyme, but it specifically methylates lysine 4 on histone H3 (H3K4), not histone H4.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Set7 specifically methylates lysine 4 on histone H3 (H3K4), not lysine 16 on histone H4 (H4K16).",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "vicuna-13b_response": "Hepcidin is a small peptide hormone that plays a crucial role in regulating iron homeostasis in the body. It has a total of four disulfide bridges, which are essential for its stability and function. These disulfide bridges are formed between the following pairs of cysteine residues: Cys1-Cys3, Cys2-Cys4, Cys1-Cys5, and Cys3-Cys6. The presence of these disulfide bridges is necessary for hepcidin to bind to its receptor, ferroportin, and inhibit iron uptake in cells. Mutations in the disulfide bridges of hepcidin can lead to defects in iron regulation and can result in iron overload disorders.",
    "vicuna-13b_fact_raw": "1. Hepcidin is a peptide hormone involved in iron homeostasis.\n2. Hepcidin contains a total of four disulfide bridges.\n3. The disulfide bridges in hepcidin are formed between cysteine residues Cys1-Cys3, Cys2-Cys4, Cys1-Cys5, and Cys3-Cys6.\n4. Disulfide bridges are essential for the stability and function of hepcidin.\n5. Mutations in the disulfide bridges of hepcidin can lead to iron overload disorders.",
    "vicuna-13b_fact": [
      "Hepcidin is a peptide hormone involved in iron homeostasis.",
      "Hepcidin contains a total of four disulfide bridges.",
      "The disulfide bridges in hepcidin are formed between cysteine residues Cys1-Cys3, Cys2-Cys4, Cys1-Cys5, and Cys3-Cys6.",
      "Disulfide bridges are essential for the stability and function of hepcidin.",
      "Mutations in the disulfide bridges of hepcidin can lead to iron overload disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Hepcidin contains a total of four disulfide bridges, which are typically formed between eight cysteine residues, but the specific pairings in the statement are incorrect.\n3. FALSE [correction]: The correct disulfide bridges in hepcidin are formed between cysteine residues Cys7-Cys23, Cys10-Cys13, Cys11-Cys19, and Cys14-Cys22.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "vicuna-13b_response": "Localization of a protein refers to its distribution and location within a cell or organism. The localization of a protein can be crucial for its function, as it determines where the protein can interact with other molecules and carry out its intended role.\nThe localization of the protein encoded by the gene DNAJC11 has not been extensively studied, and there is limited information available on this topic. However, based on the function of similar proteins, it is possible that DNAJC11 may be localized to the cytoplasm or endoplasmic reticulum (ER).\nDNAJC11 is a member of the heat shock protein (HSP) family, which are proteins that play a role in protein folding and transport. HSPs are known to be localized to the cytoplasm and ER, where they assist in the proper folding and transport of proteins. It is therefore possible that DNAJC11 is also localized to these areas.\nHowever, further research is needed to confirm the localization of DNAJC11 and to understand its specific function in the cell.",
    "vicuna-13b_fact_raw": "1. The localization of the protein encoded by the gene DNAJC11 has not been extensively studied.\n2. DNAJC11 may be localized to the cytoplasm or endoplasmic reticulum (ER) based on the function of similar proteins.\n3. DNAJC11 is a member of the heat shock protein (HSP) family.\n4. Heat shock proteins are known to be localized to the cytoplasm and ER.\n5. Heat shock proteins play a role in protein folding and transport.",
    "vicuna-13b_fact": [
      "The localization of the protein encoded by the gene DNAJC11 has not been extensively studied.",
      "DNAJC11 may be localized to the cytoplasm or endoplasmic reticulum (ER) based on the function of similar proteins.",
      "DNAJC11 is a member of the heat shock protein (HSP) family.",
      "Heat shock proteins are known to be localized to the cytoplasm and ER.",
      "Heat shock proteins play a role in protein folding and transport."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements regarding the localization of DNAJC11 and its comparison to similar proteins are difficult to verify without specific scientific evidence or studies. Therefore, the truthfulness of statements 1 and 2 cannot be determined without additional context. Statements 3, 4, and 5 are generally true about the heat shock protein family, to which DNAJC11 belongs. Heat shock proteins are indeed known to assist in protein folding and are commonly found in the cytoplasm and the endoplasmic reticulum.",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "vicuna-13b_response": "Ultraconserved elements (UCEs) are DNA sequences that are highly conserved across multiple species and are thought to play important roles in maintaining genome stability and function. Copy number variants (CNVs) are DNA alterations that involve changes in the number of copies of a particular gene or genomic region.\nSeveral studies have reported that UCEs are depleted among CNVs. For example, a study published in the journal Nature Genetics in 2011 found that UCEs are significantly underrepresented in regions with CNVs, compared to non-CNV regions. This suggests that UCEs may be more susceptible to disruption by CNVs, which could have important implications for genome stability and function.\nAnother study published in the journal Genome Research in 2012 found that UCEs are more likely to be affected by CNVs in regions that are associated with disease, such as those involved in cancer. This suggests that UCEs may play important roles in the development and progression of disease, and that disruptions to UCEs may contribute to disease pathology.\nOverall, while the evidence is not conclusive, there is some suggestion that UCEs may be depleted among CNVs, and that this could have important implications for genome stability and function, as well as disease pathology. Further research is needed to fully understand the relationship between UCEs and CNVs, and to determine the functional and clinical significance of these DNA alterations.",
    "vicuna-13b_fact_raw": "1. Ultraconserved elements (UCEs) are highly conserved DNA sequences across multiple species.\n2. Copy number variants (CNVs) involve changes in the number of copies of a particular gene or genomic region.\n3. A study published in Nature Genetics in 2011 found that UCEs are significantly underrepresented in regions with CNVs.\n4. The same study suggests that UCEs may be more susceptible to disruption by CNVs.\n5. A study published in Genome Research in 2012 found that UCEs are more likely to be affected by CNVs in regions associated with disease.",
    "vicuna-13b_fact": [
      "Ultraconserved elements (UCEs) are highly conserved DNA sequences across multiple species.",
      "Copy number variants (CNVs) involve changes in the number of copies of a particular gene or genomic region.",
      "A study published in Nature Genetics in 2011 found that UCEs are significantly underrepresented in regions with CNVs.",
      "The same study suggests that UCEs may be more susceptible to disruption by CNVs.",
      "A study published in Genome Research in 2012 found that UCEs are more likely to be affected by CNVs in regions associated with disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The study suggests that UCEs may be less susceptible to disruption by CNVs, given that they are underrepresented in regions with CNVs.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "vicuna-13b_response": "The Haspin kinase is a protein that plays a role in regulating the progression of mitosis, which is the process by which a cell divides into two daughter cells. The substrate of the Haspin kinase during mitosis is not yet clear, as it is still an area of active research. However, it is known that the Haspin kinase is involved in the regulation of the anaphase-promoting complex/cyclosome (APC/C), which is a complex that plays a critical role in the progression of mitosis by promoting the degradation of proteins that are necessary for the progression of the cell cycle.\nIt is thought that the Haspin kinase may act as a regulator of the APC/C, either by activating it or by inhibiting its activity. The Haspin kinase may also play a role in the regulation of other proteins that are involved in the progression of mitosis, such as the polo-like kinase 1 (PLK1).\nOverall, the substrate of the Haspin kinase during mitosis is still not well understood, but it is clear that this protein plays a critical role in the regulation of the progression of mitosis. Further research is needed to fully understand the role of the Haspin kinase in this process.",
    "vicuna-13b_fact_raw": "1. The Haspin kinase plays a role in regulating the progression of mitosis.\n2. The substrate of the Haspin kinase during mitosis is not yet clear and is an area of active research.\n3. The Haspin kinase is involved in the regulation of the anaphase-promoting complex/cyclosome (APC/C).\n4. The APC/C plays a critical role in the progression of mitosis by promoting the degradation of proteins necessary for the cell cycle.\n5. The Haspin kinase may regulate the activity of the polo-like kinase 1 (PLK1) during mitosis.",
    "vicuna-13b_fact": [
      "The Haspin kinase plays a role in regulating the progression of mitosis.",
      "The substrate of the Haspin kinase during mitosis is not yet clear and is an area of active research.",
      "The Haspin kinase is involved in the regulation of the anaphase-promoting complex/cyclosome (APC/C).",
      "The APC/C plays a critical role in the progression of mitosis by promoting the degradation of proteins necessary for the cell cycle.",
      "The Haspin kinase may regulate the activity of the polo-like kinase 1 (PLK1) during mitosis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The substrate of the Haspin kinase during mitosis is known to be histone H3, where it phosphorylates threonine 3 (H3T3ph).\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "vicuna-13b_response": "Viroids are non-cellular, single-stranded RNA viruses that replicate through a rolling-circle mechanism. This mechanism involves the annealing of complementary strands of RNA, followed by the synthesis of a new strand by a viral RNA-dependent RNA polymerase. The new strand is then used as a template for the synthesis of more virus particles. The rolling-circle mechanism allows for the efficient replication of viroids, as it does not require the synthesis of a new strand of DNA or RNA, and it allows for the production of multiple copies of the virus in a short amount of time.",
    "vicuna-13b_fact_raw": "1. Viroids are non-cellular, single-stranded RNA entities.\n2. Viroids replicate through a rolling-circle mechanism.\n3. The rolling-circle replication mechanism involves the annealing of complementary strands of RNA.\n4. A viral RNA-dependent RNA polymerase synthesizes a new strand during viroid replication.\n5. The rolling-circle mechanism does not require the synthesis of a new strand of DNA.",
    "vicuna-13b_fact": [
      "Viroids are non-cellular, single-stranded RNA entities.",
      "Viroids replicate through a rolling-circle mechanism.",
      "The rolling-circle replication mechanism involves the annealing of complementary strands of RNA.",
      "A viral RNA-dependent RNA polymerase synthesizes a new strand during viroid replication.",
      "The rolling-circle mechanism does not require the synthesis of a new strand of DNA."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The rolling-circle replication mechanism involves the synthesis of a new strand of RNA that is complementary to the circular RNA template, but annealing refers to the process of two single strands of DNA or RNA binding together to form a double-stranded molecule, which is not a central feature of rolling-circle replication.\n4. FALSE [correction]: A host cell's RNA polymerase, not a viral RNA-dependent RNA polymerase, synthesizes a new strand during viroid replication, as viroids do not encode their own polymerases.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "vicuna-13b_response": "Fibronectin is a protein that is involved in a variety of biological processes, including cell adhesion and migration. In the context of Duchenne muscular dystrophy (DMD), fibronectin has been studied as a potential biomarker for the disease.\nDMD is a genetic disorder that affects muscle function and results from mutations in the dystrophin gene. Dystrophin is a protein that is important for maintaining the integrity of muscle cells and protecting them from damage. In DMD, the lack of dystrophin leads to progressive muscle degeneration and weakness.\nFibronectin has been found to be elevated in the blood of individuals with DMD, and this has led to its consideration as a potential biomarker for the disease. However, the exact relationship between fibronectin levels and the severity of DMD is not well understood, and more research is needed to determine the utility of fibronectin as a diagnostic biomarker for the disease.\nIn summary, while fibronectin has been studied as a potential biomarker for DMD, its utility as a diagnostic tool is still being evaluated and more research is needed to fully understand its role in the disease.",
    "vicuna-13b_fact_raw": "1. Fibronectin is a protein involved in cell adhesion and migration.\n2. Duchenne muscular dystrophy (DMD) is a genetic disorder that results from mutations in the dystrophin gene.\n3. Dystrophin is important for maintaining the integrity of muscle cells.\n4. In individuals with DMD, fibronectin levels have been found to be elevated in the blood.\n5. The relationship between fibronectin levels and the severity of DMD is not well understood.",
    "vicuna-13b_fact": [
      "Fibronectin is a protein involved in cell adhesion and migration.",
      "Duchenne muscular dystrophy (DMD) is a genetic disorder that results from mutations in the dystrophin gene.",
      "Dystrophin is important for maintaining the integrity of muscle cells.",
      "In individuals with DMD, fibronectin levels have been found to be elevated in the blood.",
      "The relationship between fibronectin levels and the severity of DMD is not well understood."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe first three statements are accurate based on current scientific understanding. Fibronectin is indeed involved in cell adhesion and migration, Duchenne muscular dystrophy is caused by mutations in the dystrophin gene, and dystrophin is crucial for maintaining muscle cell integrity. However, without specific references to scientific studies or data, the veracity of statements 4 and 5 regarding the levels of fibronectin in the blood of individuals with DMD and the relationship between fibronectin levels and the severity of DMD cannot be determined. These would require specific empirical evidence to confirm.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "vicuna-13b_response": "The DeepBlue epigenomic data server is a comprehensive database of epigenomic data from a variety of organisms and experimental conditions. Some of the major epigenome projects that are contained in the DeepBlue database include:\n1. The Roadmap Epigenomics Project: This project is a comprehensive study of the epigenomes of over 100 different cell types from human, mouse, and rat. The data is available for browsing and download on the DeepBlue website.\n2. The ENCODE Project: This project is a large-scale effort to characterize the functional elements in the human genome, including the epigenome. The data from the ENCODE project is available on the DeepBlue website, and includes information on chromatin accessibility, DNA methylation, and histone modifications.\n3. The Epigenome Atlas Project: This project is a collaborative effort to generate and analyze epigenomic data from a variety of organisms, including human, mouse, and fruit fly. The data from the Epigenome Atlas Project is available on the DeepBlue website, and includes information on chromatin accessibility, DNA methylation, and histone modifications.\n4. The Single Cell Epigenomics Project: This project is a comprehensive study of the epigenomes of individual cells, including both normal and disease cells. The data from the Single Cell Epigenomics Project is available on the DeepBlue website, and includes information on chromatin accessibility, DNA methylation, and histone modifications.\nThese are just a few examples of the major epigenome projects that are contained in the DeepBlue epigenomic data server. The database is constantly being updated with new data, so it is a valuable resource for researchers in the field of epigenetics.",
    "vicuna-13b_fact_raw": "1. The Roadmap Epigenomics Project data, which includes over 100 different cell types from human, mouse, and rat, is available on the DeepBlue epigenomic data server.\n2. The ENCODE Project data, which aims to characterize functional elements in the human genome including the epigenome, is available on the DeepBlue epigenomic data server.\n3. The Epigenome Atlas Project data, which includes a variety of organisms such as human, mouse, and fruit fly, is available on the DeepBlue epigenomic data server.\n4. The Single Cell Epigenomics Project data, which studies the epigenomes of individual cells including normal and disease cells, is available on the DeepBlue epigenomic data server.\n5. The DeepBlue epigenomic data server is regularly updated with new data from various epigenome projects.",
    "vicuna-13b_fact": [
      "The Roadmap Epigenomics Project data, which includes over 100 different cell types from human, mouse, and rat, is available on the DeepBlue epigenomic data server.",
      "The ENCODE Project data, which aims to characterize functional elements in the human genome including the epigenome, is available on the DeepBlue epigenomic data server.",
      "The Epigenome Atlas Project data, which includes a variety of organisms such as human, mouse, and fruit fly, is available on the DeepBlue epigenomic data server.",
      "The Single Cell Epigenomics Project data, which studies the epigenomes of individual cells including normal and disease cells, is available on the DeepBlue epigenomic data server.",
      "The DeepBlue epigenomic data server is regularly updated with new data from various epigenome projects."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Roadmap Epigenomics Project data includes human cell types but does not include mouse and rat cell types.\n2. TRUE\n3. FALSE [correction]: The Epigenome Atlas Project is not a recognized project in the context of epigenomics; the data mentioned may be referring to other known projects such as the IHEC (International Human Epigenome Consortium) which does not include fruit fly data.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "vicuna-13b_response": "A self-organizing map (SOM) is a type of neural network that can be used to map high-dimensional input data to a lower-dimensional representation. In the context of analyzing codon usage in molecular biology, SOMs can be used to identify groups of codons that are functionally equivalent, despite differences in their nucleotide sequence. This can be useful for understanding how cells translate genetic information into proteins, and for identifying potential targets for genetic engineering and synthetic biology applications. Some tools that employ SOMs for analyzing synonymous codon usage include the CodonUsage tool, which is part of the Bioinformatics Toolbox in MATLAB, and the CodonW tool, which is a standalone software package for analyzing codon usage in protein-coding genes.",
    "vicuna-13b_fact_raw": "1. Self-organizing maps (SOMs) are a type of neural network used to map high-dimensional data to a lower-dimensional representation.\n2. SOMs can identify groups of codons that are functionally equivalent despite differences in nucleotide sequence.\n3. SOMs are used in molecular biology to understand how cells translate genetic information into proteins.\n4. The CodonUsage tool, which employs SOMs for analyzing synonymous codon usage, is part of the Bioinformatics Toolbox in MATLAB.\n5. CodonW is a standalone software package that uses SOMs for analyzing codon usage in protein-coding genes.",
    "vicuna-13b_fact": [
      "Self-organizing maps (SOMs) are a type of neural network used to map high-dimensional data to a lower-dimensional representation.",
      "SOMs can identify groups of codons that are functionally equivalent despite differences in nucleotide sequence.",
      "SOMs are used in molecular biology to understand how cells translate genetic information into proteins.",
      "The CodonUsage tool, which employs SOMs for analyzing synonymous codon usage, is part of the Bioinformatics Toolbox in MATLAB.",
      "CodonW is a standalone software package that uses SOMs for analyzing codon usage in protein-coding genes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: SOMs can identify clusters or patterns in data, but they do not specifically identify groups of codons that are functionally equivalent. This task is more related to the study of synonymous codons and would typically involve genetic algorithms or other methods in bioinformatics, not SOMs directly.\n3. FALSE [correction]: SOMs are a type of unsupervised learning algorithm used in various fields for data visualization and clustering. They are not specifically used to understand how cells translate genetic information into proteins. This understanding is more related to the field of molecular biology and the study of the genetic code and translation mechanisms.\n4. FALSE [correction]: The Bioinformatics Toolbox in MATLAB includes various tools for analyzing biological data, but the CodonUsage tool does not employ SOMs for analyzing synonymous codon usage. It uses other statistical and bioinformatics methods to analyze codon usage patterns.\n5. FALSE [correction]: CodonW is a standalone software package for analyzing codon usage, but it does not use SOMs. It uses statistical methods to analyze codon usage bias and other aspects of protein-coding genes.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "vicuna-13b_response": "MINDY-1 is a type of neural network architecture that is designed for natural language processing tasks. It stands for Multi-layer Intent Detection and You-detection, and it is a deep learning model that is capable of understanding the intent behind a given text and identifying the person who wrote it.\nThe MINDY-1 architecture is composed of several layers, including a convolutional layer, a bidirectional layer, and a fully connected layer. The convolutional layer is used to extract features from the input text, while the bidirectional layer is used to capture the context and dependencies between words. The fully connected layer is responsible for making predictions about the intent and author of the text.\nThe MINDY-1 model was trained on a large dataset of text samples and is capable of accurately identifying the intent and author of new, unseen text. It has been used for a variety of natural language processing tasks, including sentiment analysis, named entity recognition, and text classification.",
    "vicuna-13b_fact_raw": "1. MINDY-1 is a neural network architecture designed for natural language processing tasks.\n2. MINDY-1 stands for Multi-layer Intent Detection and You-detection.\n3. The MINDY-1 architecture includes a convolutional layer, a bidirectional layer, and a fully connected layer.\n4. The convolutional layer in MINDY-1 is used to extract features from the input text.\n5. The MINDY-1 model has been used for tasks such as sentiment analysis, named entity recognition, and text classification.",
    "vicuna-13b_fact": [
      "MINDY-1 is a neural network architecture designed for natural language processing tasks.",
      "MINDY-1 stands for Multi-layer Intent Detection and You-detection.",
      "The MINDY-1 architecture includes a convolutional layer, a bidirectional layer, and a fully connected layer.",
      "The convolutional layer in MINDY-1 is used to extract features from the input text.",
      "The MINDY-1 model has been used for tasks such as sentiment analysis, named entity recognition, and text classification."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific context or a known reference to \"MINDY-1\" as a neural network architecture, it is not possible to verify the accuracy of these statements. As of my knowledge cutoff date in early 2023, MINDY-1 is not a widely recognized or standard neural network architecture for natural language processing tasks. Therefore, I cannot confirm or correct these statements.",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "vicuna-13b_response": "There are several software packages available for the analysis of conserved genomic loci. Some of the popular ones are:\n1. Conserved Elements in Regulatory Networks (CERN): It is a web-based tool that identifies conserved non-coding elements (CNEs) in the genomic regions surrounding a gene of interest. It can also predict the potential regulatory functions of these CNEs based on their evolutionary conservation and functional annotations.\n2. PhyloBayes: It is a software package that can be used to identify conserved genomic regions based on their evolutionary history. It uses Bayesian methods to infer the evolutionary history of multiple genomes and identifies regions that are conserved across different species.\n3. Genomic Regions Enriched in Annotation (GREAT): It is a web-based tool that can be used to identify genomic regions that are enriched in functional annotations, such as transcription factor binding sites or regulatory motifs. It can also identify conserved regions based on their evolutionary conservation.\n4. Regulatory Genomic Units (RGUs): It is a software package that can be used to identify regulatory elements in the genome, including enhancers, promoters, and silencers. It can also identify conserved RGUs across different species.\n5. Genome-wide Identification of Functional Elements Using Comparative Genomics (GIFEST): It is a software package that can be used to identify functional elements in the genome based on their evolutionary conservation. It can identify conserved regions, regulatory motifs, and other functional elements.\nThese are just a few examples of the software packages available for the analysis of conserved genomic loci. The choice of software depends on the specific research question and the type of data being analyzed.",
    "vicuna-13b_fact_raw": "1. Conserved Elements in Regulatory Networks (CERN) is a web-based tool that identifies conserved non-coding elements in genomic regions.\n2. PhyloBayes uses Bayesian methods to infer the evolutionary history of multiple genomes.\n3. Genomic Regions Enriched in Annotation (GREAT) is a web-based tool used to identify genomic regions enriched in functional annotations.\n4. Regulatory Genomic Units (RGUs) is a software package used to identify regulatory elements in the genome.\n5. Genome-wide Identification of Functional Elements Using Comparative Genomics (GIFEST) is a software package that identifies functional elements in the genome based on evolutionary conservation.",
    "vicuna-13b_fact": [
      "Conserved Elements in Regulatory Networks (CERN) is a web-based tool that identifies conserved non-coding elements in genomic regions.",
      "PhyloBayes uses Bayesian methods to infer the evolutionary history of multiple genomes.",
      "Genomic Regions Enriched in Annotation (GREAT) is a web-based tool used to identify genomic regions enriched in functional annotations.",
      "Regulatory Genomic Units (RGUs) is a software package used to identify regulatory elements in the genome.",
      "Genome-wide Identification of Functional Elements Using Comparative Genomics (GIFEST) is a software package that identifies functional elements in the genome based on evolutionary conservation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: There is no widely recognized software package specifically named \"Regulatory Genomic Units (RGUs)\" for identifying regulatory elements in the genome. However, the term \"regulatory genomic unit\" could refer to a concept within genomics rather than a software tool.\n5. UNKNOWN: There is no widely recognized software package named \"Genome-wide Identification of Functional Elements Using Comparative Genomics (GIFEST).\" Without additional context, it's unclear whether this is a real tool or a fictional one.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "vicuna-13b_response": "PIEZO2 is a gene that is associated with several diseases, including:\n1. Piezo2-related primary ciliary dyskinesia (PKD): PKD is a rare genetic disorder that affects the function of cilia, which are small, hair-like structures that line the airways and help to clear mucus and debris from the lungs. Mutations in the PIEZO2 gene have been identified as a cause of PKD.\n2. Autosomal recessive lymphoedema (ARL): ARL is a genetic disorder that affects the development and function of the lymphatic system, which helps to regulate fluid balance in the body. Mutations in the PIEZO2 gene have been identified as a cause of ARL.\n3. Joubert syndrome: Joubert syndrome is a rare genetic disorder that affects the development of the brain and the cilia. Mutations in the PIEZO2 gene have been identified as a cause of Joubert syndrome.",
    "vicuna-13b_fact_raw": "1. Mutations in the PIEZO2 gene have been identified as a cause of Piezo2-related primary ciliary dyskinesia (PKD).\n2. Mutations in the PIEZO2 gene have been identified as a cause of Autosomal recessive lymphoedema (ARL).\n3. Mutations in the PIEZO2 gene have been identified as a cause of Joubert syndrome.",
    "vicuna-13b_fact": [
      "Mutations in the PIEZO2 gene have been identified as a cause of Piezo2-related primary ciliary dyskinesia (PKD).",
      "Mutations in the PIEZO2 gene have been identified as a cause of Autosomal recessive lymphoedema (ARL).",
      "Mutations in the PIEZO2 gene have been identified as a cause of Joubert syndrome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Mutations in the PIEZO2 gene have been identified as a cause of conditions related to mechanosensation, such as distal arthrogryposis and Gordon syndrome, not primary ciliary dyskinesia (PKD).\n2. UNKNOWN\n3. UNKNOWN\n\nNote: As of my last update, PIEZO2 is known for its role in the body's sense of touch and proprioception. It is not typically associated with primary ciliary dyskinesia, which is often related to mutations in genes that affect ciliary structure and function. Autosomal recessive lymphoedema (ARL) and Joubert syndrome are also typically associated with different genetic mutations. However, without specific and current information on the PIEZO2 gene's association with ARL and Joubert syndrome, the truthfulness of statements 2 and 3 cannot be determined.",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "vicuna-13b_response": "ERAP1-ERAP2 dimerization is a process that occurs in the endoplasmic reticulum (ER) of cells. The ER is a network of membranes that is responsible for many cellular functions, including protein synthesis and folding.\nERAP1 and ERAP2 are two proteins that are involved in the transport of proteins from the ER to the Golgi apparatus, which is another organelle responsible for protein processing and packaging. When ERAP1 and ERAP2 dimerize, they form a complex that can bind to and transport certain proteins from the ER to the Golgi apparatus.\nThis process is important for maintaining the proper functioning of the ER and Golgi apparatus, as well as for ensuring that proteins are transported to the correct locations within the cell. Dysfunction in ERAP1-ERAP2 dimerization has been linked to a number of diseases, including neurodegenerative disorders and cancer.",
    "vicuna-13b_fact_raw": "1. ERAP1-ERAP2 dimerization occurs in the endoplasmic reticulum (ER) of cells.\n2. The endoplasmic reticulum is responsible for protein synthesis and folding.\n3. ERAP1 and ERAP2 are involved in the transport of proteins from the ER to the Golgi apparatus.\n4. The Golgi apparatus is responsible for protein processing and packaging.\n5. Dysfunction in ERAP1-ERAP2 dimerization has been linked to diseases such as neurodegenerative disorders and cancer.",
    "vicuna-13b_fact": [
      "ERAP1-ERAP2 dimerization occurs in the endoplasmic reticulum (ER) of cells.",
      "The endoplasmic reticulum is responsible for protein synthesis and folding.",
      "ERAP1 and ERAP2 are involved in the transport of proteins from the ER to the Golgi apparatus.",
      "The Golgi apparatus is responsible for protein processing and packaging.",
      "Dysfunction in ERAP1-ERAP2 dimerization has been linked to diseases such as neurodegenerative disorders and cancer."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: The endoplasmic reticulum is responsible for protein synthesis, but protein folding is a shared function of the endoplasmic reticulum and the cytosol.\n3. FALSE [correction]: ERAP1 and ERAP2 are involved in trimming peptides for presentation by MHC class I molecules, not in the transport of proteins from the ER to the Golgi apparatus.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "vicuna-13b_response": "R-spondin 1 and noggin are two proteins that are involved in various cellular processes in the body. In the non-damaged gallbladder, R-spondin 1 and noggin play important roles in the development and function of the gallbladder.\nR-spondin 1 is a protein that is expressed in the gallbladder and other tissues, and it has been shown to play a role in the development of the gallbladder and bile ducts. R-spondin 1 is involved in the regulation of cell proliferation and differentiation, and it has been shown to be important for the normal function of the gallbladder.\nNoggin, on the other hand, is a protein that is involved in the regulation of cellular differentiation and proliferation. In the gallbladder, noggin is involved in the development and function of the epithelial cells that line the gallbladder. Noggin is also involved in the regulation of the activity of other proteins that are important for gallbladder function.\nIn summary, R-spondin 1 and noggin play important roles in the development and function of the gallbladder. They are involved in the regulation of cellular processes, including proliferation, differentiation, and the activity of other proteins that are important for gallbladder function.",
    "vicuna-13b_fact_raw": "1. R-spondin 1 is expressed in the gallbladder and plays a role in the development of the gallbladder and bile ducts.\n2. R-spondin 1 is involved in the regulation of cell proliferation and differentiation in the gallbladder.\n3. Noggin is involved in the regulation of cellular differentiation and proliferation in the gallbladder.\n4. Noggin contributes to the development and function of the epithelial cells that line the gallbladder.\n5. Both R-spondin 1 and noggin are important for the normal function of the gallbladder.",
    "vicuna-13b_fact": [
      "R-spondin 1 is expressed in the gallbladder and plays a role in the development of the gallbladder and bile ducts.",
      "R-spondin 1 is involved in the regulation of cell proliferation and differentiation in the gallbladder.",
      "Noggin is involved in the regulation of cellular differentiation and proliferation in the gallbladder.",
      "Noggin contributes to the development and function of the epithelial cells that line the gallbladder.",
      "Both R-spondin 1 and noggin are important for the normal function of the gallbladder."
    ],
    "vicuna-13b_judge_raw": "1. TRUE: R-spondin 1 is known to be expressed in various organs, including the gallbladder, and plays a role in the development of organs and tissues, including the gallbladder and bile ducts.\n2. TRUE: R-spondin 1 is involved in the regulation of Wnt signaling, which is important for cell proliferation and differentiation, and this includes its role in the gallbladder.\n3. TRUE: Noggin is a protein that is known to be involved in the regulation of cellular differentiation and proliferation, as it is an antagonist of bone morphogenetic proteins (BMPs) which are involved in these processes.\n4. TRUE: Given that noggin modulates BMP signaling, which is important for the development and function of various cell types, it is reasonable to infer that noggin contributes to the development and function of epithelial cells, including those that line the gallbladder.\n5. TRUE: Both R-spondin 1 and noggin play roles in the regulation of signaling pathways that are important for the normal function and maintenance of the gallbladder, although the specific contributions and mechanisms may vary.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "vicuna-13b_response": "NADPH oxidase 5, also known as NOX5, is a complex enzyme that generates reactive oxygen species (ROS) in response to various stimuli. While NOX5 can function as a homodimer, it also requires the presence of specific subunits for full activity.\nThe NOX5 enzyme consists of four subunits: p22phox, p40phox, p47phox, and p67phox. The first three subunits, p22phox, p40phox, and p47phox, are essential for the assembly and function of NOX5. The p22phox subunit contains the flavin adenine dinucleotide (FAD) binding site, while the p40phox and p47phox subunits contribute to the cytochrome b558 domain. The p67phox subunit, also known as RAC2, is not essential for NOX5 function but can modulate its activity.\nMutations in any of the NOX5 subunits can lead to altered enzymatic activity or dysfunction, and some of these mutations have been associated with human diseases such as chronic granulomatous disease (CGD) and age-related macular degeneration (AMD).\nIn summary, while NOX5 can function as a homodimer, it requires the presence of specific subunits for full activity. The p22phox, p40phox, and p47phox subunits are essential for NOX5 assembly and function, while the p67phox subunit can modulate its activity.",
    "vicuna-13b_fact_raw": "1. NADPH oxidase 5 (NOX5) generates reactive oxygen species (ROS) in response to various stimuli.\n2. NOX5 can function as a homodimer.\n3. The NOX5 enzyme consists of four subunits: p22phox, p40phox, p47phox, and p67phox.\n4. The p22phox, p40phox, and p47phox subunits are essential for the assembly and function of NOX5.\n5. Mutations in any of the NOX5 subunits can lead to altered enzymatic activity or dysfunction.",
    "vicuna-13b_fact": [
      "NADPH oxidase 5 (NOX5) generates reactive oxygen species (ROS) in response to various stimuli.",
      "NOX5 can function as a homodimer.",
      "The NOX5 enzyme consists of four subunits: p22phox, p40phox, p47phox, and p67phox.",
      "The p22phox, p40phox, and p47phox subunits are essential for the assembly and function of NOX5.",
      "Mutations in any of the NOX5 subunits can lead to altered enzymatic activity or dysfunction."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The NOX5 enzyme does not consist of the subunits p22phox, p40phox, p47phox, and p67phox. These subunits are associated with other NOX family members, such as NOX2. NOX5 is unique in that it does not require these subunits for its activity.\n4. FALSE [correction]: Since NOX5 does not require the p22phox, p40phox, and p47phox subunits for its assembly and function, this statement is incorrect. NOX5 functions independently of these subunits.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "vicuna-13b_response": "Furin and hepcidin are both proteases, which are enzymes that break down other proteins. Furin is a type of protease that is involved in the processing of many different proteins, including the precursor of hepcidin.\nHepcidin is a small peptide hormone that is involved in regulating iron metabolism in the body. It is produced by the liver and released into the bloodstream, where it binds to and inhibits the activity of the iron transport protein transferrin. This causes the liver to release stored iron into the bloodstream, where it can be used by other tissues.\nThe connection between furin and hepcidin is that furin is involved in the processing of the precursor protein that is converted into hepcidin. Specifically, furin cleaves the precursor protein at a specific site, releasing the mature hepcidin peptide. This processing step is necessary for the proper functioning of hepcidin and its regulation of iron metabolism in the body.",
    "vicuna-13b_fact_raw": "1. Furin and hepcidin are both proteases.\n2. Furin is involved in the processing of many different proteins, including the precursor of hepcidin.\n3. Hepcidin is a peptide hormone that regulates iron metabolism in the body.\n4. Hepcidin is produced by the liver and released into the bloodstream.\n5. Furin cleaves the precursor protein of hepcidin at a specific site to release the mature hepcidin peptide.",
    "vicuna-13b_fact": [
      "Furin and hepcidin are both proteases.",
      "Furin is involved in the processing of many different proteins, including the precursor of hepcidin.",
      "Hepcidin is a peptide hormone that regulates iron metabolism in the body.",
      "Hepcidin is produced by the liver and released into the bloodstream.",
      "Furin cleaves the precursor protein of hepcidin at a specific site to release the mature hepcidin peptide."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Furin is a protease, but hepcidin is not a protease; it is a peptide hormone.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "vicuna-13b_response": "The largest metabolic gene cluster in yeast is the glycolytic pathway, which is responsible for the breakdown of glucose into carbon dioxide and ethanol. This pathway involves a series of enzymatic reactions that convert glucose into pyruvate, which is then converted into ethanol and carbon dioxide through the fermentation process. The glycolytic pathway is essential for the survival of yeast, as it provides the energy required for cell growth and reproduction.",
    "vicuna-13b_fact_raw": "1. The largest metabolic gene cluster in yeast is the glycolytic pathway.\n2. The glycolytic pathway is responsible for the breakdown of glucose into carbon dioxide and ethanol.\n3. The glycolytic pathway involves a series of enzymatic reactions that convert glucose into pyruvate.\n4. Pyruvate is then converted into ethanol and carbon dioxide through the fermentation process in yeast.\n5. The glycolytic pathway provides the energy required for yeast cell growth and reproduction.",
    "vicuna-13b_fact": [
      "The largest metabolic gene cluster in yeast is the glycolytic pathway.",
      "The glycolytic pathway is responsible for the breakdown of glucose into carbon dioxide and ethanol.",
      "The glycolytic pathway involves a series of enzymatic reactions that convert glucose into pyruvate.",
      "Pyruvate is then converted into ethanol and carbon dioxide through the fermentation process in yeast.",
      "The glycolytic pathway provides the energy required for yeast cell growth and reproduction."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: The glycolytic pathway is responsible for the breakdown of glucose into pyruvate, not directly into carbon dioxide and ethanol.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "vicuna-13b_response": "Long non-coding RNA (lncRNA) is a type of RNA that is longer than 200 nucleotides in length and does not code for proteins. One example of an lncRNA is called LINC (Liver-Enriched Transcript 1, LncRNA) which is also known as LIMT (Liver-Enriched Motif-Containing).\nThe role of LIMT lncRNA is not yet fully understood, but studies have suggested that it plays an important role in regulating gene expression. LIMT lncRNA is specifically expressed in the liver and other tissues, and it has been shown to interact with microRNAs, which are small non-coding RNAs that play a role in regulating gene expression by binding to messenger RNAs (mRNAs) and preventing their translation into proteins.\nOne study found that LIMT lncRNA can act as a sponge for microRNAs, binding to them and preventing them from binding to their target mRNAs. This suggests that LIMT lncRNA may play a role in regulating the expression of specific genes by controlling the levels of microRNAs.\nAdditionally, LIMT lncRNA has been shown to be involved in the regulation of cell proliferation and differentiation, and it has been suggested that it may play a role in the development of liver cancer.\nOverall, the role of LIMT lncRNA is still an active area of research, and more studies are needed to fully understand its function and the specific mechanisms by which it regulates gene expression.",
    "vicuna-13b_fact_raw": "1. Long non-coding RNA (lncRNA) is a type of RNA that is longer than 200 nucleotides and does not code for proteins.\n2. LIMT lncRNA is specifically expressed in the liver and other tissues.\n3. LIMT lncRNA has been shown to interact with microRNAs.\n4. LIMT lncRNA can act as a sponge for microRNAs, preventing them from binding to their target mRNAs.\n5. LIMT lncRNA has been suggested to be involved in the regulation of cell proliferation and differentiation.",
    "vicuna-13b_fact": [
      "Long non-coding RNA (lncRNA) is a type of RNA that is longer than 200 nucleotides and does not code for proteins.",
      "LIMT lncRNA is specifically expressed in the liver and other tissues.",
      "LIMT lncRNA has been shown to interact with microRNAs.",
      "LIMT lncRNA can act as a sponge for microRNAs, preventing them from binding to their target mRNAs.",
      "LIMT lncRNA has been suggested to be involved in the regulation of cell proliferation and differentiation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements about lncRNA are generally consistent with current scientific understanding. Long non-coding RNAs are indeed longer than 200 nucleotides and do not code for proteins. They can interact with microRNAs and can act as sponges to prevent microRNAs from binding to their target mRNAs. They are also implicated in various cellular processes including cell proliferation and differentiation. However, without specific context or a reference to a study regarding LIMT lncRNA's expression in the liver and other tissues, the truth of statement 2 cannot be determined.",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "vicuna-13b_response": "The R/Bioconductor package that is commonly used for performing SNP enrichment analysis is \"Sleuth.\"",
    "vicuna-13b_fact_raw": "NO FACTS",
    "vicuna-13b_fact": [],
    "vicuna-13b_judge": []
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "vicuna-13b_response": "Radial glial cells are a type of neural stem cell that give rise to various types of neural cells, including ependymal cells, during development. The process of radial glial cell specification into ependymal cells is a complex process that involves a number of key players.\nOne of the key transcription factors involved in radial glial cell specification is the Sox2 gene. Sox2 is a transcription factor that is expressed in radial glial cells and is required for their maintenance and differentiation into ependymal cells.\nAnother key player in radial glial cell specification is the Wt1 gene. Wt1 is a transcription factor that is expressed in radial glial cells and is required for their differentiation into ependymal cells.\nAdditionally, the Notch signaling pathway plays a crucial role in radial glial cell specification. The Notch pathway is involved in cell-cell communication and regulates the differentiation of radial glial cells into ependymal cells.\nOverall, the process of radial glial cell specification into ependymal cells is a complex process that involves the interplay of multiple genetic and signaling pathways.",
    "vicuna-13b_fact_raw": "1. Radial glial cells are a type of neural stem cell that can differentiate into ependymal cells.\n2. The Sox2 gene is a transcription factor expressed in radial glial cells and is required for their maintenance and differentiation into ependymal cells.\n3. The Wt1 gene is a transcription factor expressed in radial glial cells and is required for their differentiation into ependymal cells.\n4. The Notch signaling pathway is involved in the differentiation of radial glial cells into ependymal cells.\n5. The specification of radial glial cells into ependymal cells involves multiple genetic and signaling pathways.",
    "vicuna-13b_fact": [
      "Radial glial cells are a type of neural stem cell that can differentiate into ependymal cells.",
      "The Sox2 gene is a transcription factor expressed in radial glial cells and is required for their maintenance and differentiation into ependymal cells.",
      "The Wt1 gene is a transcription factor expressed in radial glial cells and is required for their differentiation into ependymal cells.",
      "The Notch signaling pathway is involved in the differentiation of radial glial cells into ependymal cells.",
      "The specification of radial glial cells into ependymal cells involves multiple genetic and signaling pathways."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Wt1 gene is not typically associated with radial glial cell differentiation into ependymal cells. Wt1 (Wilms tumor 1) is more commonly associated with kidney development and function, as well as other roles in various cell types.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "vicuna-13b_response": "Triple negative gliomas are a type of brain tumor that are characterized by the absence of three key molecular markers: EGFR (epidermal growth factor receptor), P53 (tumor suppressor protein), and ER (estrogen receptor). These markers are often used to classify and diagnose different types of brain tumors, and their absence in triple negative gliomas distinguishes them from other types of gliomas.\nTriple negative gliomas are typically classified as grade III or IV astrocytomas, which are malignant brain tumors that arise from astrocyte cells. These tumors are highly aggressive and have a poor prognosis, with a median survival time of less than 1 year.\nIn addition to the absence of these key molecular markers, triple negative gliomas may also be characterized by other features, such as their location in the brain, their size and shape, and the presence of certain genetic mutations. For example, they are often found in the brain's hemispheres, and they can be large and difficult to remove surgically. They may also harbor mutations in genes such as IDH1 and IDH2, which are involved in the metabolism of the amino acid tryptophan.\nOverall, triple negative gliomas are a rare and aggressive type of brain tumor that are characterized by the absence of key molecular markers and other features such as their location, size, and genetic mutations.",
    "vicuna-13b_fact_raw": "1. Triple negative gliomas are characterized by the absence of three key molecular markers: EGFR, P53, and ER.\n2. These tumors are typically classified as grade III or IV astrocytomas.\n3. Triple negative gliomas are malignant brain tumors that arise from astrocyte cells.\n4. The median survival time for patients with triple negative gliomas is less than 1 year.\n5. Triple negative gliomas may harbor mutations in genes such as IDH1 and IDH2.",
    "vicuna-13b_fact": [
      "Triple negative gliomas are characterized by the absence of three key molecular markers: EGFR, P53, and ER.",
      "These tumors are typically classified as grade III or IV astrocytomas.",
      "Triple negative gliomas are malignant brain tumors that arise from astrocyte cells.",
      "The median survival time for patients with triple negative gliomas is less than 1 year.",
      "Triple negative gliomas may harbor mutations in genes such as IDH1 and IDH2."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Triple negative gliomas are characterized by the absence of three key molecular markers: IDH1, 1p/19q codeletion, and ATRX.\n2. TRUE\n3. TRUE\n4. UNKNOWN: The median survival time can vary based on a range of factors including the patient's age, overall health, the exact type of glioma, and how it responds to treatment.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "vicuna-13b_response": "TOPAZ1 is a software program developed by the United States government as part of the country's nuclear weapons program. It was used to simulate the behavior of nuclear explosions in various scenarios, including detonations above and below ground, as well as in different atmospheric conditions. The program was developed in the 1950s and was used for many years by the U.S. Department of Energy and its predecessor agencies. It was declassified in the 1990s and is now used for academic research and other non-nuclear purposes.",
    "vicuna-13b_fact_raw": "1. TOPAZ1 is a software program developed by the United States government.\n2. TOPAZ1 was part of the United States' nuclear weapons program.\n3. The software was used to simulate the behavior of nuclear explosions.\n4. TOPAZ1 was developed in the 1950s.\n5. The program was declassified in the 1990s and is now used for academic research and other non-nuclear purposes.",
    "vicuna-13b_fact": [
      "TOPAZ1 is a software program developed by the United States government.",
      "TOPAZ1 was part of the United States' nuclear weapons program.",
      "The software was used to simulate the behavior of nuclear explosions.",
      "TOPAZ1 was developed in the 1950s.",
      "The program was declassified in the 1990s and is now used for academic research and other non-nuclear purposes."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: TOPAZ1 does not refer to a software program developed in the 1950s; it is more likely associated with the TOPAZ nuclear reactor program, which was a series of Soviet-designed nuclear reactors for satellites. However, without more context, it is difficult to provide a precise correction.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "vicuna-13b_response": "The expression of GATA-1 isoforms is controlled by several genes, including GATA1, GATA2, and GATA3. These genes are part of the GATA transcription factor family, which plays a crucial role in the development and differentiation of various cell types.\nGATA1 is the founding member of the GATA family and is expressed in a variety of tissues, including the heart, kidney, and liver. Mutations in the GATA1 gene have been linked to several human diseases, including congenital heart defects and anemia.\nGATA2 is expressed in the developing heart and is essential for the development of the cardiac conduction system. Mutations in the GATA2 gene have been associated with the development of heart block, a condition in which the electrical signals that control the heartbeat are disrupted.\nGATA3 is expressed in the developing lung and is essential for the development of the pulmonary circulation. Mutations in the GATA3 gene have been linked to the development of pulmonary hypertension, a condition in which the blood pressure in the lungs is elevated.\nOverall, the expression of GATA-1 isoforms is controlled by multiple genes, and dysregulation of these genes can lead to a variety of human diseases.",
    "vicuna-13b_fact_raw": "1. The expression of GATA-1 isoforms is controlled by the genes GATA1, GATA2, and GATA3.\n2. GATA1 is expressed in various tissues, including the heart, kidney, and liver.\n3. Mutations in the GATA1 gene have been linked to congenital heart defects and anemia.\n4. GATA2 is essential for the development of the cardiac conduction system, and mutations in this gene can lead to heart block.\n5. Mutations in the GATA3 gene have been associated with the development of pulmonary hypertension.",
    "vicuna-13b_fact": [
      "The expression of GATA-1 isoforms is controlled by the genes GATA1, GATA2, and GATA3.",
      "GATA1 is expressed in various tissues, including the heart, kidney, and liver.",
      "Mutations in the GATA1 gene have been linked to congenital heart defects and anemia.",
      "GATA2 is essential for the development of the cardiac conduction system, and mutations in this gene can lead to heart block.",
      "Mutations in the GATA3 gene have been associated with the development of pulmonary hypertension."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The expression of GATA-1 isoforms is primarily controlled by the gene GATA1. GATA2 and GATA3 are related genes that also belong to the GATA family of transcription factors, but they regulate different sets of genes and are involved in different biological processes.\n2. FALSE [correction]: GATA1 is mainly expressed in hematopoietic cells, where it plays a critical role in the development of red blood cells and other cell lineages. It is not typically known for being expressed in the heart, kidney, and liver.\n3. TRUE\n4. FALSE [correction]: GATA2 is important for hematopoietic stem cell maintenance and endothelial cell function. It is not primarily known for the development of the cardiac conduction system, and mutations in GATA2 are more commonly associated with immunodeficiency syndromes, not typically heart block.\n5. FALSE [correction]: Mutations in the GATA3 gene have been associated with hypoparathyroidism, deafness, and renal dysplasia syndrome (HDR syndrome), not specifically with the development of pulmonary hypertension.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "vicuna-13b_response": "MIRA-seq (Multiplexed Ion Beam Recognition of Antigens by Sequencing) is a multiplexed sequencing-based assay used to detect and identify antibodies in a sample. It is a highly sensitive and specific method for detecting and measuring the presence of antibodies in a sample, such as blood.\nThe assay works by using a multiplexed ion beam to fragment antibodies in the sample, which are then sequenced to identify the specific antibodies present. This allows for the detection and quantification of a wide range of antibodies in a single sample, with high sensitivity and specificity.\nMIRA-seq has a wide range of applications in the field of immunology, including the detection and measurement of antibodies in disease diagnosis, monitoring of immune responses, and the study of immune system disorders. It is a powerful tool for understanding the immune system and its role in disease, and has the potential to revolutionize the way we diagnose and treat immune-related diseases.",
    "vicuna-13b_fact_raw": "1. MIRA-seq stands for Multiplexed Ion Beam Recognition of Antigens by Sequencing.\n2. MIRA-seq is used to detect and identify antibodies in a sample.\n3. The assay uses a multiplexed ion beam to fragment antibodies, which are then sequenced.\n4. MIRA-seq can detect and quantify a wide range of antibodies in a single sample.\n5. MIRA-seq has applications in disease diagnosis, monitoring immune responses, and studying immune system disorders.",
    "vicuna-13b_fact": [
      "MIRA-seq stands for Multiplexed Ion Beam Recognition of Antigens by Sequencing.",
      "MIRA-seq is used to detect and identify antibodies in a sample.",
      "The assay uses a multiplexed ion beam to fragment antibodies, which are then sequenced.",
      "MIRA-seq can detect and quantify a wide range of antibodies in a single sample.",
      "MIRA-seq has applications in disease diagnosis, monitoring immune responses, and studying immune system disorders."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: MIRA-seq stands for Multiplexed Imaging of Nucleic Acids by Sequencing.\n2. FALSE [correction]: MIRA-seq is used to detect and identify nucleic acids, not antibodies, in a sample.\n3. FALSE [correction]: MIRA-seq does not use a multiplexed ion beam to fragment antibodies. Instead, it uses oligonucleotide probes to detect nucleic acids.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "vicuna-13b_response": "ARCALYST (also known as raloxifene) is a medication that is primarily used to treat and prevent osteoporosis in postmenopausal women. It is also sometimes used to reduce the risk of breast cancer in women with a high risk of developing this disease.\nARCALYST works by binding to estrogen receptors in the body, which helps to maintain bone density and prevent bone loss. It also has anti-estrogenic effects on the uterus and breasts, which may help to reduce the risk of certain types of cancer.\nARCALYST is taken orally as a tablet, and the dosage and duration of treatment will depend on the specific condition being treated. It is important to follow your doctor's instructions carefully when taking ARCALYST, as it may interact with certain medications and may have side effects.\nIt is important to note that ARCALYST is not suitable for everyone, and it is important to speak to your doctor before starting treatment to determine if it is the right medication for you.",
    "vicuna-13b_fact_raw": "1. ARCALYST is used to treat and prevent osteoporosis in postmenopausal women.\n2. ARCALYST is sometimes used to reduce the risk of breast cancer in women with a high risk of developing the disease.\n3. ARCALYST works by binding to estrogen receptors in the body.\n4. ARCALYST is taken orally in tablet form.\n5. The dosage and duration of ARCALYST treatment depend on the specific condition being treated.",
    "vicuna-13b_fact": [
      "ARCALYST is used to treat and prevent osteoporosis in postmenopausal women.",
      "ARCALYST is sometimes used to reduce the risk of breast cancer in women with a high risk of developing the disease.",
      "ARCALYST works by binding to estrogen receptors in the body.",
      "ARCALYST is taken orally in tablet form.",
      "The dosage and duration of ARCALYST treatment depend on the specific condition being treated."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: ARCALYST (rilonacept) is used to treat Cryopyrin-Associated Periodic Syndromes (CAPS) and other inflammatory conditions, not osteoporosis.\n2. FALSE [correction]: ARCALYST is not used to reduce the risk of breast cancer; it is used for treating inflammatory conditions.\n3. FALSE [correction]: ARCALYST works by inhibiting interleukin-1 (IL-1), not by binding to estrogen receptors.\n4. FALSE [correction]: ARCALYST is not taken orally in tablet form; it is administered as a subcutaneous injection.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "vicuna-13b_response": "Robertsonian translocation is a type of chromosomal abnormality that occurs when a part of one chromosome breaks off and attaches to another chromosome. There are several human acrocentric chromosomes that are involved in Robertsonian translocation, including:\n1. Chromosome 1: The most common acrocentric chromosome involved in Robertsonian translocation is chromosome 1, which makes up about 8% of all translocations.\n2. Chromosome 9: Chromosome 9 is the second most common acrocentric chromosome involved in Robertsonian translocation, making up about 7% of all translocations.\n3. Chromosome 21: Chromosome 21 is involved in about 5% of all Robertsonian translocations.\n4. Chromosome 13: Chromosome 13 is involved in about 4% of all Robertsonian translocations.\n5. Chromosome 15: Chromosome 15 is involved in about 3% of all Robertsonian translocations.\nIt is important to note that Robertsonian translocation can occur with any acrocentric chromosome, but the ones listed above are the most commonly involved.",
    "vicuna-13b_fact_raw": "1. Chromosome 1 is involved in about 8% of all Robertsonian translocations.\n2. Chromosome 9 is involved in about 7% of all Robertsonian translocations.\n3. Chromosome 21 is involved in about 5% of all Robertsonian translocations.\n4. Chromosome 13 is involved in about 4% of all Robertsonian translocations.\n5. Chromosome 15 is involved in about 3% of all Robertsonian translocations.",
    "vicuna-13b_fact": [
      "Chromosome 1 is involved in about 8% of all Robertsonian translocations.",
      "Chromosome 9 is involved in about 7% of all Robertsonian translocations.",
      "Chromosome 21 is involved in about 5% of all Robertsonian translocations.",
      "Chromosome 13 is involved in about 4% of all Robertsonian translocations.",
      "Chromosome 15 is involved in about 3% of all Robertsonian translocations."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: Chromosome 21 is involved in a higher percentage of all Robertsonian translocations, often associated with Down syndrome.\n4. UNKNOWN\n5. UNKNOWN\n\nThe exact percentages for chromosomes 9, 13, and 15 involvement in Robertsonian translocations are not specified, and without specific data, it is difficult to confirm the accuracy of these statements. However, it is known that chromosome 21 is frequently involved in Robertsonian translocations, particularly because such translocations can lead to trisomy 21, the genetic cause of Down syndrome.",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "vicuna-13b_response": "There are several R packages that can be used for the identification of pediatric brain tumors. Some of the most commonly used packages include:\n1. \"brain\\_metadata\" - This package provides a set of functions for extracting and analyzing metadata from brain tumor imaging studies, including magnetic resonance imaging (MRI) and computed tomography (CT) scans.\n2. \"rpart\" - This package provides a set of functions for performing recursive partitioning, which is a technique used to classify objects into a set of mutually exclusive classes. Recursive partitioning can be used to identify patterns and relationships in brain tumor data, which can aid in the diagnosis and treatment of pediatric brain tumors.\n3. \"survival\" - This package provides a set of functions for analyzing survival data, which is often used in the study of brain tumors. Survival analysis can be used to estimate the probability of survival for patients with brain tumors, as well as to identify factors that are associated with improved survival.\n4. \"limma\" - This package provides a set of functions for performing linear modeling of microarray data, which can be used to identify genes that are associated with the development of brain tumors in pediatric patients.\nOverall, these packages can be used in combination with other tools and techniques to identify and diagnose pediatric brain tumors. It is important to note that the accuracy of any diagnostic tool depends on the quality and quantity of the available data, as well as the expertise of the person using the tool.",
    "vicuna-13b_fact_raw": "1. The \"brain_metadata\" R package is used for extracting and analyzing metadata from brain tumor imaging studies.\n2. The \"rpart\" R package is used for recursive partitioning to classify objects and can be applied to brain tumor data.\n3. The \"survival\" R package is used for analyzing survival data in the context of brain tumors.\n4. The \"limma\" R package is used for linear modeling of microarray data to identify genes associated with pediatric brain tumors.",
    "vicuna-13b_fact": [
      "The \"brain_metadata\" R package is used for extracting and analyzing metadata from brain tumor imaging studies.",
      "The \"rpart\" R package is used for recursive partitioning to classify objects and can be applied to brain tumor data.",
      "The \"survival\" R package is used for analyzing survival data in the context of brain tumors.",
      "The \"limma\" R package is used for linear modeling of microarray data to identify genes associated with pediatric brain tumors."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN: Without specific information about a package named \"brain_metadata,\" it is not possible to confirm or deny the purpose of this R package. This package is not well-known in the R community or might not exist.\n2. TRUE: The \"rpart\" R package is indeed used for recursive partitioning and classification, and it can be applied to various types of data, including brain tumor data.\n3. TRUE: The \"survival\" R package is a well-known package used for survival analysis, which can be applied to various contexts, including the analysis of survival data related to brain tumors.\n4. TRUE: The \"limma\" R package is commonly used for analyzing gene expression data, including linear modeling of microarray data, and can be used to identify genes associated with various conditions, including pediatric brain tumors.",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "vicuna-13b_response": "NEMO (Nuclear Factor of Activated T-Cells, also known as NF-AT) is a transcription factor that plays a role in regulating the expression of genes involved in immune cell function. It is not a zinc finger protein, but it does contain a zinc finger domain, which is a structural motif that is involved in protein-DNA interactions and is found in many transcription factors. The zinc finger domain of NEMO is involved in its binding to specific DNA sequences and regulation of gene expression.",
    "vicuna-13b_fact_raw": "1. NEMO is also known as Nuclear Factor of Activated T-Cells (NF-AT).\n2. NEMO is a transcription factor involved in regulating gene expression related to immune cell function.\n3. NEMO is not classified as a zinc finger protein.\n4. NEMO contains a zinc finger domain.\n5. The zinc finger domain of NEMO is involved in binding to specific DNA sequences and regulation of gene expression.",
    "vicuna-13b_fact": [
      "NEMO is also known as Nuclear Factor of Activated T-Cells (NF-AT).",
      "NEMO is a transcription factor involved in regulating gene expression related to immune cell function.",
      "NEMO is not classified as a zinc finger protein.",
      "NEMO contains a zinc finger domain.",
      "The zinc finger domain of NEMO is involved in binding to specific DNA sequences and regulation of gene expression."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: NEMO is not Nuclear Factor of Activated T-Cells (NF-AT); it stands for NF-kappaB Essential Modulator.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: NEMO does not contain a zinc finger domain; it contains a coiled-coil and a leucine zipper domain, among others.\n5. FALSE [correction]: Since NEMO does not contain a zinc finger domain, it is not involved in binding to specific DNA sequences through such a domain.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "vicuna-13b_response": "TFIIS (Transcription Factor IIS) is a protein that plays a role in the regulation of gene expression by controlling the initiation of transcription. It is not directly involved in the positioning of nucleosomes.\nNucleosomes are the basic units of chromatin, consisting of a DNA molecule wrapped around a histone protein core. The positioning of nucleosomes along the DNA sequence is regulated by various factors, including transcription factors, chromatin-modifying enzymes, and the DNA sequence itself.\nWhile TFIIS is not directly involved in nucleosome positioning, it is known to interact with other proteins that are involved in this process. For example, TFIIS has been shown to interact with the chromatin-modifying enzyme, ISWI (Imitation Switch/Whi5-like histone-binding protein), which is involved in the positioning of nucleosomes and other chromatin structures. Additionally, TFIIS has been shown to interact with the transcription factor, TFIIE, which is involved in the initiation of transcription and can affect nucleosome positioning by controlling the access of other transcription factors to the DNA template.\nIn summary, while TFIIS is not directly involved in nucleosome positioning, it is involved in the regulation of gene expression and can interact with other proteins that are involved in this process.",
    "vicuna-13b_fact_raw": "1. TFIIS is a protein that regulates gene expression by controlling the initiation of transcription.\n2. TFIIS is not directly involved in the positioning of nucleosomes.\n3. Nucleosomes consist of DNA wrapped around a histone protein core.\n4. The chromatin-modifying enzyme ISWI, which TFIIS can interact with, is involved in nucleosome positioning.\n5. TFIIS has been shown to interact with the transcription factor TFIIE.",
    "vicuna-13b_fact": [
      "TFIIS is a protein that regulates gene expression by controlling the initiation of transcription.",
      "TFIIS is not directly involved in the positioning of nucleosomes.",
      "Nucleosomes consist of DNA wrapped around a histone protein core.",
      "The chromatin-modifying enzyme ISWI, which TFIIS can interact with, is involved in nucleosome positioning.",
      "TFIIS has been shown to interact with the transcription factor TFIIE."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: TFIIS is a protein that regulates gene expression by enhancing the elongation phase of transcription, not the initiation.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "vicuna-13b_response": "The origins of replication close to yeast centromeres can fire either early or late during the cell cycle, depending on the specific conditions and the genetic background of the yeast strain.\nIn general, the firing of origins of replication is regulated by a complex network of signaling pathways and checkpoint mechanisms that ensure proper chromosome segregation and prevent aneuploidy. In yeast, the decision to initiate DNA replication at a specific origin is influenced by a variety of factors, including the availability of replication proteins, the level of cyclin-dependent kinase activity, and the presence of specific transcription factors.\nIn some cases, origins of replication close to yeast centromeres may fire early in the cell cycle, when the levels of cyclin-dependent kinase activity are high and the checkpoint mechanisms are less active. This can lead to the initiation of DNA replication before the proper assembly of the replication fork, which can result in errors and potentially lead to aneuploidy.\nIn other cases, origins of replication close to yeast centromeres may fire late in the cell cycle, when the levels of cyclin-dependent kinase activity are low and the checkpoint mechanisms are more active. This can lead to the initiation of DNA replication after the proper assembly of the replication fork, which can result in more accurate and efficient DNA replication.\nOverall, the firing of origins of replication close to yeast centromeres is a complex process that is influenced by a variety of factors, and the specific timing of replication initiation can vary depending on the genetic background and the specific conditions of the yeast strain.",
    "vicuna-13b_fact_raw": "1. Origins of replication close to yeast centromeres can fire either early or late during the cell cycle.\n2. The firing of origins of replication in yeast is regulated by signaling pathways and checkpoint mechanisms.\n3. The initiation of DNA replication at a specific origin in yeast is influenced by the availability of replication proteins, cyclin-dependent kinase activity, and specific transcription factors.\n4. High levels of cyclin-dependent kinase activity and less active checkpoint mechanisms can lead to early firing of origins of replication close to yeast centromeres.\n5. Low levels of cyclin-dependent kinase activity and more active checkpoint mechanisms can lead to late firing of origins of replication close to yeast centromeres.",
    "vicuna-13b_fact": [
      "Origins of replication close to yeast centromeres can fire either early or late during the cell cycle.",
      "The firing of origins of replication in yeast is regulated by signaling pathways and checkpoint mechanisms.",
      "The initiation of DNA replication at a specific origin in yeast is influenced by the availability of replication proteins, cyclin-dependent kinase activity, and specific transcription factors.",
      "High levels of cyclin-dependent kinase activity and less active checkpoint mechanisms can lead to early firing of origins of replication close to yeast centromeres.",
      "Low levels of cyclin-dependent kinase activity and more active checkpoint mechanisms can lead to late firing of origins of replication close to yeast centromeres."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements provided are consistent with the general understanding of yeast cell cycle regulation and the factors influencing the timing of origin firing during DNA replication. Origins of replication can indeed fire at different times, and their initiation is regulated by various factors including cyclin-dependent kinase activity and checkpoint mechanisms.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "vicuna-13b_response": "GA-sequences are a type of non-coding RNA that play important roles in gene regulation in mammalian cells. Some of the properties of mammalian GA-sequences include:\n1. Structure: GA-sequences are typically around 200 nucleotides in length and contain a single stem-loop structure.\n2. Localization: GA-sequences are typically found in the 3' untranslated region (3' UTR) of mRNA molecules and can act as microRNA (miRNA) precursors.\n3. Function: GA-sequences can act as miRNA precursors, which means they can be processed by the cell's miRNA biogenesis machinery to produce mature miRNA molecules that can regulate gene expression.\n4. Diversity: There are many different GA-sequence variants in mammalian cells, which can be generated through a process called alternative processing.\n5. Regulation: The expression and processing of GA-sequences can be regulated by a variety of factors, including cell type, developmental stage, and environmental cues.\nOverall, GA-sequences are important regulators of gene expression in mammalian cells and play a role in a wide range of biological processes, including development, differentiation, and disease.",
    "vicuna-13b_fact_raw": "1. GA-sequences are typically around 200 nucleotides in length and contain a single stem-loop structure.\n2. GA-sequences are typically found in the 3' untranslated region (3' UTR) of mRNA molecules.\n3. GA-sequences can act as microRNA (miRNA) precursors and be processed to produce mature miRNA molecules that regulate gene expression.\n4. There are many different GA-sequence variants in mammalian cells, generated through alternative processing.\n5. The expression and processing of GA-sequences can be regulated by factors such as cell type, developmental stage, and environmental cues.",
    "vicuna-13b_fact": [
      "GA-sequences are typically around 200 nucleotides in length and contain a single stem-loop structure.",
      "GA-sequences are typically found in the 3' untranslated region (3' UTR) of mRNA molecules.",
      "GA-sequences can act as microRNA (miRNA) precursors and be processed to produce mature miRNA molecules that regulate gene expression.",
      "There are many different GA-sequence variants in mammalian cells, generated through alternative processing.",
      "The expression and processing of GA-sequences can be regulated by factors such as cell type, developmental stage, and environmental cues."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: GA-sequences, as described, do not have a specific length of around 200 nucleotides and a single stem-loop structure. This description may be confused with microRNA (miRNA) precursors, which can form stem-loop structures, but GA-sequences are not a standard term in molecular biology and their characteristics would depend on the specific context in which they are being described.\n2. UNKNOWN: Without a specific context, it is unclear what GA-sequences refer to. If GA-sequences are being used to refer to a specific feature within mRNA, such as a regulatory sequence, they could be found in the 3' untranslated region (3' UTR), but this cannot be confirmed without additional information.\n3. UNKNOWN: While certain sequences within the 3' UTR of mRNA molecules can act as microRNA (miRNA) precursors, it is not clear what GA-sequences refer to in this context. Therefore, it cannot be determined if they can be processed to produce mature miRNA molecules without further information.\n4. UNKNOWN: The statement about the existence of many different GA-sequence variants in mammalian cells and their generation through alternative processing cannot be confirmed without a clear definition of what GA-sequences are.\n5. UNKNOWN: The regulation of expression and processing of GA-sequences by factors such as cell type, developmental stage, and environmental cues cannot be confirmed without additional context and a clear definition of GA-sequences.",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "vicuna-13b_response": "Groucho-related genes (GRGs) are a family of transcription factors that play important roles in development and differentiation in various organisms, including mice. The exact number of GRGs in the mouse genome can vary depending on the source and the specific definition of \"GRG\" used.\nAccording to the latest annotation of the mouse genome (mm11), there are at least 11 genes that are annotated as \"Groucho-related transcription factor\" (GRTF) or \"Groucho-related gene\" (GRG). These genes are:\n* Groucho (Grt1)\n* Groucho-related transcription factor 1 (Grt2)\n* Groucho-related transcription factor 2 (Grt3)\n* Groucho-related transcription factor 3 (Grt4)\n* Groucho-related transcription factor 5 (Grt5)\n* Groucho-related transcription factor 6 (Grt6)\n* Groucho-related transcription factor 7 (Grt7)\n* Groucho-related transcription factor 8 (Grt8)\n* Groucho-related transcription factor 9 (Grt9)\n* Groucho-related transcription factor 10 (Grt10)\n* Groucho-related transcription factor 11 (Grt11)\nIt's worth noting that some sources may include additional genes in the GRG family, or use a broader definition of \"Groucho-related gene\" to include genes that are not strictly related to the Groucho transcription factor.",
    "vicuna-13b_fact_raw": "1. Groucho-related genes (GRGs) are a family of transcription factors involved in development and differentiation in various organisms, including mice.\n2. The latest annotation of the mouse genome (mm11) lists at least 11 genes annotated as \"Groucho-related transcription factor\" (GRTF) or \"Groucho-related gene\" (GRG).\n3. The genes listed as part of the GRG family in the mouse genome include Groucho (Grt1), Groucho-related transcription factor 1 (Grt2), and Groucho-related transcription factor 2 (Grt3), among others.\n4. The GRG family in the mouse genome extends up to Groucho-related transcription factor 11 (Grt11).\n5. The definition of \"Groucho-related gene\" can vary depending on the source and the specific definition used, which may lead to different counts of GRGs.",
    "vicuna-13b_fact": [
      "Groucho-related genes (GRGs) are a family of transcription factors involved in development and differentiation in various organisms, including mice.",
      "The latest annotation of the mouse genome (mm11) lists at least 11 genes annotated as \"Groucho-related transcription factor\" (GRTF) or \"Groucho-related gene\" (GRG).",
      "The genes listed as part of the GRG family in the mouse genome include Groucho (Grt1), Groucho-related transcription factor 1 (Grt2), and Groucho-related transcription factor 2 (Grt3), among others.",
      "The GRG family in the mouse genome extends up to Groucho-related transcription factor 11 (Grt11).",
      "The definition of \"Groucho-related gene\" can vary depending on the source and the specific definition used, which may lead to different counts of GRGs."
    ],
    "vicuna-13b_judge_raw": "1. TRUE: Groucho-related genes (GRGs) are indeed a family of transcription factors involved in development and differentiation in various organisms, including mice.\n2. UNKNOWN: Without access to the latest annotation of the mouse genome (mm11), it is not possible to confirm the exact number of genes annotated as \"Groucho-related transcription factor\" (GRTF) or \"Groucho-related gene\" (GRG).\n3. UNKNOWN: Without specific information from the mouse genome annotation, it is not possible to confirm the names and designations of the genes listed as part of the GRG family.\n4. UNKNOWN: Without access to the latest genomic data, it is not possible to confirm whether the GRG family in the mouse genome extends up to Groucho-related transcription factor 11 (Grt11).\n5. TRUE: The definition of \"Groucho-related gene\" can indeed vary depending on the source and the specific definition used, which may lead to different counts of GRGs.",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "vicuna-13b_response": "RNA cleavage activity is not a function of RNA polymerase II subunits. RNA cleavage is typically carried out by enzymes such as RNases, which are responsible for cleaving RNA molecules. RNA polymerase II is an enzyme that is responsible for transcribing DNA into RNA. It is composed of several subunits, including a large catalytic subunit (Pol II) and several regulatory subunits. The regulatory subunits play a role in controlling the activity of Pol II and the specific genes that are transcribed. However, they do not have RNA cleavage activity.",
    "vicuna-13b_fact_raw": "1. RNA cleavage activity is not a function of RNA polymerase II subunits.\n2. RNA cleavage is typically carried out by enzymes such as RNases.\n3. RNA polymerase II is responsible for transcribing DNA into RNA.\n4. RNA polymerase II is composed of a large catalytic subunit and several regulatory subunits.\n5. The regulatory subunits of RNA polymerase II control the activity of the catalytic subunit and the specific genes that are transcribed.",
    "vicuna-13b_fact": [
      "RNA cleavage activity is not a function of RNA polymerase II subunits.",
      "RNA cleavage is typically carried out by enzymes such as RNases.",
      "RNA polymerase II is responsible for transcribing DNA into RNA.",
      "RNA polymerase II is composed of a large catalytic subunit and several regulatory subunits.",
      "The regulatory subunits of RNA polymerase II control the activity of the catalytic subunit and the specific genes that are transcribed."
    ],
    "vicuna-13b_judge_raw": "1. TRUE: RNA cleavage activity is generally not a function of RNA polymerase II subunits. RNA polymerase II's primary function is to transcribe DNA into RNA, not to cleave RNA.\n2. TRUE: RNA cleavage is typically carried out by enzymes such as RNases, which are specialized for this function.\n3. TRUE: RNA polymerase II is indeed responsible for transcribing DNA into RNA, specifically messenger RNA (mRNA) in eukaryotic cells.\n4. TRUE: RNA polymerase II is composed of a large catalytic subunit (the core enzyme) and several regulatory subunits that are necessary for its function.\n5. TRUE: The regulatory subunits of RNA polymerase II control the activity of the catalytic subunit and influence the specific genes that are transcribed by facilitating the binding of RNA polymerase II to gene promoters, among other regulatory roles.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "vicuna-13b_response": "Ohdo syndrome is a rare genetic disorder that is caused by mutations in the SLC25A20 gene. This gene provides instructions for making a protein that is involved in the transport of zinc and other metals across cell membranes.\nMutations in the SLC25A20 gene can lead to reduced zinc transport, which can cause a range of symptoms, including intellectual disability, developmental delay, and movement difficulties. The severity of these symptoms can vary widely, depending on the specific mutation and the presence of other genetic factors.\nOhdo syndrome is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated gene (one from each parent) to develop the disorder. Carriers of one copy of the mutated gene do not typically have any symptoms, but they can pass the mutation on to their children.\nDiagnosis of Ohdo syndrome is typically based on a combination of clinical features, genetic testing, and other medical tests. There is currently no cure for Ohdo syndrome, but treatment is focused on managing symptoms and providing supportive care. This may include physical therapy, occupational therapy, and other interventions to help individuals with the disorder reach their full potential.",
    "vicuna-13b_fact_raw": "1. Ohdo syndrome is a rare genetic disorder caused by mutations in the SLC25A20 gene.\n2. The SLC25A20 gene is involved in the transport of zinc and other metals across cell membranes.\n3. Symptoms of Ohdo syndrome can include intellectual disability, developmental delay, and movement difficulties.\n4. Ohdo syndrome is inherited in an autosomal recessive pattern, requiring two copies of the mutated gene for the disorder to develop.\n5. Carriers of one copy of the mutated SLC25A20 gene typically do not show symptoms of Ohdo syndrome.",
    "vicuna-13b_fact": [
      "Ohdo syndrome is a rare genetic disorder caused by mutations in the SLC25A20 gene.",
      "The SLC25A20 gene is involved in the transport of zinc and other metals across cell membranes.",
      "Symptoms of Ohdo syndrome can include intellectual disability, developmental delay, and movement difficulties.",
      "Ohdo syndrome is inherited in an autosomal recessive pattern, requiring two copies of the mutated gene for the disorder to develop.",
      "Carriers of one copy of the mutated SLC25A20 gene typically do not show symptoms of Ohdo syndrome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Ohdo syndrome is a rare genetic disorder, but it is not caused by mutations in the SLC25A20 gene. It is associated with mutations in several genes, including MED12, KAT6B, and SALL1.\n2. FALSE [correction]: The SLC25A20 gene is involved in the mitochondrial transport of carnitine, a molecule that is important for the oxidation of long-chain fatty acids, not the transport of zinc and other metals across cell membranes.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "vicuna-13b_response": "There are several R/Bioconductor packages that are commonly used for the analysis of psychiatric disease genes. Some of the most popular ones include:\n1. PsychArray: This package provides a set of functions for the analysis of gene expression data in psychiatric diseases. It includes functions for quality control, normalization, and differential expression analysis.\n2. BrainArray: This package provides a set of functions for the analysis of gene expression data in brain tissue. It includes functions for quality control, normalization, and differential expression analysis, and it is specifically designed for brain-related studies.\n3. PsychTranscriptomics: This package provides a set of functions for the analysis of transcriptomics data in psychiatric diseases. It includes functions for quality control, normalization, and differential expression analysis, and it also allows for the analysis of alternative splicing and gene fusion events.\n4. BrainTranscriptomics: This package provides a set of functions for the analysis of transcriptomics data in brain tissue. It includes functions for quality control, normalization, and differential expression analysis, and it is specifically designed for brain-related studies.\n5. RvDREAM: This package provides a set of functions for the analysis of ChIP-seq and DNase-seq data in brain tissue. It includes functions for quality control, peak calling, and peak annotation, and it is specifically designed for brain-related studies.\nIt's worth noting that these packages are not exclusive to psychiatric disease analysis, they can be used for other types of studies as well, but they have been developed with the specific aim of analyzing psychiatric disease genes.",
    "vicuna-13b_fact_raw": "1. PsychArray is an R/Bioconductor package designed for the analysis of gene expression data in psychiatric diseases.\n2. BrainArray is an R/Bioconductor package designed for the analysis of gene expression data in brain tissue.\n3. PsychTranscriptomics is an R/Bioconductor package designed for the analysis of transcriptomics data in psychiatric diseases.\n4. BrainTranscriptomics is an R/Bioconductor package designed for the analysis of transcriptomics data in brain tissue.\n5. RvDREAM is an R/Bioconductor package designed for the analysis of ChIP-seq and DNase-seq data in brain tissue.",
    "vicuna-13b_fact": [
      "PsychArray is an R/Bioconductor package designed for the analysis of gene expression data in psychiatric diseases.",
      "BrainArray is an R/Bioconductor package designed for the analysis of gene expression data in brain tissue.",
      "PsychTranscriptomics is an R/Bioconductor package designed for the analysis of transcriptomics data in psychiatric diseases.",
      "BrainTranscriptomics is an R/Bioconductor package designed for the analysis of transcriptomics data in brain tissue.",
      "RvDREAM is an R/Bioconductor package designed for the analysis of ChIP-seq and DNase-seq data in brain tissue."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN: Without specific information about a package named \"PsychArray,\" it is not possible to confirm or deny the statement's accuracy.\n2. UNKNOWN: Similarly, without specific information about a package named \"BrainArray,\" it is not possible to confirm or deny the statement's accuracy.\n3. UNKNOWN: The existence and purpose of a package named \"PsychTranscriptomics\" cannot be confirmed without additional information.\n4. UNKNOWN: The existence and purpose of a package named \"BrainTranscriptomics\" cannot be confirmed without additional information.\n5. UNKNOWN: The existence and purpose of a package named \"RvDREAM\" cannot be confirmed without additional information.\n\nNote: The R/Bioconductor project hosts a wide range of packages for various types of biological data analysis. However, without access to the current list of packages or specific knowledge about the packages mentioned, it is not possible to verify these statements. Users interested in these packages should search the R/Bioconductor repository or relevant scientific literature for accurate information.",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "vicuna-13b_response": "Swirl sign is a radiologic finding that is commonly seen in patients with intracerebral hemorrhage (ICH), which is a type of stroke caused by bleeding into the brain tissue. It is also known as a \"rice-grain\" sign or a \"floret sign\".\nThe swirl sign is caused by the presence of small, round, hyperdense areas (called \"rice grains\") within the hemorrhage. These small, round lesions are formed by the coagulation of blood within the brain tissue, and they are typically seen in the setting of ICH due to hypertension or other vascular conditions.\nThe swirl sign is often seen on CT scans of the brain, and it is a useful indicator of the presence and extent of ICH. It is important to note that the swirl sign is not specific to ICH and can also be seen in other types of brain injury or inflammation.\nIn summary, the swirl sign is a radiologic finding that is commonly seen in patients with intracerebral hemorrhage, and it is caused by the presence of small, round, hyperdense areas within the hemorrhage. It is a useful indicator of the presence and extent of ICH, and it is often seen on CT scans of the brain.",
    "vicuna-13b_fact_raw": "1. Swirl sign is a radiologic finding commonly seen in patients with intracerebral hemorrhage (ICH).\n2. Intracerebral hemorrhage is a type of stroke caused by bleeding into the brain tissue.\n3. The swirl sign is caused by the presence of small, round, hyperdense areas within the hemorrhage.\n4. These hyperdense areas, or \"rice grains,\" are formed by the coagulation of blood within the brain tissue.\n5. The swirl sign is often seen on CT scans of the brain and indicates the presence and extent of ICH.",
    "vicuna-13b_fact": [
      "Swirl sign is a radiologic finding commonly seen in patients with intracerebral hemorrhage (ICH).",
      "Intracerebral hemorrhage is a type of stroke caused by bleeding into the brain tissue.",
      "The swirl sign is caused by the presence of small, round, hyperdense areas within the hemorrhage.",
      "These hyperdense areas, or \"rice grains,\" are formed by the coagulation of blood within the brain tissue.",
      "The swirl sign is often seen on CT scans of the brain and indicates the presence and extent of ICH."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The swirl sign is caused by the presence of mixed density within the hemorrhage, often due to active bleeding where both high-density (fresh blood) and low-density (serum or cerebrospinal fluid) components are present.\n4. FALSE [correction]: The term \"rice grains\" is not typically used to describe features within a hemorrhage. The swirl sign does not specifically refer to coagulated blood appearing as small, round, hyperdense areas but rather to the heterogeneous appearance within the hemorrhage.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "vicuna-13b_response": "ROF1 is a transcription factor that is involved in regulating the response of Arabidopsis thaliana to various environmental stresses, including drought, salt, and cold. The expression of ROF1 is induced in response to these stresses, and it plays a role in the activation of genes that are involved in stress response pathways.\nSeveral studies have identified different factors that can induce the expression of ROF1 in Arabidopsis. For example, exposure to high levels of salt or mannitol can induce ROF1 expression, as can exposure to low temperatures or high light intensity. Additionally, ROF1 expression can be induced by certain hormones, such as abscisic acid or ethylene.\nIn general, the induction of ROF1 expression is thought to be mediated by a combination of environmental signals and intracellular signaling pathways. For example, ROF1 expression may be induced by the activation of specific transcription factors, such as DREB1 or HSF, which are known to be involved in regulating stress response pathways in Arabidopsis. Additionally, the activity of ROF1 itself may be regulated by post-translational modifications, such as phosphorylation or acetylation, which can affect its ability to bind to DNA and regulate gene expression.\nOverall, the induction of ROF1 expression in Arabidopsis is a complex process that is influenced by a variety of environmental and intracellular signals, and it is likely that the specific mechanisms involved in ROF1 induction will vary depending on the specific stress conditions being experienced by the plant.",
    "vicuna-13b_fact_raw": "1. ROF1 is a transcription factor that regulates the response of Arabidopsis thaliana to environmental stresses such as drought, salt, and cold.\n2. The expression of ROF1 in Arabidopsis is induced by exposure to high levels of salt or mannitol.\n3. Low temperatures or high light intensity can induce the expression of ROF1 in Arabidopsis.\n4. Hormones like abscisic acid or ethylene can induce ROF1 expression in Arabidopsis.\n5. Specific transcription factors, such as DREB1 or HSF, are involved in regulating stress response pathways and can induce ROF1 expression in Arabidopsis.",
    "vicuna-13b_fact": [
      "ROF1 is a transcription factor that regulates the response of Arabidopsis thaliana to environmental stresses such as drought, salt, and cold.",
      "The expression of ROF1 in Arabidopsis is induced by exposure to high levels of salt or mannitol.",
      "Low temperatures or high light intensity can induce the expression of ROF1 in Arabidopsis.",
      "Hormones like abscisic acid or ethylene can induce ROF1 expression in Arabidopsis.",
      "Specific transcription factors, such as DREB1 or HSF, are involved in regulating stress response pathways and can induce ROF1 expression in Arabidopsis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements provided are consistent with the general understanding of plant stress response mechanisms. ROF1 (Related to ABI3/VP1 1) is known to be involved in the response to various environmental stresses in Arabidopsis thaliana. The expression of stress-responsive genes, including ROF1, can be induced by abiotic stresses such as drought, salt, cold, and high light intensity. Additionally, plant hormones like abscisic acid (ABA) and ethylene are key regulators of stress responses and can induce the expression of stress-related genes. Transcription factors like DREB1 (Dehydration-Responsive Element-Binding protein 1) and HSF (Heat Shock Factor) are known to play roles in the regulation of stress response pathways, which could include the induction of ROF1 expression. However, without specific experimental evidence for each statement, the responses are based on typical plant stress response pathways.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "vicuna-13b_response": "The most common cause of hereditary renal amyloidosis is the accumulation of the protein transthyretin (TTR) in the kidneys. TTR is a protein that is produced in the liver and transported to the kidneys, where it is normally eliminated in the urine. In hereditary renal amyloidosis, there is a mutation in the TTR gene that causes the protein to misfold and accumulate in the kidneys, leading to the formation of amyloid fibrils. These fibrils can cause damage to the kidneys and lead to progressive kidney failure. Other proteins can also cause hereditary renal amyloidosis, but TTR is the most common.",
    "vicuna-13b_fact_raw": "1. Transthyretin (TTR) accumulation is the most common cause of hereditary renal amyloidosis.\n2. TTR is a protein produced in the liver.\n3. In hereditary renal amyloidosis, a mutation in the TTR gene causes the protein to misfold.\n4. Misfolded TTR accumulates in the kidneys, leading to the formation of amyloid fibrils.\n5. Amyloid fibrils from misfolded TTR can cause damage to the kidneys and lead to progressive kidney failure.",
    "vicuna-13b_fact": [
      "Transthyretin (TTR) accumulation is the most common cause of hereditary renal amyloidosis.",
      "TTR is a protein produced in the liver.",
      "In hereditary renal amyloidosis, a mutation in the TTR gene causes the protein to misfold.",
      "Misfolded TTR accumulates in the kidneys, leading to the formation of amyloid fibrils.",
      "Amyloid fibrils from misfolded TTR can cause damage to the kidneys and lead to progressive kidney failure."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The most common cause of hereditary renal amyloidosis is not Transthyretin (TTR) accumulation; it is often caused by mutations in genes encoding for proteins other than TTR, such as fibrinogen A alpha-chain, apolipoprotein A1, or lysozyme.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "vicuna-13b_response": "Yes, the proteome of mice hippocampus has been analyzed. The hippocampus is a structure in the brain that plays a key role in memory and spatial navigation, and it is an important region to study in the context of neuroscience and brain disease.\nSeveral proteomic studies have been conducted on the hippocampus of mice, using techniques such as 2D gel electrophoresis, mass spectrometry, and other advanced proteomics tools. These studies have identified a large number of proteins that are expressed in the hippocampus, including structural proteins, enzymes, transport proteins, and signaling molecules.\nFor example, a study published in the journal \"Proteomics\" in 2012 used 2D gel electrophoresis and mass spectrometry to identify 462 proteins in the hippocampus of mice. Another study published in the journal \"Journal of Neuroscience\" in 2015 used a combination of 2D gel electrophoresis and liquid chromatography-tandem mass spectrometry to identify 1,325 proteins in the hippocampus of mice.\nThese studies have provided valuable insights into the proteins that are involved in various brain functions, such as learning and memory, and have also helped to identify potential targets for the development of new treatments for brain diseases. However, it is important to note that these studies are still ongoing, and there is still much to be learned about the proteome of the mouse hippocampus.",
    "vicuna-13b_fact_raw": "1. The proteome of mice hippocampus has been analyzed using techniques such as 2D gel electrophoresis and mass spectrometry.\n2. A study published in the journal \"Proteomics\" in 2012 identified 462 proteins in the hippocampus of mice.\n3. Another study published in the journal \"Journal of Neuroscience\" in 2015 identified 1,325 proteins in the hippocampus of mice.\n4. The hippocampus plays a key role in memory and spatial navigation.\n5. Proteomic studies of the mouse hippocampus have contributed to the understanding of brain functions and potential targets for treating brain diseases.",
    "vicuna-13b_fact": [
      "The proteome of mice hippocampus has been analyzed using techniques such as 2D gel electrophoresis and mass spectrometry.",
      "A study published in the journal \"Proteomics\" in 2012 identified 462 proteins in the hippocampus of mice.",
      "Another study published in the journal \"Journal of Neuroscience\" in 2015 identified 1,325 proteins in the hippocampus of mice.",
      "The hippocampus plays a key role in memory and spatial navigation.",
      "Proteomic studies of the mouse hippocampus have contributed to the understanding of brain functions and potential targets for treating brain diseases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. TRUE\n\nThe first statement is true as the proteome of various tissues, including the mouse hippocampus, has been analyzed using techniques like 2D gel electrophoresis and mass spectrometry. The fourth statement is also true as the hippocampus is well-known for its role in memory and spatial navigation. The fifth statement is true as proteomic studies do contribute to understanding brain functions and identifying potential targets for treating brain diseases.\n\nHowever, without specific references to the studies mentioned in statements 2 and 3, it is not possible to verify the exact number of proteins identified in those studies. Therefore, the truthfulness of statements 2 and 3 is unknown.",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "vicuna-13b_response": "Mouse chromosomes are not acrocentric. Acrocentric chromosomes are those in which the centromere is located at the tip of the chromosome. Mouse chromosomes have a different type of centromere organization, called \"pericentromeric heterochromatin,\" which is located closer to the center of the chromosome.\nIn mice, the X and Y chromosomes are acrocentric, while the other chromosomes are metacentric or submetacentric. The X and Y chromosomes have a unique structure, with a large amount of heterochromatin at their tips, which is why they are considered acrocentric.\nIt's worth noting that the chromosome structure and organization can vary between different species, and even between different individuals of the same species.",
    "vicuna-13b_fact_raw": "1. Mouse chromosomes are not acrocentric, except for the X and Y chromosomes.\n2. Acrocentric chromosomes have the centromere located at the tip of the chromosome.\n3. Mouse chromosomes typically have \"pericentromeric heterochromatin\" centromere organization.\n4. The X and Y chromosomes in mice are considered acrocentric due to a large amount of heterochromatin at their tips.\n5. Chromosome structure and organization can vary between different species and individuals of the same species.",
    "vicuna-13b_fact": [
      "Mouse chromosomes are not acrocentric, except for the X and Y chromosomes.",
      "Acrocentric chromosomes have the centromere located at the tip of the chromosome.",
      "Mouse chromosomes typically have \"pericentromeric heterochromatin\" centromere organization.",
      "The X and Y chromosomes in mice are considered acrocentric due to a large amount of heterochromatin at their tips.",
      "Chromosome structure and organization can vary between different species and individuals of the same species."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Mouse chromosomes are acrocentric, including the X and Y chromosomes.\n2. FALSE [correction]: Acrocentric chromosomes have the centromere located close to one end of the chromosome, not at the very tip. Chromosomes with the centromere at the tip are called telocentric.\n3. TRUE\n4. FALSE [correction]: The X and Y chromosomes in mice are considered acrocentric not because of heterochromatin at their tips, but because their centromeres are located close to one end, resulting in a long arm and a very short (or almost indistinguishable) other arm.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "vicuna-13b_response": "One siRNA-based drug that is currently in clinical trials for the treatment of pancreatic cancer is called \"Onpattro\" (patisiran). Onpattro is a targeted therapy that uses RNA interference (RNAi) technology to inhibit the production of a protein called \"hematopoietic growth factor receptor 2\" (CD47), which is expressed on the surface of many types of cancer cells, including pancreatic cancer cells. By inhibiting CD47, Onpattro can help to enhance the immune system's ability to recognize and attack cancer cells.\nOnpattro is administered intravenously and has been studied in several clinical trials for the treatment of pancreatic cancer, including a phase 1b/2 clinical trial (NCT02822612) and a phase 3 clinical trial (NCT03003075). The results of these trials have shown that Onpattro can be effective in treating pancreatic cancer, with some patients experiencing significant reductions in tumor size and improvements in overall survival.\nIt's important to note that while Onpattro has shown promise in clinical trials, it is not yet approved by the FDA for the treatment of pancreatic cancer, and more research is needed to fully understand its safety and efficacy in this context.",
    "vicuna-13b_fact_raw": "1. Onpattro (patisiran) is an siRNA-based drug currently in clinical trials for the treatment of pancreatic cancer.\n2. Onpattro uses RNA interference (RNAi) technology to inhibit the production of the protein CD47.\n3. CD47 is expressed on the surface of many types of cancer cells, including pancreatic cancer cells.\n4. Onpattro has been studied in a phase 1b/2 clinical trial (NCT02822612).\n5. Onpattro has also been studied in a phase 3 clinical trial (NCT03003075).",
    "vicuna-13b_fact": [
      "Onpattro (patisiran) is an siRNA-based drug currently in clinical trials for the treatment of pancreatic cancer.",
      "Onpattro uses RNA interference (RNAi) technology to inhibit the production of the protein CD47.",
      "CD47 is expressed on the surface of many types of cancer cells, including pancreatic cancer cells.",
      "Onpattro has been studied in a phase 1b/2 clinical trial (NCT02822612).",
      "Onpattro has also been studied in a phase 3 clinical trial (NCT03003075)."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Onpattro (patisiran) is an siRNA-based drug that is approved for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR), not for the treatment of pancreatic cancer.\n2. FALSE [correction]: Onpattro uses RNA interference (RNAi) technology to inhibit the production of transthyretin (TTR) protein, not CD47.\n3. TRUE: CD47 is indeed expressed on the surface of many types of cancer cells, including pancreatic cancer cells, and is a target for cancer therapy, although this is not related to Onpattro's mechanism of action.\n4. FALSE [correction]: Onpattro has been studied in clinical trials for hereditary transthyretin-mediated amyloidosis (hATTR), not specifically in a phase 1b/2 clinical trial with the identifier NCT02822612 for pancreatic cancer.\n5. TRUE: Onpattro has been studied in a phase 3 clinical trial, but the trial identifier NCT03003075 is associated with its study for hereditary transthyretin-mediated amyloidosis (hATTR), not for pancreatic cancer.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "vicuna-13b_response": "The HPG pore, also known as the hypothalamic-pituitary-gonadal (HPG) axis, is a complex network of endocrine glands and tissues that work together to regulate various physiological processes in the body, including growth and development, reproduction, and stress response.\nThe hypothalamus is a small region of the brain that serves as the central control center for many of the body's autonomic functions, such as body temperature, hunger, and thirst. The pituitary gland, located at the base of the brain, is a small endocrine gland that plays a critical role in regulating various bodily functions through the production of hormones.\nThe gonads, which are the reproductive organs that produce gametes (testes in males, ovaries in females), are also part of the HPG axis. The HPG axis works by releasing various hormones that regulate the production and release of other hormones, creating a complex feedback loop that helps maintain homeostasis in the body.\nOverall, the HPG pore is a vital part of the endocrine system that plays a critical role in regulating many aspects of the body's physiology.",
    "vicuna-13b_fact_raw": "1. The HPG pore, also known as the hypothalamic-pituitary-gonadal axis, is a network of endocrine glands and tissues that regulate physiological processes including growth, development, reproduction, and stress response.\n2. The hypothalamus is a small region of the brain that controls autonomic functions such as body temperature, hunger, and thirst.\n3. The pituitary gland is located at the base of the brain and regulates various bodily functions through hormone production.\n4. The gonads, which are part of the HPG axis, are reproductive organs that produce gametes (testes in males, ovaries in females).\n5. The HPG axis operates through a feedback loop of hormone release and regulation to maintain homeostasis in the body.",
    "vicuna-13b_fact": [
      "The HPG pore, also known as the hypothalamic-pituitary-gonadal axis, is a network of endocrine glands and tissues that regulate physiological processes including growth, development, reproduction, and stress response.",
      "The hypothalamus is a small region of the brain that controls autonomic functions such as body temperature, hunger, and thirst.",
      "The pituitary gland is located at the base of the brain and regulates various bodily functions through hormone production.",
      "The gonads, which are part of the HPG axis, are reproductive organs that produce gametes (testes in males, ovaries in females).",
      "The HPG axis operates through a feedback loop of hormone release and regulation to maintain homeostasis in the body."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The HPG axis, also known as the hypothalamic-pituitary-gonadal axis, is a network of endocrine glands and tissues that regulate physiological processes including growth, development, reproduction, and stress response. The term \"HPG pore\" is incorrect; it is not a pore but an axis.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "vicuna-13b_response": "The 959 Nematode Genomes initiative is a large-scale research project aimed at sequencing and analyzing the genomes of 959 species of nematodes, which are a type of roundworm. The project is a collaboration between researchers from around the world and is being funded by the National Science Foundation in the United States.\nThe goal of the project is to gain a better understanding of the biology and evolution of nematodes, which are among the most diverse and abundant organisms on Earth. By sequencing the genomes of such a large number of nematode species, researchers hope to identify genetic changes that have occurred over time and to study the ways in which these changes have influenced the evolution of the organisms.\nIn addition to providing insights into the biology and evolution of nematodes, the 959 Nematode Genomes initiative is also expected to have broader implications for the field of genomics and the study of other organisms. By providing a large and diverse dataset of genomic information, researchers will be able to develop new tools and techniques for analyzing genetic data and studying the evolution of complex organisms.",
    "vicuna-13b_fact_raw": "1. The 959 Nematode Genomes initiative is a research project focused on sequencing and analyzing the genomes of 959 species of nematodes.\n2. The initiative is a collaborative effort involving researchers from around the world.\n3. The National Science Foundation in the United States is funding the 959 Nematode Genomes initiative.\n4. The goal of the project is to improve understanding of the biology and evolution of nematodes.\n5. The initiative aims to provide a large dataset of genomic information that can aid in the development of new tools and techniques for genetic analysis.",
    "vicuna-13b_fact": [
      "The 959 Nematode Genomes initiative is a research project focused on sequencing and analyzing the genomes of 959 species of nematodes.",
      "The initiative is a collaborative effort involving researchers from around the world.",
      "The National Science Foundation in the United States is funding the 959 Nematode Genomes initiative.",
      "The goal of the project is to improve understanding of the biology and evolution of nematodes.",
      "The initiative aims to provide a large dataset of genomic information that can aid in the development of new tools and techniques for genetic analysis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "vicuna-13b_response": "The \"nipy\" package is a popular R package for analyzing Non-invasive prenatal testing (NIPT) data. It provides functions for processing NIPT data, including calling variants, estimating fraction of cells, and calculating metrics such as cell-free DNA (cfDNA) and percent fetal DNA. The package also includes functions for visualizing NIPT data, including scatter plots and heatmaps. Additionally, there are other packages such as \"nipst\" and \"prenet\" that can be used for NIPT data analysis.",
    "vicuna-13b_fact_raw": "1. The \"nipy\" package is an R package developed for analyzing Non-invasive prenatal testing (NIPT) data.\n2. The \"nipy\" package includes functions for calling variants in NIPT data.\n3. The \"nipy\" package can estimate the fraction of fetal cells in NIPT data.\n4. The \"nipy\" package provides functions for calculating metrics such as cell-free DNA (cfDNA) and percent fetal DNA.\n5. Other R packages for NIPT data analysis include \"nipst\" and \"prenet\".",
    "vicuna-13b_fact": [
      "The \"nipy\" package is an R package developed for analyzing Non-invasive prenatal testing (NIPT) data.",
      "The \"nipy\" package includes functions for calling variants in NIPT data.",
      "The \"nipy\" package can estimate the fraction of fetal cells in NIPT data.",
      "The \"nipy\" package provides functions for calculating metrics such as cell-free DNA (cfDNA) and percent fetal DNA.",
      "Other R packages for NIPT data analysis include \"nipst\" and \"prenet\"."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The \"nipy\" package is a Python package developed for the analysis of neuroimaging data, not Non-invasive prenatal testing (NIPT) data.\n2. FALSE [correction]: Since \"nipy\" is not an R package for NIPT data, it does not include functions for calling variants in NIPT data.\n3. FALSE [correction]: The \"nipy\" package is not designed to estimate the fraction of fetal cells in NIPT data as it is for neuroimaging analysis.\n4. FALSE [correction]: The \"nipy\" package does not provide functions for calculating metrics such as cell-free DNA (cfDNA) and percent fetal DNA, as it is not related to NIPT data analysis.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbachâs syndrome.",
    "vicuna-13b_response": "Achenbach's syndrome is a rare congenital disorder characterized by the association of a cranial nerve palsy (usually of the third, fourth, or sixth cranial nerve) with a limb deformity, most commonly a congenital talipes equinovarus (clubfoot) or a congenital hip dislocation. The condition is named after the German pediatrician Franz Achenbach, who first described it in 1914.\nThe exact cause of Achenbach's syndrome is not known, but it is thought to be due to a developmental abnormality of the brain or spinal cord. The cranial nerve palsy is usually present at birth or within the first few months of life, and the limb deformity may be apparent at birth or become apparent later in infancy or early childhood.\nThe clinical features of Achenbach's syndrome include a cranial nerve palsy (usually of the third, fourth, or sixth cranial nerve) resulting in weakness or paralysis of the muscles of the face, arm, or leg on the affected side. The limb deformity may be mild or severe, and may be unilateral (affecting one limb) or bilateral (affecting both limbs).\nDiagnosis of Achenbach's syndrome is typically made through a combination of physical examination, medical imaging (such as MRI), and genetic testing. Treatment of Achenbach's syndrome is typically focused on managing the symptoms of the condition, and may include physical therapy, orthotic devices, or surgery to correct the limb deformity. In some cases, medications may be prescribed to manage the symptoms of the cranial nerve palsy.\nIt is important to note that Achenbach's syndrome is a rare condition, and the prognosis for individuals with the condition can vary widely depending on the severity of the cranial nerve palsy and limb deformity, as well as the response to treatment.",
    "vicuna-13b_fact_raw": "1. Achenbach's syndrome is a rare congenital disorder associated with cranial nerve palsy and limb deformity.\n2. The condition was first described by the German pediatrician Franz Achenbach in 1914.\n3. Common limb deformities associated with Achenbach's syndrome include congenital talipes equinovarus (clubfoot) or a congenital hip dislocation.\n4. Diagnosis of Achenbach's syndrome is typically made through physical examination, medical imaging, and genetic testing.\n5. Treatment options for Achenbach's syndrome may include physical therapy, orthotic devices, or surgery to correct the limb deformity.",
    "vicuna-13b_fact": [
      "Achenbach's syndrome is a rare congenital disorder associated with cranial nerve palsy and limb deformity.",
      "The condition was first described by the German pediatrician Franz Achenbach in 1914.",
      "Common limb deformities associated with Achenbach's syndrome include congenital talipes equinovarus (clubfoot) or a congenital hip dislocation.",
      "Diagnosis of Achenbach's syndrome is typically made through physical examination, medical imaging, and genetic testing.",
      "Treatment options for Achenbach's syndrome may include physical therapy, orthotic devices, or surgery to correct the limb deformity."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Achenbach's syndrome is not a congenital disorder but a rare condition characterized by spontaneous bruising in the hand or fingers.\n2. FALSE [correction]: Achenbach's syndrome was first described by the German physician Dr. Paul Achenbach in 1958, not by Franz Achenbach in 1914.\n3. FALSE [correction]: Since Achenbach's syndrome is related to spontaneous bruising of the hands or fingers, it is not associated with congenital limb deformities such as clubfoot or congenital hip dislocation.\n4. FALSE [correction]: Diagnosis of Achenbach's syndrome is typically made through clinical observation of the symptoms, as it is characterized by bruising without a clear cause. Medical imaging may be used to rule out other conditions, but genetic testing is not a standard diagnostic tool for this syndrome.\n5. FALSE [correction]: Treatment options for Achenbach's syndrome are generally conservative, as the condition is self-limiting. It may include reassurance and explanation of the benign nature of the syndrome. Physical therapy, orthotic devices, or surgery are not typical treatments for Achenbach's syndrome, as they would be for congenital limb deformities.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "vicuna-13b_response": "There are several algorithms that can be used for the detection of long repeat expansions, including:\n1. Longest Common Subsequence (LCS) algorithm: This algorithm is used to find the longest sequence of consecutive characters that are common to two or more strings. In the context of detecting long repeat expansions, the LCS algorithm can be used to identify the presence of long repeat sequences in a genome.\n2. Smith-Waterman algorithm: This algorithm is a dynamic programming algorithm that is commonly used for comparing biological sequences. It can be used to identify the presence of long repeat sequences in a genome by comparing the sequence to a known reference sequence.\n3. Repeat-induced polymerase chain reaction (RIP-PCR): This is a PCR-based method that can be used to amplify and detect long repeat sequences in a genome. RIP-PCR is based on the fact that repeat sequences can act as templates for the polymerase chain reaction, leading to the amplification of the repeat sequence.\n4. Next-generation sequencing (NGS) technologies: NGS technologies, such as whole-genome sequencing, can be used to identify long repeat expansions directly from the genome sequence. NGS technologies allow for the simultaneous detection of multiple repeat sequences, making them a powerful tool for the study of repeat disorders.\nOverall, the choice of algorithm will depend on the specific needs of the research question and the available resources.",
    "vicuna-13b_fact_raw": "1. The Longest Common Subsequence (LCS) algorithm is used to find the longest sequence of consecutive characters that are common to two or more strings.\n2. The Smith-Waterman algorithm is a dynamic programming algorithm used for comparing biological sequences.\n3. Repeat-induced polymerase chain reaction (RIP-PCR) is a PCR-based method used to amplify and detect long repeat sequences in a genome.\n4. Next-generation sequencing (NGS) technologies can be used to identify long repeat expansions directly from the genome sequence.\n5. NGS technologies allow for the simultaneous detection of multiple repeat sequences.",
    "vicuna-13b_fact": [
      "The Longest Common Subsequence (LCS) algorithm is used to find the longest sequence of consecutive characters that are common to two or more strings.",
      "The Smith-Waterman algorithm is a dynamic programming algorithm used for comparing biological sequences.",
      "Repeat-induced polymerase chain reaction (RIP-PCR) is a PCR-based method used to amplify and detect long repeat sequences in a genome.",
      "Next-generation sequencing (NGS) technologies can be used to identify long repeat expansions directly from the genome sequence.",
      "NGS technologies allow for the simultaneous detection of multiple repeat sequences."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Longest Common Subsequence (LCS) algorithm is used to find the longest subsequence (not necessarily consecutive characters) that is common to two or more strings.\n2. TRUE\n3. FALSE [correction]: Repeat-induced point mutation (RIP) is a fungal-specific genome defense mechanism against transposons and repetitive sequences, and it is not a PCR-based method. The correct term for the PCR-based method used to amplify and detect long repeat sequences in a genome is \"Repeat-Primed PCR (RP-PCR).\"\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "vicuna-13b_response": "Neuroligin-3 is a protein that is expressed on the surface of neurons and plays a role in synaptic transmission. It has been implicated in the development and progression of certain types of brain tumors, specifically glioblastoma and medulloblastoma.\nGlioblastoma is a highly aggressive and malignant brain tumor that arises from astrocytes, a type of glial cell. Studies have shown that high levels of neuroligin-3 are associated with a poor prognosis in patients with glioblastoma. Increased expression of neuroligin-3 has been linked to increased cell proliferation, migration, and invasion, all of which are characteristics of cancer cells.\nMedulloblastoma is a type of brain tumor that arises from embryonic cells in the cerebellum. Studies have also shown that neuroligin-3 is expressed in medulloblastoma cells and that high levels of neuroligin-3 are associated with a poor prognosis in patients with this type of brain tumor.\nIt is important to note that while neuroligin-3 has been implicated in the development and progression of certain types of brain tumors, it is not the only factor that contributes to the development and progression of these tumors. Other genetic and environmental factors also play a role.",
    "vicuna-13b_fact_raw": "1. Neuroligin-3 is a protein expressed on the surface of neurons and is involved in synaptic transmission.\n2. Neuroligin-3 has been implicated in the development and progression of glioblastoma and medulloblastoma brain tumors.\n3. Glioblastoma is a highly aggressive and malignant brain tumor that originates from astrocytes.\n4. High levels of neuroligin-3 are associated with a poor prognosis in patients with glioblastoma.\n5. Medulloblastoma is a brain tumor that arises from embryonic cells in the cerebellum, and high levels of neuroligin-3 are associated with a poor prognosis in patients with this tumor.",
    "vicuna-13b_fact": [
      "Neuroligin-3 is a protein expressed on the surface of neurons and is involved in synaptic transmission.",
      "Neuroligin-3 has been implicated in the development and progression of glioblastoma and medulloblastoma brain tumors.",
      "Glioblastoma is a highly aggressive and malignant brain tumor that originates from astrocytes.",
      "High levels of neuroligin-3 are associated with a poor prognosis in patients with glioblastoma.",
      "Medulloblastoma is a brain tumor that arises from embryonic cells in the cerebellum, and high levels of neuroligin-3 are associated with a poor prognosis in patients with this tumor."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe first three statements are accurate based on current scientific understanding. Neuroligin-3 is indeed a protein involved in synaptic transmission and has been implicated in the development and progression of certain brain tumors, including glioblastoma and medulloblastoma. Glioblastoma is a highly aggressive brain tumor that originates from astrocytes.\n\nHowever, the fourth and fifth statements regarding the association of high levels of neuroligin-3 with a poor prognosis in patients with glioblastoma and medulloblastoma are specific claims that would require access to recent scientific studies or medical data to verify. Without that information, we cannot determine the truthfulness of these statements, hence the response \"UNKNOWN\".",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "vicuna-13b_response": "Gas vesicles are small, hollow, gas-filled structures that are found in certain types of aquatic plants and animals, such as blue-green algae, dinoflagellates, and some species of fish. The size of gas vesicles can vary depending on the species, but they are typically very small, ranging in size from a few micrometers to a few hundred micrometers in diameter.\nIn general, gas vesicles are much smaller than the cells that contain them, and they are used by the organism to float in the water or to adjust its buoyancy. The size and shape of the gas vesicles can also vary depending on the function they serve in the organism. For example, some gas vesicles may be larger and more spherical in shape, while others may be smaller and more elongated.\nOverall, the size of gas vesicles is an important characteristic of the organism that produces them, and it can be used to help identify different species and to understand their ecological role in the aquatic environment.",
    "vicuna-13b_fact_raw": "1. Gas vesicles are found in certain types of aquatic plants and animals, such as blue-green algae, dinoflagellates, and some species of fish.\n2. The size of gas vesicles typically ranges from a few micrometers to a few hundred micrometers in diameter.\n3. Gas vesicles are smaller than the cells that contain them.\n4. Organisms use gas vesicles to float in the water or to adjust their buoyancy.\n5. The size and shape of gas vesicles can vary depending on the function they serve in the organism.",
    "vicuna-13b_fact": [
      "Gas vesicles are found in certain types of aquatic plants and animals, such as blue-green algae, dinoflagellates, and some species of fish.",
      "The size of gas vesicles typically ranges from a few micrometers to a few hundred micrometers in diameter.",
      "Gas vesicles are smaller than the cells that contain them.",
      "Organisms use gas vesicles to float in the water or to adjust their buoyancy.",
      "The size and shape of gas vesicles can vary depending on the function they serve in the organism."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Gas vesicles are found in certain types of bacteria and archaea, such as cyanobacteria (often referred to as blue-green algae), not in aquatic plants and animals.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "vicuna-13b_response": "BET (bromodomain and extraterminal) proteins are a family of transcription factors that play a critical role in regulating gene expression in response to environmental cues. There are three main members of the BET family: BRD2, BRD3, and BRD4.\nBRD2 is a ubiquitously expressed protein that is involved in the regulation of many different genes. It has been shown to play a role in the development of hematopoietic cells, and mutations in BRD2 have been linked to the development of certain types of leukemia.\nBRD3 is a protein that is primarily expressed in the brain, and it has been shown to play a role in the regulation of neuronal differentiation and survival. Mutations in BRD3 have been linked to the development of certain types of brain tumors.\nBRD4 is a protein that is expressed in many different tissues, and it has been shown to play a role in the regulation of cell proliferation and differentiation. Mutations in BRD4 have been linked to the development of certain types of cancer, including acute myeloid leukemia and myelodysplastic syndromes.\nOverall, BET proteins are important regulators of gene expression, and dysregulation of BET proteins has been linked to the development of a variety of diseases.",
    "vicuna-13b_fact_raw": "1. BET proteins are a family of transcription factors that include BRD2, BRD3, and BRD4.\n2. BRD2 is involved in the regulation of many different genes and plays a role in the development of hematopoietic cells.\n3. Mutations in BRD2 have been linked to the development of certain types of leukemia.\n4. BRD3 is primarily expressed in the brain and is involved in the regulation of neuronal differentiation and survival.\n5. Mutations in BRD4 have been linked to the development of certain types of cancer, including acute myeloid leukemia and myelodysplastic syndromes.",
    "vicuna-13b_fact": [
      "BET proteins are a family of transcription factors that include BRD2, BRD3, and BRD4.",
      "BRD2 is involved in the regulation of many different genes and plays a role in the development of hematopoietic cells.",
      "Mutations in BRD2 have been linked to the development of certain types of leukemia.",
      "BRD3 is primarily expressed in the brain and is involved in the regulation of neuronal differentiation and survival.",
      "Mutations in BRD4 have been linked to the development of certain types of cancer, including acute myeloid leukemia and myelodysplastic syndromes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "vicuna-13b_response": "There are several algorithms that have been developed for prediction of protein subcellular localization using deep learning. Some of the popular ones are:\n1. DeepLoc: This algorithm uses a deep convolutional neural network (CNN) to predict the subcellular localization of proteins based on their amino acid sequences. The CNN is trained on a large dataset of protein sequences and their corresponding subcellular localization labels.\n2. LocNet: This algorithm is a fully convolutional network that is designed to predict the subcellular localization of proteins. It uses a combination of convolutional and fully connected layers to extract features from the protein sequences and then uses these features to make predictions.\n3. ProtTrans: This algorithm uses a multi-task learning approach to predict both the subcellular localization and the protein's function. It uses a combination of convolutional and recurrent neural networks to extract features from the protein sequences and then uses these features to make predictions.\n4. DeepPLoc: This algorithm uses a deep belief network (DBN) to predict the subcellular localization of proteins. It uses a hierarchical architecture that consists of multiple layers of DBNs to learn the complex patterns in the protein sequences.\nThese algorithms have been shown to achieve high accuracy in predicting the subcellular localization of proteins, and they have become popular in the field of protein bioinformatics.",
    "vicuna-13b_fact_raw": "1. DeepLoc is an algorithm that uses a deep convolutional neural network to predict protein subcellular localization.\n2. LocNet is a fully convolutional network designed to predict the subcellular localization of proteins.\n3. ProtTrans is an algorithm that predicts both the subcellular localization and the function of proteins using a multi-task learning approach.\n4. DeepPLoc uses a deep belief network to predict the subcellular localization of proteins.\n5. These algorithms are used in the field of protein bioinformatics and have achieved high accuracy in predicting protein subcellular localization.",
    "vicuna-13b_fact": [
      "DeepLoc is an algorithm that uses a deep convolutional neural network to predict protein subcellular localization.",
      "LocNet is a fully convolutional network designed to predict the subcellular localization of proteins.",
      "ProtTrans is an algorithm that predicts both the subcellular localization and the function of proteins using a multi-task learning approach.",
      "DeepPLoc uses a deep belief network to predict the subcellular localization of proteins.",
      "These algorithms are used in the field of protein bioinformatics and have achieved high accuracy in predicting protein subcellular localization."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: ProtTrans is a transformer-based model that was pre-trained on a large corpus of protein sequences and can be fine-tuned for various downstream tasks, including protein property prediction, but it is not specifically described as using a multi-task learning approach for simultaneous prediction of subcellular localization and function.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "vicuna-13b_response": "MULTOVL is a programming language that is designed to be easy to learn and use, while also being powerful and flexible. It is a high-level language, which means that it allows developers to write code in a more natural and intuitive way, without having to worry about the low-level details of how the code is executed.\nOne of the key features of MULTOVL is its support for multiple inheritance. This means that a class can inherit properties and methods from multiple other classes, rather than just one. This allows for more flexible and reusable code, as well as the ability to create more complex and hierarchical structures.\nMULTOVL also supports polymorphism, which allows objects of different classes to be treated as if they were the same type. This makes it easier to write code that can work with different types of objects in a consistent way.\nOverall, MULTOVL is a powerful and versatile programming language that is well-suited for a wide range of applications.",
    "vicuna-13b_fact_raw": "1. MULTOVL is a programming language.\n2. MULTOVL is designed to be easy to learn and use.\n3. MULTOVL is a high-level language.\n4. MULTOVL supports multiple inheritance.\n5. MULTOVL supports polymorphism.",
    "vicuna-13b_fact": [
      "MULTOVL is a programming language.",
      "MULTOVL is designed to be easy to learn and use.",
      "MULTOVL is a high-level language.",
      "MULTOVL supports multiple inheritance.",
      "MULTOVL supports polymorphism."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: MULTOVL is not a programming language; it appears to be a fabricated term as there is no widely recognized programming language by that name.\n2. FALSE [correction]: Since MULTOVL is not a recognized programming language, it cannot be designed to be easy to learn and use.\n3. FALSE [correction]: As MULTOVL is not a recognized programming language, it cannot be classified as a high-level language.\n4. FALSE [correction]: Since MULTOVL is not a recognized programming language, it does not support multiple inheritance.\n5. FALSE [correction]: Since MULTOVL is not a recognized programming language, it does not support polymorphism.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "vicuna-13b_response": "GDF15, also known as growth differentiation factor 15, is a protein that has been studied in the context of metformin treatment for type 2 diabetes. Metformin is a widely used oral medication for the treatment of type 2 diabetes, and it works by decreasing glucose production in the liver and increasing insulin sensitivity in muscle and fat tissue.\nSeveral studies have suggested that GDF15 may be a potential biomarker for the effectiveness of metformin treatment in patients with type 2 diabetes. GDF15 levels have been shown to decrease in response to metformin treatment, and this decrease has been associated with improvements in glycemic control and insulin sensitivity.\nHowever, more research is needed to fully understand the role of GDF15 as a biomarker for metformin treatment. It is also important to note that other biomarkers, such as HbA1c and fasting plasma glucose, are more widely used and established as markers of glycemic control in patients with type 2 diabetes.\nIn conclusion, while GDF15 may have potential as a biomarker for metformin treatment in patients with type 2 diabetes, further research is needed to fully understand its role and to establish its clinical utility.",
    "vicuna-13b_fact_raw": "1. GDF15 stands for growth differentiation factor 15.\n2. Metformin is an oral medication used for the treatment of type 2 diabetes.\n3. Metformin works by decreasing glucose production in the liver and increasing insulin sensitivity in muscle and fat tissue.\n4. Studies have suggested that GDF15 levels decrease in response to metformin treatment.\n5. The decrease in GDF15 levels has been associated with improvements in glycemic control and insulin sensitivity in patients with type 2 diabetes.",
    "vicuna-13b_fact": [
      "GDF15 stands for growth differentiation factor 15.",
      "Metformin is an oral medication used for the treatment of type 2 diabetes.",
      "Metformin works by decreasing glucose production in the liver and increasing insulin sensitivity in muscle and fat tissue.",
      "Studies have suggested that GDF15 levels decrease in response to metformin treatment.",
      "The decrease in GDF15 levels has been associated with improvements in glycemic control and insulin sensitivity in patients with type 2 diabetes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Studies have suggested that GDF15 levels increase in response to metformin treatment.\n5. FALSE [correction]: The increase in GDF15 levels, not decrease, has been associated with improvements in glycemic control and insulin sensitivity in patients with type 2 diabetes.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "vicuna-13b_response": "Recursive splicing is a process in which a splicing event occurs within a previously spliced intron. It is a form of alternative splicing, which is a process in which a single gene can produce multiple mRNA isoforms by using different combinations of exons.\nRecursive splicing can occur in both long and short introns, but it is more common in short introns. This is because short introns have a lower energy state, which makes them more susceptible to splicing events. Additionally, short introns are more likely to be included in the splicing machinery's search for a splice site, as they are more accessible to the splicing factors.\nRecursive splicing can also occur in introns that are too short to be spliced out, this is called intron retention. This process can be regulated by different factors such as the presence of specific proteins or RNA elements in the intron.\nIt's important to note that the length of the intron is not the only factor that determines whether recursive splicing will occur, other factors such as the presence of specific proteins or RNA elements in the intron, the presence of specific miRNA, and the chromatin structure can also regulate recursive splicing.",
    "vicuna-13b_fact_raw": "1. Recursive splicing is a process where a splicing event occurs within a previously spliced intron.\n2. Recursive splicing is more common in short introns.\n3. Short introns have a lower energy state, making them more susceptible to splicing events.\n4. Short introns are more likely to be included in the splicing machinery's search for a splice site.\n5. Intron retention can occur in introns that are too short to be spliced out.",
    "vicuna-13b_fact": [
      "Recursive splicing is a process where a splicing event occurs within a previously spliced intron.",
      "Recursive splicing is more common in short introns.",
      "Short introns have a lower energy state, making them more susceptible to splicing events.",
      "Short introns are more likely to be included in the splicing machinery's search for a splice site.",
      "Intron retention can occur in introns that are too short to be spliced out."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Recursive splicing is more common in long introns, as they may contain internal splice sites that facilitate recursive splicing.\n3. UNKNOWN: The statement about the energy state of short introns and their susceptibility to splicing events is not standard terminology in molecular biology and requires specific context to evaluate.\n4. TRUE: Short introns are indeed more likely to be efficiently recognized by the splicing machinery due to their proximity to exonic splice enhancer sequences.\n5. FALSE [correction]: Intron retention typically refers to the failure of an intron to be spliced out, which can occur regardless of intron length. However, it is not specifically associated with introns being too short to be spliced out.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "vicuna-13b_response": "The TALE-iD method is a systematic approach to identifying potential ecological risks associated with the use of engineered nanomaterials (ENMs) in various applications. The acronym TALE-iD stands for \"Target-Organism-Affected-Life-cycle-Stage-Endpoint-Individual-Dose,\" which describes the key components of the method.\nThe TALE-iD method is used to evaluate the potential ecological risks of ENMs by considering the interactions between the ENMs and various components of the environment, including living organisms, their life cycle stages, and the various endpoints that may be affected. The method is designed to be used in the early stages of ENM development, to help identify potential risks and inform the design of safer and more sustainable ENMs.\nThe TALE-iD method involves a systematic process of identifying the potential target organisms and life cycle stages that may be affected by the ENMs, as well as the endpoints that may be affected, such as reproductive success, survival, or behavior. The method also considers the individual dose of the ENMs, which is the amount of ENMs that may be taken up by an individual organism or cell.\nOverall, the TALE-iD method is a valuable tool for identifying potential ecological risks associated with the use of ENMs, and can help inform the development of safer and more sustainable ENMs.",
    "vicuna-13b_fact_raw": "1. The TALE-iD method is used for identifying potential ecological risks associated with the use of engineered nanomaterials (ENMs).\n2. TALE-iD stands for \"Target-Organism-Affected-Life-cycle-Stage-Endpoint-Individual-Dose.\"\n3. The TALE-iD method evaluates the interactions between ENMs and various components of the environment, including living organisms and their life cycle stages.\n4. The method is intended to be used in the early stages of ENM development.\n5. The TALE-iD method involves identifying potential target organisms, life cycle stages, and endpoints that may be affected by ENMs, as well as considering the individual dose of ENMs.",
    "vicuna-13b_fact": [
      "The TALE-iD method is used for identifying potential ecological risks associated with the use of engineered nanomaterials (ENMs).",
      "TALE-iD stands for \"Target-Organism-Affected-Life-cycle-Stage-Endpoint-Individual-Dose.\"",
      "The TALE-iD method evaluates the interactions between ENMs and various components of the environment, including living organisms and their life cycle stages.",
      "The method is intended to be used in the early stages of ENM development.",
      "The TALE-iD method involves identifying potential target organisms, life cycle stages, and endpoints that may be affected by ENMs, as well as considering the individual dose of ENMs."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: TALE-iD stands for \"Target-Affected-Life-stage-Endpoint-Individual-Dose.\"\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "vicuna-13b_response": "One popular Lisp framework for image processing is called \"CL-PNG\". CL-PNG is a Common Lisp library for working with PNG (Portable Network Graphics) images. It provides a simple and efficient way to read, manipulate, and write PNG images in Lisp. The library supports all the features of the PNG format, including transparency, gamma correction, and interlacing.\nCL-PNG is just one example of a Lisp framework for image processing. There are many other Lisp libraries and frameworks available for image processing, including CL-GD (for working with GIF images), CL-JPEG (for working with JPEG images), and CL-GIF (for working with animated GIF images).\nTo use CL-PNG or any other Lisp image processing library, you will need to have a working installation of a Common Lisp compiler or interpreter. You can then load the library into your Lisp program and use its functions to process images.",
    "vicuna-13b_fact_raw": "1. CL-PNG is a Common Lisp library for working with PNG images.\n2. CL-PNG supports features of the PNG format such as transparency, gamma correction, and interlacing.\n3. Other Lisp libraries for image processing include CL-GD, CL-JPEG, and CL-GIF.\n4. CL-GD is used for working with GIF images.\n5. CL-JPEG is used for working with JPEG images.",
    "vicuna-13b_fact": [
      "CL-PNG is a Common Lisp library for working with PNG images.",
      "CL-PNG supports features of the PNG format such as transparency, gamma correction, and interlacing.",
      "Other Lisp libraries for image processing include CL-GD, CL-JPEG, and CL-GIF.",
      "CL-GD is used for working with GIF images.",
      "CL-JPEG is used for working with JPEG images."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: CL-GD is used for working with graphics in general, including PNG, JPEG, and GIF, not just GIF images.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "vicuna-13b_response": "Whole genome duplication (WGD) events are known to have occurred in the evolutionary history of many eukaryotic species, including Saccharomyces cerevisiae, the baker's yeast. WGD events result in the duplication of an entire genome, leading to the creation of multiple copies of each gene. The exact number of genes in S. cerevisiae that are the result of an ancient WGD event is not well established, but it is estimated to be around 50-100 genes. These genes are thought to be responsible for a variety of functions, including the regulation of gene expression, DNA repair, and the maintenance of chromosome stability.",
    "vicuna-13b_fact_raw": "1. Whole genome duplication events have occurred in the evolutionary history of Saccharomyces cerevisiae.\n2. Whole genome duplication results in the duplication of an entire genome.\n3. It is estimated that around 50-100 genes in Saccharomyces cerevisiae are the result of an ancient whole genome duplication event.\n4. Genes resulting from the whole genome duplication in Saccharomyces cerevisiae are involved in functions such as regulation of gene expression, DNA repair, and maintenance of chromosome stability.",
    "vicuna-13b_fact": [
      "Whole genome duplication events have occurred in the evolutionary history of Saccharomyces cerevisiae.",
      "Whole genome duplication results in the duplication of an entire genome.",
      "It is estimated that around 50-100 genes in Saccharomyces cerevisiae are the result of an ancient whole genome duplication event.",
      "Genes resulting from the whole genome duplication in Saccharomyces cerevisiae are involved in functions such as regulation of gene expression, DNA repair, and maintenance of chromosome stability."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: It is estimated that several hundred to over a thousand genes in Saccharomyces cerevisiae are the result of an ancient whole genome duplication event.\n4. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor Î² (Esrrb)?",
    "vicuna-13b_response": "Estrogen-related receptor Î² (Esrrb) is a transcription factor that binds to specific DNA sequences to regulate gene expression. Esrrb is known to bind to a variety of estrogen response elements (EREs) in the promoter regions of target genes, and plays a role in the regulation of cell proliferation, differentiation, and apoptosis.\nIn terms of which complex is bound by Esrrb, it is not clear if Esrrb binds to a specific complex or if it interacts with multiple complexes. However, Esrrb has been shown to interact with other transcription factors, such as AP-1, Sp1, and NF-ÎºB, and these interactions can modulate its transcriptional activity. Additionally, Esrrb has been shown to interact with coactivators and corepressors, such as p300 and HDAC1, which can affect its ability to bind to DNA and regulate gene expression.\nOverall, while Esrrb is known to bind to specific DNA sequences, it is not clear if it is specifically bound to a particular complex.",
    "vicuna-13b_fact_raw": "1. Estrogen-related receptor Î² (Esrrb) is a transcription factor that regulates gene expression by binding to specific DNA sequences.\n2. Esrrb binds to estrogen response elements (EREs) in the promoter regions of target genes.\n3. Esrrb plays a role in the regulation of cell proliferation, differentiation, and apoptosis.\n4. Esrrb has been shown to interact with other transcription factors such as AP-1, Sp1, and NF-ÎºB.\n5. Esrrb can interact with coactivators and corepressors, including p300 and HDAC1, which influence its DNA binding and gene regulation capabilities.",
    "vicuna-13b_fact": [
      "Estrogen-related receptor Î² (Esrrb) is a transcription factor that regulates gene expression by binding to specific DNA sequences.",
      "Esrrb binds to estrogen response elements (EREs) in the promoter regions of target genes.",
      "Esrrb plays a role in the regulation of cell proliferation, differentiation, and apoptosis.",
      "Esrrb has been shown to interact with other transcription factors such as AP-1, Sp1, and NF-ÎºB.",
      "Esrrb can interact with coactivators and corepressors, including p300 and HDAC1, which influence its DNA binding and gene regulation capabilities."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Estrogen-related receptor Î² (Esrrb) does not bind to estrogen response elements (EREs) as it is not activated by estrogen; instead, it binds to estrogen-related response elements (ERREs) or other response elements in the promoter regions of target genes.\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "vicuna-13b_response": "ZCCHC17 is a protein that plays a critical role in regulating the activity of other proteins in the body. Specifically, it is a chaperone protein, which helps to fold and assemble other proteins into their proper, functional forms.\nChaperone proteins are important because they help to ensure that proteins are properly folded and assembled, which is critical for their function. If proteins are not properly folded and assembled, they can become misfolded and aggregate, leading to harmful effects on the body.\nZCCHC17 is a member of the heat shock protein (HSP) family, which are proteins that are expressed in response to stress or other adverse conditions in the body. HSPs help to protect cells from damage and promote the proper folding and assembly of proteins.\nOverall, the role of ZCCHC17 is to help regulate the activity of other proteins in the body, ensuring that they are properly folded and assembled into their functional forms.",
    "vicuna-13b_fact_raw": "1. ZCCHC17 is a protein that plays a role in regulating the activity of other proteins in the body.\n2. ZCCHC17 functions as a chaperone protein, assisting in the folding and assembly of other proteins.\n3. Chaperone proteins are essential for the proper folding and assembly of proteins, which is critical for their function.\n4. Improperly folded and assembled proteins can lead to aggregation and harmful effects on the body.\n5. ZCCHC17 is part of the heat shock protein (HSP) family, which is expressed in response to stress or adverse conditions.",
    "vicuna-13b_fact": [
      "ZCCHC17 is a protein that plays a role in regulating the activity of other proteins in the body.",
      "ZCCHC17 functions as a chaperone protein, assisting in the folding and assembly of other proteins.",
      "Chaperone proteins are essential for the proper folding and assembly of proteins, which is critical for their function.",
      "Improperly folded and assembled proteins can lead to aggregation and harmful effects on the body.",
      "ZCCHC17 is part of the heat shock protein (HSP) family, which is expressed in response to stress or adverse conditions."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN: Without specific scientific literature or data on ZCCHC17, it is not possible to confirm its role in regulating the activity of other proteins.\n2. UNKNOWN: The function of ZCCHC17 as a chaperone protein is not confirmed without specific information or scientific references.\n3. TRUE: Chaperone proteins are indeed essential for the proper folding and assembly of proteins, which is critical for their function.\n4. TRUE: Improperly folded and assembled proteins can lead to aggregation, which can have harmful effects on the body, including the development of various diseases.\n5. FALSE [correction]: ZCCHC17 is not typically classified as part of the heat shock protein (HSP) family. Heat shock proteins are a specific group of proteins that are expressed in response to stress, and without specific evidence, it cannot be claimed that ZCCHC17 is one of them.",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "vicuna-13b_response": "The nuclear pore basket in human cells is formed by a complex of proteins known as nuclear pore complex (NPC) proteins. The NPC is a large macromolecular structure that spans the nuclear envelope and forms the nuclear pore. It is composed of multiple copies of different NPC proteins, which are arranged in a specific order to form a filamentous structure that extends across the nuclear envelope.\nThere are several different types of NPC proteins that are involved in forming the nuclear pore basket in human cells. These include:\n1. Nup1-100: These are the most abundant NPC proteins and form the core of the nuclear pore basket. They are responsible for the formation of the central channel of the nuclear pore, which is the pathway for the movement of molecules between the cytoplasm and the nucleus.\n2. Nup11-16: These NPC proteins are involved in the formation of the nuclear pore basket and help to anchor the NPC to the nuclear envelope.\n3. Nup17-18: These NPC proteins are involved in the formation of the nuclear pore basket and are thought to play a role in the regulation of nuclear transport.\n4. Nup21-20: These NPC proteins are involved in the formation of the nuclear pore basket and are thought to play a role in the regulation of nuclear transport.\nOverall, the nuclear pore basket is a complex structure that is formed by multiple copies of different NPC proteins, and it plays a critical role in regulating the movement of molecules between the cytoplasm and the nucleus in human cells.",
    "vicuna-13b_fact_raw": "1. The nuclear pore complex (NPC) proteins form the nuclear pore basket in human cells.\n2. The NPC is a large macromolecular structure that spans the nuclear envelope.\n3. Nup1-100 proteins are the most abundant NPC proteins and form the core of the nuclear pore basket.\n4. Nup11-16 NPC proteins help to anchor the NPC to the nuclear envelope.\n5. Nup17-18 and Nup21-20 NPC proteins are involved in the regulation of nuclear transport.",
    "vicuna-13b_fact": [
      "The nuclear pore complex (NPC) proteins form the nuclear pore basket in human cells.",
      "The NPC is a large macromolecular structure that spans the nuclear envelope.",
      "Nup1-100 proteins are the most abundant NPC proteins and form the core of the nuclear pore basket.",
      "Nup11-16 NPC proteins help to anchor the NPC to the nuclear envelope.",
      "Nup17-18 and Nup21-20 NPC proteins are involved in the regulation of nuclear transport."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The nuclear pore complex (NPC) proteins form the structure of the nuclear pore, but the term \"nuclear pore basket\" typically refers to a specific structure within the NPC that extends into the nucleoplasm, and it is not formed by the NPC proteins alone.\n2. TRUE\n3. FALSE [correction]: There are no NPC proteins designated as Nup1-100. The most abundant NPC proteins are not referred to in this manner, and the core scaffold of the NPC is formed by multiple nucleoporins, not a single group called Nup1-100.\n4. FALSE [correction]: There are no NPC proteins designated as Nup11-16. NPC proteins that help to anchor the NPC to the nuclear envelope include nucleoporins like gp210 and POM121, not a group referred to as Nup11-16.\n5. FALSE [correction]: There are no NPC proteins designated as Nup17-18 and Nup21-20. NPC proteins are involved in the regulation of nuclear transport, but they are not named in this manner. Specific nucleoporins like Nup153 and Nup50, among others, are involved in nuclear transport regulation.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "vicuna-13b_response": "Gepotidacin is a type of topoisomerase inhibitor known as a pyrazole-containing topoisomerase inhibitor. Topoisomerase inhibitors are a class of antibiotics that target the enzymes responsible for regulating the topology of DNA, which is the way that the DNA molecule is organized and folded within a cell. Topoisomerase inhibitors are commonly used to treat bacterial infections, particularly those caused by Gram-positive bacteria. Gepotidacin is a newer antibiotic that has been shown to be effective against a wide range of bacterial pathogens, including those that are resistant to other types of antibiotics. It is currently in clinical trials for the treatment of various bacterial infections.",
    "vicuna-13b_fact_raw": "1. Gepotidacin is a pyrazole-containing topoisomerase inhibitor.\n2. Topoisomerase inhibitors target enzymes that regulate the topology of DNA.\n3. Topoisomerase inhibitors are used to treat bacterial infections, especially those caused by Gram-positive bacteria.\n4. Gepotidacin has been shown to be effective against a wide range of bacterial pathogens.\n5. Gepotidacin is currently in clinical trials for the treatment of various bacterial infections.",
    "vicuna-13b_fact": [
      "Gepotidacin is a pyrazole-containing topoisomerase inhibitor.",
      "Topoisomerase inhibitors target enzymes that regulate the topology of DNA.",
      "Topoisomerase inhibitors are used to treat bacterial infections, especially those caused by Gram-positive bacteria.",
      "Gepotidacin has been shown to be effective against a wide range of bacterial pathogens.",
      "Gepotidacin is currently in clinical trials for the treatment of various bacterial infections."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nBased on the information provided, all statements appear to be true. Gepotidacin is indeed a topoisomerase inhibitor, which is a class of drugs that target enzymes involved in the regulation of DNA topology. These inhibitors are used to treat bacterial infections, including those caused by Gram-positive bacteria. If gepotidacin has been shown to be effective against a wide range of bacterial pathogens and is currently in clinical trials, then the last two statements would also be true. However, without specific data or results from the clinical trials, the effectiveness and current status of gepotidacin's clinical trials cannot be verified beyond the provided statements.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "vicuna-13b_response": "Canvas SPW (Single Page Web) is a web application that allows users to create and edit web pages using a simple, intuitive interface. It is designed to be easy to use for both beginners and experienced web developers.\nCanvas SPW allows users to create and edit web pages using a variety of tools, including a visual editor, a code editor, and a range of design and layout tools. Users can choose to work in the visual editor, which provides a WYSIWYG (What You See Is What You Get) interface for creating and editing web pages, or they can use the code editor to work directly with HTML, CSS, and JavaScript code.\nOne of the key features of Canvas SPW is its support for responsive design, which allows users to create web pages that are optimized for viewing on a range of devices, including smartphones, tablets, and desktop computers. Canvas SPW also includes a range of templates and themes that users can use to quickly create professional-looking web pages.\nIn addition to its core web page creation and editing tools, Canvas SPW also includes a range of other features, such as a file manager for uploading and organizing files, a project manager for managing multiple web pages and sites, and a range of integrations with other tools and services.\nOverall, Canvas SPW is a powerful and versatile web application that provides users with a wide range of tools and features for creating and editing web pages. Its intuitive interface and support for responsive design make it an excellent choice for both beginners and experienced web developers.",
    "vicuna-13b_fact_raw": "1. Canvas SPW is a web application designed for creating and editing web pages.\n2. It includes a visual editor and a code editor for users to work with.\n3. Canvas SPW supports responsive design for optimization on various devices like smartphones, tablets, and desktop computers.\n4. The application offers templates and themes for creating professional-looking web pages.\n5. Canvas SPW features a file manager and a project manager for organizing files and managing multiple web pages or sites.",
    "vicuna-13b_fact": [
      "Canvas SPW is a web application designed for creating and editing web pages.",
      "It includes a visual editor and a code editor for users to work with.",
      "Canvas SPW supports responsive design for optimization on various devices like smartphones, tablets, and desktop computers.",
      "The application offers templates and themes for creating professional-looking web pages.",
      "Canvas SPW features a file manager and a project manager for organizing files and managing multiple web pages or sites."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific information about a web application named \"Canvas SPW,\" it is not possible to verify the accuracy of these statements. The name \"Canvas SPW\" does not correspond to a widely recognized web application as of my knowledge cutoff date, and without additional context, the details provided cannot be confirmed as true or false.",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "vicuna-13b_response": "STING (Stimulator of Interferon Genes) is a critical sensor of the cGAS-cGAS sensor complex that detects intracellular DNA and triggers an interferon response. Inhibition of STING has been shown to be a promising strategy for treating viral infections and cancer. Here are some known STING agonists:\n1. Cyclic dinucleotides (CDNs): CDNs are small molecules that mimic the activity of viral DNA and activate STING. CDNs include the natural product cytidine-5'-triphosphate (cGMP) and synthetic analogs such as 2',3'-cGAMP and 2',6'-cGAMP.\n2. Synthetic STING agonists: Synthetic molecules that directly bind to STING and activate it have also been developed. Examples include compounds such as JQ1, MRT68111, and JNJ-752605.\n3. Endogenous STING agonists: Certain viruses and bacteria have evolved mechanisms to activate STING through the use of viral DNA sensors or bacterial toxins. For example, the herpesvirus US11 activates STING through its viral DNA sensor, while the bacterial toxin anthrax protective antigen activates STING through a different mechanism.\nOverall, STING agonists have shown promise as potential therapeutics for treating viral infections and cancer, and further research is ongoing to identify and develop new and more effective STING agonists.",
    "vicuna-13b_fact_raw": "1. STING (Stimulator of Interferon Genes) is a sensor that detects intracellular DNA and triggers an interferon response.\n2. Inhibition of STING is considered a promising strategy for treating viral infections and cancer.\n3. Cyclic dinucleotides (CDNs) are a type of STING agonist that includes cytidine-5'-triphosphate (cGMP) and synthetic analogs such as 2',3'-cGAMP and 2',6'-cGAMP.\n4. Synthetic STING agonists, such as JQ1, MRT68111, and JNJ-752605, have been developed to directly bind to and activate STING.\n5. The herpesvirus US11 activates STING through its viral DNA sensor, and the bacterial toxin anthrax protective antigen activates STING through a different mechanism.",
    "vicuna-13b_fact": [
      "STING (Stimulator of Interferon Genes) is a sensor that detects intracellular DNA and triggers an interferon response.",
      "Inhibition of STING is considered a promising strategy for treating viral infections and cancer.",
      "Cyclic dinucleotides (CDNs) are a type of STING agonist that includes cytidine-5'-triphosphate (cGMP) and synthetic analogs such as 2',3'-cGAMP and 2',6'-cGAMP.",
      "Synthetic STING agonists, such as JQ1, MRT68111, and JNJ-752605, have been developed to directly bind to and activate STING.",
      "The herpesvirus US11 activates STING through its viral DNA sensor, and the bacterial toxin anthrax protective antigen activates STING through a different mechanism."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Inhibition of STING is generally not considered a strategy for treating viral infections and cancer. Instead, activation of STING is often explored as a potential therapeutic approach to enhance the immune response against these diseases.\n3. FALSE [correction]: Cyclic dinucleotides (CDNs) are indeed a type of STING agonist, but cytidine-5'-triphosphate (CTP) is not one of them. The correct examples of CDNs include cyclic GMP-AMP (cGAMP) and its synthetic analogs such as 2',3'-cGAMP and 2',6'-cGAMP.\n4. FALSE [correction]: JQ1 is not a STING agonist; it is a BET bromodomain inhibitor. MRT68111 is a herpesvirus helicase-primase inhibitor, not a STING agonist. JNJ-752605 does not appear to be a recognized compound related to STING; this may be a typographical error or a fictional compound. Examples of synthetic STING agonists include compounds like DMXAA (also known as ASA404) and ADU-S100 (also known as MIW815).\n5. FALSE [correction]: The herpesvirus protein US11 does not activate STING; it is known to inhibit the STING pathway to evade immune detection. The bacterial toxin anthrax protective antigen is part of the anthrax toxin complex and does not directly activate STING.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "vicuna-13b_response": "SLIC-CAGE (Spatially Localized Implicit Computational Assemblies for Geometric Engineering) is a computational framework for designing and optimizing the geometry of structures. It is a combination of two methods: SLIC (Spatially Localized Implicit Computation) and CAGE (Computational Assembly of Geometric Elements).\nSLIC is a method for solving partial differential equations (PDEs) that describe the behavior of materials in response to external loads. It does this by dividing the solution domain into small, non-overlapping elements, and solving for each element independently using the finite element method. The key innovation of SLIC is that it uses a sparse linear algebra solver to solve the system of equations, which makes it much more efficient than traditional finite element methods.\nCAGE is a method for designing the geometry of structures by optimizing a set of design variables that define the shape of the structure. It does this by using a optimization algorithm to find the configuration of the design variables that minimizes a cost function that reflects the desired behavior of the structure.\nThe combination of SLIC and CAGE in SLIC-CAGE allows for the efficient and accurate design and optimization of the geometry of structures. By using SLIC to solve the PDEs that describe the behavior of the structure, and CAGE to optimize the geometry, SLIC-CAGE can find the optimal shape of a structure that satisfies a set of design constraints and performance requirements. This can be used in a wide range of applications, such as in the design of bridges, buildings, and aircraft.",
    "vicuna-13b_fact_raw": "1. SLIC-CAGE is a computational framework used for designing and optimizing the geometry of structures.\n2. SLIC-CAGE combines two methods: SLIC (Spatially Localized Implicit Computation) and CAGE (Computational Assembly of Geometric Elements).\n3. SLIC is a method that solves partial differential equations (PDEs) using the finite element method and a sparse linear algebra solver.\n4. CAGE is a method that designs the geometry of structures by optimizing design variables through an optimization algorithm.\n5. SLIC-CAGE is applied in various fields, including the design of bridges, buildings, and aircraft.",
    "vicuna-13b_fact": [
      "SLIC-CAGE is a computational framework used for designing and optimizing the geometry of structures.",
      "SLIC-CAGE combines two methods: SLIC (Spatially Localized Implicit Computation) and CAGE (Computational Assembly of Geometric Elements).",
      "SLIC is a method that solves partial differential equations (PDEs) using the finite element method and a sparse linear algebra solver.",
      "CAGE is a method that designs the geometry of structures by optimizing design variables through an optimization algorithm.",
      "SLIC-CAGE is applied in various fields, including the design of bridges, buildings, and aircraft."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN: Without specific information about the computational framework named SLIC-CAGE, it is not possible to verify the accuracy of this statement.\n2. UNKNOWN: Similarly, without detailed knowledge about SLIC-CAGE and its components, the accuracy of this statement cannot be confirmed.\n3. UNKNOWN: The description of SLIC as a method that solves PDEs using the finite element method and a sparse linear algebra solver could be plausible, but without specific information about SLIC, the truth of this statement cannot be determined.\n4. UNKNOWN: The statement about CAGE designing the geometry of structures through optimization could be true for a computational framework, but without concrete details about CAGE, the accuracy of this statement is unclear.\n5. UNKNOWN: While it is plausible that a computational framework like SLIC-CAGE could be applied in the design of bridges, buildings, and aircraft, without specific information confirming its application in these fields, the truth of this statement cannot be ascertained.",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "vicuna-13b_response": "LEM-3 stands for Lunar Exploration Module-3, which was a spacecraft designed by NASA to land on the Moon during the Apollo 15 mission in 1971. The primary role of LEM-3 was to transport astronauts and their equipment to the lunar surface and back to the command module in orbit around the Moon.\nThe LEM-3 was a two-stage spacecraft, consisting of a descent stage and an ascent stage. The descent stage was designed to land on the Moon and support the astronauts during their stay on the lunar surface. It had a landing gear system that allowed it to touch down on the Moon's surface and a rocket engine that enabled it to take off from the lunar surface and return to orbit.\nThe ascent stage, on the other hand, was designed to carry the astronauts back to the command module in orbit around the Moon. It had a rocket engine that propelled it upward and a cabin that housed the astronauts during their journey back to orbit.\nIn addition to its primary role, LEM-3 also served as a laboratory for the astronauts to conduct scientific experiments on the lunar surface. The spacecraft was equipped with various instruments and tools that allowed the astronauts to study the lunar environment, including the Moon's surface, rocks, and soil.\nOverall, the LEM-3 played a crucial role in the Apollo 15 mission, enabling the astronauts to successfully land on the Moon and conduct a range of scientific experiments on the lunar surface.",
    "vicuna-13b_fact_raw": "1. LEM-3 was designed by NASA to land on the Moon during the Apollo 15 mission in 1971.\n2. The primary role of LEM-3 was to transport astronauts and their equipment to the lunar surface and back to the command module in orbit around the Moon.\n3. The LEM-3 was a two-stage spacecraft, consisting of a descent stage for landing and an ascent stage for returning to orbit.\n4. The descent stage of LEM-3 had a landing gear system and a rocket engine for landing and taking off from the Moon's surface.\n5. LEM-3 served as a laboratory for astronauts to conduct scientific experiments on the lunar surface.",
    "vicuna-13b_fact": [
      "LEM-3 was designed by NASA to land on the Moon during the Apollo 15 mission in 1971.",
      "The primary role of LEM-3 was to transport astronauts and their equipment to the lunar surface and back to the command module in orbit around the Moon.",
      "The LEM-3 was a two-stage spacecraft, consisting of a descent stage for landing and an ascent stage for returning to orbit.",
      "The descent stage of LEM-3 had a landing gear system and a rocket engine for landing and taking off from the Moon's surface.",
      "LEM-3 served as a laboratory for astronauts to conduct scientific experiments on the lunar surface."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Lunar Module used for the Apollo 15 mission was designated LM-10, not LEM-3. LEM-3 (or LM-3) was used during the Apollo 9 mission for testing in Earth orbit.\n2. TRUE: The primary role of the Lunar Module (LM), including LM-3, was to transport astronauts and their equipment to the lunar surface and back to the command module in orbit around the Moon.\n3. TRUE: The Lunar Module was a two-stage spacecraft, consisting of a descent stage for landing and an ascent stage for returning to orbit.\n4. TRUE: The descent stage of the Lunar Module had a landing gear system and a rocket engine for landing and taking off from the Moon's surface.\n5. FALSE [correction]: The Lunar Module served as a transport vehicle for astronauts to reach the lunar surface and return to the command module. It was not designed as a laboratory. Scientific experiments were conducted on the lunar surface, but the Lunar Module itself was not a laboratory.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "vicuna-13b_response": "Here is a list of releases of `tmVar`, which is a package for managing temporary variables in Haskell:\n* `tmVar` version 1.0.0\n* `tmVar` version 1.1.0\n* `tmVar` version 1.2.0\n* `tmVar` version 1.2.1\n* `tmVar` version 1.2.2\n* `tmVar` version 1.2.3\n* `tmVar` version 1.2.4\n* `tmVar` version 1.2.5\n* `tmVar` version 1.2.6\n* `tmVar` version 1.2.7\n* `tmVar` version 1.2.8\n* `tmVar` version 1.2.9\n* `tmVar` version 1.2.10\n* `tmVar` version 1.2.11\n* `tmVar` version 1.2.12\n* `tmVar` version 1.2.13\n* `tmVar` version 1.2.14\n* `tmVar` version 1.2.15\n* `tmVar` version 1.2.16\n* `tmVar` version 1.2.17\n* `tmVar` version 1.2.18\n* `tmVar` version 1.2.19\n* `tmVar` version 1.2.20\n* `tmVar` version 1.2.21\n* `tmVar` version 1.2.22\n* `tmVar` version 1.2.23\n* `tmVar` version 1.2.24\n* `tmVar` version 1.2.25\n* `tmVar` version 1.2.26\n* `tmVar` version 1.2.27\n* `tmVar` version 1.2.28\n* `tmVar` version 1.2.29\n* `tmVar` version 1.2.30\n* `tmVar` version 1.2.31\n* `tmVar` version 1.2.32\n* `tmVar` version 1",
    "vicuna-13b_fact_raw": "1. `tmVar` is a package for managing temporary variables in Haskell.\n2. `tmVar` version 1.0.0 is a release of the `tmVar` package.\n3. `tmVar` has a version 1.2.0.\n4. `tmVar` has a version 1.2.31.\n5. `tmVar` has a version 1.2.32.",
    "vicuna-13b_fact": [
      "`tmVar` is a package for managing temporary variables in Haskell.",
      "`tmVar` version 1.0.0 is a release of the `tmVar` package.",
      "`tmVar` has a version 1.2.0.",
      "`tmVar` has a version 1.2.31.",
      "`tmVar` has a version 1.2.32."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: `TVar` is the correct term for a package for managing temporary variables in Haskell, specifically in the context of software transactional memory.\n2. UNKNOWN: Without specific information about the `tmVar` package releases, it is not possible to confirm or deny the existence of version 1.0.0.\n3. UNKNOWN: Similarly, without specific information about the `tmVar` package releases, it is not possible to confirm or deny the existence of version 1.2.0.\n4. UNKNOWN: Without specific information about the `tmVar` package releases, it is not possible to confirm or deny the existence of version 1.2.31.\n5. UNKNOWN: Without specific information about the `tmVar` package releases, it is not possible to confirm or deny the existence of version 1.2.32.",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "vicuna-13b_response": "There are several databases of somatic mutations in normal cells, including:\n1. The Cancer Genome Atlas (TCGA) - a publicly available database that provides genomic and molecular characterization of a variety of cancer types, including somatic mutations in normal cells.\n2. The International Cancer Genome Consortium (ICGC) - a global collaboration that aims to perform comprehensive genomic analyses of a range of cancer types, including somatic mutations in normal cells.\n3. The Mutation Analysis in Non-small Cell Lung Cancer (Miracle) database - a resource that provides detailed information on somatic mutations in non-small cell lung cancer, including those that occur in normal cells.\n4. The Clinical Somatic Genome Project (CSGP) - a large-scale effort to analyze the genomes of patients with a range of somatic diseases, including those that involve normal cells.\nThese databases provide valuable resources for researchers and clinicians interested in understanding the genetic changes that occur in normal cells during the development of cancer.",
    "vicuna-13b_fact_raw": "1. The Cancer Genome Atlas (TCGA) is a publicly available database that includes somatic mutations in normal cells.\n2. The International Cancer Genome Consortium (ICGC) performs comprehensive genomic analyses of cancer types, which encompass somatic mutations in normal cells.\n3. The Mutation Analysis in Non-small Cell Lung Cancer (Miracle) database provides information on somatic mutations in non-small cell lung cancer, including those in normal cells.\n4. The Clinical Somatic Genome Project (CSGP) analyzes genomes of patients with somatic diseases, including genetic changes in normal cells.",
    "vicuna-13b_fact": [
      "The Cancer Genome Atlas (TCGA) is a publicly available database that includes somatic mutations in normal cells.",
      "The International Cancer Genome Consortium (ICGC) performs comprehensive genomic analyses of cancer types, which encompass somatic mutations in normal cells.",
      "The Mutation Analysis in Non-small Cell Lung Cancer (Miracle) database provides information on somatic mutations in non-small cell lung cancer, including those in normal cells.",
      "The Clinical Somatic Genome Project (CSGP) analyzes genomes of patients with somatic diseases, including genetic changes in normal cells."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Cancer Genome Atlas (TCGA) is a publicly available database that includes somatic mutations in cancer cells, not normal cells.\n2. FALSE [correction]: The International Cancer Genome Consortium (ICGC) performs comprehensive genomic analyses of different cancer types, which encompass somatic mutations in cancer cells, not normal cells.\n3. FALSE [correction]: The Mutation Analysis in Non-small Cell Lung Cancer (Miracle) database likely provides information on somatic mutations in non-small cell lung cancer, not including those in normal cells, as somatic mutations are generally associated with cancer cells.\n4. FALSE [correction]: The Clinical Somatic Genome Project (CSGP) does not exist as a recognized project or database. If it did, it would likely analyze genomes of patients with somatic diseases, focusing on genetic changes in diseased cells rather than normal cells.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "vicuna-13b_response": "Yes, there are several graph kernel libraries available that are implemented in Java. Some of the popular ones are:\n1. JUNG: JUNG (Java Universal Network/Graph) is a Java library for graph data structures and graph algorithms. It provides a wide range of graph algorithms, including PageRank, Breadth-First Search, Dijkstra's algorithm, and more.\n2. GraphX: GraphX is a distributed graph processing system for Apache Spark. It provides a set of graph algorithms and allows for efficient processing of large-scale graph data.\n3. GraphML Java: GraphML Java is a Java library for parsing and generating GraphML, a standard format for graph data. It provides a set of tools for working with GraphML files, including parsing, serialization, and visualization.\n4. Gephi: Gephi is a popular graph visualization tool that also provides a Java API for working with graph data. The API allows for custom visualizations and provides access to the graph's data and layout.\n5. NetworkX: NetworkX is a Python library for graph data structures and graph algorithms, but it also has a Java port called JNetworkX. It provides a wide range of graph algorithms and data structures, including directed and undirected graphs, weighted and unweighted graphs, and more.\nThese libraries provide a variety of tools and algorithms for working with graph data in Java, and can be used for tasks such as graph analysis, visualization, and processing.",
    "vicuna-13b_fact_raw": "1. JUNG is a Java library that includes graph algorithms like PageRank, Breadth-First Search, and Dijkstra's algorithm.\n2. GraphX is a distributed graph processing system for Apache Spark that offers graph algorithms and large-scale graph data processing.\n3. GraphML Java is a Java library for parsing and generating GraphML files.\n4. Gephi provides a Java API for graph data manipulation and custom visualizations.\n5. NetworkX, a Python library, has a Java port called JNetworkX that offers a range of graph algorithms and data structures.",
    "vicuna-13b_fact": [
      "JUNG is a Java library that includes graph algorithms like PageRank, Breadth-First Search, and Dijkstra's algorithm.",
      "GraphX is a distributed graph processing system for Apache Spark that offers graph algorithms and large-scale graph data processing.",
      "GraphML Java is a Java library for parsing and generating GraphML files.",
      "Gephi provides a Java API for graph data manipulation and custom visualizations.",
      "NetworkX, a Python library, has a Java port called JNetworkX that offers a range of graph algorithms and data structures."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: NetworkX is a Python library for graph manipulation and analysis, and there is no official Java port called JNetworkX.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "vicuna-13b_response": "SHERLOCKv2 is an advanced platform for automated threat intelligence and active defense. It integrates four key advances to provide comprehensive and effective cybersecurity capabilities. These advances are:\n1. Data Science: SHERLOCKv2 leverages data science techniques to provide advanced analytics and machine learning capabilities. This allows the platform to automatically detect and respond to threats in real-time, and to continuously learn and adapt to new threats and attack techniques.\n2. Automation: SHERLOCKv2 automates many of the tasks involved in threat intelligence and active defense, such as data collection, analysis, and response. This enables security teams to focus on higher-level tasks and strategic decision-making, while the platform handles the day-to-day operational tasks.\n3. Artificial Intelligence (AI): SHERLOCKv2 incorporates AI technologies such as natural language processing (NLP) and computer vision to provide advanced threat detection and response capabilities. For example, the platform can automatically analyze and interpret threat intelligence feeds, network traffic, and other data sources to identify potential threats and take appropriate action.\n4. Open Architecture: SHERLOCKv2 is built on an open architecture that allows it to integrate with other security tools and systems. This enables the platform to leverage existing security investments and to provide a seamless and integrated security solution that can meet the needs of organizations of all sizes and types.\nOverall, the integration of these four advances makes SHERLOCKv2 a powerful and effective platform for automated threat intelligence and active defense. It provides organizations with the advanced capabilities they need to detect and respond to threats quickly and effectively, and to stay ahead of the constantly evolving threat landscape.",
    "vicuna-13b_fact_raw": "1. SHERLOCKv2 uses data science techniques for advanced analytics and machine learning capabilities.\n2. The platform automates tasks involved in threat intelligence and active defense.\n3. SHERLOCKv2 incorporates AI technologies, including natural language processing and computer vision.\n4. It has an open architecture that allows integration with other security tools and systems.",
    "vicuna-13b_fact": [
      "SHERLOCKv2 uses data science techniques for advanced analytics and machine learning capabilities.",
      "The platform automates tasks involved in threat intelligence and active defense.",
      "SHERLOCKv2 incorporates AI technologies, including natural language processing and computer vision.",
      "It has an open architecture that allows integration with other security tools and systems."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nWithout specific context or a reference to a known platform named SHERLOCKv2, it is not possible to determine the veracity of these statements.",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "vicuna-13b_response": "The bartender algorithm is a heuristic search algorithm that is used to find the shortest path between two nodes in a graph. It is commonly used in artificial intelligence applications, such as in robotics and computer games, to find the optimal path between two points.\nThe algorithm works by simulating a bartender who is trying to minimize the distance that customers have to travel to reach their desired location. The bartender starts at the starting node and selects the closest unvisited neighbor. The bartender then moves to the selected neighbor and selects the closest unvisited neighbor again. This process continues until the bartender reaches the goal node.\nThe bartender algorithm uses a heuristic function to guide the search process. The heuristic function estimates the distance between the current node and the goal node. The bartender algorithm uses this heuristic function to determine which neighbor to select next, based on the estimated distance to the goal node.\nOne of the advantages of the bartender algorithm is that it is very efficient and can find the shortest path between two nodes in a graph. However, it is not guaranteed to find the optimal path, and there may be other algorithms that are better suited for certain types of problems.\nOverall, the bartender algorithm is a useful tool for finding the shortest path between two nodes in a graph, and it is commonly used in a variety of artificial intelligence applications.",
    "vicuna-13b_fact_raw": "1. The bartender algorithm is a heuristic search algorithm used to find the shortest path between two nodes in a graph.\n2. It is commonly used in artificial intelligence applications, such as robotics and computer games.\n3. The algorithm simulates a bartender minimizing the distance for customers to reach their desired location.\n4. The bartender algorithm uses a heuristic function to estimate the distance between the current node and the goal node.\n5. The bartender algorithm is not guaranteed to find the optimal path between two nodes.",
    "vicuna-13b_fact": [
      "The bartender algorithm is a heuristic search algorithm used to find the shortest path between two nodes in a graph.",
      "It is commonly used in artificial intelligence applications, such as robotics and computer games.",
      "The algorithm simulates a bartender minimizing the distance for customers to reach their desired location.",
      "The bartender algorithm uses a heuristic function to estimate the distance between the current node and the goal node.",
      "The bartender algorithm is not guaranteed to find the optimal path between two nodes."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: There is no widely recognized heuristic search algorithm known as the \"bartender algorithm.\" A well-known algorithm for finding the shortest path is the A* (A-star) algorithm.\n2. UNKNOWN: Since the \"bartender algorithm\" is not a recognized search algorithm, the statement's validity regarding its common use in AI applications cannot be determined.\n3. FALSE [correction]: Since the \"bartender algorithm\" does not exist, it does not simulate a bartender minimizing the distance for customers to reach their desired location. This might be a misunderstanding or a fictional representation of an algorithm.\n4. UNKNOWN: As the \"bartender algorithm\" is not established, we cannot determine if it uses a heuristic function or any other method to estimate distances.\n5. UNKNOWN: Without a recognized \"bartender algorithm,\" we cannot comment on whether it is guaranteed to find the optimal path or not. However, in general, not all heuristic algorithms are guaranteed to find the optimal path.",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "vicuna-13b_response": "There are several web-based pedigree editors available, including:\n1. GenoPro: A free, open-source, web-based genealogy software that allows users to create and edit family trees.\n2. MyHeritage: A paid web-based genealogy software that allows users to create and edit family trees, as well as search for ancestors and collaborate with other family members.\n3. Ancestry: A paid web-based genealogy software that allows users to create and edit family trees, as well as search for ancestors and collaborate with other family members.\n4. FamilySearch: A free, web-based genealogy software that allows users to create and edit family trees, as well as search for ancestors and collaborate with other family members.\n5. Geni: A free, web-based genealogy software that allows users to create and edit family trees, as well as search for ancestors and collaborate with other family members.\n6. WikiTree: A free, web-based genealogy software that allows users to create and edit family trees, as well as search for ancestors and collaborate with other family members.\nIt is important to note that the features and capabilities of these web-based pedigree editors may vary, and it is recommended to research and compare them before making a decision.",
    "vicuna-13b_fact_raw": "1. GenoPro is a free, open-source, web-based genealogy software.\n2. MyHeritage is a paid web-based genealogy software.\n3. Ancestry is a paid web-based genealogy software.\n4. FamilySearch is a free, web-based genealogy software.\n5. Geni is a free, web-based genealogy software.",
    "vicuna-13b_fact": [
      "GenoPro is a free, open-source, web-based genealogy software.",
      "MyHeritage is a paid web-based genealogy software.",
      "Ancestry is a paid web-based genealogy software.",
      "FamilySearch is a free, web-based genealogy software.",
      "Geni is a free, web-based genealogy software."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: GenoPro is not open-source, and while it offers a free trial, it requires a purchase for full functionality.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Geni offers a basic free account, but full functionality requires a paid subscription.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "vicuna-13b_response": "There are several curated databases that contain information on spider venom toxins. Some of the most well-known databases include:\n1. The Spider Venom Database (SVD): This database is maintained by the Australian Venom Research Unit and contains information on the venoms of spiders from around the world. It includes information on the toxins found in spider venom, their molecular structures, and their biological activities.\n2. The Toxin Database: This database is maintained by the National Center for Biotechnology Information (NCBI) and contains information on toxins from a variety of sources, including spider venom. It includes information on the molecular structures of toxins, their biological activities, and their taxonomic affiliations.\n3. The Venomous Animals Database: This database is maintained by the Venomous Animals Toxin Database (VATD) project and contains information on the venoms of a variety of animals, including spiders. It includes information on the toxins found in spider venom, their molecular structures, and their biological activities.\n4. The Spider Venomics Resource: This database is maintained by the University of California, Santa Cruz, and contains information on the transcriptomes of spiders and their venoms. It includes information on the genes and proteins involved in spider venom production, as well as the toxins themselves.\nThese databases are a great resource for researchers and others interested in spider venom toxins, and they provide a wealth of information on these fascinating molecules.",
    "vicuna-13b_fact_raw": "1. The Spider Venom Database (SVD) is maintained by the Australian Venom Research Unit.\n2. The Toxin Database contains information on toxins from various sources, including spider venom, and is maintained by the National Center for Biotechnology Information (NCBI).\n3. The Venomous Animals Database is part of the Venomous Animals Toxin Database (VATD) project and includes information on spider venom.\n4. The Spider Venomics Resource is maintained by the University of California, Santa Cruz, and focuses on the transcriptomes of spiders and their venoms.",
    "vicuna-13b_fact": [
      "The Spider Venom Database (SVD) is maintained by the Australian Venom Research Unit.",
      "The Toxin Database contains information on toxins from various sources, including spider venom, and is maintained by the National Center for Biotechnology Information (NCBI).",
      "The Venomous Animals Database is part of the Venomous Animals Toxin Database (VATD) project and includes information on spider venom.",
      "The Spider Venomics Resource is maintained by the University of California, Santa Cruz, and focuses on the transcriptomes of spiders and their venoms."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n\nThe accuracy of the statements regarding the specific databases and their maintenance can be difficult to confirm without current and specific knowledge about these resources. While the National Center for Biotechnology Information (NCBI) is known for maintaining various databases related to biotechnology and is likely to maintain a toxin database, the details about the Spider Venom Database (SVD), the Venomous Animals Database, and the Spider Venomics Resource, including their maintenance by the specified organizations, cannot be confirmed without additional information.",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "vicuna-13b_response": "Axitinib is a tyrosine kinase inhibitor (TKI) that has been studied in the treatment of various types of cancer, including pancreatic cancer. While Axitinib has shown some promise in the treatment of pancreatic cancer, its effectiveness in prolonging survival in patients with this disease has been mixed.\nA number of clinical trials have been conducted to evaluate the safety and efficacy of Axitinib in the treatment of pancreatic cancer. One of the most significant studies was a phase III clinical trial known as the \"AGILE\" trial, which involved over 800 patients with advanced pancreatic cancer. The results of this trial showed that Axitinib did not significantly improve overall survival compared to standard chemotherapy in patients with advanced pancreatic cancer.\nHowever, some smaller studies have suggested that Axitinib may benefit certain subgroups of pancreatic cancer patients. For example, a 2017 study published in the journal Cancer Research found that Axitinib may benefit patients with pancreatic cancer that has a specific genetic mutation known as CDH1. Additionally, a 2019 study published in the Journal of Clinical Oncology found that Axitinib may benefit patients with pancreatic cancer that has a high level of a protein called \"PD-L1\".\nIt is important to note that the use of Axitinib in the treatment of pancreatic cancer is still being studied, and more research is needed to fully understand its effectiveness in this context. Currently, Axitinib is not approved by the FDA for the treatment of pancreatic cancer.\nIn conclusion, while Axitinib has shown some promise in the treatment of pancreatic cancer, its effectiveness in prolonging survival in patients with this disease has been mixed. Further research is needed to fully understand the potential benefits and risks of Axitinib in the treatment of pancreatic cancer.",
    "vicuna-13b_fact_raw": "1. Axitinib is a tyrosine kinase inhibitor (TKI) that has been studied for the treatment of pancreatic cancer.\n2. The \"AGILE\" phase III clinical trial involved over 800 patients with advanced pancreatic cancer.\n3. The results of the \"AGILE\" trial indicated that Axitinib did not significantly improve overall survival compared to standard chemotherapy in patients with advanced pancreatic cancer.\n4. A 2017 study suggested that Axitinib may benefit pancreatic cancer patients with a specific genetic mutation known as CDH1.\n5. A 2019 study indicated that Axitinib may benefit pancreatic cancer patients with a high level of a protein called \"PD-L1\".",
    "vicuna-13b_fact": [
      "Axitinib is a tyrosine kinase inhibitor (TKI) that has been studied for the treatment of pancreatic cancer.",
      "The \"AGILE\" phase III clinical trial involved over 800 patients with advanced pancreatic cancer.",
      "The results of the \"AGILE\" trial indicated that Axitinib did not significantly improve overall survival compared to standard chemotherapy in patients with advanced pancreatic cancer.",
      "A 2017 study suggested that Axitinib may benefit pancreatic cancer patients with a specific genetic mutation known as CDH1.",
      "A 2019 study indicated that Axitinib may benefit pancreatic cancer patients with a high level of a protein called \"PD-L1\"."
    ],
    "vicuna-13b_judge_raw": "1. TRUE: Axitinib is a tyrosine kinase inhibitor (TKI) that has been studied for the treatment of various types of cancer, including pancreatic cancer.\n2. UNKNOWN: Without specific information about the \"AGILE\" phase III clinical trial, it is not possible to confirm the number of patients involved or the details of the trial.\n3. UNKNOWN: The outcome of the \"AGILE\" trial regarding Axitinib's effectiveness in improving overall survival compared to standard chemotherapy in patients with advanced pancreatic cancer cannot be determined without access to the trial results.\n4. UNKNOWN: Without access to the specific 2017 study, the claim that Axitinib may benefit pancreatic cancer patients with a specific genetic mutation known as CDH1 cannot be verified.\n5. UNKNOWN: Similarly, without access to the specific 2019 study, the claim that Axitinib may benefit pancreatic cancer patients with a high level of a protein called \"PD-L1\" cannot be verified.",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "vicuna-13b_response": "MLP (myosin regulatory light chain) is a protein that plays a key role in regulating the dynamics of F-actin, a key component of the cytoskeleton. MLP regulates the interaction between myosin motor proteins and actin filaments, allowing for the controlled contraction and relaxation of muscle cells.\nMLP regulates the interaction between myosin motor proteins and actin filaments by binding to the regulatory light chain of myosin. This binding causes a conformational change in the myosin protein, which allows it to bind to actin filaments and generate force. MLP also helps to regulate the activity of myosin motor proteins by inhibiting their activity when they are not needed, and activating them when they are needed to generate force.\nIn addition to regulating the interaction between myosin and actin, MLP also interacts with other proteins that are involved in cytoskeletal dynamics, such as tropomyosin and actinin. These interactions help to stabilize the actin filament network and regulate its dynamics.\nOverall, the regulation of F-actin dynamics by MLP is a complex process that involves multiple protein interactions and conformational changes. Understanding the details of these interactions is important for understanding the mechanisms that underlie muscle contraction and other cytoskeletal functions.",
    "vicuna-13b_fact_raw": "1. MLP (myosin regulatory light chain) regulates the dynamics of F-actin, a component of the cytoskeleton.\n2. MLP regulates the interaction between myosin motor proteins and actin filaments, which is essential for muscle cell contraction and relaxation.\n3. MLP binds to the regulatory light chain of myosin, causing a conformational change that allows myosin to bind to actin filaments and generate force.\n4. MLP can inhibit the activity of myosin motor proteins when they are not needed and activate them when force generation is required.\n5. MLP interacts with other proteins involved in cytoskeletal dynamics, such as tropomyosin and actinin, to stabilize the actin filament network.",
    "vicuna-13b_fact": [
      "MLP (myosin regulatory light chain) regulates the dynamics of F-actin, a component of the cytoskeleton.",
      "MLP regulates the interaction between myosin motor proteins and actin filaments, which is essential for muscle cell contraction and relaxation.",
      "MLP binds to the regulatory light chain of myosin, causing a conformational change that allows myosin to bind to actin filaments and generate force.",
      "MLP can inhibit the activity of myosin motor proteins when they are not needed and activate them when force generation is required.",
      "MLP interacts with other proteins involved in cytoskeletal dynamics, such as tropomyosin and actinin, to stabilize the actin filament network."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: MLP (myosin light chain phosphatase) does not regulate the dynamics of F-actin directly; it is involved in the dephosphorylation of the regulatory light chain of myosin II, which affects muscle contraction.\n2. TRUE\n3. FALSE [correction]: MLP does not bind to the regulatory light chain of myosin to cause a conformational change. Instead, it dephosphorylates the myosin light chain, which affects the interaction between myosin and actin.\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "vicuna-13b_response": "A pseudokinase is a protein that has some of the structural features of a kinase, but does not have the enzymatic activity of a kinase. In the human kinome, there are several hundred pseudokinases. The exact number can vary depending on the source and the specific definition of a pseudokinase used. However, it is estimated that there are around 300-500 pseudokinases in the human genome.",
    "vicuna-13b_fact_raw": "1. Pseudokinases are proteins that have structural features of a kinase but lack enzymatic activity.\n2. There are several hundred pseudokinases in the human kinome.\n3. The estimated number of pseudokinases in the human genome is around 300-500.",
    "vicuna-13b_fact": [
      "Pseudokinases are proteins that have structural features of a kinase but lack enzymatic activity.",
      "There are several hundred pseudokinases in the human kinome.",
      "The estimated number of pseudokinases in the human genome is around 300-500."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "vicuna-13b_response": "ApoE mimetics are molecules that mimic the activity of apolipoprotein E (ApoE), a protein that plays a critical role in lipid metabolism and transport. Here are three examples of ApoE mimetics:\n1. Mimetic peptides: Short peptides that mimic the structural and functional properties of ApoE have been developed. These peptides can bind to ApoE receptors and enhance the clearance of lipids from the bloodstream, reducing the risk of cardiovascular disease.\n2. Antibodies: Monoclonal antibodies that bind to ApoE and inhibit its activity have been developed. These antibodies can reduce the levels of ApoE in the bloodstream, leading to a decrease in the concentration of lipids and a lower risk of cardiovascular disease.\n3. Small molecules: Small molecules that mimic the activity of ApoE have been developed. These molecules can bind to ApoE receptors and enhance the clearance of lipids from the bloodstream, reducing the risk of cardiovascular disease.",
    "vicuna-13b_fact_raw": "1. Mimetic peptides have been developed to mimic the structural and functional properties of ApoE.\n2. Monoclonal antibodies that bind to ApoE and inhibit its activity have been developed.\n3. Small molecules that mimic the activity of ApoE have been developed.",
    "vicuna-13b_fact": [
      "Mimetic peptides have been developed to mimic the structural and functional properties of ApoE.",
      "Monoclonal antibodies that bind to ApoE and inhibit its activity have been developed.",
      "Small molecules that mimic the activity of ApoE have been developed."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Monoclonal antibodies have been developed to target and clear amyloid-beta, not to inhibit the activity of ApoE. ApoE is involved in the lipid metabolism and its activity is generally not inhibited for therapeutic purposes.\n3. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "vicuna-13b_response": "SAMHD1 (Sterile alpha motif and HD-domain containing 1) is an enzyme that plays a role in regulating the replication of HIV and other viruses. There is evidence to suggest that there are sex differences in SAMHD1 activity.\nStudies have shown that SAMHD1 activity is higher in females compared to males. This suggests that females may be more resistant to HIV infection due to higher SAMHD1 activity. Additionally, some studies have found that SAMHD1 activity is higher in the female genital tract compared to the male genital tract, which may also contribute to the higher resistance to HIV infection in females.\nIt is important to note that these findings are not universal and more research is needed to fully understand the role of SAMHD1 in HIV infection and the potential sex differences in SAMHD1 activity.",
    "vicuna-13b_fact_raw": "1. SAMHD1 is an enzyme that regulates the replication of HIV and other viruses.\n2. There is evidence suggesting sex differences in SAMHD1 activity.\n3. Studies have shown that SAMHD1 activity is higher in females compared to males.\n4. Higher SAMHD1 activity in females may contribute to more resistance to HIV infection.\n5. SAMHD1 activity has been found to be higher in the female genital tract compared to the male genital tract.",
    "vicuna-13b_fact": [
      "SAMHD1 is an enzyme that regulates the replication of HIV and other viruses.",
      "There is evidence suggesting sex differences in SAMHD1 activity.",
      "Studies have shown that SAMHD1 activity is higher in females compared to males.",
      "Higher SAMHD1 activity in females may contribute to more resistance to HIV infection.",
      "SAMHD1 activity has been found to be higher in the female genital tract compared to the male genital tract."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nBased on the context provided, it appears that the statements are consistent with scientific findings regarding SAMHD1. However, it's important to note that scientific knowledge is always evolving, and these statements should be cross-referenced with the latest research for the most current information.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "vicuna-13b_response": "RUNX2 is a transcription factor that plays a critical role in regulating the differentiation and development of various cell types, including astrocytes. While some studies have suggested that RUNX2 may inhibit astrocyte differentiation, other studies have shown that RUNX2 can promote astrocyte differentiation.\nOne study published in the journal \"Neurochemistry International\" in 2011 found that RUNX2 inhibited the differentiation of astrocytes in vitro by suppressing the expression of genes involved in the astrocyte phenotype. However, other studies have shown that RUNX2 can promote astrocyte differentiation by activating the expression of genes involved in astrocyte development.\nFor example, a study published in the journal \"Gene Expression Patterns\" in 2010 found that RUNX2 was required for the differentiation of astrocytes in the developing brain. The study showed that RUNX2 activated the expression of genes involved in the astrocyte phenotype and that this process was necessary for the proper development of astrocytes in the brain.\nOverall, the available evidence suggests that the effect of RUNX2 on astrocyte differentiation is complex and may depend on the specific context and developmental stage being studied. Further research is needed to fully understand the role of RUNX2 in regulating astrocyte differentiation.",
    "vicuna-13b_fact_raw": "1. RUNX2 is a transcription factor that regulates the differentiation and development of various cell types, including astrocytes.\n2. A study published in \"Neurochemistry International\" in 2011 found that RUNX2 inhibited astrocyte differentiation in vitro.\n3. The same study indicated that RUNX2 suppressed the expression of genes involved in the astrocyte phenotype.\n4. A study published in \"Gene Expression Patterns\" in 2010 found that RUNX2 was required for the differentiation of astrocytes in the developing brain.\n5. The 2010 study showed that RUNX2 activated the expression of genes involved in the astrocyte phenotype necessary for proper astrocyte development in the brain.",
    "vicuna-13b_fact": [
      "RUNX2 is a transcription factor that regulates the differentiation and development of various cell types, including astrocytes.",
      "A study published in \"Neurochemistry International\" in 2011 found that RUNX2 inhibited astrocyte differentiation in vitro.",
      "The same study indicated that RUNX2 suppressed the expression of genes involved in the astrocyte phenotype.",
      "A study published in \"Gene Expression Patterns\" in 2010 found that RUNX2 was required for the differentiation of astrocytes in the developing brain.",
      "The 2010 study showed that RUNX2 activated the expression of genes involved in the astrocyte phenotype necessary for proper astrocyte development in the brain."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: RUNX2 is a transcription factor that is primarily known for its role in regulating the differentiation and development of osteoblasts, which are bone-forming cells, not astrocytes.\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: Given that RUNX2 is primarily associated with bone development, it is unlikely that a study would find it required for the differentiation of astrocytes in the developing brain. However, without access to the specific study, the statement's accuracy cannot be confirmed.\n5. FALSE [correction]: Based on the primary role of RUNX2 in bone development, it is unlikely that it would activate the expression of genes involved in the astrocyte phenotype for proper astrocyte development in the brain. However, this correction is based on general knowledge of RUNX2's role, and without the specific study, the statement's accuracy cannot be confirmed.",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "vicuna-13b_response": "The Cobb-Stainsby excision arthroplasty is a surgical procedure performed to treat osteoarthritis of the hip. During the procedure, the surgeon will make an incision over the hip joint and remove the damaged cartilage and bone. The damaged joint is then replaced with an artificial joint made of metal, plastic, or ceramic materials.\nThe specific location where the Cobb-Stainsby excision arthroplasty is performed will depend on the specific needs of the patient and the location of the damaged joint. The incision will typically be made over the hip joint, which is located in the upper part of the leg, just below the gluteal muscles. The surgeon will carefully dissect the tissue and muscles to access the hip joint and perform the procedure.\nAfter the procedure, the patient will typically spend several days in the hospital recovering and undergoing physical therapy. The recovery process can take several months, during which time the patient will need to follow specific instructions to ensure proper healing and prevent complications.",
    "vicuna-13b_fact_raw": "1. The Cobb-Stainsby excision arthroplasty is a surgical procedure used to treat osteoarthritis of the hip.\n2. During the Cobb-Stainsby excision arthroplasty, the surgeon removes the damaged cartilage and bone from the hip joint.\n3. An artificial joint made of metal, plastic, or ceramic materials is used to replace the damaged joint in the Cobb-Stainsby excision arthroplasty.\n4. The incision for the Cobb-Stainsby excision arthroplasty is typically made over the hip joint, which is located just below the gluteal muscles.\n5. After the Cobb-Stainsby excision arthroplasty, patients usually spend several days in the hospital and undergo physical therapy.",
    "vicuna-13b_fact": [
      "The Cobb-Stainsby excision arthroplasty is a surgical procedure used to treat osteoarthritis of the hip.",
      "During the Cobb-Stainsby excision arthroplasty, the surgeon removes the damaged cartilage and bone from the hip joint.",
      "An artificial joint made of metal, plastic, or ceramic materials is used to replace the damaged joint in the Cobb-Stainsby excision arthroplasty.",
      "The incision for the Cobb-Stainsby excision arthroplasty is typically made over the hip joint, which is located just below the gluteal muscles.",
      "After the Cobb-Stainsby excision arthroplasty, patients usually spend several days in the hospital and undergo physical therapy."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Cobb-Stainsby excision arthroplasty involves the removal of the femoral head and the interposition of a fascia lata graft, not the placement of an artificial joint.\n4. UNKNOWN (The specific location of the incision can vary and is not detailed enough to confirm as true or false without specific medical procedural knowledge.)\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "vicuna-13b_response": "Yes, over-expression of the Growth Regulation by Heterologous Ligand 2 (GRHL2) gene has been shown to lead to the development of an epithelial-to-mesenchymal transition (EMT) phenotype in certain cell types. EMT is a process by which epithelial cells, which typically form tight junctions and cover the surface of organs and glands, transform into mesenchymal cells, which are more mobile and have a more fibroblast-like appearance.\nGRHL2 is a transcription factor that plays a role in regulating the expression of genes involved in cell growth and differentiation. Over-expression of GRHL2 has been shown to promote the proliferation and survival of cells, and to inhibit their differentiation. In some cases, this can lead to the development of a more mesenchymal phenotype, including the loss of epithelial cell characteristics and the acquisition of mesenchymal cell characteristics.\nOver-expression of GRHL2 has been observed in a variety of cancer types, including breast cancer, gastric cancer, and lung cancer, and has been associated with poor prognosis and increased risk of metastasis. In addition, over-expression of GRHL2 has been shown to promote the development of resistance to chemotherapy in cancer cells.\nOverall, while the exact mechanisms by which GRHL2 over-expression leads to EMT are not fully understood, it is clear that this process plays a role in the development of certain cancer types and may contribute to the progression of cancer and the acquisition of drug resistance.",
    "vicuna-13b_fact_raw": "1. Over-expression of the GRHL2 gene can lead to the development of an epithelial-to-mesenchymal transition (EMT) phenotype in certain cell types.\n2. GRHL2 is a transcription factor involved in regulating gene expression related to cell growth and differentiation.\n3. Over-expression of GRHL2 can promote cell proliferation and survival, and inhibit cell differentiation.\n4. GRHL2 over-expression has been observed in various cancer types, including breast cancer, gastric cancer, and lung cancer.\n5. Over-expression of GRHL2 has been associated with poor prognosis and increased risk of metastasis in cancer.",
    "vicuna-13b_fact": [
      "Over-expression of the GRHL2 gene can lead to the development of an epithelial-to-mesenchymal transition (EMT) phenotype in certain cell types.",
      "GRHL2 is a transcription factor involved in regulating gene expression related to cell growth and differentiation.",
      "Over-expression of GRHL2 can promote cell proliferation and survival, and inhibit cell differentiation.",
      "GRHL2 over-expression has been observed in various cancer types, including breast cancer, gastric cancer, and lung cancer.",
      "Over-expression of GRHL2 has been associated with poor prognosis and increased risk of metastasis in cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE: Over-expression of the GRHL2 gene has been reported to lead to the development of an epithelial-to-mesenchymal transition (EMT) phenotype in certain cell types, which is a process where epithelial cells acquire mesenchymal characteristics, contributing to cancer progression.\n2. TRUE: GRHL2 is indeed a transcription factor that plays a role in regulating gene expression related to cell growth and differentiation.\n3. TRUE: Over-expression of GRHL2 can promote cell proliferation and survival, and it has been reported to inhibit cell differentiation in certain contexts, which can contribute to tumorigenesis.\n4. TRUE: GRHL2 over-expression has been observed in various cancer types, including breast cancer, gastric cancer, and lung cancer, and is often associated with tumor progression.\n5. TRUE: Over-expression of GRHL2 has been associated with poor prognosis and increased risk of metastasis in cancer, as it can contribute to the EMT process and cancer cell dissemination.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "vicuna-13b_response": "T-UCRs, or Tumor-Upregulated Conserved Regulators, are genes that are upregulated (i.e., expressed at higher levels) in cancer cells compared to normal cells. Several T-UCRs have been implicated in the development and progression of lung cancer.\nOne example is the T-UCR known as TWIST1. TWIST1 is a transcription factor that has been shown to play a role in the development and progression of several types of cancer, including lung cancer. In lung cancer, TWIST1 is often upregulated and has been shown to promote the growth and survival of cancer cells.\nAnother example is the T-UCR known as FOXM1. FOXM1 is a transcription factor that has been shown to be involved in the regulation of cell proliferation and differentiation. In lung cancer, FOXM1 is often upregulated and has been shown to promote the growth and survival of cancer cells.\nIt is important to note that while T-UCRs have been implicated in the development and progression of lung cancer, they are not the only genes that are involved in this process. There are many other genes and pathways that are involved in the development and progression of lung cancer, and a better understanding of these pathways is needed in order to develop effective treatments for this disease.",
    "vicuna-13b_fact_raw": "1. T-UCRs, or Tumor-Upregulated Conserved Regulators, are genes that are expressed at higher levels in cancer cells compared to normal cells.\n2. Several T-UCRs have been implicated in the development and progression of lung cancer.\n3. TWIST1 is a T-UCR that is often upregulated in lung cancer and promotes the growth and survival of cancer cells.\n4. FOXM1 is a T-UCR that is often upregulated in lung cancer and promotes the growth and survival of cancer cells.\n5. TWIST1 and FOXM1 are transcription factors.",
    "vicuna-13b_fact": [
      "T-UCRs, or Tumor-Upregulated Conserved Regulators, are genes that are expressed at higher levels in cancer cells compared to normal cells.",
      "Several T-UCRs have been implicated in the development and progression of lung cancer.",
      "TWIST1 is a T-UCR that is often upregulated in lung cancer and promotes the growth and survival of cancer cells.",
      "FOXM1 is a T-UCR that is often upregulated in lung cancer and promotes the growth and survival of cancer cells.",
      "TWIST1 and FOXM1 are transcription factors."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: TWIST1 is not a T-UCR; it is a transcription factor that is often upregulated in lung cancer and promotes the growth and survival of cancer cells.\n4. FALSE [correction]: FOXM1 is not a T-UCR; it is a transcription factor that is often upregulated in lung cancer and promotes the growth and survival of cancer cells.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "vicuna-13b_response": "GPR151 (also known as G protein-coupled receptor 151) is a member of the G protein-coupled receptor (GPCR) family of membrane receptors. It is a seven transmembrane domain receptor and is thought to play a role in regulating various physiological processes, including glucose metabolism and inflammation.\nGPR151 has been found to be expressed in various tissues, including the pancreas, intestine, and adipose tissue. It has been shown to regulate glucose-stimulated insulin secretion in pancreatic beta cells and to play a role in regulating glucose uptake in adipose tissue.\nStudies have also suggested that GPR151 may be involved in the regulation of inflammation. For example, GPR151 has been shown to regulate the production of inflammatory cytokines in macrophages and to play a role in the regulation of the immune response.\nOverall, while much is still unknown about the function and regulation of GPR151, it is thought to play an important role in various physiological processes and may be a potential target for the development of new therapies for diseases such as diabetes and inflammation.",
    "vicuna-13b_fact_raw": "1. GPR151 is a member of the G protein-coupled receptor (GPCR) family.\n2. GPR151 is a seven transmembrane domain receptor.\n3. GPR151 is expressed in various tissues, including the pancreas, intestine, and adipose tissue.\n4. GPR151 has been shown to regulate glucose-stimulated insulin secretion in pancreatic beta cells.\n5. GPR151 may be involved in the regulation of inflammation, including the production of inflammatory cytokines in macrophages.",
    "vicuna-13b_fact": [
      "GPR151 is a member of the G protein-coupled receptor (GPCR) family.",
      "GPR151 is a seven transmembrane domain receptor.",
      "GPR151 is expressed in various tissues, including the pancreas, intestine, and adipose tissue.",
      "GPR151 has been shown to regulate glucose-stimulated insulin secretion in pancreatic beta cells.",
      "GPR151 may be involved in the regulation of inflammation, including the production of inflammatory cytokines in macrophages."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: GPR151 is primarily expressed in the central nervous system, with particularly high levels in the brain. It is not typically associated with expression in the pancreas, intestine, or adipose tissue.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "vicuna-13b_response": "The Fluzone intradermal quadrivalent vaccine is a vaccine that is used to protect against four different strains of the influenza virus. It contains attenuated live viruses, which means that the viruses have been weakened in order to stimulate an immune response without causing serious illness.\nThe four strains of the influenza virus that are included in the Fluzone intradermal quadrivalent vaccine are:\n* A/Brisbane/10/2019 (H1N1)\n* A/Kansas/14/2019 (H3N2)\n* B/Colorado/06/2017\n* B/Phuket/3073/2018\nIt is important to note that the viruses in the vaccine are attenuated, which means they are weakened and cannot cause serious illness. However, it is possible to experience side effects from the vaccine, such as pain, redness, or swelling at the injection site. It is also possible to experience mild symptoms, such as fever or fatigue, after receiving the vaccine. These side effects are generally mild and short-lived.",
    "vicuna-13b_fact_raw": "1. The Fluzone intradermal quadrivalent vaccine is used to protect against four different strains of the influenza virus.\n2. The vaccine contains attenuated live viruses.\n3. The influenza virus strains included in the Fluzone intradermal quadrivalent vaccine are A/Brisbane/10/2019 (H1N1) and A/Kansas/14/2019 (H3N2).\n4. The influenza virus strains included in the Fluzone intradermal quadrivalent vaccine are B/Colorado/06/2017 and B/Phuket/3073/2018.\n5. The attenuated viruses in the vaccine are weakened and cannot cause serious illness.",
    "vicuna-13b_fact": [
      "The Fluzone intradermal quadrivalent vaccine is used to protect against four different strains of the influenza virus.",
      "The vaccine contains attenuated live viruses.",
      "The influenza virus strains included in the Fluzone intradermal quadrivalent vaccine are A/Brisbane/10/2019 (H1N1) and A/Kansas/14/2019 (H3N2).",
      "The influenza virus strains included in the Fluzone intradermal quadrivalent vaccine are B/Colorado/06/2017 and B/Phuket/3073/2018.",
      "The attenuated viruses in the vaccine are weakened and cannot cause serious illness."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Fluzone intradermal quadrivalent vaccine contains inactivated (killed) viruses, not attenuated live viruses.\n3. UNKNOWN (The specific strains included in the vaccine can vary from year to year, and without a specific year or confirmation from the manufacturer, it's not possible to confirm the accuracy of these strains.)\n4. UNKNOWN (As with statement 3, the specific strains included can vary, and without additional context, the accuracy of these strains cannot be confirmed.)\n5. FALSE [correction]: Since the Fluzone intradermal quadrivalent vaccine contains inactivated viruses, the statement about attenuated viruses does not apply. However, it is true that inactivated viruses in the vaccine cannot cause the flu.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "vicuna-13b_response": "Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organs and systems in the body. There are several genetic factors that have been identified as contributing to the development of SLE, including variations in the TNFR2 gene.\nThe TNFR2 gene provides instructions for making a protein called tumor necrosis factor receptor superfamily member 2 (TNFRSF2), which is involved in the immune response and inflammation. Variations in the TNFR2 gene have been associated with an increased risk of developing SLE.\nSpecifically, a variation in the TNFR2 gene called the 196G>C polymorphism has been identified as a genetic risk factor for SLE. This variation is located in the promoter region of the TNFR2 gene and has been shown to affect the expression of the TNFRSF2 protein.\nIt is important to note that genetic variations are only one of many factors that can contribute to the development of SLE, and that other environmental and lifestyle factors are also thought to play a role in the disease.",
    "vicuna-13b_fact_raw": "1. The TNFR2 gene is associated with an increased risk of developing Systemic Lupus Erythematosus (SLE).\n2. The TNFR2 gene provides instructions for making the protein called tumor necrosis factor receptor superfamily member 2 (TNFRSF2).\n3. The TNFRSF2 protein is involved in the immune response and inflammation.\n4. A variation in the TNFR2 gene known as the 196G>C polymorphism has been identified as a genetic risk factor for SLE.\n5. The 196G>C polymorphism is located in the promoter region of the TNFR2 gene and affects the expression of the TNFRSF2 protein.",
    "vicuna-13b_fact": [
      "The TNFR2 gene is associated with an increased risk of developing Systemic Lupus Erythematosus (SLE).",
      "The TNFR2 gene provides instructions for making the protein called tumor necrosis factor receptor superfamily member 2 (TNFRSF2).",
      "The TNFRSF2 protein is involved in the immune response and inflammation.",
      "A variation in the TNFR2 gene known as the 196G>C polymorphism has been identified as a genetic risk factor for SLE.",
      "The 196G>C polymorphism is located in the promoter region of the TNFR2 gene and affects the expression of the TNFRSF2 protein."
    ],
    "vicuna-13b_judge_raw": "1. TRUE: The TNFR2 gene has been associated with an increased risk of developing Systemic Lupus Erythematosus (SLE) in various studies.\n2. TRUE: The TNFR2 gene does provide instructions for making the protein known as tumor necrosis factor receptor superfamily member 2 (TNFRSF2).\n3. TRUE: The TNFRSF2 protein is indeed involved in the immune response and inflammation, acting as a receptor for tumor necrosis factor (TNF), which is a cytokine involved in systemic inflammation.\n4. UNKNOWN: Without specific scientific references, it is difficult to confirm the association of a particular polymorphism such as 196G>C with SLE. This would require access to current genetic research data.\n5. UNKNOWN: Similarly, the exact location of the 196G>C polymorphism and its effect on the expression of the TNFRSF2 protein would need to be verified with scientific literature specific to this polymorphism.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "vicuna-13b_response": "Yes, there is a vaccine for peanut allergy, but it is not yet widely available. The vaccine is called Palforzia and was approved by the U.S. Food and Drug Administration (FDA) in December 2020. It is given as an injection and is intended for use in people aged 4 to 17 years old who have a peanut allergy.\nPalforzia works by gradually exposing the body to small amounts of peanut protein over a period of several months. This helps the immune system to become less sensitive to peanuts and reduce the risk of a severe allergic reaction.\nIt is important to note that Palforzia is not a cure for peanut allergy and it does not guarantee protection against allergic reactions. It is also important to continue to follow a peanut-free diet and carry epinephrine injectors (such as EpiPens) in case of a severe allergic reaction.\nIt is also important to note that the vaccine is not yet available in all countries and it is important to check with your doctor or local health authority for availability and the latest information.",
    "vicuna-13b_fact_raw": "1. There is a vaccine for peanut allergy called Palforzia.\n2. Palforzia was approved by the U.S. Food and Drug Administration (FDA) in December 2020.\n3. Palforzia is intended for use in people aged 4 to 17 years old with a peanut allergy.\n4. Palforzia is given as an injection and involves gradually exposing the body to small amounts of peanut protein.\n5. Palforzia does not cure peanut allergy nor does it guarantee protection against allergic reactions.",
    "vicuna-13b_fact": [
      "There is a vaccine for peanut allergy called Palforzia.",
      "Palforzia was approved by the U.S. Food and Drug Administration (FDA) in December 2020.",
      "Palforzia is intended for use in people aged 4 to 17 years old with a peanut allergy.",
      "Palforzia is given as an injection and involves gradually exposing the body to small amounts of peanut protein.",
      "Palforzia does not cure peanut allergy nor does it guarantee protection against allergic reactions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Palforzia was approved by the U.S. Food and Drug Administration (FDA) in January 2020.\n3. TRUE\n4. FALSE [correction]: Palforzia is not given as an injection; it is an oral immunotherapy treatment that involves gradually exposing the body to small amounts of peanut protein.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "vicuna-13b_response": "The Fxy gene is a gene that is responsible for the development of the mouse coat color. The Fxy gene is located on the X chromosome of the mouse, which is one of the two sex chromosomes in mice. The X chromosome is the larger of the two sex chromosomes and contains a large number of genes that are involved in various biological processes, including development, growth, and reproduction.\nThe Fxy gene is specifically located on the distal end of the X chromosome, which is the part of the chromosome that is closest to the centromere. The centromere is the point on the chromosome where the two arms of the chromosome are joined. The distal end of the X chromosome is also known as the Xp region.\nThe chromosomal position of a gene is important because it determines the location of the gene on the chromosome and can affect the expression of the gene. The Fxy gene is expressed in the coat cells of the mouse, and its expression is regulated by the surrounding environment and other genetic factors. The chromosomal position of the Fxy gene can affect its expression and can also affect the inheritance of the coat color trait in mice.",
    "vicuna-13b_fact_raw": "1. The Fxy gene is responsible for the development of the mouse coat color.\n2. The Fxy gene is located on the X chromosome in mice.\n3. The X chromosome is one of the two sex chromosomes in mice and is the larger of the two.\n4. The Fxy gene is specifically located on the distal end of the X chromosome, also known as the Xp region.\n5. The expression of the Fxy gene is regulated by the surrounding environment and other genetic factors.",
    "vicuna-13b_fact": [
      "The Fxy gene is responsible for the development of the mouse coat color.",
      "The Fxy gene is located on the X chromosome in mice.",
      "The X chromosome is one of the two sex chromosomes in mice and is the larger of the two.",
      "The Fxy gene is specifically located on the distal end of the X chromosome, also known as the Xp region.",
      "The expression of the Fxy gene is regulated by the surrounding environment and other genetic factors."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE\n\nWithout specific scientific literature or context to confirm the existence and characteristics of an \"Fxy gene\" in mice, the statements regarding the gene's responsibility for coat color, its location on the X chromosome, and its specific location on the distal end of the X chromosome (Xp region) cannot be verified as true or false. However, it is generally true that the expression of genes can be regulated by the surrounding environment and other genetic factors, so the last statement is true. The statement about the X chromosome being one of the two sex chromosomes in mice and being the larger of the two is also true, as it is a well-established fact in genetics.",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "vicuna-13b_response": "Methyl-propyl-EDTA (MPE) sequencing is a method used to analyze the methylation status of DNA. The method is based on the ability of MPE to selectively bind to methylated DNA, allowing for the separation of methylated and unmethylated DNA.\nThe MPE-seq method involves treating DNA with MPE, which binds to methylated DNA, and then isolating the bound DNA. The bound DNA is then sequenced using next-generation sequencing technologies, allowing for the identification of methylated and unmethylated regions of the genome.\nThe basis of the MPE-seq method is the specific binding of MPE to methylated DNA, which is due to the presence of a methyl group on the cytosine residue in the DNA. MPE has a higher affinity for methylated DNA than for unmethylated DNA, allowing for the selective isolation of methylated DNA.\nOnce the methylated DNA is isolated, it can be sequenced using next-generation sequencing technologies, such as Illumina or PacBio, to identify the methylation status of each base in the genome. The resulting data can be used to generate methylation maps, which can be used to study the role of DNA methylation in various biological processes, such as gene regulation and disease.\nOverall, the MPE-seq method is a powerful tool for studying DNA methylation, and its basis lies in the specific binding of MPE to methylated DNA, which allows for the selective isolation and sequencing of methylated DNA.",
    "vicuna-13b_fact_raw": "1. Methyl-propyl-EDTA (MPE) sequencing is used to analyze the methylation status of DNA.\n2. MPE selectively binds to methylated DNA, which allows for the separation of methylated and unmethylated DNA.\n3. The MPE-seq method involves treating DNA with MPE and then isolating the bound DNA for sequencing.\n4. MPE has a higher affinity for methylated DNA than for unmethylated DNA.\n5. Next-generation sequencing technologies, such as Illumina or PacBio, are used to sequence the isolated methylated DNA in the MPE-seq method.",
    "vicuna-13b_fact": [
      "Methyl-propyl-EDTA (MPE) sequencing is used to analyze the methylation status of DNA.",
      "MPE selectively binds to methylated DNA, which allows for the separation of methylated and unmethylated DNA.",
      "The MPE-seq method involves treating DNA with MPE and then isolating the bound DNA for sequencing.",
      "MPE has a higher affinity for methylated DNA than for unmethylated DNA.",
      "Next-generation sequencing technologies, such as Illumina or PacBio, are used to sequence the isolated methylated DNA in the MPE-seq method."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The correct term is Methylated DNA immunoprecipitation sequencing (MeDIP-seq), not Methyl-propyl-EDTA (MPE) sequencing. MeDIP-seq is used to analyze the methylation status of DNA.\n2. TRUE: MeDIP-seq (assuming MPE is a typo for MeDIP) selectively binds to methylated DNA, which allows for the separation of methylated and unmethylated DNA.\n3. TRUE: The MeDIP-seq method involves treating DNA with an antibody that binds to methylated DNA and then isolating the bound DNA for sequencing.\n4. TRUE: In the context of MeDIP-seq, the antibody used has a higher affinity for methylated DNA than for unmethylated DNA.\n5. TRUE: Next-generation sequencing technologies, such as Illumina or PacBio, are indeed used to sequence the isolated methylated DNA in the MeDIP-seq method.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "vicuna-13b_response": "GWAR (GNU Wget for Autonomous Robots) is a software system used for controlling and coordinating a swarm of robots. The programming language used for implementing GWAR can vary depending on the specific implementation and the preferences of the developers.\nHowever, in the case of the original GWAR implementation developed by the Robotics Institute at Carnegie Mellon University, the programming language used was Python. Python is a popular, high-level programming language that is well-suited for tasks such as coordinating complex systems and working with large amounts of data. Its ease of use and flexibility make it a popular choice for many applications, including robotics and machine learning.\nIn summary, the programming language used for implementing GWAR can vary, but in the case of the original implementation, Python was used.",
    "vicuna-13b_fact_raw": "1. GWAR stands for GNU Wget for Autonomous Robots.\n2. GWAR is a software system used for controlling and coordinating a swarm of robots.\n3. The original GWAR implementation was developed by the Robotics Institute at Carnegie Mellon University.\n4. Python was the programming language used for the original implementation of GWAR.",
    "vicuna-13b_fact": [
      "GWAR stands for GNU Wget for Autonomous Robots.",
      "GWAR is a software system used for controlling and coordinating a swarm of robots.",
      "The original GWAR implementation was developed by the Robotics Institute at Carnegie Mellon University.",
      "Python was the programming language used for the original implementation of GWAR."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: GWAR does not stand for GNU Wget for Autonomous Robots. GWAR is a rock band known for its elaborate science fiction-themed costumes and graphic stage performances.\n2. FALSE [correction]: GWAR is not a software system for controlling and coordinating a swarm of robots. As mentioned above, GWAR is a rock band.\n3. FALSE [correction]: The original GWAR implementation was not developed by the Robotics Institute at Carnegie Mellon University because GWAR is not a software system but a rock band.\n4. FALSE [correction]: Since GWAR is not a software system, Python was not the programming language used for its original implementation. The statement is based on a false premise.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "vicuna-13b_response": "Xaliproden (also known as riluzole) is a medication that is commonly used to treat amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord. The main cause of ALS is not well understood, but it is thought to involve a combination of genetic and environmental factors.\nThere is some evidence to suggest that xaliproden may improve the prognosis of ALS. In clinical trials, xaliproden has been shown to slow the progression of ALS and improve survival in patients with the disease. However, the extent to which xaliproden improves prognosis in ALS is still being studied, and more research is needed to fully understand its effects.\nIt is important to note that the use of xaliproden in ALS is still considered experimental, and it is not yet approved by the FDA for the treatment of ALS. Additionally, the benefits of xaliproden in ALS may vary from person to person, and it is important to discuss the potential benefits and risks of this medication with a healthcare provider before starting treatment.",
    "vicuna-13b_fact_raw": "1. Xaliproden is commonly used to treat amyotrophic lateral sclerosis (ALS).\n2. ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.\n3. Clinical trials have shown that xaliproden can slow the progression of ALS and improve survival in patients.\n4. The use of xaliproden in ALS is considered experimental and is not yet approved by the FDA for the treatment of ALS.\n5. The benefits of xaliproden in ALS may vary from person to person.",
    "vicuna-13b_fact": [
      "Xaliproden is commonly used to treat amyotrophic lateral sclerosis (ALS).",
      "ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.",
      "Clinical trials have shown that xaliproden can slow the progression of ALS and improve survival in patients.",
      "The use of xaliproden in ALS is considered experimental and is not yet approved by the FDA for the treatment of ALS.",
      "The benefits of xaliproden in ALS may vary from person to person."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Xaliproden is not commonly used to treat amyotrophic lateral sclerosis (ALS); it has been investigated in clinical trials but is not a standard treatment.\n2. TRUE\n3. FALSE [correction]: While xaliproden has been investigated in clinical trials, it has not been conclusively shown to slow the progression of ALS or improve survival in patients.\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "vicuna-13b_response": "The LiPS-A3S line is a transgenic line of plants that has been engineered to express a bacterial gene called nopaline synthase (NOS) under the control of a plant promoter. The NOS gene is inserted into the chloroplast genome of the plant, specifically into the large inverted repeat (LIT) region of chromosome 1.\nThe LiPS-A3S line was created by Agrobacterium-mediated transformation, which involves the introduction of a DNA construct into plant cells using the Agrobacterium tumefaciens bacterium as a vector. The DNA construct contains the NOS gene, which is driven by a plant promoter called the 35S promoter, and a selection marker gene called the bar gene, which confers resistance to the herbicide bialaphos.\nThe LiPS-A3S line is a useful tool for studying plant metabolism and for developing new strategies for crop improvement. It has been used to study the biosynthesis of secondary metabolites, such as flavonoids and alkaloids, and to develop new methods for the production of valuable compounds in plants.",
    "vicuna-13b_fact_raw": "1. The NOS gene is inserted into the chloroplast genome of the LiPS-A3S line.\n2. The NOS gene is specifically inserted into the large inverted repeat (LIR) region of chromosome 1 in the LiPS-A3S line.\n3. The LiPS-A3S line was created using Agrobacterium-mediated transformation.\n4. The DNA construct used in the creation of the LiPS-A3S line includes the 35S promoter and the bar gene.\n5. The bar gene in the LiPS-A3S line confers resistance to the herbicide bialaphos.",
    "vicuna-13b_fact": [
      "The NOS gene is inserted into the chloroplast genome of the LiPS-A3S line.",
      "The NOS gene is specifically inserted into the large inverted repeat (LIR) region of chromosome 1 in the LiPS-A3S line.",
      "The LiPS-A3S line was created using Agrobacterium-mediated transformation.",
      "The DNA construct used in the creation of the LiPS-A3S line includes the 35S promoter and the bar gene.",
      "The bar gene in the LiPS-A3S line confers resistance to the herbicide bialaphos."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN: Without specific context or additional information about the LiPS-A3S line, it is not possible to determine the accuracy of the statement regarding the insertion of the NOS gene into the chloroplast genome.\n2. FALSE [correction]: The large inverted repeat (LIR) region is a feature of chloroplast genomes, not of a specific chromosome. If the NOS gene was inserted into the chloroplast genome, it would not be correct to refer to it as being inserted into chromosome 1.\n3. UNKNOWN: The method used to create the LiPS-A3S line is not specified in the provided statements, so it is not possible to confirm whether Agrobacterium-mediated transformation was used without additional information.\n4. UNKNOWN: Without specific details about the DNA construct used in the creation of the LiPS-A3S line, it is not possible to confirm the presence of the 35S promoter and the bar gene.\n5. TRUE: The bar gene is commonly used in plant genetic engineering to confer resistance to the herbicide bialaphos. However, without specific context confirming that this is the case for the LiPS-A3S line, this statement is assumed to be true based on common genetic engineering practices.",
    "vicuna-13b_judge": [
      "unknown",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "vicuna-13b_response": "There are several tools that use deep learning to predict drug synergy. One example is the DeepSynergy tool, which was developed by researchers at the University of California, San Francisco. This tool uses a deep neural network to predict the synergistic interactions between drugs based on their molecular properties.\nAnother example is the DeepDrug tool, which was developed by researchers at the Massachusetts Institute of Technology. This tool uses a deep convolutional neural network to analyze images of cells and predict the synergistic interactions between drugs based on their effects on cellular processes.\nThere are also several commercial tools that use deep learning for drug discovery, such as the Paige.AI platform and the DrugSpace platform from IBM. These platforms use machine learning algorithms, including deep learning, to analyze large datasets of drug and disease information and identify potential drug candidates and drug combinations.\nIt's important to note that while deep learning has shown promise in predicting drug synergy, it is still a developing field and these tools are not yet widely adopted in the pharmaceutical industry. Additionally, these tools require large amounts of data and computational resources to train and run, and may not be accessible to all researchers.",
    "vicuna-13b_fact_raw": "1. The DeepSynergy tool uses a deep neural network to predict drug interactions and was developed by researchers at the University of California, San Francisco.\n2. The DeepDrug tool uses a deep convolutional neural network to predict drug interactions based on cellular processes and was developed by researchers at the Massachusetts Institute of Technology.\n3. Paige.AI is a commercial platform that uses machine learning algorithms, including deep learning, for drug discovery.\n4. IBM's DrugSpace platform uses machine learning algorithms to analyze drug and disease information for identifying potential drug candidates and combinations.\n5. Deep learning tools for predicting drug synergy require substantial data and computational resources to train and operate.",
    "vicuna-13b_fact": [
      "The DeepSynergy tool uses a deep neural network to predict drug interactions and was developed by researchers at the University of California, San Francisco.",
      "The DeepDrug tool uses a deep convolutional neural network to predict drug interactions based on cellular processes and was developed by researchers at the Massachusetts Institute of Technology.",
      "Paige.AI is a commercial platform that uses machine learning algorithms, including deep learning, for drug discovery.",
      "IBM's DrugSpace platform uses machine learning algorithms to analyze drug and disease information for identifying potential drug candidates and combinations.",
      "Deep learning tools for predicting drug synergy require substantial data and computational resources to train and operate."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The DeepDrug tool uses a deep convolutional neural network to predict how drugs will interact with human cells and was developed by researchers at Purdue University.\n3. FALSE [correction]: Paige.AI is a commercial platform that uses machine learning algorithms, including deep learning, for pathology and cancer diagnosis, not specifically for drug discovery.\n4. UNKNOWN (While IBM has been involved in using machine learning in drug discovery, without specific information about a platform named \"DrugSpace,\" the accuracy of this statement cannot be determined.)\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "vicuna-13b_response": "There are several cloud-based platforms that have been developed for comparing GWAS (Genome-Wide Association Studies). Some of the popular ones are:\n1. Amazon Web Services (AWS): AWS offers a variety of cloud-based services, including Amazon Elastic Compute Cloud (EC2) and Amazon S3, which can be used for storing and analyzing large-scale GWAS data.\n2. Google Cloud Platform (GCP): GCP provides a variety of cloud-based services, including Google BigQuery and Google Cloud Storage, which can be used for managing and analyzing large-scale GWAS data.\n3. Microsoft Azure: Azure provides a variety of cloud-based services, including Azure Blob Storage and Azure Machine Learning, which can be used for storing and analyzing large-scale GWAS data.\n4. IBM Cloud: IBM Cloud provides a variety of cloud-based services, including IBM Cloud Object Storage and IBM Watson Studio, which can be used for managing and analyzing large-scale GWAS data.\nThese cloud-based platforms offer a range of tools and services that can be used for comparing GWAS, including data storage, data processing, data analysis, and data visualization. They also provide scalable infrastructure that can handle large-scale GWAS data, making it easier to compare GWAS across different populations and identify genetic variants that are associated with disease.",
    "vicuna-13b_fact_raw": "1. Amazon Web Services (AWS) offers cloud-based services such as Amazon Elastic Compute Cloud (EC2) and Amazon S3 for storing and analyzing GWAS data.\n2. Google Cloud Platform (GCP) provides services like Google BigQuery and Google Cloud Storage for managing and analyzing GWAS data.\n3. Microsoft Azure offers cloud-based services including Azure Blob Storage and Azure Machine Learning for GWAS data storage and analysis.\n4. IBM Cloud provides services such as IBM Cloud Object Storage and IBM Watson Studio for managing and analyzing GWAS data.\n5. These cloud-based platforms provide tools for data storage, processing, analysis, and visualization, and offer scalable infrastructure for large-scale GWAS data.",
    "vicuna-13b_fact": [
      "Amazon Web Services (AWS) offers cloud-based services such as Amazon Elastic Compute Cloud (EC2) and Amazon S3 for storing and analyzing GWAS data.",
      "Google Cloud Platform (GCP) provides services like Google BigQuery and Google Cloud Storage for managing and analyzing GWAS data.",
      "Microsoft Azure offers cloud-based services including Azure Blob Storage and Azure Machine Learning for GWAS data storage and analysis.",
      "IBM Cloud provides services such as IBM Cloud Object Storage and IBM Watson Studio for managing and analyzing GWAS data.",
      "These cloud-based platforms provide tools for data storage, processing, analysis, and visualization, and offer scalable infrastructure for large-scale GWAS data."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "vicuna-13b_response": "CMB305 is a monoclonal antibody drug that is currently being investigated for its potential to treat various types of cancer. While it has shown promise in early clinical trials for the treatment of some types of cancer, it has not yet been approved by regulatory authorities for use against sarcomas specifically.\nSarcomas are a rare type of cancer that can arise from various types of cells in the body, including bone, muscle, and connective tissue. They are relatively uncommon, accounting for less than 1% of all cancer cases.\nCMB305 is a bispecific antibody that targets the CD19 and CD3 molecules on the surface of cancer cells. It has been studied primarily in clinical trials for the treatment of B-cell malignancies, such as non-Hodgkin lymphoma and chronic lymphocytic leukemia. While early results from these trials have been promising, more research is needed to determine the safety and efficacy of CMB305 for the treatment of sarcomas.\nIt is important to note that the development of new treatments for cancer is a complex and lengthy process that involves extensive research and clinical testing. While CMB305 has shown promise in early trials, it may not ultimately be effective or safe for the treatment of sarcomas. Further research is needed to determine the potential of CMB305 for the treatment of this rare and complex type of cancer.",
    "vicuna-13b_fact_raw": "1. CMB305 is a monoclonal antibody drug being investigated for the treatment of various types of cancer.\n2. CMB305 has not been approved by regulatory authorities for use against sarcomas specifically.\n3. Sarcomas account for less than 1% of all cancer cases.\n4. CMB305 is a bispecific antibody that targets the CD19 and CD3 molecules on the surface of cancer cells.\n5. CMB305 has been studied primarily in clinical trials for the treatment of B-cell malignancies, such as non-Hodgkin lymphoma and chronic lymphocytic leukemia.",
    "vicuna-13b_fact": [
      "CMB305 is a monoclonal antibody drug being investigated for the treatment of various types of cancer.",
      "CMB305 has not been approved by regulatory authorities for use against sarcomas specifically.",
      "Sarcomas account for less than 1% of all cancer cases.",
      "CMB305 is a bispecific antibody that targets the CD19 and CD3 molecules on the surface of cancer cells.",
      "CMB305 has been studied primarily in clinical trials for the treatment of B-cell malignancies, such as non-Hodgkin lymphoma and chronic lymphocytic leukemia."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: CMB305 is not a bispecific antibody targeting CD19 and CD3 molecules. It is a cancer vaccine that targets the NY-ESO-1 protein expressed in various cancers.\n5. FALSE [correction]: CMB305 has been studied primarily in clinical trials for the treatment of cancers expressing the NY-ESO-1 protein, not specifically for B-cell malignancies like non-Hodgkin lymphoma and chronic lymphocytic leukemia.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "vicuna-13b_response": "The Saint's Triad is a concept in Christian theology that describes the threefold office of Christ: prophet, priest, and king. These three roles are seen as being united in one person, Jesus Christ. The manifestations of the Saint's Triad can be seen in various aspects of Christ's life and ministry, including his teachings, his sacrificial death, and his reign as King of kings and Lord of lords.\n1. Prophet: As a prophet, Christ is seen as the ultimate revealer of God's truth and will. He taught with authority and power, and his teachings continue to be a source of guidance and inspiration for Christians today.\n2. Priest: As a priest, Christ is seen as the mediator between God and humanity. He offered himself as a sacrifice for the sins of the world, and through his death and resurrection, he made it possible for people to be reconciled to God.\n3. King: As a king, Christ is seen as the ruler and sovereign over all creation. He reigns in glory and power, and one day he will return to establish his kingdom in its fullness.\nThe manifestations of the Saint's Triad can also be seen in the lives of the saints, who are seen as living examples of the Christian life. They embody the virtues and values of the Christian faith, and they serve as inspiration for others to follow in their footsteps.",
    "vicuna-13b_fact_raw": "1. The Saint's Triad in Christian theology refers to the threefold office of Christ as prophet, priest, and king.\n2. Christ is considered the ultimate revealer of God's truth and will in his role as a prophet.\n3. Christ is viewed as the mediator between God and humanity in his role as a priest.\n4. Christ's sacrificial death is believed to make reconciliation with God possible.\n5. Christ is seen as the ruler and sovereign over all creation in his role as a king.",
    "vicuna-13b_fact": [
      "The Saint's Triad in Christian theology refers to the threefold office of Christ as prophet, priest, and king.",
      "Christ is considered the ultimate revealer of God's truth and will in his role as a prophet.",
      "Christ is viewed as the mediator between God and humanity in his role as a priest.",
      "Christ's sacrificial death is believed to make reconciliation with God possible.",
      "Christ is seen as the ruler and sovereign over all creation in his role as a king."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "vicuna-13b_response": "Overexpression of LY6K, also known as LY6K/KLH, is a protein that has been identified as a potential biomarker for non-small cell lung cancer (NSCLC). However, the relationship between LY6K overexpression and patient prognosis is not straightforward and may depend on various factors.\nSome studies have suggested that LY6K overexpression may be associated with a better prognosis for NSCLC patients. For example, a study published in the journal Clinical Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC. Another study published in the journal Cancer Research in 2018 also found that LY6K overexpression was associated with better prognosis in patients with NSCLC, particularly in those with squamous cell carcinoma subtype.\nHowever, other studies have reported conflicting results or have found no association between LY6K overexpression and patient prognosis. For example, a study published in the journal Lung Cancer in 2019 found that high levels of LY6K expression were not significantly associated with overall survival in NSCLC patients.\nIt is important to note that the relationship between LY6K overexpression and patient prognosis may be influenced by various factors, such as the stage and histology of the cancer, the patient's age and smoking history, and the presence of other biomarkers. Therefore, further research is needed to fully understand the role of LY6K in NSCLC and its potential as a biomarker for prognosis.\nIn conclusion, while some studies have suggested that overexpression of LY6K may be associated with a better prognosis for NSCLC patients, the relationship between LY6K and patient prognosis is not well established and may depend on various factors. Further research is needed to fully understand the role of LY6K in NSCLC and its potential as a biomarker for prognosis.",
    "vicuna-13b_fact_raw": "1. LY6K, also known as LY6K/KLH, is a protein identified as a potential biomarker for non-small cell lung cancer (NSCLC).\n2. A study published in the journal Clinical Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC.\n3. Another study published in the journal Cancer Research in 2018 reported that LY6K overexpression was associated with better prognosis in NSCLC patients, particularly those with squamous cell carcinoma subtype.\n4. A study published in the journal Lung Cancer in 2019 found that high levels of LY6K expression were not significantly associated with overall survival in NSCLC patients.\n5. The relationship between LY6K overexpression and patient prognosis in NSCLC may be influenced by factors such as the stage and histology of the cancer, the patient's age and smoking history, and the presence of other biomarkers.",
    "vicuna-13b_fact": [
      "LY6K, also known as LY6K/KLH, is a protein identified as a potential biomarker for non-small cell lung cancer (NSCLC).",
      "A study published in the journal Clinical Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC.",
      "Another study published in the journal Cancer Research in 2018 reported that LY6K overexpression was associated with better prognosis in NSCLC patients, particularly those with squamous cell carcinoma subtype.",
      "A study published in the journal Lung Cancer in 2019 found that high levels of LY6K expression were not significantly associated with overall survival in NSCLC patients.",
      "The relationship between LY6K overexpression and patient prognosis in NSCLC may be influenced by factors such as the stage and histology of the cancer, the patient's age and smoking history, and the presence of other biomarkers."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: A study published in the journal Clinical Cancer Research in 2015 found that high levels of LY6K expression were associated with poor overall survival in patients with NSCLC.\n3. FALSE [correction]: Another study published in the journal Cancer Research in 2018 reported that LY6K overexpression was associated with worse prognosis in NSCLC patients, particularly those with squamous cell carcinoma subtype.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "vicuna-13b_response": "Cytokinesis is the final stage of cell division, where the cell physically splits into two daughter cells. During cytokinesis, several CDK (cyclin-dependent kinase) targets are dephosphorylated to facilitate the process of cell division. These targets include:\n1. Cdc28 - a CDK that is involved in the progression of the cell cycle in yeast. Cdc28 is dephosphorylated during cytokinesis, which allows it to enter a new cell cycle.\n2. Polo - a CDK that is involved in the regulation of mitosis in animals. Polo is dephosphorylated during cytokinesis, which allows it to activate the spindle assembly checkpoint and ensure that the cell has properly divided.\n3. Aurora B - a CDK that is involved in the regulation of mitosis in animals. Aurora B is dephosphorylated during cytokinesis, which allows it to activate the spindle assembly checkpoint and ensure that the cell has properly divided.\n4. Myt1 - a CDK that is involved in the regulation of mitosis in plants. Myt1 is dephosphorylated during cytokinesis, which allows it to activate the spindle assembly checkpoint and ensure that the cell has properly divided.\nOverall, the dephosphorylation of these CDK targets during cytokinesis plays a crucial role in the proper division of cells.",
    "vicuna-13b_fact_raw": "1. Cytokinesis is the final stage of cell division where the cell splits into two daughter cells.\n2. Cdc28 is a cyclin-dependent kinase involved in the cell cycle progression in yeast and is dephosphorylated during cytokinesis.\n3. Polo is a cyclin-dependent kinase involved in the regulation of mitosis in animals and is dephosphorylated during cytokinesis.\n4. Aurora B is a cyclin-dependent kinase involved in the regulation of mitosis in animals and is dephosphorylated during cytokinesis.\n5. Myt1 is a cyclin-dependent kinase involved in the regulation of mitosis in plants and is dephosphorylated during cytokinesis.",
    "vicuna-13b_fact": [
      "Cytokinesis is the final stage of cell division where the cell splits into two daughter cells.",
      "Cdc28 is a cyclin-dependent kinase involved in the cell cycle progression in yeast and is dephosphorylated during cytokinesis.",
      "Polo is a cyclin-dependent kinase involved in the regulation of mitosis in animals and is dephosphorylated during cytokinesis.",
      "Aurora B is a cyclin-dependent kinase involved in the regulation of mitosis in animals and is dephosphorylated during cytokinesis.",
      "Myt1 is a cyclin-dependent kinase involved in the regulation of mitosis in plants and is dephosphorylated during cytokinesis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Polo is not a cyclin-dependent kinase; it is a protein kinase that is involved in the regulation of mitosis in animals, but it is not classified as a cyclin-dependent kinase.\n4. FALSE [correction]: Aurora B is a kinase involved in the regulation of mitosis in animals, but it is not a cyclin-dependent kinase. It is a member of the Aurora kinase family and plays a role in chromosome alignment, spindle assembly checkpoint, and cytokinesis.\n5. FALSE [correction]: Myt1 is not a cyclin-dependent kinase; it is a kinase that inhibits the cyclin-dependent kinase Cdc2 and is involved in the regulation of mitosis, but it is not specific to plants and does not act as a cyclin-dependent kinase itself.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "vicuna-13b_response": "Xanamem is a drug that is used to treat acid reflux, also known as gastroesophageal reflux disease (GERD). It is a type of medication called a proton pump inhibitor (PPI), which works by reducing the amount of acid produced by the stomach. Xanamem is available in tablet form and is taken orally. It is usually taken once a day, with or without food. Xanamem is used to treat symptoms of acid reflux such as heartburn, regurgitation, and difficulty swallowing. It is also used to prevent acid reflux from occurring in the first place. Xanamem is available by prescription only and should only be taken under the guidance of a healthcare professional.",
    "vicuna-13b_fact_raw": "1. Xanamem is used to treat acid reflux or gastroesophageal reflux disease (GERD).\n2. Xanamem is a proton pump inhibitor (PPI).\n3. Xanamem works by reducing the amount of acid produced by the stomach.\n4. Xanamem is available in tablet form and is taken orally.\n5. Xanamem is available by prescription only.",
    "vicuna-13b_fact": [
      "Xanamem is used to treat acid reflux or gastroesophageal reflux disease (GERD).",
      "Xanamem is a proton pump inhibitor (PPI).",
      "Xanamem works by reducing the amount of acid produced by the stomach.",
      "Xanamem is available in tablet form and is taken orally.",
      "Xanamem is available by prescription only."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Xanamem is not used to treat acid reflux or gastroesophageal reflux disease (GERD); it is a drug being investigated for the treatment of Alzheimer's disease.\n2. FALSE [correction]: Xanamem is not a proton pump inhibitor (PPI); it is designed to inhibit the 11Î²-HSD1 enzyme, which is associated with the production of cortisol in the brain.\n3. FALSE [correction]: Xanamem does not work by reducing the amount of acid produced by the stomach; it is intended to affect cortisol levels in the brain.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "vicuna-13b_response": "The Hof1-Cyk3 interaction is a protein-protein interaction that occurs in the yeast Saccharomyces cerevisiae. Hof1 is a transcription factor that regulates the expression of genes involved in stress response and metabolism, while Cyk3 is a cyclin-dependent kinase inhibitor that regulates the activity of cyclin-dependent kinases.\nThe Hof1-Cyk3 interaction plays a crucial role in regulating the stress response in yeast. When the cell is exposed to stress, Hof1 is activated and interacts with Cyk3 to inhibit the activity of cyclin-dependent kinases. This inhibition leads to the accumulation of the transcription factor Skn7, which then activates the expression of genes involved in the stress response.\nThe Hof1-Cyk3 interaction also plays a role in regulating metabolism in yeast. When the cell is exposed to nutrient limitation, Hof1-Cyk3 complex formation is induced, which leads to the activation of genes involved in glycolysis and other metabolic pathways.\nOverall, the Hof1-Cyk3 interaction is a critical regulatory mechanism in yeast that helps the cell respond to environmental stress and maintain metabolic homeostasis.",
    "vicuna-13b_fact_raw": "1. The Hof1-Cyk3 interaction is a protein-protein interaction that occurs in the yeast Saccharomyces cerevisiae.\n2. Hof1 is a transcription factor that regulates the expression of genes involved in stress response and metabolism in yeast.\n3. Cyk3 is a cyclin-dependent kinase inhibitor that regulates the activity of cyclin-dependent kinases in yeast.\n4. The Hof1-Cyk3 interaction inhibits the activity of cyclin-dependent kinases when yeast cells are exposed to stress.\n5. The Hof1-Cyk3 interaction leads to the activation of genes involved in glycolysis and other metabolic pathways when yeast cells experience nutrient limitation.",
    "vicuna-13b_fact": [
      "The Hof1-Cyk3 interaction is a protein-protein interaction that occurs in the yeast Saccharomyces cerevisiae.",
      "Hof1 is a transcription factor that regulates the expression of genes involved in stress response and metabolism in yeast.",
      "Cyk3 is a cyclin-dependent kinase inhibitor that regulates the activity of cyclin-dependent kinases in yeast.",
      "The Hof1-Cyk3 interaction inhibits the activity of cyclin-dependent kinases when yeast cells are exposed to stress.",
      "The Hof1-Cyk3 interaction leads to the activation of genes involved in glycolysis and other metabolic pathways when yeast cells experience nutrient limitation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Hof1 is not a transcription factor; it is a protein involved in cytokinesis, the process of cell division in yeast.\n3. FALSE [correction]: Cyk3 is not a cyclin-dependent kinase inhibitor; it is a protein that also plays a role in cytokinesis in yeast.\n4. FALSE [correction]: The Hof1-Cyk3 interaction is not known to inhibit the activity of cyclin-dependent kinases. Instead, it is involved in the process of cell division.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "vicuna-13b_response": "T-UCRs, or Tumor-Upregulated Conserved Regions, are genomic regions that are commonly altered in cancer cells. Several T-UCRs have been implicated in the development and progression of gastric cancer, a type of cancer that affects the stomach.\nOne of the most well-known T-UCRs in gastric cancer is the CDH1 gene, which codes for the E-cadherin protein. Loss of CDH1 expression has been shown to be a common event in gastric cancer and is associated with poor prognosis.\nAnother T-UCR that has been implicated in gastric cancer is the TP53 gene, which is a tumor suppressor gene that plays a crucial role in maintaining genomic stability. Mutations in TP53 have been identified in a significant percentage of gastric cancer cases and are associated with poor prognosis.\nAdditionally, the PIK3CA gene, which codes for a protein that regulates cell growth and survival, has also been implicated in gastric cancer. Mutations in PIK3CA have been identified in a subset of gastric cancer cases and are associated with poor prognosis.\nOverall, these T-UCRs are among the most commonly implicated in gastric cancer, and their alteration has been shown to play a role in the development and progression of this disease.",
    "vicuna-13b_fact_raw": "1. T-UCRs, or Tumor-Upregulated Conserved Regions, are genomic regions commonly altered in cancer cells.\n2. The CDH1 gene, which codes for the E-cadherin protein, has been implicated in gastric cancer and is associated with poor prognosis.\n3. Loss of CDH1 expression is a common event in gastric cancer.\n4. Mutations in the TP53 gene, a tumor suppressor gene, have been identified in a significant percentage of gastric cancer cases and are associated with poor prognosis.\n5. The PIK3CA gene, which regulates cell growth and survival, has been implicated in gastric cancer, with mutations identified in a subset of cases.",
    "vicuna-13b_fact": [
      "T-UCRs, or Tumor-Upregulated Conserved Regions, are genomic regions commonly altered in cancer cells.",
      "The CDH1 gene, which codes for the E-cadherin protein, has been implicated in gastric cancer and is associated with poor prognosis.",
      "Loss of CDH1 expression is a common event in gastric cancer.",
      "Mutations in the TP53 gene, a tumor suppressor gene, have been identified in a significant percentage of gastric cancer cases and are associated with poor prognosis.",
      "The PIK3CA gene, which regulates cell growth and survival, has been implicated in gastric cancer, with mutations identified in a subset of cases."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "vicuna-13b_response": "The Lupus Severity Index (LSI) is a scoring system that is used to assess the severity of systemic lupus erythematosus (SLE), a chronic autoimmune disease that can affect many parts of the body, including the skin, joints, and organs such as the kidneys, heart, and lungs. The LSI is based on the presence of certain clinical features and laboratory abnormalities that are commonly seen in SLE.\nThe LSI is a simple, easy-to-use tool that can be used by healthcare providers to quickly assess the severity of lupus in a patient. It is based on a total score of 100 points, which can be divided into three categories:\n1. Organ involvement: This category includes points for the presence of active disease in any organ system, such as the skin, joints, kidneys, heart, lungs, and central nervous system.\n2. Activity: This category includes points for the level of activity of the disease, such as whether it is quiescent (inactive), mildly active, moderately active, or severely active.\n3. Chronicity: This category includes points for the duration of disease, such as whether it is new (less than 1 year), established (1-5 years), or long-standing (more than 5 years).\nThe LSI can be used to assess the severity of lupus at a single point in time, or it can be used to track changes in severity over time. It is important to note that the LSI is not specific to lupus and may not accurately reflect the severity of the disease in all patients. It should be used in conjunction with other clinical assessments and laboratory tests to determine the best course of treatment for each individual patient.",
    "vicuna-13b_fact_raw": "1. The Lupus Severity Index (LSI) is used to assess the severity of systemic lupus erythematosus (SLE).\n2. The LSI includes clinical features and laboratory abnormalities commonly seen in SLE.\n3. The LSI uses a scoring system with a total of 100 points.\n4. The LSI scoring is divided into three categories: organ involvement, activity, and chronicity.\n5. The LSI can be used to track changes in the severity of lupus over time.",
    "vicuna-13b_fact": [
      "The Lupus Severity Index (LSI) is used to assess the severity of systemic lupus erythematosus (SLE).",
      "The LSI includes clinical features and laboratory abnormalities commonly seen in SLE.",
      "The LSI uses a scoring system with a total of 100 points.",
      "The LSI scoring is divided into three categories: organ involvement, activity, and chronicity.",
      "The LSI can be used to track changes in the severity of lupus over time."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE\n\nThe Lupus Severity Index (LSI) is not a standard or widely recognized tool for assessing systemic lupus erythematosus (SLE) as of my last update. The statements regarding the specific scoring system and categories within the LSI cannot be verified without additional context or reference to a specific medical tool or study. However, it is true that tools used to assess SLE often include clinical features and laboratory abnormalities, and they can be used to track changes in disease severity over time.",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "vicuna-13b_response": "ZSWIM6 is a gene that plays a role in the development and function of the brain, and mutations in this gene have been associated with several neurodevelopmental disorders.\nOne disorder that is caused by de novo mutations in ZSWIM6 is schizophrenia. Studies have found that individuals with schizophrenia are more likely to have de novo mutations in ZSWIM6 than individuals without the disorder.\nAnother disorder that may be caused by de novo mutations in ZSWIM6 is autism spectrum disorder (ASD). While the evidence is still inconclusive, some studies have suggested that de novo mutations in ZSWIM6 may contribute to the development of ASD in some individuals.\nIt is important to note that while mutations in ZSWIM6 have been associated with these disorders, the relationship between the gene and the disorders is complex and not fully understood. Further research is needed to determine the exact role of ZSWIM6 in the development and function of the brain, and to better understand the relationship between ZSWIM6 mutations and these disorders.",
    "vicuna-13b_fact_raw": "1. ZSWIM6 is a gene associated with the development and function of the brain.\n2. De novo mutations in ZSWIM6 have been associated with schizophrenia.\n3. Individuals with schizophrenia are more likely to have de novo mutations in ZSWIM6 than individuals without the disorder.\n4. De novo mutations in ZSWIM6 may contribute to the development of autism spectrum disorder (ASD), according to some studies.\n5. The relationship between ZSWIM6 mutations and neurodevelopmental disorders is complex and not fully understood.",
    "vicuna-13b_fact": [
      "ZSWIM6 is a gene associated with the development and function of the brain.",
      "De novo mutations in ZSWIM6 have been associated with schizophrenia.",
      "Individuals with schizophrenia are more likely to have de novo mutations in ZSWIM6 than individuals without the disorder.",
      "De novo mutations in ZSWIM6 may contribute to the development of autism spectrum disorder (ASD), according to some studies.",
      "The relationship between ZSWIM6 mutations and neurodevelopmental disorders is complex and not fully understood."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "vicuna-13b_response": "The Koos Classification is a system for classifying bacteria based on their cell wall composition. It is used primarily for the identification of bacteria in the laboratory. The classification system is based on the composition of the bacterial cell wall and divides bacteria into four main groups: A, B, C, and D.\nGroup A bacteria have a cell wall containing peptidoglycan and muramic acid. Group B bacteria have a cell wall containing peptidoglycan and lipids. Group C bacteria have a cell wall containing peptidoglycan and glycans. Group D bacteria have a cell wall containing only lipids.\nThe Koos Classification is useful for identifying bacteria, but it is not used to classify diseases. Diseases are classified based on the symptoms they cause and the underlying medical conditions that lead to those symptoms. For example, a disease like pneumonia can be classified based on the cause, such as bacterial, viral, or fungal, and the severity of the disease.\nIn summary, the Koos Classification is a system for classifying bacteria based on their cell wall composition, but it is not used to classify diseases. Diseases are classified based on the symptoms they cause and the underlying medical conditions that lead to those symptoms.",
    "vicuna-13b_fact_raw": "1. The Koos Classification is a system used for classifying bacteria based on their cell wall composition.\n2. The Koos Classification divides bacteria into four main groups: A, B, C, and D.\n3. Group A bacteria have a cell wall containing peptidoglycan and muramic acid.\n4. Group B bacteria have a cell wall containing peptidoglycan and lipids.\n5. The Koos Classification is not used to classify diseases.",
    "vicuna-13b_fact": [
      "The Koos Classification is a system used for classifying bacteria based on their cell wall composition.",
      "The Koos Classification divides bacteria into four main groups: A, B, C, and D.",
      "Group A bacteria have a cell wall containing peptidoglycan and muramic acid.",
      "Group B bacteria have a cell wall containing peptidoglycan and lipids.",
      "The Koos Classification is not used to classify diseases."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Koos Classification is not a system used for classifying bacteria; it is actually used for classifying vestibular schwannomas (acoustic neuromas) based on their size and location.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "vicuna-13b_response": "AZD8601 is a drug that is being developed for the treatment of various diseases, including cancer. The in vivo effects of AZD8601 refer to its effects on living organisms, as opposed to in vitro effects, which are observed in laboratory conditions.\nThe in vivo effects of AZD8601 have been studied in various preclinical models, and some promising results have been observed. For example, AZD8601 has been shown to have anti-tumor effects in models of cancer, by inhibiting the activity of a protein called CDK12. In addition, AZD8601 has been shown to have immunomodulatory effects, which may help to enhance the effects of cancer immunotherapy.\nIt is important to note that the in vivo effects of AZD8601 may vary depending on the disease being targeted, the dose and schedule of administration, and other factors. Further research is needed to fully understand the in vivo effects of AZD8601 and to determine its potential as a treatment for various diseases.",
    "vicuna-13b_fact_raw": "1. AZD8601 is a drug being developed for the treatment of various diseases, including cancer.\n2. The in vivo effects of AZD8601 have been studied in preclinical models.\n3. AZD8601 has shown anti-tumor effects in models of cancer by inhibiting the activity of a protein called CDK12.\n4. AZD8601 has demonstrated immunomodulatory effects in preclinical studies.\n5. The in vivo effects of AZD8601 may vary depending on factors such as the disease targeted, dosage, and administration schedule.",
    "vicuna-13b_fact": [
      "AZD8601 is a drug being developed for the treatment of various diseases, including cancer.",
      "The in vivo effects of AZD8601 have been studied in preclinical models.",
      "AZD8601 has shown anti-tumor effects in models of cancer by inhibiting the activity of a protein called CDK12.",
      "AZD8601 has demonstrated immunomodulatory effects in preclinical studies.",
      "The in vivo effects of AZD8601 may vary depending on factors such as the disease targeted, dosage, and administration schedule."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN: Without specific information about AZD8601 and its uses, it is not possible to determine the accuracy of this statement.\n2. TRUE: If AZD8601 is a drug being developed, it would have been studied in preclinical models to determine its in vivo effects.\n3. UNKNOWN: The statement about AZD8601 inhibiting the activity of a protein called CDK12 and showing anti-tumor effects in models of cancer cannot be verified without specific data or research findings.\n4. UNKNOWN: The statement regarding immunomodulatory effects of AZD8601 in preclinical studies cannot be verified without specific data or research findings.\n5. TRUE: It is a general principle in pharmacology that the in vivo effects of a drug can vary depending on factors such as the disease targeted, dosage, and administration schedule.",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "vicuna-13b_response": "SAHFS stands for Secure Hash Functions (SHA) with a Hash Value of 160 bits. These hash functions are used to create a unique fixed-length output, known as a hash value or digest, from an input of any size. The input can be any type of data, such as a message, file, or password.\nThere are several ways to create a SAHFS, but the most commonly used method is through the use of a cryptographic algorithm. This algorithm takes the input data and performs a series of mathematical operations on it, which results in the creation of the hash value. The specific algorithm used to create a SAHFS is defined by the National Institute of Standards and Technology (NIST) in their Federal Information Processing Standards (FIPS) publication 180-4.\nThe process of creating a SAHFS is generally considered to be one-way, meaning that it is computationally infeasible to recreate the original input data from the hash value. This makes SAHFS useful for a variety of purposes, such as verifying the integrity of data, authenticating the identity of a sender, and storing passwords securely.\nIn summary, SAHFS are created through the use of a cryptographic algorithm that takes an input of any size and produces a fixed-length output, known as a hash value or digest. This process is defined by the National Institute of Standards and Technology (NIST) in their Federal Information Processing Standards (FIPS) publication 180-4.",
    "vicuna-13b_fact_raw": "1. SAHFS stands for Secure Hash Functions with a Hash Value of 160 bits.\n2. SAHFS produce a unique fixed-length output from an input of any size.\n3. The creation of a SAHFS typically involves a cryptographic algorithm performing a series of mathematical operations on the input data.\n4. The specific algorithm used to create a SAHFS is defined by the National Institute of Standards and Technology (NIST) in their Federal Information Processing Standards (FIPS) publication 180-4.\n5. The process of creating a SAHFS is considered to be one-way, making it computationally infeasible to recreate the original input from the hash value.",
    "vicuna-13b_fact": [
      "SAHFS stands for Secure Hash Functions with a Hash Value of 160 bits.",
      "SAHFS produce a unique fixed-length output from an input of any size.",
      "The creation of a SAHFS typically involves a cryptographic algorithm performing a series of mathematical operations on the input data.",
      "The specific algorithm used to create a SAHFS is defined by the National Institute of Standards and Technology (NIST) in their Federal Information Processing Standards (FIPS) publication 180-4.",
      "The process of creating a SAHFS is considered to be one-way, making it computationally infeasible to recreate the original input from the hash value."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The acronym for Secure Hash Functions with a Hash Value of 160 bits is SHA-1, which stands for Secure Hash Algorithm 1.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The specific algorithm used to create a SHA-1 hash function is defined by the National Institute of Standards and Technology (NIST) in their Federal Information Processing Standards (FIPS) publication, but the correct publication number is 180-1 for SHA-1. FIPS 180-4 includes specifications for SHA-2 and SHA-3.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "vicuna-13b_response": "The PDZ domain is a protein domain found in the SATB1 (Special AT-rich binding protein 1) protein. The PDZ domain is a common protein interaction domain that is involved in the regulation of various cellular processes, including cell signaling, trafficking, and development.\nThe PDZ domain of SATB1 is involved in protein-protein interactions with other proteins, including receptors, ion channels, and scaffolding proteins. These interactions play a role in the regulation of cellular responses to various stimuli, including hormones, neurotransmitters, and growth factors.\nSATB1 is expressed in various tissues, including the brain, heart, and pancreas, and is involved in the regulation of cellular processes such as cell proliferation, differentiation, and survival. The PDZ domain of SATB1 is thought to play a role in these processes by mediating interactions with other proteins that regulate cellular signaling pathways.\nOverall, the function of the PDZ domain in SATB1 is to mediate protein-protein interactions that regulate cellular processes, including cell signaling, trafficking, and development.",
    "vicuna-13b_fact_raw": "1. The PDZ domain is a protein interaction domain found in the SATB1 protein.\n2. The PDZ domain of SATB1 is involved in protein-protein interactions with receptors, ion channels, and scaffolding proteins.\n3. SATB1 is expressed in various tissues, including the brain, heart, and pancreas.\n4. SATB1 is involved in the regulation of cellular processes such as cell proliferation, differentiation, and survival.\n5. The PDZ domain of SATB1 mediates interactions with other proteins that regulate cellular signaling pathways.",
    "vicuna-13b_fact": [
      "The PDZ domain is a protein interaction domain found in the SATB1 protein.",
      "The PDZ domain of SATB1 is involved in protein-protein interactions with receptors, ion channels, and scaffolding proteins.",
      "SATB1 is expressed in various tissues, including the brain, heart, and pancreas.",
      "SATB1 is involved in the regulation of cellular processes such as cell proliferation, differentiation, and survival.",
      "The PDZ domain of SATB1 mediates interactions with other proteins that regulate cellular signaling pathways."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements provided are consistent with general knowledge about PDZ domains and the SATB1 protein. PDZ domains are known for their role in protein-protein interactions, and SATB1 is a protein that is expressed in various tissues and involved in the regulation of several cellular processes. The PDZ domain's role in mediating interactions with other proteins that regulate cellular signaling pathways is also a characteristic function of such domains. Without specific contradictory information, these statements are assumed to be true.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "vicuna-13b_response": "The BLISS technique is a method for improving sleep quality and reducing insomnia symptoms. It is an acronym that stands for:\nB - Bedtime routine: Establishing a consistent bedtime routine can help regulate the sleep-wake cycle and promote better sleep.\nL - Light exposure: Exposure to natural light during the day and dim red light in the evening can help regulate the sleep-wake cycle and improve sleep quality.\nI - Insomnia-specific exercises: Cognitive-behavioral therapy for insomnia (CBT-I) is a type of therapy that can help people with insomnia improve their sleep by changing negative thoughts and behaviors related to sleep.\nS - Sleep hygiene: Practicing good sleep hygiene, such as maintaining a dark, cool, and quiet sleep environment, can improve sleep quality.\nS - Sleep restriction: Limiting time in bed to the amount of time spent asleep can help increase the sleep drive and improve sleep quality.\nOverall, the BLISS technique is based on the principles of cognitive-behavioral therapy for insomnia (CBT-I) and emphasizes the importance of establishing a consistent bedtime routine, regulating light exposure, and practicing good sleep hygiene to improve sleep quality and reduce insomnia symptoms.",
    "vicuna-13b_fact_raw": "1. The BLISS technique is a method for improving sleep quality and reducing insomnia symptoms.\n2. The \"B\" in BLISS stands for establishing a consistent bedtime routine to help regulate the sleep-wake cycle.\n3. The \"L\" in BLISS refers to regulating light exposure, including exposure to natural light during the day and dim red light in the evening.\n4. The \"I\" in BLISS involves insomnia-specific exercises, including cognitive-behavioral therapy for insomnia (CBT-I).\n5. The \"S\" in BLISS for sleep hygiene suggests maintaining a dark, cool, and quiet sleep environment to improve sleep quality.",
    "vicuna-13b_fact": [
      "The BLISS technique is a method for improving sleep quality and reducing insomnia symptoms.",
      "The \"B\" in BLISS stands for establishing a consistent bedtime routine to help regulate the sleep-wake cycle.",
      "The \"L\" in BLISS refers to regulating light exposure, including exposure to natural light during the day and dim red light in the evening.",
      "The \"I\" in BLISS involves insomnia-specific exercises, including cognitive-behavioral therapy for insomnia (CBT-I).",
      "The \"S\" in BLISS for sleep hygiene suggests maintaining a dark, cool, and quiet sleep environment to improve sleep quality."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN: Without additional context or a recognized sleep technique known as BLISS, it's unclear whether this statement is true or false.\n2. UNKNOWN: Since the validity of the BLISS technique itself is unknown, the meaning of \"B\" in BLISS cannot be confirmed.\n3. UNKNOWN: Similar to the previous statements, the meaning of \"L\" in BLISS cannot be confirmed without more information.\n4. UNKNOWN: The \"I\" in BLISS and its association with insomnia-specific exercises or CBT-I cannot be confirmed without further context.\n5. UNKNOWN: The \"S\" in BLISS and its relation to sleep hygiene is also unknown without additional information or a recognized source describing the BLISS technique.",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "vicuna-13b_response": "NK3R (Neurokinin-3 receptor) is a G protein-coupled receptor that is involved in various physiological processes, including pain, inflammation, and gastrointestinal motility. Antagonists of NK3R can bind to the receptor and block its activation, leading to various therapeutic effects. Here are three examples of NK3R antagonists:\n1. Aprepitant: Aprepitant is a synthetic analogue of the natural neurotransmitter substance P, which is a potent antagonist of NK3R. Aprepitant is used as an antiemetic drug to prevent nausea and vomiting associated with chemotherapy. It is also being investigated for its potential use in treating other conditions, such as pain and inflammation.\n2. Emend: Emend (fosaprepitant) is a prodrug of aprepitant and is used to prevent nausea and vomiting associated with chemotherapy. It is a long-acting form of aprepitant and is administered as a single dose on the day of chemotherapy. Emend has been shown to have anti-inflammatory and analgesic effects in addition to its antiemetic effects.\n3. MK-8628: MK-8628 is a potent and selective NK3R antagonist that has been shown to have anti-inflammatory and analgesic effects in animal models. It has been proposed as a potential treatment for chronic pain conditions, such as fibromyalgia and neuropathic pain. MK-8628 is currently in preclinical development and has not yet been approved for use in humans.",
    "vicuna-13b_fact_raw": "1. Aprepitant is an antagonist of NK3R used as an antiemetic drug to prevent nausea and vomiting associated with chemotherapy.\n2. Emend (fosaprepitant) is a prodrug of aprepitant and is used to prevent chemotherapy-associated nausea and vomiting.\n3. MK-8628 is a selective NK3R antagonist that is in preclinical development and has not yet been approved for use in humans.",
    "vicuna-13b_fact": [
      "Aprepitant is an antagonist of NK3R used as an antiemetic drug to prevent nausea and vomiting associated with chemotherapy.",
      "Emend (fosaprepitant) is a prodrug of aprepitant and is used to prevent chemotherapy-associated nausea and vomiting.",
      "MK-8628 is a selective NK3R antagonist that is in preclinical development and has not yet been approved for use in humans."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Aprepitant is an antagonist of NK1R (neurokinin 1 receptor), not NK3R, used as an antiemetic drug to prevent nausea and vomiting associated with chemotherapy.\n2. TRUE\n3. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "vicuna-13b_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is called \"drug X\". Unfortunately, I do not have any further information about this drug as my training data only goes up until 2021 and I don't have access to any confidential or proprietary information. However, I can tell you that ghrelin is a hormone that plays a role in regulating appetite and energy homeostasis in the body. Inverse agonists are a type of drug that bind to a receptor but do not activate it, instead they block the activation of the receptor.",
    "vicuna-13b_fact_raw": "1. \"Drug X\" is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.\n2. Ghrelin is a hormone that regulates appetite and energy homeostasis in the body.\n3. Inverse agonists are drugs that bind to a receptor and block the activation of the receptor.",
    "vicuna-13b_fact": [
      "\"Drug X\" is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.",
      "Ghrelin is a hormone that regulates appetite and energy homeostasis in the body.",
      "Inverse agonists are drugs that bind to a receptor and block the activation of the receptor."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: Inverse agonists are drugs that bind to a receptor and cause the opposite action to that of an agonist, effectively reducing the activity of the receptor below its basal level.",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "vicuna-13b_response": "Vaxchora is a cholera vaccine that is given as a single dose and is approved for the prevention of moderate to severe cholera in adults and children six years of age and older. The protective efficacy of Vaxchora against moderate to severe cholera has been demonstrated in clinical trials.\nIn a study conducted in Bangladesh, Vaxchora was found to be 85% effective in preventing moderate to severe cholera in adults and children six years of age and older. In another study conducted in Haiti, Vaxchora was found to be 90% effective in preventing moderate to severe cholera in adults and children six years of age and older.\nIt is important to note that the protective efficacy of a vaccine can vary depending on a number of factors, including the population being vaccinated, the strain of cholera being targeted, and the timing of vaccination relative to exposure to cholera.\nIt is also important to follow the vaccination schedule and advice of your healthcare professional for the best protection.",
    "vicuna-13b_fact_raw": "1. Vaxchora is a cholera vaccine approved for the prevention of moderate to severe cholera in adults and children six years of age and older.\n2. Vaxchora is administered as a single dose.\n3. In a study conducted in Bangladesh, Vaxchora was found to be 85% effective in preventing moderate to severe cholera in adults and children six years of age and older.\n4. In a study conducted in Haiti, Vaxchora was found to be 90% effective in preventing moderate to severe cholera in adults and children six years of age and older.\n5. The protective efficacy of Vaxchora can vary based on factors such as the population vaccinated, the cholera strain targeted, and the timing of vaccination relative to exposure.",
    "vicuna-13b_fact": [
      "Vaxchora is a cholera vaccine approved for the prevention of moderate to severe cholera in adults and children six years of age and older.",
      "Vaxchora is administered as a single dose.",
      "In a study conducted in Bangladesh, Vaxchora was found to be 85% effective in preventing moderate to severe cholera in adults and children six years of age and older.",
      "In a study conducted in Haiti, Vaxchora was found to be 90% effective in preventing moderate to severe cholera in adults and children six years of age and older.",
      "The protective efficacy of Vaxchora can vary based on factors such as the population vaccinated, the cholera strain targeted, and the timing of vaccination relative to exposure."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Vaxchora is a cholera vaccine approved for the prevention of cholera in adults 18 through 64 years of age.\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "vicuna-13b_response": "The first cholera vaccine approved in the United States was the Vaxchora vaccine, which was approved by the Food and Drug Administration (FDA) in 2016. Vaxchora is a single-dose, oral cholera vaccine that is administered in a single dose and is designed to provide protection against cholera for up to six months. The Vaxchora vaccine was developed by PaxVax, a biotechnology company based in California.\nCholera is an acute diarrheal disease that is caused by infection with the bacterium Vibrio cholerae. It is spread through contaminated food or water and can cause severe dehydration and even death if left untreated. Cholera vaccines are an important tool in preventing the spread of cholera in endemic areas and in travelers to areas where cholera is common. The Vaxchora vaccine is the first cholera vaccine to be approved in the United States and it is an important step in the prevention and control of cholera.",
    "vicuna-13b_fact_raw": "1. The Vaxchora vaccine was the first cholera vaccine approved in the United States.\n2. The Food and Drug Administration (FDA) approved the Vaxchora vaccine in 2016.\n3. Vaxchora is an oral cholera vaccine administered in a single dose.\n4. The Vaxchora vaccine is designed to provide protection against cholera for up to six months.\n5. The Vaxchora vaccine was developed by PaxVax, a biotechnology company based in California.",
    "vicuna-13b_fact": [
      "The Vaxchora vaccine was the first cholera vaccine approved in the United States.",
      "The Food and Drug Administration (FDA) approved the Vaxchora vaccine in 2016.",
      "Vaxchora is an oral cholera vaccine administered in a single dose.",
      "The Vaxchora vaccine is designed to provide protection against cholera for up to six months.",
      "The Vaxchora vaccine was developed by PaxVax, a biotechnology company based in California."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The Vaxchora vaccine is designed to provide protection against cholera for up to 3 years in adults aged 18 through 64.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "vicuna-13b_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is a mutation in the BTK gene. This gene provides instructions for making a protein called Bruton's tyrosine kinase, which plays a key role in the development and function of immune cells. Mutations in the BTK gene can lead to a reduction in the number of immune cells and an increased susceptibility to infections, which are characteristic of CVID. Other genetic causes of CVID include mutations in the IL-21R, CD40, and STAT3 genes.",
    "vicuna-13b_fact_raw": "1. A mutation in the BTK gene is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.\n2. The BTK gene is responsible for making a protein called Bruton's tyrosine kinase.\n3. Bruton's tyrosine kinase is important for the development and function of immune cells.\n4. Mutations in the BTK gene can result in a reduced number of immune cells.\n5. Mutations in the IL-21R, CD40, and STAT3 genes are also genetic causes of CVID.",
    "vicuna-13b_fact": [
      "A mutation in the BTK gene is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.",
      "The BTK gene is responsible for making a protein called Bruton's tyrosine kinase.",
      "Bruton's tyrosine kinase is important for the development and function of immune cells.",
      "Mutations in the BTK gene can result in a reduced number of immune cells.",
      "Mutations in the IL-21R, CD40, and STAT3 genes are also genetic causes of CVID."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: A mutation in the BTK gene is not the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans. Mutations in the BTK gene cause X-linked agammaglobulinemia (XLA), which is a different condition. The most common genetic defects causing CVID are not well defined, but they can include mutations in genes such as ICOS, TNFRSF13B (TACI), and TNFRSF13C (BAFFR).\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Mutations in the BTK gene typically result in a block in B cell development, leading to a nearly complete absence of B cells and low levels of immunoglobulins, rather than a reduced number of all types of immune cells.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "vicuna-13b_response": "The IFIT1 gene is a key regulator of the antiviral response and has been implicated in the pathogenesis of systemic lupus erythematosus (SLE), an autoimmune disease characterized by chronic inflammation and the production of autoantibodies.\nStudies have shown that IFIT1 plays a critical role in the regulation of the immune response and the prevention of autoimmunity. Mutations in the IFIT1 gene have been associated with an increased risk of developing SLE, and individuals with SLE often have lower levels of IFIT1 expression in their cells.\nThe IFIT1 protein has been shown to interact with the signaling lymphocytic activation molecule (SLAM) family of receptors, which are involved in the activation and regulation of immune cells. In the context of SLE, IFIT1 may regulate the activation and function of immune cells, such as T cells and B cells, and prevent the development of autoantibodies.\nOverall, the IFIT1 gene plays a critical role in regulating the immune response and preventing autoimmunity, and its dysregulation has been implicated in the pathogenesis of SLE. Further research is needed to fully understand the role of IFIT1 in SLE and to develop new treatments for this debilitating autoimmune disease.",
    "vicuna-13b_fact_raw": "1. The IFIT1 gene is implicated in the pathogenesis of systemic lupus erythematosus (SLE).\n2. Mutations in the IFIT1 gene have been associated with an increased risk of developing SLE.\n3. Individuals with SLE often have lower levels of IFIT1 expression in their cells.\n4. The IFIT1 protein interacts with the signaling lymphocytic activation molecule (SLAM) family of receptors.\n5. The IFIT1 gene is involved in the regulation of the immune response and the prevention of autoimmunity.",
    "vicuna-13b_fact": [
      "The IFIT1 gene is implicated in the pathogenesis of systemic lupus erythematosus (SLE).",
      "Mutations in the IFIT1 gene have been associated with an increased risk of developing SLE.",
      "Individuals with SLE often have lower levels of IFIT1 expression in their cells.",
      "The IFIT1 protein interacts with the signaling lymphocytic activation molecule (SLAM) family of receptors.",
      "The IFIT1 gene is involved in the regulation of the immune response and the prevention of autoimmunity."
    ],
    "vicuna-13b_judge_raw": "1. TRUE: The IFIT1 gene has been implicated in the pathogenesis of systemic lupus erythematosus (SLE) as it plays a role in the immune response and may be involved in the development of this autoimmune disease.\n2. UNKNOWN: While IFIT1 is involved in immune responses, without specific research data or studies to reference, it is not possible to confirm whether mutations in the IFIT1 gene are associated with an increased risk of developing SLE.\n3. UNKNOWN: The statement about IFIT1 expression levels in individuals with SLE is specific and would require empirical data to confirm or refute. Without such data, the truth of this statement cannot be determined.\n4. UNKNOWN: The interaction of the IFIT1 protein with the SLAM family of receptors is a specific biological interaction that would need to be confirmed by scientific research. Without reference to specific studies or data, the truth of this statement cannot be determined.\n5. TRUE: The IFIT1 gene is known to be involved in the regulation of the immune response, and dysregulation of immune response genes can contribute to the development of autoimmunity, which is consistent with the role of IFIT1 in the immune system.",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "vicuna-13b_response": "The Liverpool Elbow Score is a tool used to assess the severity of elbow injuries in children. It was developed by the Liverpool Elbow Score Group, which was a collaboration between several hospitals in the United Kingdom. The score is used to evaluate the degree of elbow fractures, dislocations, and other injuries in children. It helps healthcare providers to determine the best course of treatment for a child's elbow injury based on the severity of the injury. The Liverpool Elbow Score is used in conjunction with other factors, such as the child's age, overall health, and activity level, to determine the best treatment approach. The score is typically calculated based on the results of an X-ray or other imaging test, and it ranges from 0 to 100, with higher scores indicating more severe injuries.",
    "vicuna-13b_fact_raw": "1. The Liverpool Elbow Score is used to assess the severity of elbow injuries in children.\n2. The Liverpool Elbow Score was developed by a collaboration between several hospitals in the United Kingdom.\n3. The score evaluates the degree of elbow fractures, dislocations, and other injuries in children.\n4. The Liverpool Elbow Score helps healthcare providers determine the best course of treatment for a child's elbow injury.\n5. The score ranges from 0 to 100, with higher scores indicating more severe injuries.",
    "vicuna-13b_fact": [
      "The Liverpool Elbow Score is used to assess the severity of elbow injuries in children.",
      "The Liverpool Elbow Score was developed by a collaboration between several hospitals in the United Kingdom.",
      "The score evaluates the degree of elbow fractures, dislocations, and other injuries in children.",
      "The Liverpool Elbow Score helps healthcare providers determine the best course of treatment for a child's elbow injury.",
      "The score ranges from 0 to 100, with higher scores indicating more severe injuries."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Liverpool Elbow Score is used to assess the outcome following treatment of elbow fractures in adults, not specifically in children.\n2. TRUE\n3. FALSE [correction]: The Liverpool Elbow Score is not used to evaluate the degree of elbow injuries but rather the outcome following treatment of such injuries.\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "vicuna-13b_response": "The 100,000 Genomes Project is a large-scale genomics project that was launched in the UK in 2012 with the goal of sequencing the genomes of 100,000 participants in order to advance our understanding of genetics and genomics and to improve the diagnosis and treatment of genetic diseases.\nIn terms of sarcoma, the 100,000 Genomes Project has made significant efforts to understand the genetic basis of this disease. Sarcoma is a rare type of cancer that affects connective tissue, such as bone, muscle, and cartilage. It is estimated that around 3,000 people in the UK are diagnosed with sarcoma each year.\nThe project has collected and analyzed whole-genome sequences of sarcoma patients, as well as healthy individuals, to identify genetic variations that may be associated with the development and progression of sarcoma. The project has also analyzed RNA sequencing data to identify changes in gene expression that may be associated with the disease.\nIn addition, the project has also established a network of sarcoma clinical trials that aim to test new treatments for sarcoma patients based on the genetic changes identified through the project.\nOverall, the efforts of the 100,000 Genomes Project on sarcoma have led to a better understanding of the genetic basis of this disease, and have paved the way for the development of new, more effective treatments for sarcoma patients.",
    "vicuna-13b_fact_raw": "1. The 100,000 Genomes Project was launched in the UK in 2012.\n2. The goal of the project is to sequence the genomes of 100,000 participants to improve the diagnosis and treatment of genetic diseases.\n3. Sarcoma affects connective tissue and around 3,000 people in the UK are diagnosed with it each year.\n4. The project has collected and analyzed whole-genome sequences of sarcoma patients to identify genetic variations associated with the disease.\n5. The 100,000 Genomes Project has established a network of sarcoma clinical trials to test new treatments based on genetic changes identified through the project.",
    "vicuna-13b_fact": [
      "The 100,000 Genomes Project was launched in the UK in 2012.",
      "The goal of the project is to sequence the genomes of 100,000 participants to improve the diagnosis and treatment of genetic diseases.",
      "Sarcoma affects connective tissue and around 3,000 people in the UK are diagnosed with it each year.",
      "The project has collected and analyzed whole-genome sequences of sarcoma patients to identify genetic variations associated with the disease.",
      "The 100,000 Genomes Project has established a network of sarcoma clinical trials to test new treatments based on genetic changes identified through the project."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The 100,000 Genomes Project was launched in the UK in 2013.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The 100,000 Genomes Project's primary aim was to sequence genomes to aid in the understanding of genetic diseases and cancer, not to establish a network of clinical trials. However, the data obtained may be used to inform clinical trials conducted by other organizations or as part of separate initiatives.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "vicuna-13b_response": "I'm sorry, but I couldn't find any information about a protein called ALEX1 that contains armadillo repeats. Armadillo repeats are a type of protein motif that are found in many proteins and are characterized by a repeated sequence of 34-37 amino acids. They are often found in proteins that are involved in cell adhesion and signaling.\nIt's possible that ALEX1 is a newly discovered protein or that it doesn't contain armadillo repeats. Without more information, it's difficult to say for sure. If you have any additional information about ALEX1 or why you are interested in its potential armadillo repeat content, I may be able to provide more specific information.",
    "vicuna-13b_fact_raw": "1. ALEX1 is a protein.\n2. Armadillo repeats are characterized by a repeated sequence of 34-37 amino acids.\n3. Proteins with armadillo repeats are often involved in cell adhesion and signaling.",
    "vicuna-13b_fact": [
      "ALEX1 is a protein.",
      "Armadillo repeats are characterized by a repeated sequence of 34-37 amino acids.",
      "Proteins with armadillo repeats are often involved in cell adhesion and signaling."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "vicuna-13b_response": "Enzymes that remove histone modifications include:\n1. Histone demethylases: These enzymes remove methyl groups from histone tails, such as Lysine-specific demethylase 1 (LSD1) and Lysine-specific demethylase 2 (LSD2).\n2. Histone acetyltransferases (HATs): These enzymes add acetyl groups to histone tails, such as GCN5 and CBP.\n3. Histone deacetylases (HDACs): These enzymes remove acetyl groups from histone tails.\n4. Histone phosphatases: These enzymes remove phosphate groups from histone tails, such as PP2A and PP1.\n5. Histone ubiquitin ligases: These enzymes add ubiquitin molecules to histone tails, leading to their degradation by the proteasome.\nThese enzymes play a crucial role in regulating gene expression by controlling the accessibility of chromatin to transcription factors and the compaction of chromatin.",
    "vicuna-13b_fact_raw": "1. Histone demethylases are enzymes that remove methyl groups from histone tails.\n2. Lysine-specific demethylase 1 (LSD1) and Lysine-specific demethylase 2 (LSD2) are examples of histone demethylases.\n3. Histone deacetylases (HDACs) are enzymes that remove acetyl groups from histone tails.\n4. Histone phosphatases, such as PP2A and PP1, remove phosphate groups from histone tails.\n5. The statement about Histone acetyltransferases (HATs) adding acetyl groups and Histone ubiquitin ligases adding ubiquitin molecules is incorrect in the context of the query, as these enzymes do not remove but rather add modifications.",
    "vicuna-13b_fact": [
      "Histone demethylases are enzymes that remove methyl groups from histone tails.",
      "Lysine-specific demethylase 1 (LSD1) and Lysine-specific demethylase 2 (LSD2) are examples of histone demethylases.",
      "Histone deacetylases (HDACs) are enzymes that remove acetyl groups from histone tails.",
      "Histone phosphatases, such as PP2A and PP1, remove phosphate groups from histone tails.",
      "The statement about Histone acetyltransferases (HATs) adding acetyl groups and Histone ubiquitin ligases adding ubiquitin molecules is incorrect in the context of the query, as these enzymes do not remove but rather add modifications."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "vicuna-13b_response": "There is some evidence to suggest that head CT scans may increase the risk of brain tumors, although the absolute risk is small. CT scans use ionizing radiation, which can cause DNA damage and increase the risk of cancer. However, the risk of brain tumors from a single CT scan is generally considered to be low, and the benefits of the scan in diagnosing and treating medical conditions usually outweigh the risks.\nThat being said, it's important to minimize radiation exposure whenever possible, especially in children and young adults who are more sensitive to the effects of radiation. If you need a CT scan, it's important to discuss the risks and benefits with your doctor and to choose the most appropriate imaging test for your medical condition.\nIt's also worth noting that advances in CT technology have led to significant reductions in radiation dose over the years, and some scans may use lower doses of radiation than others. Your doctor can help determine which type of scan is best for you based on your individual medical needs.",
    "vicuna-13b_fact_raw": "1. Head CT scans use ionizing radiation, which can cause DNA damage.\n2. Ionizing radiation from CT scans can increase the risk of cancer.\n3. The risk of brain tumors from a single CT scan is generally considered to be low.\n4. The benefits of a CT scan in diagnosing and treating medical conditions usually outweigh the risks.\n5. Advances in CT technology have led to significant reductions in radiation dose over the years.",
    "vicuna-13b_fact": [
      "Head CT scans use ionizing radiation, which can cause DNA damage.",
      "Ionizing radiation from CT scans can increase the risk of cancer.",
      "The risk of brain tumors from a single CT scan is generally considered to be low.",
      "The benefits of a CT scan in diagnosing and treating medical conditions usually outweigh the risks.",
      "Advances in CT technology have led to significant reductions in radiation dose over the years."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "vicuna-13b_response": "Otx2 is a transcription factor that is involved in the regulation of embryonic development in many organisms, including mammals. Otx2 is known to be involved in the maintenance of embryonic stem cell (ESC) pluripotency, which is a type of pluripotency that allows ESCs to differentiate into any cell type in the body.\nOtx2 is a key transcription factor in the maintenance of ESC pluripotency in mice, and it is believed to play a similar role in other mammals. Otx2 is required for the self-renewal of ESCs and for the maintenance of their pluripotent state. Loss of Otx2 function in ESCs leads to a loss of pluripotency and differentiation of the cells.\nIn summary, Otx2 is associated with the maintenance of ESC pluripotency, which is a type of pluripotency that allows ESCs to differentiate into any cell type in the body.",
    "vicuna-13b_fact_raw": "1. Otx2 is a transcription factor involved in the regulation of embryonic development in mammals.\n2. Otx2 is involved in the maintenance of embryonic stem cell (ESC) pluripotency.\n3. ESC pluripotency allows ESCs to differentiate into any cell type in the body.\n4. Otx2 is required for the self-renewal of ESCs.\n5. Loss of Otx2 function in ESCs leads to a loss of pluripotency and differentiation of the cells.",
    "vicuna-13b_fact": [
      "Otx2 is a transcription factor involved in the regulation of embryonic development in mammals.",
      "Otx2 is involved in the maintenance of embryonic stem cell (ESC) pluripotency.",
      "ESC pluripotency allows ESCs to differentiate into any cell type in the body.",
      "Otx2 is required for the self-renewal of ESCs.",
      "Loss of Otx2 function in ESCs leads to a loss of pluripotency and differentiation of the cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Otx2 is not required for the self-renewal of ESCs; self-renewal is regulated by a network of transcription factors including Oct4, Sox2, and Nanog.\n5. FALSE [correction]: While Otx2 plays a role in the differentiation of certain cell types, the loss of Otx2 alone does not necessarily lead to a loss of pluripotency and differentiation of ESCs. The regulation of pluripotency and differentiation is a complex process involving multiple factors.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "vicuna-13b_response": "The number of DNaseI hypersensitive sites (DHS) marking the murine beta globin locus region can vary depending on the specific strain of mouse and the conditions used for the experiment. However, in general, the beta globin locus region is known to contain several DHS sites that are recognized by the DNaseI enzyme.\nThe beta globin locus region is a complex genomic region that contains several genes, including the beta globin genes, which encode the beta chains of hemoglobin. The DNaseI hypersensitive sites in this region are typically associated with active transcription, as the region is highly transcribed. The number and distribution of DHS sites in the beta globin locus region can vary depending on the stage of development, cell type, and other factors.\nIn general, the number of DHS sites in the murine beta globin locus region is estimated to be around 20 to 30. However, the exact number of DHS sites in this region can vary depending on the specific strain of mouse and the experimental conditions used.",
    "vicuna-13b_fact_raw": "1. The murine beta globin locus region contains several DNaseI hypersensitive sites (DHS).\n2. The beta globin genes within the murine beta globin locus region encode the beta chains of hemoglobin.\n3. DNaseI hypersensitive sites are typically associated with active transcription.\n4. The number of DHS sites in the murine beta globin locus region is estimated to be around 20 to 30.\n5. The number and distribution of DHS sites can vary depending on the stage of development, cell type, and other factors.",
    "vicuna-13b_fact": [
      "The murine beta globin locus region contains several DNaseI hypersensitive sites (DHS).",
      "The beta globin genes within the murine beta globin locus region encode the beta chains of hemoglobin.",
      "DNaseI hypersensitive sites are typically associated with active transcription.",
      "The number of DHS sites in the murine beta globin locus region is estimated to be around 20 to 30.",
      "The number and distribution of DHS sites can vary depending on the stage of development, cell type, and other factors."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The exact number of DNaseI hypersensitive sites in the murine beta globin locus region is not specified here, and without specific data, it's not possible to confirm the estimate of 20 to 30. The number of DHS sites can vary, but typically a locus like the beta globin locus would have fewer than 20 to 30 DHS sites.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "vicuna-13b_response": "Here is a list of some European influenza vaccines:\n1. Fluarix - manufactured by GlaxoSmithKline\n2. Influvac - manufactured by Sanofi Pasteur\n3. Afluria - manufactured by Seqirus\n4. FluLaval - manufactured by Bio-Rad Laboratories\n5. FluMist - manufactured by AstraZeneca\n6. FluNase - manufactured by Sanofi Pasteur\n7. Fluarix Tetra - manufactured by GlaxoSmithKline\n8. Influvac Tetra - manufactured by Sanofi Pasteur\n9. Afluria Tetra - manufactured by Seqirus\n10. FluLaval Tetra - manufactured by Bio-Rad Laboratories\nIt's important to note that the availability of these vaccines may vary by country and by year, as well as the specific strains included in the vaccine. Additionally, new vaccines may be developed and approved in the future.",
    "vicuna-13b_fact_raw": "1. Fluarix is a European influenza vaccine manufactured by GlaxoSmithKline.\n2. Influvac is a European influenza vaccine manufactured by Sanofi Pasteur.\n3. Afluria is a European influenza vaccine manufactured by Seqirus.\n4. FluLaval is a European influenza vaccine manufactured by Bio-Rad Laboratories.\n5. FluMist is a European influenza vaccine manufactured by AstraZeneca.",
    "vicuna-13b_fact": [
      "Fluarix is a European influenza vaccine manufactured by GlaxoSmithKline.",
      "Influvac is a European influenza vaccine manufactured by Sanofi Pasteur.",
      "Afluria is a European influenza vaccine manufactured by Seqirus.",
      "FluLaval is a European influenza vaccine manufactured by Bio-Rad Laboratories.",
      "FluMist is a European influenza vaccine manufactured by AstraZeneca."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Influvac is a European influenza vaccine manufactured by Abbott, not Sanofi Pasteur.\n3. UNKNOWN\n4. FALSE [correction]: FluLaval is a European influenza vaccine manufactured by GlaxoSmithKline, not Bio-Rad Laboratories.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "vicuna-13b_response": "Yes, the Paramyxovirus genome is segmented, negative-sense RNA. The Paramyxovirus genus is a group of viruses that cause a range of diseases in humans and animals, including measles, mumps, and respiratory syncytial virus. The genome of Paramyxoviruses is segmented, meaning that it is divided into multiple segments of negative-sense RNA.\nNegative-sense RNA refers to the way in which the genetic information is stored in the RNA molecule. In negative-sense RNA, the genetic information is stored in a complementary strand to the messenger RNA (mRNA) that is used for protein translation. This means that the genetic information in negative-sense RNA is complementary to the amino acid sequence of the proteins that are produced from it.\nThe segmented nature of the Paramyxovirus genome is important for the replication and transcription of the virus. Each segment of the genome is replicated and transcribed independently, allowing the virus to produce multiple copies of its genome during infection. This also allows the virus to evolve rapidly, as mutations in one segment of the genome may not affect the function of the other segments.\nOverall, the segmented, negative-sense RNA genome of the Paramyxovirus is a key feature of these viruses and is important for their replication and evolution.",
    "vicuna-13b_fact_raw": "1. The Paramyxovirus genome is segmented.\n2. The Paramyxovirus genome is composed of negative-sense RNA.\n3. The Paramyxovirus genus includes viruses that cause diseases such as measles, mumps, and respiratory syncytial virus.\n4. In negative-sense RNA, the genetic information is stored in a complementary strand to the messenger RNA (mRNA).\n5. Each segment of the Paramyxovirus genome is replicated and transcribed independently.",
    "vicuna-13b_fact": [
      "The Paramyxovirus genome is segmented.",
      "The Paramyxovirus genome is composed of negative-sense RNA.",
      "The Paramyxovirus genus includes viruses that cause diseases such as measles, mumps, and respiratory syncytial virus.",
      "In negative-sense RNA, the genetic information is stored in a complementary strand to the messenger RNA (mRNA).",
      "Each segment of the Paramyxovirus genome is replicated and transcribed independently."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Paramyxovirus genome is non-segmented.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Since the Paramyxovirus genome is non-segmented, it does not have segments that are replicated and transcribed independently. Instead, the entire genome is replicated and transcribed as a single continuous strand.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3869,
    "user_query": "Roflumilast Cream is effective for which disease?",
    "vicuna-13b_response": "Roflumilast Cream is a medication used to treat the symptoms of eczema, a chronic skin condition that causes red, itchy, and inflamed patches on the skin. It is a topical cream that is applied directly to the affected areas of the skin. Roflumilast Cream works by inhibiting the action of certain enzymes that contribute to the inflammation and itching associated with eczema. It is intended for use in adults and children aged 2 years and older.",
    "vicuna-13b_fact_raw": "1. Roflumilast Cream is used to treat the symptoms of eczema.\n2. Eczema is a chronic skin condition that causes red, itchy, and inflamed patches on the skin.\n3. Roflumilast Cream is a topical medication applied directly to the affected skin areas.\n4. The cream works by inhibiting the action of enzymes that contribute to inflammation and itching.\n5. Roflumilast Cream is intended for use in adults and children aged 2 years and older.",
    "vicuna-13b_fact": [
      "Roflumilast Cream is used to treat the symptoms of eczema.",
      "Eczema is a chronic skin condition that causes red, itchy, and inflamed patches on the skin.",
      "Roflumilast Cream is a topical medication applied directly to the affected skin areas.",
      "The cream works by inhibiting the action of enzymes that contribute to inflammation and itching.",
      "Roflumilast Cream is intended for use in adults and children aged 2 years and older."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN\n\nThe correctness of statements 1 and 5 depends on the specific indications and age recommendations for Roflumilast Cream, which may vary and require verification from medical sources or the product's prescribing information. As of my last update, I do not have the specific details regarding the use of Roflumilast Cream for eczema or the age range for its use.",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3885,
    "user_query": "Which tools have been developed for identifying and visualising ncRNA promoters?",
    "vicuna-13b_response": "There are several tools that have been developed for identifying and visualizing ncRNA promoters. Some of these tools include:\n1. HOTSPOTTER: This tool is a web-based software that uses a combination of statistical and bioinformatic approaches to identify potential ncRNA promoters in genomic regions. It can also visualize the predicted promoters in the context of the genomic sequence.\n2. RNAmap: This tool is a command-line program that can be used to identify and visualize the distribution of ncRNAs in the genome. It can also identify potential ncRNA promoters and track the expression of ncRNAs in different cell types.\n3. ncRNA Promoter Finder: This tool is a web-based software that uses a combination of machine learning and bioinformatic approaches to identify potential ncRNA promoters in the genome. It can also visualize the predicted promoters in the context of the genomic sequence.\n4. RNAhybrid: This tool is a command-line program that can be used to identify and analyze ncRNA-protein interactions in the genome. It can also identify potential ncRNA promoters and track the expression of ncRNAs in different cell types.\n5. ncRNA-Promoter Finder: This tool is a web-based software that uses a combination of machine learning and bioinformatic approaches to identify potential ncRNA promoters in the genome. It can also visualize the predicted promoters in the context of the genomic sequence.\nThese are some of the tools that have been developed for identifying and visualizing ncRNA promoters, and they can be used to help researchers better understand the role of ncRNAs in gene regulation.",
    "vicuna-13b_fact_raw": "1. HOTSPOTTER is a web-based software designed to identify potential ncRNA promoters using statistical and bioinformatic approaches.\n2. RNAmap is a command-line program that identifies and visualizes the distribution of ncRNAs and potential ncRNA promoters in the genome.\n3. ncRNA Promoter Finder is a web-based software that employs machine learning and bioinformatic approaches to identify potential ncRNA promoters.\n4. RNAhybrid is a command-line program that can identify ncRNA-protein interactions and potential ncRNA promoters in the genome.\n5. ncRNA-Promoter Finder is a web-based software that uses machine learning and bioinformatic approaches to identify potential ncRNA promoters.",
    "vicuna-13b_fact": [
      "HOTSPOTTER is a web-based software designed to identify potential ncRNA promoters using statistical and bioinformatic approaches.",
      "RNAmap is a command-line program that identifies and visualizes the distribution of ncRNAs and potential ncRNA promoters in the genome.",
      "ncRNA Promoter Finder is a web-based software that employs machine learning and bioinformatic approaches to identify potential ncRNA promoters.",
      "RNAhybrid is a command-line program that can identify ncRNA-protein interactions and potential ncRNA promoters in the genome.",
      "ncRNA-Promoter Finder is a web-based software that uses machine learning and bioinformatic approaches to identify potential ncRNA promoters."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: RNAhybrid is a tool for finding the minimum free energy hybridization of a long and a short RNA. It is not specifically designed to identify ncRNA-protein interactions or potential ncRNA promoters.\n5. UNKNOWN\n\nThe truth value of statements 1, 2, 3, and 5 cannot be determined without additional context or access to information about these specific software tools and their capabilities. The correction for statement 4 is based on the known function of RNAhybrid as per the information available up to the knowledge cutoff date.",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3918,
    "user_query": "List example genes that SWIM tool has identified and which are down-regulated in glioblastoma",
    "vicuna-13b_response": "The SWIM (Sparse Weighted Integrated Matrix) tool is a bioinformatics tool that can be used to identify genes that are differentially expressed in a given dataset, such as a set of glioblastoma samples. Glioblastoma is a type of brain cancer that is highly aggressive and difficult to treat.\nThere are several ways to identify genes that are down-regulated in glioblastoma using the SWIM tool. One approach is to compare the expression levels of genes in a set of glioblastoma samples to the expression levels of the same genes in a control sample, such as normal brain tissue. The SWIM tool can then identify genes that have lower expression levels in the glioblastoma samples compared to the control samples.\nHere are a few examples of genes that have been identified as being down-regulated in glioblastoma using the SWIM tool:\n1. PTEN (Phosphatase and Tensin Homolog): PTEN is a tumor suppressor gene that plays a role in regulating cell growth and survival. Loss of PTEN function has been associated with the development and progression of glioblastoma.\n2. CDKN2A (Cyclin-Dependent Kinase Inhibitor 2A): CDKN2A is a tumor suppressor gene that encodes a protein that inhibits cyclin-dependent kinase activity. Loss of CDKN2A function has been associated with the development and progression of glioblastoma.\n3. PTK2 (Protein Tyrosine Kinase 2): PTK2 is a gene that encodes a protein that plays a role in cell growth and differentiation. Loss of PTK2 function has been associated with the development and progression of glioblastoma.\n4. TP53 (Tumor Protein 53): TP53 is a tumor suppressor gene that plays a role in regulating cell growth and apoptosis (programmed cell death). Mutations in TP53 have been associated with the development and progression of glioblastoma.\nIt's important to note that these are just a few examples of genes that have been identified as being down-regulated in glioblastoma using the SWIM tool, and",
    "vicuna-13b_fact_raw": "1. The SWIM tool can identify genes that are differentially expressed in glioblastoma samples.\n2. PTEN is a tumor suppressor gene that has been identified as being down-regulated in glioblastoma.\n3. CDKN2A is a tumor suppressor gene that has been identified as being down-regulated in glioblastoma.\n4. PTK2 is a gene associated with cell growth and differentiation and has been identified as being down-regulated in glioblastoma.\n5. TP53 is a tumor suppressor gene associated with regulating cell growth and apoptosis, and mutations in TP53 have been linked to glioblastoma.",
    "vicuna-13b_fact": [
      "The SWIM tool can identify genes that are differentially expressed in glioblastoma samples.",
      "PTEN is a tumor suppressor gene that has been identified as being down-regulated in glioblastoma.",
      "CDKN2A is a tumor suppressor gene that has been identified as being down-regulated in glioblastoma.",
      "PTK2 is a gene associated with cell growth and differentiation and has been identified as being down-regulated in glioblastoma.",
      "TP53 is a tumor suppressor gene associated with regulating cell growth and apoptosis, and mutations in TP53 have been linked to glioblastoma."
    ],
    "vicuna-13b_judge_raw": "1. TRUE: The SWIM (SWItchMiner) tool is designed to identify switch genes that are differentially expressed in different conditions, which can include glioblastoma samples.\n2. TRUE: PTEN is a well-known tumor suppressor gene that is often found to be down-regulated or mutated in various cancers, including glioblastoma.\n3. TRUE: CDKN2A is another tumor suppressor gene that is frequently altered in glioblastoma, often through deletion or methylation leading to its down-regulation.\n4. FALSE [correction]: PTK2 (also known as FAK or focal adhesion kinase) is a gene that is generally associated with cell migration and proliferation. In the context of glioblastoma, PTK2 is often found to be up-regulated or overexpressed, not down-regulated.\n5. TRUE: TP53 is a critical tumor suppressor gene involved in cell cycle regulation, DNA repair, and apoptosis. Mutations in the TP53 gene are common in glioblastoma and contribute to the development and progression of the disease.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3926,
    "user_query": "Which R packages have been developed for studying TADs?",
    "vicuna-13b_response": "TADs, or Topologically Associated Domains, are regions of the genome that are associated with specific chromatin structures and are thought to play important roles in regulating gene expression. There are several R packages that have been developed for studying TADs, including:\n1. TAD-seq: This package provides functions for analyzing TAD-seq data, which is a technique used to identify and characterize TADs in the genome.\n2. TADtools: This package provides a suite of tools for analyzing TADs, including functions for identifying TAD boundaries, visualizing TADs, and comparing TADs between samples.\n3. TADgraph: This package provides a graph-based representation of TADs that can be used to analyze the interactions between TADs and other genomic features.\n4. TADb: This package provides a database of TADs for a variety of organisms, including humans, mice, and yeast.\n5. TAD-seqR: This package provides functions for analyzing TAD-seq data and visualizing TADs, as well as tools for comparing TADs between samples.\n6. TAD-enrichment: This package provides functions for identifying enriched TADs in a given sample, such as enriched TADs in a specific cell type or developmental stage.\n7. TAD-discover: This package provides functions for discovering new TADs in a genome, such as identifying TADs that are not present in a reference genome.\n8. TAD-regions: This package provides functions for identifying TAD regions that are associated with specific gene expression patterns or other genomic features.\nThese packages can be used to analyze TADs in a variety of organisms and for a variety of research questions related to TADs and their role in regulating gene expression.",
    "vicuna-13b_fact_raw": "1. TAD-seq is an R package designed for analyzing TAD-seq data to identify and characterize Topologically Associated Domains (TADs) in the genome.\n2. TADtools is an R package that includes functions for identifying TAD boundaries and visualizing TADs.\n3. TADgraph is an R package that offers a graph-based representation of TADs for analyzing their interactions with other genomic features.\n4. TADb is an R package that provides a database of TADs for various organisms, including humans, mice, and yeast.\n5. TAD-seqR is an R package that provides tools for analyzing TAD-seq data, visualizing TADs, and comparing TADs between samples.",
    "vicuna-13b_fact": [
      "TAD-seq is an R package designed for analyzing TAD-seq data to identify and characterize Topologically Associated Domains (TADs) in the genome.",
      "TADtools is an R package that includes functions for identifying TAD boundaries and visualizing TADs.",
      "TADgraph is an R package that offers a graph-based representation of TADs for analyzing their interactions with other genomic features.",
      "TADb is an R package that provides a database of TADs for various organisms, including humans, mice, and yeast.",
      "TAD-seqR is an R package that provides tools for analyzing TAD-seq data, visualizing TADs, and comparing TADs between samples."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN: Without specific information about an R package named \"TAD-seq,\" it is not possible to confirm the accuracy of this statement. TAD-seq is a method for identifying TADs, but whether there is an R package specifically designed for it with that name is not verifiable with the given information.\n2. TRUE: TADtools is indeed an R package that provides functions for the identification of TAD boundaries and visualization of TADs.\n3. UNKNOWN: There is no widely recognized R package named \"TADgraph\" that is known for offering a graph-based representation of TADs. However, without additional context or information, it is not possible to definitively confirm or deny the existence of such a package.\n4. UNKNOWN: The existence of an R package named \"TADb\" that provides a database of TADs for various organisms cannot be confirmed without additional information. While databases for TADs exist, whether there is an R package with this specific name and functionality is unclear.\n5. UNKNOWN: Similar to the first statement, without specific information about an R package named \"TAD-seqR,\" it is not possible to confirm the accuracy of this statement. While tools for analyzing TAD-seq data do exist, the existence of an R package with this exact name offering the described functionalities is not verifiable with the given information.",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3927,
    "user_query": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
    "vicuna-13b_response": "Bioconductor is a widely used open-source software package for computational molecular biology. There are several Bioconductor tools that can be used to access bacterial regulatory networks, including:\n1. Bacillus Regulon DB (BacillusReg): Bacillus Regulon DB is a database of gene regulatory interactions in Bacillus subtilis. It provides a comprehensive and curated collection of regulatory interactions, including information on transcriptional and post-transcriptional regulation.\n2. RegulonBuilder: RegulonBuilder is a tool for constructing gene regulatory networks from microarray data. It can be used to identify transcriptional regulators and predict regulatory interactions based on gene expression data.\n3. PromoterVista: PromoterVista is a tool for analyzing gene promoter sequences and identifying potential regulatory elements. It can be used to identify transcription factor binding sites and predict the regulatory effects of mutations or polymorphisms in promoter regions.\n4. Genetic Regulatory Elements (GREs): Genetic Regulatory Elements (GREs) is a collection of regulatory sequence motifs that are recognized by transcription factors in Bacillus subtilis. It provides a comprehensive and curated collection of regulatory elements, including information on the binding sites and regulatory effects of transcription factors.\nOverall, these Bioconductor tools can be used to access and analyze bacterial regulatory networks, providing valuable insights into the complex regulatory mechanisms that control gene expression in bacteria.",
    "vicuna-13b_fact_raw": "1. Bacillus Regulon DB (BacillusReg) is a database for gene regulatory interactions in Bacillus subtilis.\n2. RegulonBuilder is a Bioconductor tool used to construct gene regulatory networks from microarray data.\n3. PromoterVista is a tool for analyzing gene promoter sequences to identify potential regulatory elements.\n4. Genetic Regulatory Elements (GREs) is a collection of regulatory sequence motifs recognized by transcription factors in Bacillus subtilis.",
    "vicuna-13b_fact": [
      "Bacillus Regulon DB (BacillusReg) is a database for gene regulatory interactions in Bacillus subtilis.",
      "RegulonBuilder is a Bioconductor tool used to construct gene regulatory networks from microarray data.",
      "PromoterVista is a tool for analyzing gene promoter sequences to identify potential regulatory elements.",
      "Genetic Regulatory Elements (GREs) is a collection of regulatory sequence motifs recognized by transcription factors in Bacillus subtilis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: Genetic Regulatory Elements (GREs) are not a specific collection but rather a general term for regulatory sequence motifs recognized by transcription factors in various organisms, not limited to Bacillus subtilis.",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3933,
    "user_query": "What are the end products of the shikimate pathway?",
    "vicuna-13b_response": "The shikimate pathway is a metabolic pathway that occurs in plants, fungi, and bacteria. It is involved in the biosynthesis of aromatic amino acids, such as phenylalanine, tyrosine, and tryptophan, as well as the precursor for the production of the aromatic compound, anthocyanins, which are responsible for the red, purple, and blue colors in fruits and flowers. The end products of the shikimate pathway are aromatic amino acids, anthocyanins, and other aromatic compounds.",
    "vicuna-13b_fact_raw": "1. The shikimate pathway occurs in plants, fungi, and bacteria.\n2. The shikimate pathway is involved in the biosynthesis of aromatic amino acids.\n3. Phenylalanine, tyrosine, and tryptophan are aromatic amino acids produced by the shikimate pathway.\n4. Anthocyanins, which give red, purple, and blue colors to fruits and flowers, are produced through the shikimate pathway.\n5. The end products of the shikimate pathway include aromatic amino acids and other aromatic compounds.",
    "vicuna-13b_fact": [
      "The shikimate pathway occurs in plants, fungi, and bacteria.",
      "The shikimate pathway is involved in the biosynthesis of aromatic amino acids.",
      "Phenylalanine, tyrosine, and tryptophan are aromatic amino acids produced by the shikimate pathway.",
      "Anthocyanins, which give red, purple, and blue colors to fruits and flowers, are produced through the shikimate pathway.",
      "The end products of the shikimate pathway include aromatic amino acids and other aromatic compounds."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Anthocyanins are not produced through the shikimate pathway. They are synthesized via the phenylpropanoid pathway, which is connected to the shikimate pathway through the aromatic amino acid phenylalanine.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3936,
    "user_query": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "vicuna-13b_response": "Nelson's syndrome is a rare condition characterized by the growth of a pheochromocytoma, a type of adrenal gland tumor, in association with a hyperparathyroidism, a condition in which the parathyroid gland becomes overactive and produces too much parathyroid hormone. Cabergoline is a medication that is used to treat hyperprolactinemia, a condition in which the pituitary gland produces too much prolactin, a hormone that stimulates milk production in women. Cabergoline works by decreasing the amount of prolactin produced by the pituitary gland.\nThere is no evidence to suggest that cabergoline is used for the treatment of Nelson's syndrome. The treatment of Nelson's syndrome typically involves surgery to remove the pheochromocytoma and parathyroid gland, as well as medications to manage the symptoms of the condition. If you have been diagnosed with Nelson's syndrome, it is important to work closely with your healthcare team to develop a treatment plan that is appropriate for your specific needs.",
    "vicuna-13b_fact_raw": "1. Nelson's syndrome is characterized by the growth of a pheochromocytoma, a type of adrenal gland tumor.\n2. Nelson's syndrome is associated with hyperparathyroidism, a condition where the parathyroid gland produces too much parathyroid hormone.\n3. Cabergoline is used to treat hyperprolactinemia, a condition where the pituitary gland produces too much prolactin.\n4. Cabergoline decreases the amount of prolactin produced by the pituitary gland.\n5. The treatment of Nelson's syndrome typically involves surgery to remove the pheochromocytoma and parathyroid gland.",
    "vicuna-13b_fact": [
      "Nelson's syndrome is characterized by the growth of a pheochromocytoma, a type of adrenal gland tumor.",
      "Nelson's syndrome is associated with hyperparathyroidism, a condition where the parathyroid gland produces too much parathyroid hormone.",
      "Cabergoline is used to treat hyperprolactinemia, a condition where the pituitary gland produces too much prolactin.",
      "Cabergoline decreases the amount of prolactin produced by the pituitary gland.",
      "The treatment of Nelson's syndrome typically involves surgery to remove the pheochromocytoma and parathyroid gland."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Nelson's syndrome is characterized by the growth of pituitary adenomas, not pheochromocytomas.\n2. FALSE [correction]: Nelson's syndrome is not directly associated with hyperparathyroidism. It is a condition that can occur after the removal of the adrenal glands, leading to the growth of pituitary adenomas that secrete ACTH.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The treatment of Nelson's syndrome typically involves surgery to remove the pituitary adenoma. Pheochromocytomas and the parathyroid gland are not typically involved in Nelson's syndrome.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3939,
    "user_query": "What is the main manifestation of Liebenberg syndrome?",
    "vicuna-13b_response": "Liebenberg syndrome is a rare genetic disorder that is characterized by the presence of multiple cafÃ©-au-lait spots, which are light-brown pigmented skin lesions, and other symptoms. The main manifestation of Liebenberg syndrome is the presence of multiple cafÃ©-au-lait spots, which are typically found on the trunk of the body, but can also be found on the limbs and face. These spots are usually symmetrically distributed and are usually benign, meaning they do not pose any medical risk.\nIn addition to the cafÃ©-au-lait spots, people with Liebenberg syndrome may also have other symptoms, such as nevi (moles), freckles, or other pigmented skin lesions. They may also have a higher risk of developing other pigmented skin conditions, such as melanoma, a type of skin cancer.\nIt is important to note that the presence of cafÃ©-au-lait spots does not necessarily mean that a person has Liebenberg syndrome. The diagnosis of Liebenberg syndrome is made based on the presence of multiple cafÃ©-au-lait spots and other symptoms, such as nevi or freckles, and a thorough examination by a dermatologist or other healthcare provider.",
    "vicuna-13b_fact_raw": "1. Liebenberg syndrome is a rare genetic disorder.\n2. The main manifestation of Liebenberg syndrome is the presence of multiple cafÃ©-au-lait spots.\n3. CafÃ©-au-lait spots associated with Liebenberg syndrome are typically found on the trunk of the body, but can also be found on the limbs and face.\n4. These cafÃ©-au-lait spots are usually symmetrically distributed and benign.\n5. People with Liebenberg syndrome may have a higher risk of developing melanoma, a type of skin cancer.",
    "vicuna-13b_fact": [
      "Liebenberg syndrome is a rare genetic disorder.",
      "The main manifestation of Liebenberg syndrome is the presence of multiple cafÃ©-au-lait spots.",
      "CafÃ©-au-lait spots associated with Liebenberg syndrome are typically found on the trunk of the body, but can also be found on the limbs and face.",
      "These cafÃ©-au-lait spots are usually symmetrically distributed and benign.",
      "People with Liebenberg syndrome may have a higher risk of developing melanoma, a type of skin cancer."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Liebenberg syndrome is characterized by the development of limb malformations resembling those of a winged scapula, not by the presence of multiple cafÃ©-au-lait spots.\n3. FALSE [correction]: Since Liebenberg syndrome is not associated with cafÃ©-au-lait spots, the statement about their location is also incorrect.\n4. FALSE [correction]: This statement is based on the incorrect premise that cafÃ©-au-lait spots are a manifestation of Liebenberg syndrome.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3977,
    "user_query": "List orally bioavailable MPS1 kinase inhibitors",
    "vicuna-13b_response": "MPS1 (mono-ADP-ribosylation factor 1) is a protein that plays a role in cellular metabolism and is involved in the regulation of cell growth and division. Inhibition of MPS1 kinase has been shown to have potential therapeutic effects in various diseases, including cancer. Here are some orally bioavailable MPS1 kinase inhibitors:\n1. S61045: This is a potent and selective MPS1 kinase inhibitor that has been shown to inhibit the growth of cancer cells in vitro and in vivo.\n2. AZD1284: This is a potent and selective MPS1 kinase inhibitor that has been shown to inhibit the growth of cancer cells in vitro and in vivo.\n3. MK-8628: This is a potent and selective MPS1 kinase inhibitor that has been shown to inhibit the growth of cancer cells in vitro and in vivo.\n4. S63845: This is a potent and selective MPS1 kinase inhibitor that has been shown to inhibit the growth of cancer cells in vitro and in vivo.\n5. MK-5686: This is a potent and selective MPS1 kinase inhibitor that has been shown to inhibit the growth of cancer cells in vitro and in vivo.\nIt is important to note that these are just a few examples of MPS1 kinase inhibitors and that there may be others that are orally bioavailable. Additionally, the effectiveness and safety of these inhibitors may vary depending on the specific disease being targeted and the individual patient. Therefore, it is important to consult with a healthcare professional for proper evaluation and treatment.",
    "vicuna-13b_fact_raw": "1. S61045 is an orally bioavailable MPS1 kinase inhibitor.\n2. AZD1284 is an orally bioavailable MPS1 kinase inhibitor.\n3. MK-8628 is an orally bioavailable MPS1 kinase inhibitor.\n4. S63845 is an orally bioavailable MPS1 kinase inhibitor.\n5. MK-5686 is an orally bioavailable MPS1 kinase inhibitor.",
    "vicuna-13b_fact": [
      "S61045 is an orally bioavailable MPS1 kinase inhibitor.",
      "AZD1284 is an orally bioavailable MPS1 kinase inhibitor.",
      "MK-8628 is an orally bioavailable MPS1 kinase inhibitor.",
      "S63845 is an orally bioavailable MPS1 kinase inhibitor.",
      "MK-5686 is an orally bioavailable MPS1 kinase inhibitor."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: S63845 is not an MPS1 kinase inhibitor; it is a selective MCL1 inhibitor.\n5. UNKNOWN\n\nThe correctness of statements 1, 2, 3, and 5 regarding the specificity of the compounds as MPS1 kinase inhibitors cannot be determined without additional context or information. However, statement 4 is false as S63845 is known to be an inhibitor of the protein MCL1, not MPS1 kinase.",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 4031,
    "user_query": "Was golimumab tested for diabetes?",
    "vicuna-13b_response": "Golimumab is a monoclonal antibody drug that is approved for the treatment of various autoimmune diseases, such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It is not specifically approved for the treatment of diabetes.\nThere have been some studies that have explored the potential of golimumab in treating diabetes-related complications, such as diabetic nephropathy (kidney disease) and diabetic retinopathy (eye disease). However, these studies have been limited and have not yet resulted in the approval of golimumab for the treatment of diabetes or its complications.\nIt is important to note that golimumab is a potent immunosuppressive drug that can affect the immune system's response to various diseases, including diabetes. Therefore, it is crucial to closely monitor patients with diabetes who are receiving golimumab therapy and to consult with a healthcare provider regarding any changes in diabetes management that may be necessary.",
    "vicuna-13b_fact_raw": "1. Golimumab is approved for the treatment of various autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.\n2. Golimumab is not specifically approved for the treatment of diabetes.\n3. Studies have been conducted to explore the potential of golimumab in treating diabetes-related complications such as diabetic nephropathy and diabetic retinopathy.\n4. These studies have not resulted in the approval of golimumab for the treatment of diabetes or its complications.\n5. Golimumab is an immunosuppressive drug that can affect the immune system's response to diseases, including diabetes.",
    "vicuna-13b_fact": [
      "Golimumab is approved for the treatment of various autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.",
      "Golimumab is not specifically approved for the treatment of diabetes.",
      "Studies have been conducted to explore the potential of golimumab in treating diabetes-related complications such as diabetic nephropathy and diabetic retinopathy.",
      "These studies have not resulted in the approval of golimumab for the treatment of diabetes or its complications.",
      "Golimumab is an immunosuppressive drug that can affect the immune system's response to diseases, including diabetes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: While golimumab is an immunosuppressive drug that affects the immune system's response to autoimmune diseases, it is not used to treat diabetes, which is primarily a metabolic disorder rather than an autoimmune disease. However, Type 1 diabetes is an autoimmune disease, but there is no specific mention of golimumab being used for its treatment.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 4055,
    "user_query": "Is progeria caused by an autosomal recessive gene?",
    "vicuna-13b_response": "Progeria is a rare, progressive, and fatal genetic disorder that affects children. It is characterized by an appearance that is older than their chronological age, including wrinkled skin, a thin and fragile body, and a small stature. The disorder is caused by a mutation in the LMNA gene, which is located on chromosome 1.\nThe LMNA gene provides instructions for making a protein called lamin A, which is a key component of the cell's inner membrane. The mutation in the LMNA gene that causes progeria leads to the production of an abnormal form of lamin A, which disrupts the structure and function of the cell's inner membrane. This disruption can cause a range of problems, including premature aging and a variety of health issues.\nProgeria is inherited in an autosomal recessive pattern, which means that a person must inherit two copies of the mutated gene (one from each parent) to develop the disorder. If a person has only one copy of the mutated gene, they are a carrier of the disorder and are not likely to be affected. However, if a carrier has a child with a partner who is also a carrier, there is a 25% chance that their child will inherit both copies of the mutated gene and develop progeria.",
    "vicuna-13b_fact_raw": "1. Progeria is a rare, progressive, and fatal genetic disorder that affects children.\n2. The disorder is caused by a mutation in the LMNA gene, which is located on chromosome 1.\n3. The mutation in the LMNA gene leads to the production of an abnormal form of lamin A.\n4. This abnormal form of lamin A disrupts the structure and function of the cell's inner membrane.\n5. Progeria is inherited in an autosomal recessive pattern, requiring two copies of the mutated gene to develop the disorder.",
    "vicuna-13b_fact": [
      "Progeria is a rare, progressive, and fatal genetic disorder that affects children.",
      "The disorder is caused by a mutation in the LMNA gene, which is located on chromosome 1.",
      "The mutation in the LMNA gene leads to the production of an abnormal form of lamin A.",
      "This abnormal form of lamin A disrupts the structure and function of the cell's inner membrane.",
      "Progeria is inherited in an autosomal recessive pattern, requiring two copies of the mutated gene to develop the disorder."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Progeria is not inherited in an autosomal recessive pattern. It is usually caused by a new (de novo) mutation and is inherited in an autosomal dominant pattern, meaning only one copy of the mutated gene is sufficient to cause the disorder.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 4082,
    "user_query": "What are common variants at 12q14 and 12q24 associated with?",
    "vicuna-13b_response": "12q14 and 12q24 are two regions on chromosome 12 that have been associated with various diseases and traits.\n12q14 is commonly associated with cancer, particularly with the development and progression of breast, ovarian, and prostate cancers. It is also associated with schizophrenia, a mental disorder characterized by symptoms such as delusions, hallucinations, and disorganized thinking.\n12q24 is associated with several diseases and traits, including cancer, particularly with the development of leukemia and lymphoma. It is also associated with autoimmune disorders, such as rheumatoid arthritis, and with cardiovascular disease, particularly with the risk of myocardial infarction. Additionally, 12q24 has been associated with type 2 diabetes, as well as with certain traits such as height and body mass index (BMI).\nIt is important to note that the association between these regions and the diseases/traits they are associated with is complex and multifactorial, and further research is needed to fully understand the underlying mechanisms.",
    "vicuna-13b_fact_raw": "1. The 12q14 region on chromosome 12 is associated with the development and progression of breast, ovarian, and prostate cancers.\n2. The 12q14 region is also associated with schizophrenia.\n3. The 12q24 region on chromosome 12 is associated with the development of leukemia and lymphoma.\n4. The 12q24 region is associated with autoimmune disorders, such as rheumatoid arthritis, and with cardiovascular disease, particularly with the risk of myocardial infarction.\n5. The 12q24 region has been associated with type 2 diabetes, as well as with certain traits such as height and body mass index (BMI).",
    "vicuna-13b_fact": [
      "The 12q14 region on chromosome 12 is associated with the development and progression of breast, ovarian, and prostate cancers.",
      "The 12q14 region is also associated with schizophrenia.",
      "The 12q24 region on chromosome 12 is associated with the development of leukemia and lymphoma.",
      "The 12q24 region is associated with autoimmune disorders, such as rheumatoid arthritis, and with cardiovascular disease, particularly with the risk of myocardial infarction.",
      "The 12q24 region has been associated with type 2 diabetes, as well as with certain traits such as height and body mass index (BMI)."
    ],
    "vicuna-13b_judge_raw": "1. TRUE: The 12q14 region on chromosome 12 has been associated with various types of cancer, including breast, ovarian, and prostate cancers, through different studies that have identified genetic alterations in this region that may contribute to the development and progression of these cancers.\n\n2. TRUE: The 12q14 region has been implicated in schizophrenia as well, with some genetic studies suggesting a link between genetic variations in this region and the risk of developing the condition.\n\n3. TRUE: The 12q24 region on chromosome 12 has been associated with hematological malignancies such as leukemia and lymphoma. Genetic studies have identified certain genetic variants in this region that may increase the risk of these diseases.\n\n4. TRUE: The 12q24 region has been linked to autoimmune disorders, including rheumatoid arthritis, and with cardiovascular diseases. Studies have found associations between genetic variants in this region and the risk of myocardial infarction.\n\n5. TRUE: The 12q24 region has also been associated with type 2 diabetes and traits such as height and body mass index (BMI). Genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) in this region that are associated with these conditions and traits.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4096,
    "user_query": "Which are the ligands of the Roundabout (Robo) receptors?",
    "vicuna-13b_response": "Roundabout (Robo) receptors are a family of G protein-coupled receptors that play important roles in various biological processes, including cell migration, cell adhesion, and axon guidance. The ligands of Roundabout (Robo) receptors include:\n1. Slit: Slit is a protein that is found in the extracellular matrix and is expressed in a variety of tissues. It is a ligand for Robo1, Robo2, and Robo3 receptors and plays a role in the regulation of cell migration and axon guidance.\n2. Netrin: Netrin is a protein that is found in the extracellular matrix and is expressed in a variety of tissues. It is a ligand for Robo1, Robo2, and Robo3 receptors and plays a role in the regulation of cell migration and axon guidance.\n3. Cone-rod dystrophy protein: Cone-rod dystrophy protein is a protein that is found in the extracellular matrix and is expressed in a variety of tissues. It is a ligand for Robo1, Robo2, and Robo3 receptors and plays a role in the regulation of cell migration and axon guidance.\n4. Thrombospondin: Thrombospondin is a protein that is found in the extracellular matrix and is expressed in a variety of tissues. It is a ligand for Robo1, Robo2, and Robo3 receptors and plays a role in the regulation of cell migration and axon guidance.\nOverall, Roundabout (Robo) receptors are G protein-coupled receptors that play important roles in various biological processes, including cell migration, cell adhesion, and axon guidance. The ligands of Roundabout (Robo) receptors include Slit, Netrin, Cone-rod dystrophy protein, and Thrombospondin.",
    "vicuna-13b_fact_raw": "1. Slit is a ligand for Robo1, Robo2, and Robo3 receptors.\n2. Netrin is a ligand for Robo1, Robo2, and Robo3 receptors.\n3. Cone-rod dystrophy protein is a ligand for Robo1, Robo2, and Robo3 receptors.\n4. Thrombospondin is a ligand for Robo1, Robo2, and Robo3 receptors.\n5. Roundabout (Robo) receptors are a family of G protein-coupled receptors.",
    "vicuna-13b_fact": [
      "Slit is a ligand for Robo1, Robo2, and Robo3 receptors.",
      "Netrin is a ligand for Robo1, Robo2, and Robo3 receptors.",
      "Cone-rod dystrophy protein is a ligand for Robo1, Robo2, and Robo3 receptors.",
      "Thrombospondin is a ligand for Robo1, Robo2, and Robo3 receptors.",
      "Roundabout (Robo) receptors are a family of G protein-coupled receptors."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Netrin is not a ligand for Robo receptors; it is a ligand for DCC (Deleted in Colorectal Cancer) and UNC5 receptors.\n3. FALSE [correction]: Cone-rod dystrophy protein is not known to be a ligand for Robo receptors. It is associated with a group of eye disorders.\n4. UNKNOWN\n5. FALSE [correction]: Roundabout (Robo) receptors are not G protein-coupled receptors; they are a family of single-pass transmembrane receptors that are important for the development of the central nervous system and are part of the immunoglobulin superfamily.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 4112,
    "user_query": "Is there a role for TFII-I in megakaryopoiesis?",
    "vicuna-13b_response": "TFII-I, also known as transcription factor II-I, is a protein that plays a role in the regulation of gene expression during cellular differentiation and development. While TFII-I has been shown to play a role in the differentiation of several cell types, its role in megakaryopoiesis, the process by which megakaryocytes develop from hematopoietic stem cells, is not well understood.\nSome studies have suggested that TFII-I may be involved in the regulation of genes that are important for megakaryopoiesis, such as the thrombopoietin receptor (MPO) and the platelet-derived growth factor receptor (PDGFR-Î²). Other studies have found that TFII-I is expressed in megakaryocytes and that its depletion can lead to a decrease in the number of megakaryocytes in the bone marrow.\nOverall, while there is evidence to suggest that TFII-I may play a role in megakaryopoiesis, the exact nature of its involvement in this process is not yet fully understood. Further research is needed to determine the specific mechanisms by which TFII-I regulates megakaryopoiesis and the role it plays in the development of megakaryocytes.",
    "vicuna-13b_fact_raw": "1. TFII-I is known as transcription factor II-I.\n2. TFII-I plays a role in the regulation of gene expression during cellular differentiation and development.\n3. TFII-I has been shown to play a role in the differentiation of several cell types.\n4. Some studies suggest that TFII-I may be involved in the regulation of genes important for megakaryopoiesis, such as the thrombopoietin receptor (MPO) and the platelet-derived growth factor receptor (PDGFR-Î²).\n5. Research has found that TFII-I is expressed in megakaryocytes and that its depletion can lead to a decrease in the number of megakaryocytes in the bone marrow.",
    "vicuna-13b_fact": [
      "TFII-I is known as transcription factor II-I.",
      "TFII-I plays a role in the regulation of gene expression during cellular differentiation and development.",
      "TFII-I has been shown to play a role in the differentiation of several cell types.",
      "Some studies suggest that TFII-I may be involved in the regulation of genes important for megakaryopoiesis, such as the thrombopoietin receptor (MPO) and the platelet-derived growth factor receptor (PDGFR-Î²).",
      "Research has found that TFII-I is expressed in megakaryocytes and that its depletion can lead to a decrease in the number of megakaryocytes in the bone marrow."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Some studies suggest that TFII-I may be involved in the regulation of genes important for megakaryopoiesis, such as the thrombopoietin receptor (MPL) and the platelet-derived growth factor receptor (PDGFR-Î²).\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 4145,
    "user_query": "Is atenolol metabolized by CYP2D6?",
    "vicuna-13b_response": "Atenolol is a beta-blocker medication that is commonly used to treat hypertension, angina, and certain types of heart arrhythmias. It is metabolized by several enzymes, including CYP2D6, which is a member of the cytochrome P450 family of enzymes.\nCYP2D6 is responsible for converting atenolol to its active metabolite, which is then further metabolized by other enzymes. The conversion of atenolol to its active metabolite is an important step in the elimination of the drug from the body.\nIt is important to note that the metabolism of atenolol, including its conversion to its active metabolite, can be affected by various factors, such as genetic differences in the CYP2D6 enzyme, other medications that a person is taking, and other health conditions. Therefore, the metabolism of atenolol can vary from person to person, and the effectiveness and safety of the drug may be influenced by these factors.\nIn conclusion, while CYP2D6 is one of the enzymes involved in the metabolism of atenolol, it is not the only enzyme responsible for this process. The metabolism of atenolol can be influenced by various factors, and the effectiveness and safety of the drug may be influenced by these factors.",
    "vicuna-13b_fact_raw": "1. Atenolol is a beta-blocker medication used to treat hypertension, angina, and certain types of heart arrhythmias.\n2. Atenolol is metabolized by several enzymes, including CYP2D6.\n3. CYP2D6 is a member of the cytochrome P450 family of enzymes.\n4. CYP2D6 is responsible for converting atenolol to its active metabolite.\n5. The metabolism of atenolol can be affected by genetic differences in the CYP2D6 enzyme, other medications, and other health conditions.",
    "vicuna-13b_fact": [
      "Atenolol is a beta-blocker medication used to treat hypertension, angina, and certain types of heart arrhythmias.",
      "Atenolol is metabolized by several enzymes, including CYP2D6.",
      "CYP2D6 is a member of the cytochrome P450 family of enzymes.",
      "CYP2D6 is responsible for converting atenolol to its active metabolite.",
      "The metabolism of atenolol can be affected by genetic differences in the CYP2D6 enzyme, other medications, and other health conditions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Atenolol is not significantly metabolized by the liver and does not involve CYP2D6; it is primarily excreted unchanged in the urine.\n3. TRUE\n4. FALSE [correction]: Atenolol does not have an active metabolite; it is active in its original form and does not rely on CYP2D6 for conversion.\n5. TRUE (although the statement about genetic differences in CYP2D6 affecting atenolol metabolism is not accurate, the metabolism of atenolol can indeed be affected by other medications and health conditions, particularly those affecting renal function).",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 4158,
    "user_query": "List versions of ExpansionHunter",
    "vicuna-13b_response": "ExpansionHunter is a software tool that is used to detect and remove unwanted software from a computer system. It is developed by Emsisoft, a German software company.\nHere are the versions of ExpansionHunter that are currently available:\n1. ExpansionHunter 2.31.0.35\n2. ExpansionHunter 2.31.0.34\n3. ExpansionHunter 2.31.0.33\n4. ExpansionHunter 2.31.0.32\n5. ExpansionHunter 2.31.0.31\n6. ExpansionHunter 2.31.0.30\n7. ExpansionHunter 2.31.0.29\n8. ExpansionHunter 2.31.0.28\n9. ExpansionHunter 2.31.0.27\n10. ExpansionHunter 2.31.0.26\nNote: The version numbers may change as new versions of the software are released.",
    "vicuna-13b_fact_raw": "1. ExpansionHunter is a software tool developed by Emsisoft.\n2. Emsisoft is a German software company.\n3. ExpansionHunter version 2.31.0.35 is available.\n4. ExpansionHunter version 2.31.0.34 is available.\n5. ExpansionHunter version 2.31.0.33 is available.",
    "vicuna-13b_fact": [
      "ExpansionHunter is a software tool developed by Emsisoft.",
      "Emsisoft is a German software company.",
      "ExpansionHunter version 2.31.0.35 is available.",
      "ExpansionHunter version 2.31.0.34 is available.",
      "ExpansionHunter version 2.31.0.33 is available."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: ExpansionHunter is not developed by Emsisoft; it is a software tool designed to analyze regions of the genome for repeat expansions, often used in genomic research, and is not associated with Emsisoft.\n2. TRUE\n3. UNKNOWN: Without current version information, it is not possible to verify the availability of ExpansionHunter version 2.31.0.35.\n4. UNKNOWN: Without current version information, it is not possible to verify the availability of ExpansionHunter version 2.31.0.34.\n5. UNKNOWN: Without current version information, it is not possible to verify the availability of ExpansionHunter version 2.31.0.33.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4164,
    "user_query": "What is the role of Adamts18 in hormone receptor signaling?",
    "vicuna-13b_response": "Adamts18 (A Disintegrin and Metalloprotease with Thrombospondin Type 1 Motifs 18) is a protein that plays a role in regulating hormone receptor signaling. It is a member of the ADAMTS (A Disintegrin And Metalloprotease With Thrombospondin Motifs) family of proteins, which are known to be involved in the regulation of various cellular processes, including cell adhesion, migration, and differentiation.\nAdamts18 is expressed in various tissues, including the brain, and it is thought to play a role in the regulation of neurotransmitter release and neuronal plasticity. In the context of hormone receptor signaling, Adamts18 has been shown to regulate the activity of the estrogen receptor (ER), a hormone receptor that plays a critical role in the regulation of various physiological processes, including reproduction and bone health.\nStudies have shown that Adamts18 can interact with the ER and modulate its activity by regulating the proteolytic processing of the ER. Specifically, Adamts18 can cleave the ER protein, leading to its degradation and decreased activity. In this way, Adamts18 acts as a negative regulator of ER signaling, helping to maintain proper levels of ER activity and prevent excessive signaling.\nOverall, the role of Adamts18 in hormone receptor signaling is to regulate the activity of the estrogen receptor and other hormone receptors, thereby helping to maintain proper levels of hormone signaling and prevent excessive signaling that could lead to disease or other adverse effects.",
    "vicuna-13b_fact_raw": "1. Adamts18 is a protein that plays a role in regulating hormone receptor signaling.\n2. It is a member of the ADAMTS family of proteins.\n3. Adamts18 is expressed in various tissues, including the brain.\n4. Adamts18 has been shown to regulate the activity of the estrogen receptor (ER).\n5. Adamts18 can cleave the ER protein, leading to its degradation and decreased activity.",
    "vicuna-13b_fact": [
      "Adamts18 is a protein that plays a role in regulating hormone receptor signaling.",
      "It is a member of the ADAMTS family of proteins.",
      "Adamts18 is expressed in various tissues, including the brain.",
      "Adamts18 has been shown to regulate the activity of the estrogen receptor (ER).",
      "Adamts18 can cleave the ER protein, leading to its degradation and decreased activity."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements regarding Adamts18's specific functions, expression in various tissues, and its interaction with the estrogen receptor (ER) would require specific scientific references to confirm their accuracy. Without the context of the passage or access to current scientific literature, it is not possible to verify these claims.",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4208,
    "user_query": "What is the mode of action of Thiazovivin?",
    "vicuna-13b_response": "Thiazovivin is an antiviral drug that is used to treat hepatitis B and C. Its mode of action is to inhibit the activity of the hepatitis B virus (HBV) and hepatitis C virus (HCV) by targeting the viral replication complex.\nThiazovivin binds to the HBV and HCV RNA and inhibits viral replication by preventing viral RNA transcription and assembly of viral particles. It also inhibits the activity of the viral reverse transcriptase, which is responsible for the reverse transcription of viral RNA into DNA.\nThiazovivin has a unique mechanism of action compared to other antiviral drugs, as it does not target the viral envelope or the viral protease, which are the common targets of other antiviral drugs.\nIt is important to note that Thiazovivin should only be used under the guidance of a healthcare professional, as it can have side effects and interactions with other medications.",
    "vicuna-13b_fact_raw": "1. Thiazovivin is used to treat hepatitis B and C.\n2. Thiazovivin inhibits the activity of the hepatitis B virus (HBV) and hepatitis C virus (HCV).\n3. Thiazovivin targets the viral replication complex of HBV and HCV.\n4. Thiazovivin prevents viral RNA transcription and assembly of viral particles.\n5. Thiazovivin inhibits the activity of the viral reverse transcriptase.",
    "vicuna-13b_fact": [
      "Thiazovivin is used to treat hepatitis B and C.",
      "Thiazovivin inhibits the activity of the hepatitis B virus (HBV) and hepatitis C virus (HCV).",
      "Thiazovivin targets the viral replication complex of HBV and HCV.",
      "Thiazovivin prevents viral RNA transcription and assembly of viral particles.",
      "Thiazovivin inhibits the activity of the viral reverse transcriptase."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Thiazovivin is not used to treat hepatitis B and C; it is a small molecule that acts as a ROCK inhibitor, which is used to improve the survival of human embryonic stem cells.\n2. FALSE [correction]: Thiazovivin does not inhibit the activity of the hepatitis B virus (HBV) and hepatitis C virus (HCV); it is not an antiviral medication but a ROCK inhibitor used in stem cell research.\n3. FALSE [correction]: Thiazovivin does not target the viral replication complex of HBV and HCV; it targets Rho-associated protein kinase (ROCK) which is involved in cell adhesion and survival.\n4. FALSE [correction]: Thiazovivin does not prevent viral RNA transcription and assembly of viral particles; it is involved in enhancing cell survival and adhesion, not in antiviral mechanisms.\n5. FALSE [correction]: Thiazovivin does not inhibit the activity of the viral reverse transcriptase; it is a ROCK inhibitor and does not have activity against viral enzymes.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  }
]